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Mohr syndrome is a rare autosomal recessive disorder belonging to a 
multisystemic and heterogeneous group of diseases called oral-facial-digital 
(OFD) syndromes. OFD comprises 14 clinical subtypes that are characterized 
by congenital defects in the oral cavity, facial structure, and digits. Until now, 
only 6 OFD genes responsible for types (I, IV, VI, XI, XIII and XIV), have 
been identified and the encoded proteins were found to play important roles in 
primary cilia formation and/or function. We ascertained two girls affected 
with Mohr syndrome (OFDII) in a consanguineous Jordanian family. Both 
presented with craniofacial dysmorphisms, clefts of the lip and palate, dental 
abnormalities and digital anomalies indicative of a ciliopathy.  
Following homozygosity mapping and massive parallel sequencing we found 
a homozygous frameshift mutation in the ASUN gene that segregated with the 
disease. This mutation results in the production of a truncated protein in 
patients‟ cells. In Drosophila where asun is crucial for spermatogenesis, this 
human ASUN mutant allele failed to rescue asun null flies, suggesting that it 
behaves as a loss-of -function allele. 
In mammalian cells, we found that ASUN displays ubiquitous localization in 
nucleus, cytoplasm and marks primary cilia. In patient‟s ciliated cells, we 
found that although the frameshift mutation had no effect on primary cilia 
formation in vitro, motile cilia formation was disrupted in patients‟ nasal 
epithelial cells. This suggests that the mutant allele is hypomorphic or 
specifically affects motile cilia formation. 
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In line with this hypothesis, loss of ASUN functions using either RNAi or 
morpholino (MO)-mediated knock-down in both cultured RPE cells and 
animal models lead to defective cilia formation and function. Both zebrafish 
and Xenopus morphant embryos showed developmental delay accompanied 
with motility defects and specific ciliary phenotypes. 
Overall, I conclude that ASUN plays an essential role in cilia formation and 
function and that its biallelic disruption in humans causes Mohr Syndrome. 
The identification of ASUN as a causative gene for OFDII may provide 
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Chapter 1: Introduction 
1.1. Congenital defects 
          The failure to initiate or complete key developmental processes during 
embryogenesis can lead to congenital malformations also referred to as birth 
defects. It is estimated that over 3.3 million children under the age of 5 years 
die every year and around 270,000 newborns die during the first 28 days of 
their life every year (Disease Control Priorities Project (DCP2, 2008), 
Congenital Anomalies WHO, 2012) as a consequence of congenital 
anomalies. Whereas, congenital birth defects are frequent, the underlying 
causes for most of them are still unclear. Around 9 million children are born 
every year with serious congenital defects with estimated birth prevalence 
over 82 per 1,000 in middle- and low-income countries compared to 40 per 
1,000 live births in high-income countries (DCP2, 2008). Congenital 
anomalies are defined as physical and developmental abnormalities affecting 
the body structure or functions that are present before birth, at birth and even 
after birth. These defects can affect one or several organs in the body and can 
also be associated with mental, visual and auditory abnormalities. These 
defects cause adverse effects on embryonic development, health, or functional 
abilities which may lead to a strong impact on the quality of life for infants 
and their parents or even be lethal leading to fetal death or stillbirth. 
Congenital defects can be inherited or can be found as isolated in particular 
pregnancies. Chromosomal abnormalities, single gene defects, environmental 
factors and multifactorial inheritance (genetic and environmental interaction) 
are the major causes of birth defects. It has been reported that around 6% and 
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7.5% of birth defects are caused by chromosomal and single gene defects, 
respectively; 5% to 10% are due to environmental factors (drug or chemical 
exposures during the pregnancy) and 20% to 30% are associated with a 
multifactorial inheritance (Turnpenny and Ellard, 2005).  The causes of the 
majority of congenital anomalies (50% to 70%) remain unknown, while some 
of them could be due to de novo autosomal dominant mutations, uniparental 
disomy or submicroscopic chromosomal deletions (Turnpenny and Ellard, 
2005). Thousands of genetic disorders have been identified so far, with 
multiple congenital malformations and most of them are inherited as 
autosomal recessive or dominant, or X-linked. The rate of autosomal recessive 
disorders is much higher in countries where consanguineous marriages are 
common; at least 20% of general population (DCP2, 2008). This social custom 
also increases the prevalence of unknown congenital disorders in these 
communities. The majority of these disorders are monogenic, caused by single 
gene mutations. Around two thirds of all disease-associated mutations are 
caused by base pair (bp) substitutions. Chromosomal abnormalities including 
deletions, insertions and duplications account for one third and mutations in 
regulatory regions that affect the level of expression of a gene account for only 
1% of known mutations (Krawczak et al., 2000). It was reported that many 
single-gene disorders causing defects in multi-system organ result in a wide 
range of phenotypes with a variable severity that can be correlated to the type 
and the position of the mutation (Coene et al., 2009; Delous et al., 2007; 
Leitch et al., 2008; Valente et al., 2010). The overall birth prevalence of 
disorders due to morphogenesis defects is approximately estimated to 2% to 3 
% of the population (Kalter and Warkany, 1983). Craniofacial anomalies, 
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skeletal dysplasia, congenital heart disease and neural tube defects are among 
the most common congenital anomalies of the fetus or newborn and comprise 
approximately one third of all congenital abnormalities.  
1.1.1. Craniofacial anomalies  
Craniofacial anomalies are a group of deformities affecting facial bones and 
the head (WHO - Craniofacial abnormalities). Orofacial clefts of lip and palate 
are the most common craniofacial malformation. Orofacial clefts have been 
categorized into two groups: (i) Cleft palate only (CPO) and (ii) Cleft lip with 
or without cleft palate (CL/P) and they can be found as unilateral, bilateral, 
median, complete, or incomplete. These anomalies can be found as isolated 
(non-syndromic) anomalies with an estimated incidence of approximately 
1:600 and affecting around 70% of infants with CL/P and approximately 50% 
of CPO (Dixon et al., 2011; Jugessur and Murray, 2005; Mangold et al., 
2011). The remaining percentage, cleft palate and lip can be associated with 
other congenital anomalies including other facial dysmorphisms, oral 
anomalies (tongue, teeth), liver and kidney cysts, heart defects and 
neurological features (central nervous system, mental retardation). The causes 
of orofacial clefts are complex or unknown; some of them are caused by 
multifactorial inheritance or could be only environmental, for example, due to 
a maternal exposure to teratogens or folic acid deficiency during pregnancy.  
1.1.2. Skeletal defects 
Skeletal defects are a group of anomalies affecting the formation and the 
development of the skeleton resulting in abnormalities in the development, 
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growth of bones and cartilage tissues of a baby (Alman, 2008; Ikegawa, 2006). 
The classification of these conditions is based on clinical and radiological 
criteria. The defect in skeleton results in malformation of skull and limbs 
along with various abnormalities in the shape and structure of other skeletal 
structures. Limb defects are characterized by missing, extra, or abnormalities 
in the digits (fingers or toes), malformation of the entire leg, arm, hand, or 
foot, spine, pelvis and thorax. Skeletal anomalies are also frequent among 
birth defects with an estimated prevalence around 2.4/10,000 pregnancy in the 
neonatal period and accounts for 1% to 2% of perinatal deaths, mainly 
stillbirths (Pradhan et al., 2007). Skull abnormalities usually results from 
neural tube defects that may cause abnormalities in the brain, which in turn 
leads to skull developmental defect such as microcephaly. 
Skeletal abnormalities as well as craniofacial anomalies can be found 
separately or as a combination, and potentially associated with other organ 
system defects. These conditions collectively can cause a group of rare 
syndromes known as ciliopathies. The aetiology of these congenital 
syndromes has been shown to be associated with ciliary function and/or 
formation defects resulting in disruption of developmental signaling pathways 
that play an essential role during embryonic development (Adams et al., 2008; 
Baker and Beales, 2009; Brugmann et al., 2010b; Ferkol and Leigh, 2012; 
Fliegauf et al., 2007; Toriello and Parisi, 2009; Waters and Beales, 2011). 
More than 50 ciliary related disorders have been identified so far; however, 
hundreds of diseases are potentially linked to ciliary function are still 
uncharacterized. Examples of ciliopathies include the following syndromes: 
Bardet-Biedl syndrome (BBS, MIM 209900), Meckel syndrome (MKS, MIM 
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249000), Joubert syndrome (JBTS, MIM 213300), Oral-facial digital 
syndrome type I (OFDI, MIM) and IV (OFDIV, MIM), Ellis van Creveld 
(MIM 225500), Jeune asphyxiating thoracic dystrophy syndrome (JATD, 
MIM 208500) Kartagener syndrome (KS, MIM 244400), Alstrom syndrome 
(ALMS, MIM 203800), Polycystic kidney diseases (ADPKD, MIM 173900, 
613095; ARPKD, MIM 263200 ), Primary cilia dyskinesis (PCD, MIM 
242650), Leber Congenital Amaurosis 1 (LCA1, MIM 204000), Short rib 
polydactyly syndrome, type II (SRPII / Majewski syndrome, MIM 263520), 
and others.  
The discovery of the genetic causes of many congenital disorders and the 
knowledge gained about these birth defects played an essential role in 
decreasing the prevalence of these defects and maximizing the number of 
healthy children. A growing number of countries are putting in place policies 
in order to reduce the burden of many common and serious birth defects. 
These policies include education programs, genetic counseling, premarital, 
prenatal and postnatal screening for common recessive disorders, control of 
women‟s diets and regular follow up of pregnant women. These strategies 
have contributed significantly to the decrease of birth defects (March of Dimes 
Global Report, 2006; DCP2, 2008). 
In line with this approach, I undertook to elucidate the genetic aetiology of a 
rare recessive syndrome that was first reported by Otto L. Mohr in 1941 
(Martinot et al., 1994; Toriello, 2009). This disorder, called Mohr syndrome 
belongs to the class of Oral-facial digital syndromes (OFD) causing congenital 
anomalies in craniofacial structures, digits and other organs. Till date, the 
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genetic aetiology of Mohr syndrome has not been determined. This syndrome 
was diagnosed in two patients born to consanguineous parents in Jordan. The 
two affected girls, display similar phenotypes consisting of a constellation of 
craniofacial dysmorphisms (hypertelorism, microcephaly, wild nasal bridge, 
low-set ears, cleft lip and micrognathia); abnormalities in the oral cavity (cleft 
palate, epiglottis anomalies and teeth defects) and digits anomalies 
(polydactyly and clinodactyly). Other marked features include heart defects, 
ear discharge associated with deafness and recurrent respiratory tract 
infections accompanied by chronic cough and other manifestations. The 
observed phenotypes in the two affected girls bear cardinal features of 
ciliopathies, suggesting that the causative gene could be associated to cilia 
biogenesis and or ciliary functions. 
After this brief introduction, I will provide in the next chapter a detailed 
description of cilia structure, biogenesis, function and the most common 
developmental signaling pathways associated with these organelles. At the end 
of this chapter, I will also provide a general overview about ciliopathies 
including OFD and finally give a thorough clinical description of symptoms 
specifically encountered in Mohr syndrome patients. 
1.2. Cilia: a general introduction  
Cilia (or cilium in singular meaning eyelash in Latin) were first observed in 
protozoans by Anthony van Leeuwenhoek in 1679 using light microscope. He 
defined them as little legs or thin feet, which were moving very nimbly (Satir, 
1995). Early research on these organelles were started in 1786 and focused on 
their motility (Satir, 1995). Cilia are ancient structures and highly conserved 
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throughout evolution found in all vertebrates such as mouse, zebrafish, 
chicken or Xenopus. The ciliated  Paramecium and Tetrahymena, the 
nematode Caenorhabditis elegans, Chlamydomonas, Trypanosoma and the 
green algae also are also recognized as ciliary organisms, and have provided 
great insights in cilium biology, with the exception of many fungi, yeast, red 
algae and higher plants, and invertebrates such as Drosophila are not ciliated 
(Ginger et al., 2008; Vincensini et al., 2011a). Since then a lot of research 
using advanced technologies and different model organisms have propelled 
the study of cilium structure and function and confirmed the crucial role of 
these organelles for human biology and developmental disorders. 
1.3. Cilium structure  
Cilia are tiny microtubule-based organelles that extend from the surface of 
almost all cells. Although cilia are found across a wide range of organisms, 
they are ubiquitous only in vertebrates (Fliegauf et al., 2007). Cilia can be 
found in two categories depending on the cell type as either a single (non-
motile) or clusters of multi-cilia (motile) (Figure 1). The structure of cilia is 
conserved and can be subdivided into different compartments that include the 
basal body (BB) (a specialized centriole), the transition zone (TZ), the 
axoneme, the ciliary membrane and the tip. A schematic representation of the 





Figure 1: Schematic representation of a basic cilium structure. A typical cilium 
consists of the basal body (BB), the transition zone (TZ), the axoneme, the ciliary 
membrane and the tip. Both motile and non-motile cilia share common ciliary 
architectures. Motile cilia axonemal cross section (9+2) is composed of nine MT 
doublets (A and B tubules) surrounding two single central MT. Inner and outer 
dynein arms are attached to A-tubules joining to the B-tubules of the next doublet. 
The doublets are connected to each other by nexin links. This cilium also contains 
radial spokes that are projected towards the central pair of MT. However, the central 
MT, the radial spokes as well as the inner and outer dynein arms are absent in the 
non-motile (9+0) axonemal cilia. The BB composed of 9 triplets MT and is docked at 
the cytosolic MT through the basal feet, and it is anchored to the ciliary membrane by 
the transition fibers. The ciliary rootlets extend from the BB into the cytoplasm. The 
TZ is characterized by the presence of Y-links. The cilium is shielded by the ciliary 
membrane, and at the ciliary base a plasma membrane invagination, called the ciliary 
pocket. Adapted from Broekhuis (2013), cross section of axoneme adapted from 




The BB is located at the base of cilia, normally originates from the mother 
centriole and anchors the cilium on the cell surface. Other than the anchoring 
of cilia, BB is required for the correct positioning and orientation of cilia in 
response to fluid flow. Moreover, BB regulates the entry of ciliary proteins 
that are required for cilia biogenesis through the intraflagellar transport (IFT) 
machinery (Stephan et al., 2007). The internal structure of BB is identical to a 
centriole. Therefore it is also known as a specialized centriole. Centrioles are 
cylindrical hollow structures typically consisted of a set of nine triplet 
microtubules (MT) designated as A, B, and C and arranged in a circular 
manner (Figure 1). Pair of centrioles are located perpendicular to each other 
and embedded in an electron-dense pretentious mass called the pericentriolar 
material (PCM) that forms the core of the centrosome and harbors a large 
number of proteins required for MT maintenance, anchoring and nucleation 
(Moser et al., 2010) (Figure 2a). These include PCM-1 and the mother 
centriole subdistal appendages proteins (ninein, centrosomal protein 83 kDa 
(CEP170), end-binding protein 1 (EB1), or EB3 that are involved in MT 
anchoring, whereas γ-tubulin and other associated proteins such as pericentrin, 
polo and aurora kinases are required for MT nucleation. Other proteins such as 
katanin are accountable for releasing MT from the centrosome into the 
cytoplasm (Badano et al., 2005; Blagden and Glover, 2003; Bornens, 2002). 
Cells usually exhibit single centrosome (two centrioles) or two centrosomes 
(two pairs of centrioles) depending on whether they are in G1 or G2 phases of 
the cell cycle, respectively. The centrosome is relatively small (1 µm in 
diameter) and was first described by Theodor Boveri at the end of 19
th
 century 
as a special compartment of cell cycle. The vertebrate centrosome/centrioles 
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are highly organized structure and serve as the cell MT organizing center 
(MTOC) that regulates MT of cytoskeleton and spindle of mitotic cells which 
are required for cell division (Nigg and Raff, 2009). The centrosome plays a 
pivotal role in several cellular processes, including cell motility, polarity, 
adhesion, maintenance the cell shape, vesicles transportation and harbor many 
signaling proteins (Bettencourt-Dias and Glover, 2007; Debec et al., 2010; 
Moser et al., 2010)  
 At the BB, the A and B tubules extend to form the axoneme and the C tubules 
terminate before the axoneme at a region is annotated as the transition zone 
(TZ) (Figure 1). The TZ is located distal to the mother centriole, above the BB 
linking it to the upper part of cilia, the ciliary axoneme, where the triplet MT 
of the BB become more characteristic and convert into doublet microtubular 
structure of the axoneme. The TZ is also characterized by distinct structures 
called transition fibers or alar sheets which are enriched with proteins 
implicated in cilia biogenesis and required for entry of ciliary proteins to the 
cilium. Transition fibers are electron dense fibers that typically originate from 
the distal appendages of mother centriole, and contain several proteins such as 
OFDI (oral-facial-digital syndrome type 1), ODF2 (outer dense fiber 2), 
CEP164 (centrosomal protein 164 kDa), CEP83, SCTL1  and transition fiber 
protein (FBF1) required for the BB docking and anchoring to the cell 
membrane (Ishikawa et al., 2005; Kim and Dynlacht, 2013; Pedersen et al., 
2012; Schmidt et al., 2012). On the other hand centrosomal proteins such as, 
CEP97, CP110 and kinesin family member 24 (Kif24) suppress ciliogenesis 
(Kobayashi et al., 2011; Spektor et al., 2007). TZ is also composed of Y-
shaped linker fibers that anchor the MT in their position to the most proximal 
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region of the ciliary membrane, a protein-rich membrane region called ciliary 
necklace (ciliary pores). This region is likely function as a membrane diffusion 
barrier, regulating the entry of ciliary proteins from the cytoplasm to the cilia 
and vice versa (Garcia-Gonzalo et al., 2011; Omran, 2010). The TZ and BB 
comprise a growing number of proteins which constitute the ciliary gate and 
function as gatekeepers that regulate the ciliary trafficking (Benzing and 
Schermer, 2011; Williams et al., 2011).  
The extracellular part of cilia called the axoneme, which extends from the BB 
and is surrounded by a ciliary membrane. The axoneme structure represents 
the core of cilia and consists of nine doublets MT, A and B MT arrange in a 
circle (Ringo, 1967) (Figure 1). These MT are composed of polymers of α- 
and β- tubulin that undergo posttranslational modifications and rapidly 
growing at one end (plus-end). The other end of MT (minus-end) usually 
anchors at the BB and assemble more slowly, resulting in a directional 
growing of MT toward the ciliary tip. The ciliary tip is the most distal part of 
the cilium that harbors the MT plus-end. The ciliary tip is a highly specialized 
structure, at which the IFT cargo proteins are switched between anterograde 
and retrograde transport. The ciliary tip is enriched with end-binding proteins 
that maintain the axoneme structure by regulating the MT dynamics (Pedersen 
et al., 2012; Sloboda, 2005). 
The extracellular part of cilia is surrounded by a bilayer lipid membrane called 
the ciliary membrane which extends from the plasma membrane of the cell 
and is enriched with many receptors, ion channels and signaling molecules, 
12 
 
suggesting that cilia and flagella function as cellular signaling centers (Berbari 




1.4. Types of cilia 
1.4.1. Motile cilia 
Motile cilia length is ~10-15 μm and normally found as clusters of multi-cilia 
on the epithelial cells of many organs in the body (Figure 2a). The axoneme of 
motile cilia contains, in addition to the A and B tubules, a central pair of MT 
which is found predominantly in these types of cilia; therefore, they are 
defined as (9+2) axonemal cilia. This central pair is important to generate 
force required to induce motility. The doublets MT of motile cilia are attached 
to each other by nexin links and they are fixed in their place along the 
axoneme structure by radial spokes that extend into the central MT pair. The 
outer doublets are also decorated with several protein complexes called inner 
dynein (IDA) and outer dynein (ODA) arms. These motor arms are rigidly 
attached to A tubules that cause sliding of MT over each other by ATP-
dependent reactions, thus regulating their dynamics and they are responsible 
for the circular movement of cilia (Colantonio et al., 2009; Ibanez-Tallon et 
al., 2003; Lindemann and Lesich, 2010; Marshall and Nonaka, 2006).  
1.4.2. Primary cilia  
Primary cilia are highly conserved organelles, found in a single entity on the 
surface of most vertebrate cells (Figure 2b,c). The length of primary cilia 
ranges from 3 to 10 µm. The axoneme of primary cilia is devoid of several 
structural components present in motile cilia such as, the motor structures and 
the central MT pair; therefore they are non-motile and designated as (9+0) 
axonemal cilia.  
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1.4.3. Other types of cilia 
Based on whether the axoneme of cilium has the central MT pair, cilia are 
categorized into motile (9+2) and non-motile (primary) (9+0) cilia. Many 
studies showed an exception to this classification in few cell types. For 
example, motile cilia with axoneme architecture (9+0) which incorporate 
radial spokes and dynein arms can be found in the embryonic node (nodal 
cilia), that generate leftward fluid flow required for left-right asymmetry of 
developed embryo (Hirokawa et al., 2006; Ibanez-Tallon et al., 2003; Nonaka 
et al., 1998; Praetorius and Spring, 2005). However, their motility is different 
from that of motile cilia (McGrath et al., 2003). The photoreceptor connecting 
cilia in the retinal epithelia have a (9+0) axoneme (Figure 2d). The vertebrate 
hair cells in the inner ear are required for hearing and balance. Each of these 
cells consists of a hair bundle comprises of specialized actin-based microvilli, 
known as stereocilia (Figure 2e). The stereocilia are arranged in a staircase-
like pattern and the kinocilium is located adjacent to each bundle. Mature 
kinocilia possesses a (9+2) ultrastructure, while immature cilia have the (9+0) 
but they are not motile (Dabdoub and Kelley, 2005; Muller, 2008; Nayak et 
al., 2007). These cilia play a role in the development and polarity of the 
stereocilia bundle (Montcouquiol et al., 2003). In our olfactory tissues, the site 
of odorants sensation, also have non-motile (9+2) cilia on the olfactory 
sensory neurons (ONS) (McEwen et al., 2008; Moran et al., 1982; Satir and 
Christensen, 2007) (Figure 2f). Interestingly, in many vertebrates, such as 
zebrafish and frogs, they display both „9+0‟ and „9+2‟ cilia (Malicki et al., 
2011; McEwen et al., 2008). 
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Rare structure of motile cilia with „9+4‟ axoneme has been identified in rabbit 
embryos notochordal plate (Feistel and Blum, 2006). Cilia with variable 
axoneme structures can be seen in other organisms such as Caenorhabditis 
elegans and protists expressing non-motile and motile cilia, respectively 





Figure 2: Ultrastructure of different types of cilia. (a-c,e,f) Scanning electron 
microscopy (SEM) and (d) Transmission electron microscopy (TEM). (a) Motile cilia 
in the epithelial cells of trachea. (b) Nodal cilia. (c) Renal primary cilia. (d) 
Longitudinal section of the connecting cilium of a mouse rod photoreceptor cell. CC, 
connecting cilium; IS, inner segment; OS, outer segment. (e) Stereociliary bundle (red 
arrows) with kinocilium (black arrows) and cuticular plate. (f) Olfactory cilia. 
Pictures (a and b) are adapted from http://biodidac.bio.uottawa.ca/search.htm; (c-f) 





1.5. Formation of a cilium 
Cilia are synthesized de novo in cells before emanating to the cell surface and 
in most cells, this occurs more than once during the lifetime of single cell. The 
formation of cilia is known as ciliogenesis, and it is strongly coordinated with 
the cell cycle (Quarmby and Parker, 2005). Cilia normally nucleate and grow 
to the cell surface during G1/G0 phase of the cell cycle. Once mitosis is 
completed, each new cell contains only one centrosome that harbors a single 
pair of centrioles, located perpendicular to each other and in close proximity to 
the surface of the nuclear envelop (Figure 3a). One of these centrioles is called 
the mature (mother) centriole; at which the cilium is extended and the other is 
less mature known as the (daughter) centriole. Cells then enter quiescent state 
(G0) or proceed to G1 phase of cell cycle; during which the centrosome 
migrates to cell surface and cilia are formed. Prior to mitotic cell cycle entry, 
the cilium is gradually resorbed and BB and centrioles are freed. Centrioles 
are then duplicated during S phase and progressively elongated throughout the 
G2 phase. At G2 phase, cells have a pair of centrosomes attached to each 
other, each of them comprising two mature (mother and daughter) centrioles 
surrounding by PCM (Pan and Snell, 2007; Rohatgi and Snell, 2010; Tanos et 
al., 2013) (Figure 3b). Centrosomes are then separate from each other and 
move to the poles of cells during mitosis, to allow for the formation of spindle 
MT. Spindles are required for correct chromosomal segregation and 
downstream mitotic events. When cells complete cell cycle, the mother 





Figure 3: Assembly and disassembly of primary cilia. (a) Scheme of a 
centrosome/centrioles structures. The mammalian centrosome is composed of two 
(mother and daughter) centrioles which are cylindrical in structures each one is 
composed of 9 triplets of MT and connected to each other by rootlet filaments at their 
proximal regions. The mother centriole represents the site of the basal body 
nucleation. It has distal (blue) and subdistal (purple) appendages where MT 
nucleation takes place. The two centrioles are embedded in the pericentriolar matrix 
(PCM). Adapted from (Anderhub et al., 2012). (b) Primary cilia and cell cycle. 
Formation of the primary cilium is coordinated by cell cycle and is assembled and 
completely formed cells in the G0/G1 phase of the cell cycle. As cells prepare for cell 
cycle, the cilium starts to resorb and then duplicates in the S phase of the cycle. The 
old centrioles become mother centrioles associated with newly daughter centrioles 
followed by elongation and maturation of centrioles occurs during the G2/M phase of 
the cycle. During mitosis the mature centrosomes are separated and migrate to the 
poles of the nucleus, an essential step for mitotic spindles assembly. At the end of 
mitosis, two cells are produced each with single centrosome (mother and daughter) 




1.6. Constructing a functional cilium 
The cilium is a compartmentalized structure which is devoid of ribosome. 
Thus, there is no protein synthesis within the ciliary matrix.  Proteins that 
contribute to the formation, function and maintenance of cilia are transported 
from the cell body along the ciliary axoneme toward the tip (anterograde) and 
then back down to the cell body (retrograde), a process mediated by a 
conserved machinery of transport called IFT (Figure 4). IFT was first observed 
by Kozminski in 1993 in the green alga Chlamydomonas. It is composed of 
two MT-associated motor protein complexes called kinesins and dyneins 
(Cole et al., 1998). IFT machinery is well conserved in eukaryotes and is 
indispensable for assembly, disassembly, function and maintenance of cilia 
and flagella, as well its vital role in these organelles for generating signaling 
(Scholey and Anderson, 2006). In the anterograde transport, the cargo of 
proteins derived from Golgi-derived vesicles are loaded onto IFT and then 
attached to a heterotrimeric complex kinesin-II. A kinesin-II complex consists 
of two motor subunits (KIF3A and KIF3B) and a non-motor subunit kinesin-
associated protein (KAP) (Cardenas-Rodriguez and Badano, 2009; Pedersen 
and Rosenbaum, 2008). The IFT particles composed of 2 distinct sub-
complexes IFT-B (involved in anterograde transport) and IFT-A (involved in 
retrograde transport); and each sub-complexes comprises of 14 and 6 protein 
subunits, respectively (Ishikawa and Marshall, 2011; Scholey, 2008) (Figure 
4). Once the kinesin-II motors reach the ciliary tip, the IFT is remodeled, thus 
the proteins cargo is released. The kinesin-II motors become inactive and 
cytoplasmic dynein 2 motors hence are activated, and initiating the retrograde 
transport back to the cilium base, (Lucker et al., 2005; Scholey and Anderson, 
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2006). Cytoplasmic dynein 2 is composed of a homodimeric heavy chain; 
DYNC2-H1, a light intermediate chain; DYNC2LI1, an intermediate chain, 
WDR34, and a light chain, DYNLL (Broekhuis et al., 2013). Many proteins 
that are associated with BBS form a large protein complex called a BBSome, 
that have been shown to be involved in proteins trafficking to the cilium (Jin et 
al., 2010; Nachury et al., 2007). BBSome also corporates with multiple small 
GTPases, such as rab8 and other GTPases to regulate protein passage from 
Golgi vesicles to the cilium and vice versa (Drummond, 2012; Nachury et al., 
2007; Westlake et al., 2011).  
The length of cilia is not fixed and can be modified. After cilia are assembled, 
they undergo continuous growing and turnover at their tips. This dynamic 
process depends on the balance between the anterograde and retrograde 
transport, modification of mictrobular axoneme and other structural proteins 
such as TCTN1, TCTN3 and MKS proteins that reside at the TZ (Broekhuis et 
al., 2013). Impairment of their function may cause Meckel and Joubert 
syndromes which are associated with shortened cilia. Mutations in many 
nephronophthisis (NPHP) proteins result in elongation of primary cilia (Patzke 
et al., 2010). Conversely, components of IFT-A complex, a centrosomal 
protein Nde1 and many proteins involved in deacetylation of ciliary axoneme, 
depolymerization of MT and polymerization of actin filaments, all negatively 
regulate cilia length (Kim and Dynlacht, 2013). In addition, several regulatory 
proteins (e.g. mitogen-activated protein (MAP) kinases, NIMA-related 
kinases, cyclin-dependent protein kinase (CDK)-related kinase, aurora-like 
kinases, and GSK3) (Malicki et al., 2011) have been identified  to affect cilia 





Figure 4: Cilia structure and the intraflagellar transport (IFT). A typical cilium 
consists of an axoneme of nine doublets MT extend from the basal body MT triplets. 
The axoneme is surrounded by a ciliary membrane that is separated from the cell 
membrane by a zone of transition fibers. Ciliary assembly and maintenance is 
achieved by IFT, which consists of IFT particles (protein sub-complexes: IFT-A and 
IFT-B and are possibly associated with the BBSome which coat the IFT particles). 
BBSome regulates vesicle trafficking from post-Golgi vesicles through the interaction 
with Rab8. The MT motor proteins kinesin 2 and cytoplasmic dynein-2 move the IFT 
particles and their associated cargo up and down the length of the cilium. Adapted 





1.7. Function of cilia 
The major function of cilia is motility, which is predominantly attributed by 
motile cilia. Motile cilia are found in clusters with large numbers on the 
surface of many cells in the body, and they beat in a coordinated fashion 
resulting in cellular movement and fluid flow generation. They line the upper 
and lower respiratory system (trachea and bronchial tubules) where they are 
required for mucus clearance. They are also found to be enriched on the 
ependymal surface of the brain and responsible for cerebrospinal fluid 
movement.  Furthermore, motile cilia are located on the epithelial cells lining 
the fallopian tube of the female reproductive system; carrying the ova along 
the female reproductive tracts (Johnson et al., 2008). Likewise, they are 
expressed on the epididymis of male reproductive system, which serve as 
absorptive function (Davenport and Yoder, 2005). The sperm is also 
considered a specialized cilium with (9+2) architecture that confers motility 
(Satir and Christensen, 2007). 
In contrast to motile cilia, primary cilia are found virtually on most cells in our 
body as a single cilium. Currently, a primary Cilia Resource Site 
(http://www.primary-cilium.co.uk/) has developed, listing the cell types 
known to possess primary cilia.  They are found on epithelial cells such as the 
liver cholangiocytes that line the bile duct (Masyuk et al., 2008), the kidney 
tubules (Praetorius and Spring, 2005), the endocrine cells of the Langerhans 
islets and ductal epithelia, the pancreas (Cano et al., 2004), mammary gland 
(McDermott et al., 2010) and the thyroid. Non-motile cilia are also present on 
non-epithelial cells such as fibroblasts, neurons, endothelial cells of the 
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cardiovascular system(Geerts et al., 2011), Schwann cells (Satir and 
Christensen, 2007), osteocytes and chondrocytes (Jensen et al., 2004; 
Whitfield, 2003). primary cilia were proposed to be vestigial structures in 
these cells and tissues; however, this thought has changed in the beginning of 
this century (Veland et al., 2009).  
Non-motile cilia are sensory organelles which have also been shown to play a 
role in mechanosensation. For example, polycystic kidney disease proteins 
complex (PKD1 and PKD2) in renal tubular primary cilia regulates the 
intracellular calcium (Ca
+2
) level which in turn modulates the downstream 
signaling pathways in response to fluid flow (Basten and Giles, 2013). In 
addition, non-motile cilia function as chemosensing organelles. For example, 
sensing of light through the specialized cilia in photoreceptor cells (retinal-
connecting cilium) (Insinna and Besharse, 2008). In pancreatic cells, they 
potentially play a significant role in chemosensing (Cano et al., 2004). In 
addition, sounds vibrations by kinocilia and stereocilia as well as smell 
sensation by olfactory sensory neurons (Snell et al., 2004). The sensory 
function of cilia has also been established in motile cilia (Shah et al., 2009). 
For example, the angiopoietin receptors (Tie-1 and Tie-2), progesterone 
receptor, PKD1 and PKD2 as well as a transient receptor potential vaniloid 4 
channel (TRPV4) localize to motile cilia of mammalian oviduct (Pedersen et 




1.8. Cilia and left-right determination 
In vertebrates including human, the external body plan show bilaterally 
symmetry of many of structures, such as eye, ear and limb and clear left-right 
asymmetry in the position of internal organs. They are normally placed 
between the left and right (LR) side of the body including heart, spleen and 
pancreas lie to left side and the liver always located to the right. This normal 
pattern of sidedness called situs solitus which is evolutionary conserved 
throughout vertebrates and controlled by the activity of motile and non-motile 
primary cilia in the embryonic node (McGrath et al., 2003). Disruption of 
symmetry during embryonic development leads to complete randomization of 
body axis referred to situs inversus or partial defect of organs positioning 
denoted heterotaxy. Interestingly, the link between cilia and asymmetries in 
LR was first described in 1976 in patients with KS, presented with situs 
inversus in about half of patients and respiratory dysfunction as a result of 
defective cilia in their airway (Afzelius, 1976). In mice embryos with 
mutations in ciliary proteins Pkd-1 (polycystin-1) and Pkd-2 cause LR defects 
(Nauli et al., 2003). Likewise, lacking of ciliary kinesins (Kif3a and Kif3b), 
and OfdI caused absent of nodal cilia and failure of LR asymmetries 
specification (Ferrante et al., 2006; Hirokawa et al., 2006; Nonaka et al., 1998; 
Takeda et al., 1999). 
The LR asymmetry in vertebrates occurs very early during embryonic 
development and depends on the leftward fluid flow in the node. In humans 
and chick, as well as mouse embryos, the node represents the site of the 
organizer located at the anterior end (the tip) of the primitive streak during 
gastrulation. The primitive streak defines the dorso-ventral axis. The ventral 
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part of the node is covered with cilia rotating clockwise and generating 
leftward fluid flow called (nodal flow) (Essner et al., 2002; Hirokawa et al., 
2006; McGrath and Brueckner, 2003).  Similarly, in Xenopus the gastrocoel 
roof plate (GRP) (Schweickert et al., 2007) and zebrafish Kupffer‟s vesicle 
(KV) (Essner et al., 2005) embryos are equivalent to the mammalian node. 
These structures express motile primary cilia that are required for the 
establishment of LR patterning. This nodal flow results in activation of Nodal 
signaling pathway at the left side of the node. TGFβ family proteins (Nodal 
and Lefty) and the transcription factor Pitx2 play significant roles in the 
initiation of LR asymmetry. The mechanism of transmission is still unclear, 
but it is known that the fibroblast growth factor (FGF), Wnt, Hedgehog (HH), 
Bone morphogenetic protein (BMP) and Notch pathways regulate the activity 
of Nodal (Hirokawa et al., 2006; Okada et al., 2005; Raya and Izpisua 
Belmonte, 2006; Shiratori and Hamada, 2006). 
1.9. Cilia as developmental signaling centers  
The ubiquity of primary cilia on the surface of a wide variety of organs and 
tissues including those derived from the three germ layers, argues that they 
may have a central role in the development of organs and tissues. Cilia serve 
as hubs for a variety of developmental signaling pathways implicated in 
organogenesis, skeleton and craniofacial structure development as well as 
tissue homeostasis (Berbari et al., 2009). For example, sonic hedgehog 
signaling (Shh) (Haycraft et al., 2005; Rohatgi et al., 2007; Siggins et al., 
2009); Wnt signaling (Corbit et al., 2008; Rohatgi et al., 2007; Siggins et al., 
2009); platelet-derived growth factor (PDGF) signaling (Schneider et al., 
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2005); FGF (Hong and Dawid, 2009; Tanaka et al., 2005), notch (Ezratty et 
al., 2011; Marcet et al., 2011) and others (Figure 7). 
1.9.1. Sonic hedgehog signaling (Shh) 
The Hh pathway was first identified in Drosophila (Nusslein-Volhard and 
Wieschaus, 1980). The vertebrate hedgehog family comprises 3 members: 
Sonic hedgehog (Shh), Indian hedgehog (Ihh), and Desert hedgehog (Dhh). 
Shh signaling pathway is the most widely studied Hh pathway and it plays a 
critical role during embryonic development and it is importance extends into 
adulthood. Shh signaling components Smoothened (Smo), Patched1 (Ptch1), 
Suppressor of fused (Sufu) and the Gli transcription factors (Gli1, Gli2, and 
Gli3), localize to the  primary cilium and play a critical role in patterning of 
several organs such as lung, gut, teeth, hair follicle and limb bud where it is 
essential for specifying the number and identity of digits. Shh signaling is also 
essential for patterning craniofacial structures, the neural tube and brain 
(Drummond, 2012; Eggenschwiler and Anderson, 2007; Goetz and Anderson, 
2010; Michaud and Yoder, 2006; Nozawa et al., 2013). Mutations in any of 
these components lead to a plethora of congenital abnormalities such as 
polydactyly, hypertelorism, cyclopia (fused brain structure) and clefts of lip 
and palate (Lipinski et al., 2010). Moreover, mutations in many of ciliary 
genes such as Ift122, Kif3a, Ift88,Ift172, Ofd1 and many others cause 
patterning defects in the limb, neural tube, and hair follicle that are 
characteristic of aberrant Shh signaling (Eggenschwiler and Anderson, 2007; 
Goetz and Anderson, 2010; Huangfu and Anderson, 2005; Huangfu et al., 
2003; Sharma et al., 2008).  
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Shh is also implicated in the development of different kinds of cancers (Al-
Halabi et al., 2011; Chari and McDonnell, 2007; Pasca di Magliano and 
Hebrok, 2003; Song et al., 2011). Shh signaling pathway is conserved from 
flies to mammals. In brief, Hh signaling pathway is initiated by binding of Hh 
ligands to the transmembrane receptor, Ptch1 that is localized at the cilia base 
and axoneme (Rohatgi et al., 2007) and works as negative regulator of the 
pathway by inhibiting the activation of another transmembrane protein 
Smoothened (Smo) in the absence of Hh ligand. Once Hh ligand bound to Ptch, 
the Smo becomes active and accumulates at the ciliary membrane. 
Consecutively, active Smo will activate the Gli transcription factors (GliA) 
that is normally inhibited by the Sufu protein. GliA then transfers to the 
nucleus and initiates transcription of downstream Hh genes. In the absence of 
Hh ligand, Ptchs inhibit Smo to transduce the signal, consequently, the Gli 
transcription factors are proteolytically processed to a repressor forms (GliRs) 
that keep the Hh pathway switched off (Corbit et al., 2005; Rohatgi et al., 
2007; Wilson and Stainier, 2010). Figure 5 outlines the mechanism of the Shh 
transduction pathway. 
Dhh is expressed in neuronal compartments and testes, where it is essential for 
the development of testis, spermatogenesis and external genitalia (Bitgood et 
al., 1996; Zou et al., 2012). Ihh has been found in the mesenchymal cells 
around the eye (Wallace and Raff, 1999), in the osteocytes and the 
chondrocytes where it is needed for cartilage and bone growth including the 
axial, appendicular and facial skeleton (Hilton et al., 2005; Pan et al., 2013). 
All Hh members bind to the same receptor (Ptch1) and they have similar 




Figure 5: The mechanism of the Shh transduction pathway. (a) In the absence of 
Shh ligand, Ptch1 enriched in primary cilium and prevents Smo from entering the 
cilium. Sufu is localized to the tip of the cilium and Kif7 is localized to the base of 
cilium, both contribute to the inhibition of the pathway. The repressor forms of the 
Gli proteins (GliR) inhibit transcription of downstream Hh target genes. (b) In the 
presence of Shh ligand, Ptch1 moves out of the cilium and targeting of Smo into the 
cilium. Smo and Kif7 inhibit the Sufu resulting in proteasomally processing of Gli 
proteins into their activator (GliA) isoforms, activating transcription of Hh targets. 




1.9.2. Wnt signaling  
The Wnt signaling pathway like the Shh pathway is a primordial pathway 
during development that regulates embryonic cell migration, stem cell renewal, 
cell polarity, cell patterning, cell fate determination, cell survival and 
apoptosis (Hari et al., 2002; Li et al., 2006; Pecina-Slaus, 2010). Wnt pathway 
is also essential for the patterning of body axis and the development of 
cardiovascular and central nervous system and other organogenesis including 
ear, craniofacial structures, limb bud, and kidney (Li et al., 2006; Patapoutian 
and Reichardt, 2000; Wang et al., 2011). 
Traditionally, Wnt pathway is divided into 2 evolutionarily conserved 
branches; a canonical (Wnt/β-catenin dependent) pathway and a non-canonical 
(β-catenin independent) pathway which can be further divided into a Planar 





pathways. These pathways are usually induced through the activation of a 
cytoplasmic phospho-protein Dishevelled (Dsh/Dvl) by binding of Wnt 
proteins to Frizzled (Fz) receptors and the Low Density Lipoprotein (LDL) 
receptor-related proteins (Lrp5/6), both are localized to the ciliary membrane. 
In the canonical pathway, Dvl controls the activity of β-catenin by 
destabilizing the destruction complex, that consists of β-catenin, casein kinase 
I (CKI), adenomatous polyposis coli (APC), axin 1 and glycogen synthase 
kinase 3β (GSK3β). The β-catenin then released from the complex and 
translocates to the nucleus which serves as a transcriptional co-regulator 
interacting with transcription of T cell factor (TCF)/lymphocyte enhancer 
factor (LEF) to activate downstream target genes (Gerdes and Katsanis, 2008; 
Komiya and Habas, 2008; Reya and Clevers, 2005; Veland et al., 2009; Vlad 
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et al., 2008; Widelitz, 2005). In contrast, in the absence of Wnt ligand, the 
inhibition of destruction complex by Dv1 no longer exists, the cytoplasmic β-
catenin then is captured in the destruction complex and becomes 
phosphorylated by GSK3β, which in turn is targeted for degradation by the 
proteasome (Saito-Diaz et al., 2013). The canonical pathway was shown to be 
negatively regulated by the Wnt/PCP and Wnt/Ca
+2 
in ciliated cells (Basten 
and Giles, 2013). 
In non-canonical pathway (PCP), binding of Wnt with FZ receptors, recruits 
Dvl to the plasma membrane resulting in activation of small GTPases such as 
Rho, Rac, and Cdc42 which have a direct role on the cytoskeleton 
organization and docking of basal bodies for cilia formation (Matthews et al., 
2008; Pan et al., 2007). Additionally, PCP controls cell polarity that is 
responsible for the correct orientation of cells within a tissue such as 
convergent extension (CE) (movement of cells during gastrulation, necessary 
for establishing the germ layers and body axis) through the activation of JNK 
pathway (Kim and Han, 2005; May-Simera and Kelley, 2012; Yamanaka et 
al., 2002; Ybot-Gonzalez et al., 2007). Figure 6, describes the mechanism of 
the Wnt signaling pathways.  
PCP proteins have been shown to localize at primary cilia and play a role in 
ciliogenesis (Jones and Chen, 2007). PCP is also implicated in organization 
and orientation of the mitotic spindle, stereocilia in the inner ear (Gong et al., 
2004; Kelly and Chen, 2007), cilia on the reproductive, respiratory tracts, 
kidney tubular epithelial cells, neural crest migration as well as controlling the 
patterns of hair follicles on the skin of mammals.  
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Disruption of PCP in mouse causes shortened body axis and failure to close 
the neural tube as a result of a defective of CE, craniofacial dysmorphisms, 
open eye lid and disturbance of the stereociliary hair bundles in cochlea 
(Badano et al., 2006; Jones et al., 2008; Ross et al., 2005; Simons et al., 2005). 
Mutation in PCP genes such as Inversin (Inv) causes inversion of LR 
asymmetry and severe renal cysts formation (Simons et al., 2005). A recent 
study showed that disruption of PCP signaling in mouse causes limb 
morphogenesis and skeletal defects (Wang et al., 2011). Similar PCP-related 
defects were observed in zebrafish and Xenopus ciliary mutants (Ferrante et 





Figure 6: Overview of canonical and non-canonical Wnt signaling pathways. (a) 
The absence of the Wnt ligand, the destruction complex (Axin, APC, and GSK3β) 
promotes the β-catenin phosphorylation and targeting it for degradation. The Wnt 
targeted genes are then repressed by TCF/LEF. In the canonical pathway, binding of 
Wnt to Frizzled (Fz) receptor and Lrp5/6, activates cytoplasmic Dvl. Dvl then recruits 
Axin to the plasma membrane, inhibiting the β-catenin degradation by destruction 
complex resulting in β-catenin stabilization. The β-catenin then translocates to 
nucleus and interacts with TCF/LEF to activate transcriptional of target genes. In 
non-canonical signaling, Dvl recruits to the plasma membrane and activates 
downstream targets. (b) Effects of ciliary and basal body disruption on Wnt signaling. 
The canonical pathway is also activated and suppressed by the primary cilia. In 
ciliated cells, this pathway is repressed by the noncanonical pathway resulting in β-
catenin degradation and membrane targeting of Dvl. In non-ciliated cells or 
ddisruption of ciliary or basal body components, canonical Wnt signaling stabilizes 
cytoplasmic β-catenin and Dvl, leading to increased nuclear levels of both Dvl and β-
catenin, initiating transcription of TCF/LEF1-responsive genes. Adapted from 




1.9.3. Other signaling pathways coordinated by cilia 
In addition to HH and Wnt signaling pathways, primary cilia coordinate 
different branches of receptor tyrosine kinase (RTK) signaling transduction 
pathways such as platelet-derived growth factor receptor-α (PDGFRα) 
signaling cascade (Figure 7). This pathway is linked to primary cilia in 
fibroblast at G0 phase to promote cell cycle entry and progression, fibroblast 
migration, proliferation and apoptosis and its role in wound healing 
regeneration (Christensen et al., 2012; Schneider et al., 2010). Binding of 
PDGFRα ligand with receptors results in activation of the Akt and the 
MEK1/2-ERK1/2 (mitogen-activated protein kinase kinase-extracellular signal 
regulated kinase) pathways (Schneider et al., 2005). PDGFRα signaling plays 
a vital role in gastrulation and in the development of variety of organs and 
tissues such as neural crest cells formation, lung, intestine, teeth, gonads, skin, 
central nervous system (CNS), and skeleton (Andrae et al., 2008). Moreover, it 
provides a link between cilia and different types of tumors (Mans et al., 2008). 
FGF is another pathway with links to cilia through binding of a family of 
RTKs called fibroblast growth factor receptors (FGFR 1-4) (Christensen et al., 
2012; Eswarakumar et al., 2005) (Figure 7). This signaling pathway plays 
multiple pivotal roles in both vertebrates and invertebrates development; 
regulating cell proliferation, differentiation and migration. FGFs comprise a 
large group of genes that are expressed during early embryonic development 
and play dynamic roles in patterning of the nervous system, limb outgrowth 
and craniofacial development, development of eye, ear, heart, palate, teeth and 
salivary glands (Marques et al., 2008; Nakayama et al., 2008; Nie et al., 2006; 
Pirvola et al., 2000). FGF also works as a morphogen in the embryonic node 
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that is involved in the establishment of LR asymmetry in mice and zebrafish 
embryos (Tanaka et al., 2005; Yamauchi et al., 2009). In addition, FGF 
pathway activates several downstream signaling pathways such as p38 
mitogen-activated kinases, extracellular signal-regulated kinase (ERK), 
phospholipase C gamma, protein kinase C (PKC) and phosphatidylinositol 3-
kinase (PI3K) (Maffucci et al., 2009; Mason, 2007). 
Furthermore, FGF is involved in the regulation of cilia biogenesis, function 
and length in zebrafish and Xenopus through the regulation of many ciliary 
genes (Neugebauer et al., 2009). Knock-down of FGFR2, FGF8 and FGF24 
causes shortened cilia and perturbation of nodal fluid flow (Neugebauer et al., 
2009). Likewise, disruption of FGF signaling is associated with CLP, skeletal 
and neurological defects in a variety of human diseases such as 
craniosynostosis (Kimonis et al., 2007) and skeletal dysplasia syndromes, 
Kallmann syndrome (KS) (Dode et al., 2003; Kim et al., 2005; Riley et al., 
2007) and Apert syndrome (Riley et al., 2007; Slaney et al., 1996). Other 
RTKs have also been linked to cilia and play essential events in cell cycle, 
migration and differentiation including epidermal growth factor receptor 
(EGFR), insulin-like growth factor receptor (IGFIR) and the angiopoietin 
receptor (Tie-2) (Christensen et al., 2012).  
Notch signaling is another signaling pathway involved to control cilia function 
(Figure 7). Notch signaling is well studied in vertebrates and invertebrates, is 
essential for embryonic development, where mutations in this pathway lead to 
defects in several organs and tissues such as the heart, kidney, limb, rib, and 
the craniofacial structures (Iso et al., 2003). Recent studies have demonstrated 
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the link between Notch and cilia in vertebrates. Notch signaling is important 
for cell fate determination and differentiation of many cell types such as the 
multi-ciliated cells in skin and respiratory and tubular epithelial cells (Ezratty 
et al., 2011; Liu et al., 2007; Marcet et al., 2011). Notch regulates the cilia 
length which is essential for establishment of LR asymmetry, as the up-
regulation of Notch leads to longer cilia, whereas the down-regulation of the 
pathway leads to shorter cilia in the embryonic node (Lopes et al., 2010). 
 
Other biochemical signaling transduction pathways have also been shown to 
be modulated by primary cilia such as the Hippo signaling (Habbig et al., 
2011), phosphatidylinositol signaling (Conduit et al., 2012), mTOR (Bell et al., 
2011; Boehlke et al., 2010), neuronal signaling receptors include G protein-
coupled receptors (GPCRs) such as somatostatin receptor 3 (SSTR3), 5-
HT6 serotonin receptor, Jouberin (AHI1) and melanin-concentrating hormone 
receptor 1 (MCHR1) and their downstream signaling cascades (Berbari et al., 
2008a; Berbari et al., 2008b; Pedersen et al., 2012).  
Primary cilia also harbor other chemosensory signaling receptors in renal 
epithelial cells to regulate ion channels function include vasopressin receptor 
(V2R), GPCRs e.g. purinergic (P2Y and P2Y) receptors, Tie-1 and Tie-2 
receptors and a variety of other signaling receptors e.g. Transient receptor 
potential vaniloid 4 channel (TRPV4) that have osmo-, thermo-, chemo-, and 
mechano-sensory functions in many tissues (Figure 7). The defects of these 
receptors cause e.g. cystic and fibrotic liver diseases (Christensen et al., 2007; 





Figure 7: Brief overview of different signaling pathways through cilia. The 
polycystin multiprotein (PKD2)/PKD1/PKHD1) complex serves as a regulator of 
mechanosensation of cilia, regulates the intracellular Ca
2+
 levels and other specific 
signal transduction pathways (MEK/ERK and mTOR). Cilia also possess other ion 
channels such as TRPV4 and purinergic receptors P2X and P2Y that plays role in 
osmo-, thermo-, chemo-, and mechano-sensation. Additional signaling cascades 
implicated at the cilium include, the extra-cellular matrix (ECM) receptors which play 
role in mechanosensation and GPCRs (Sstr3, Mchr1, 5-HT6) signaling that mediates 
neurotransmission and neuronal regulation. Other signaling at least partly regulated 
through the cilium including TGFβ and Notch and Hippo-signaling. PDGFRα 
signaling through their receptors in cilium leads to the activation of two pathways: the 
Akt and the MEK1/2-ERK1/2 pathways. In addition to PDGFRα other receptors 
including IGF-1, EGFR and FGFR also regulate the RTK signaling. This figure was 
created by me according to all published ciliary signaling pathways. I collected these 




1.10. The ciliary proteome 
A paradigm shift has occurred during the last decade in the field of cilia 
biology with the initiation of repertoires of ciliary proteins derived from 
different species thus defining the ciliary proteome 
(http://v3.ciliaproteome.org/cgi-bin/) or ciliome (www.sfu.ca). These 
databases contain more than 2700 different ciliary proteins (Fliegauf and 
Omran, 2006; Gherman et al., 2006; Inglis et al., 2006). Recently, new 
databases have been further developed such as a centrosomal proteomic 
database: centrosome:db (www.centrosome.dacya.ucm.es) and more extensive 
database: Cildb (www.cildb.cgm.cnrs-gif.fr), that contains the proteomes of 33 
different species, each relevant protein is linked to human diseases 
information OMIM database and to the reported high throughput ciliary 
studies  (Arnaiz et al., 2009; Nogales-Cadenas et al., 2009). These databases 
are available as a freely accessible online resource. New proteomic 
information has also been generated from the proteomic analysis of cilia of 
specific organisms and tissues for example, the Chlamydomonas reinhardtii 
flagellar phosphoproteome and the rat olfactory sensory neurons cilia 
proteome (Boesger et al., 2009; Mayer et al., 2009). These resources will 
provide valuable information that may help to further understanding of the 
molecular composition of cilia and their role in the development of disorders.  
The same ciliary protein has been found to be mutated in more than one type 
of ciliopathy. This may explain the phenotypic overlap, variability and 
severity within ciliary diseases which have been explained by genetic and 
physical interactions between ciliary proteins that share a ciliary localization. 
Using proteomic techniques such as mass spectrometry, comparative genomic 
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or transcriptional profiling and bioinformatics resulted in identification of 
several protein complexes (Boldt et al., 2009) such as BBSome complex 
(Nachury et al., 2007), Usher network (Richardson et al., 2011), NPHP-MKS-
JS proteins (Sang et al., 2011), central spindle/midbody complex (Smith et al., 
2011), LisH/CTLH protein complex and polycystin complex (Wang et al., 
2007), that interact separately with each other. Other unique protein-protein 
interactions have been also reported including Nek4/ RPGRIP1 and 
RPGRIP1L (Coene et al., 2011), CC2D2A/CEP290 (Gorden et al., 2008), 
Lebercilin-OFDI interactions (Coene et al., 2009) and many others. These 
distinct protein-protein interactions have provided valuable insights in the 
function of ciliopathy proteins and facilitate the delineation of disease 
mechanisms. Together, the available databases and the reported protein-
protein interaction networks would help researchers to identify novel 
ciliopathies causative genes. Additionally, using a combination of genetic, in 
silico proteomics and biochemistry tools could therefore help to identify a 
possible interaction between the novel proteins and those implicated in similar 







Figure 8: The ciliopathy protein interaction network. This network shows the 
interaction of proteins (red spheres) known to be associated with phenotypically 
overlapping human ciliopathies (cyan spheres). In this network, the BBSome, the 
Usher network and NPHP-JS-MKS modules and other reported Protein–protein 
interactions can be distinguished.  Protein–protein interactions, direct and complex, 
(grey lines) were derived from the literature. Blue lines indicate that a specific protein 






Because of the fundamental role of cilia in the normal physiology and 
development of many tissues and organs in our body, mutations of ciliary 
genes, which encode for proteins localized to the cilium, BB or centrosome 
(Baker and Beales, 2009) give rise to devastating genetic disorders 
collectively classified as ciliopathies.  Both motile and non-motile cilia are 
associated with ciliary disorders but the majority of ciliopathies results from 
perturbation of primary cilia; and are termed non-motile ciliopathies. 
Ciliopathies are rare and heterogeneous disorders that lead to a wide range of 
clinical phenotypes that include craniofacial dysmorphisms, polydactyly, 
organ asymmetry, retinal degeneration, cognitive defects and anosmia, 
although other manifestations can be seen in organs including ear, brain, heart, 
kidney, liver, biliary duct, pancreas and skeletal tissues (Badano et al., 2006; 
Baker and Beales, 2009; Ferkol and Leigh, 2012; Waters and Beales, 2011) 
(Figure 9). Impairment of respiratory tract functions, infertility and obesity 
have also been observed in several ciliopathies. Phenotypic manifestations of 
ciliopathies can affect a single organ such as polycystic kidney disease (PKD) 
as well as multiple organs, resulting in a low quality of life and often lethality 
(Figure 9). Many syndromes such as BBS, MKS, EVC, JATD, Sensenbrenner 
syndrome (MIM 218330) JBTS, OFD, KS, ALMS, PKD, PCD, LCA and 
SRPII, are also categorized as ciliopathies (Figure 9). In addition, several 
studies have confirmed the association of ciliopathies with many types of 




The first ciliary gene was described by Ansley‟s group in 2003 (Ansley et al., 
2003). Since then, hundreds of ciliary related genes have been identified. 
Since the list of ciliopathies is growing, scientists have categorized these 
diseases into two main groups according to the clinical features: ciliopathies 
with skeletal defects such as JATD, OFD and recently SRPII, and those 
without skeletal anomalies including BBS, NPHP, MKS, JBTS, ALMS and 
LCA (Hildebrandt et al., 2011; Tobin and Beales, 2009; Waters and Beales, 
2011). The increasing number of ciliopathies with craniofacial anomalies has 
led to them to be further classified as craniofacial ciliopathies (Brugmann et 
al., 2010b). These craniofacial ciliopathies can be further categorized into 
renal and retinal ciliopathies when renal or retinal manifestations are present, 
respectively. (Arts and Knoers, 2013; Otto et al., 2010). The overlap of 
phenotypes within these disorders has raised the possibility that other 





Figure 9: Cilia related disorders. Ciliopathies show prominent and overlapping 
features in several organs including the brain, craniofacial structures, digits, kidney, 
liver, eye, heart, genitalia and skeleton. Adapted from (Goetz and Anderson, 2010; 









1.12. Oral-facial-digital syndromes (OFD) 
1.12.1. Clinical manifestation of patients with OFD 
All OFD patients have oral anomalies, facial dysmorphisms, and digital 
malformation; which together constitute the cardinal features of OFD. The 
oral features include cleft palate or high arched palate, multiple oral frenula, 
tongue anomalies, alveolar ridge clefting, hypoplastic zygomatic arches and 
teeth abnormalities. The common facial features include ocular hypertelorism, 
cleft lip and malformed nose. The digital findings in hands and feet include 
polydactyly, syndactyly, brachydactyly and camptodactyly or a combination 
of these. Various additional malformations have also been described in skin, 
brain, kidney, genitalia and limb. Detailed clinical manifestations are 











General features of OFD 
Oral features 
Hypertrophic or duplicated frenula, lobulated or nodular tongue 
(lingula hamartoma), bifid or trifid tongue, absent or 
supernumerary teeth, especially incisors (primary and 
secondary), widely spaced teeth, cleft palate (primary or 
secondary), High arched palate, cleft alveolar ridge, vomer, 
ethmoid, and crista galli hypoplastic zygomatic arches, cleft 
uvula, odontogenic keratocys     
Facial features 
Frontal bossing, ocular hypertelorism / telecanthus, nasal 
changes: Broad, flat nasal bridge, Broad nasal tip, alar anomalies 
Notched or hypoplastic alae, short columella, thin nares, hoanal 
atresia, low set or posteriorly rotated ears, hypoplastic maxilla, 
cleft lip (median, pseudocleft), micrognathia 
Digital features 
(hands and feet) 
Polydactyly (meso-, pre- or postaxial), syndactyly, brachy-
dactyly, clinodactyly, duplicated hallux (generally involving 






Agenesis of the corpus callosum, intracerebral, single or multiple 
epithelial or arachnoid cysts and porencephaly, heterotopia of 
gray matter, cerebellar, malformations, abnormal gyrations, and 
microcephaly, vermis hypoplasia/aplasia, Dandy–Walker 
anomaly, myelomeningocele, stenosis of the acqueduct of sylvius 
Kidney Polycystic or ectopic kidney, hydronephrosis 
Heart 
Cardiac malformation (endocardial cushion defect, tetralogy of 
Fallot, aortic stenosis, heart malformations, such as 
atrioventricular canal and endocardial cushion defects 
Limbs 
Skeletal dysplasia, especially mesomelic, short, variably bowed 
tibiae, joint, dislocations, shortened arms, narrow thorax; short 
sternum; abnormal ribs, wide metaphyses, talipes deformities 
Reproductive system 
Genital defects (agenesis or hypoplasia of penis, hypospadias, 
shawl scrotum, cryptorchidism, testicular hypoplasia, ambiguous 
female genitalia) 
Respiratory system 
Defects of upper airway (paresis of hypopharynx; hypoplasia of 
epiglottis, larynx, or trachea; tracheomalacia) 
Cutaneous findings  Milia, alopecia 
Miscellaneous 
Hearing impairment, eye abnormalities, perforated anus, adrenal 
hyperplasia, absent of pituitary  
Table 1: Summary of general features in the OFD types. Source from Guerrier 




1.12.2. Classification of OFD 
OFD are very rare disorders that occur 1:50000 to 1:250000 live births. The 
incidence is higher in females than in males, approximating 2:1 and much 
higher in patients with cleft lip or palate (Sakai et al., 2002; Siebert, 2008). 
The most common types are OFDII and OFDI (Toriello, 2009). OFDI is an X-
linked dominant disorder that occurs in 1:50,000 births and causes prenatal 
lethality in affected males.  
The first case reported as OFD was in 1941 by Mohr, followed by another 
case reported by Papillon-Le´age and Psaume in 1954. These two cases were 
latter termed the autosomal recessive OFDII (Mohr syndrome) and OFDI 
(Papillon-Leage-Psaume syndromes), respectively (Pedersen and Rosenbaum, 
2008). Since then, hundreds of cases have been reported as OFD with 
additional, variable and overlapping phenotypes, resulting into the delineation 
of new types (Baraitser, 1986). Besides the well-defined conditions of OFDI 
and OFDII, 7 subtypes have been classified based on the presence of one or 
more unusual clinical manifestations (Toriello, 1988). This classification has 
changed over time. For instance, a case of OFD diagnosed with Mohr 
syndrome by Edwards is now classified as OFDVIII (Edwards Syndrome) 
(Edwards et al., 1988). Later on, OFDIX (OFD syndrome with retinal 
degeneration or Guerrier syndrome) (Gurrieri et al., 1992; Jamieson and 
Collins, 1993; Nagai et al., 1998) was added to the group. In 1993, an affected 
girl with a new combination of manifestations was included as a new OFD 
subtype (Figuera et al., 1993) which is known as OFDX (OFD with fibular 
aplasia or Figuera syndrome). A year later, an affected fetus showed a 
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transitional phenotype between OFDII and OFDVI syndromes (Camera et al., 
1994), which is called OFDXI (Gabrielli syndrome). In 1997, the first 7 OFD 
subtypes were re-classified according to the limb anomalies in the affected 
patients (al-Qattan and Hassanain, 1997). In 1998, an additional type of OFD 
with myelomeningocele and heart defects was named Moran-Barroso 
syndrome or OFDXII  (Moran-Barroso et al., 1998). A year later, OFDXIII 
(Degner syndrome) characterized by additional brain abnormalities were 
described (Degner et al., 1999; Gurrieri et al., 2007).  
To conclude, 13 subtypes have been reported and characterized based on 
specific and distinctive clinical features (Gurrieri et al., 2007; Toriello, 2009) 
(Table 2). This classification is based on the extent and the severity of 
characteristic clinical manifestations and mode of inheritance.  
However, this classification is not always straightforward since most of the 
reported cases were single cases or patients within a same family displayed 
phenotypic variability that hinders the diagnosis. Moreover, many cases are 
difficult to classify due to the phenotypic similarity between OFD (Digilio et 
al., 1996; Gabrielli et al., 1994; Martin et al., 1971; Moran-Barroso et al., 
1998). For instance, Chung reported a case of OFD with overlapping 
manifestations between OFDV and OFDVI, suggesting a possible new OFD 
variant (Chung and Chung, 1999). Recently, another patient has been reported 
with similar features between Mohr syndrome and OFDVI indicating a new 
OFD subtype (Panigrahi et al., 2013). On the other hand, OFDIV shares a 
combination of manifestations between OFDII and SRPII (Baraitser et al., 
1983; Silengo et al., 1987). This syndrome was thought to be allelic of Mohr 
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syndrome until recently, when it was re-diagnosed as a distinct syndrome 
(Thomas et al., 2012).  
Besides phenotypic similarity between OFD subclasses, OFD often occurs in 
conjunction with other congenital diseases. For instance, two OFD cases 
reported in 1997 and 1999 showed high phenotypic resemblance with EVC 
(Phadke et al., 1999; Toriello et al., 1997). Many patients with Short rib 
polydactyly syndrome type IV (SRPIV; MIM 269860), SRPII, Acrocallosal 
syndrome (ACLS, MIM 200990), Carpenter syndrome (CRPT1, MIM 
201000), Pallister-Hall syndrome (PHS, MIM 146510), Acro-fronto-facio-
nasal syndrome (MIM 239710, 201180), Craniofrontonasal dysplasia (CFNS, 
MIM 304110), Hydrolethalus syndromes (HLS1, MIM 236680), Joubert 
syndrome, and Smith-Lemli-Opitz syndrome (SLOS, MIM 270400), have 
similar and indistinguishable clinical features with that of OFD variants 
(Siebert, 2008). 
As a conclusion, the classification of these disorders is very complex and 
mainly due to the clinical overlaps between each other and with other known 
congenital diseases, as well as, the wide spectrum of symptoms. New 
manifestations are often added to the known OFD (Ghossaini et al., 2002; Liu 
et al., 2012). Many cases are still unclassified and wait to be added to the 
official list of OFD as new subtypes (Siebert, 2008). Although diagnosis may 
be sometimes challenging, it is highly recommended to perform a detailed 
clinical synopsis of each patient and family members before classification and 
identification of the genetic aetiology. Several isolated OFD phenotypes are 
commonly found within the general population, such as cleft lip and palate, 
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digits abnormalities, polycystic kidney and heart dysfunction. Unraveling the 
genetic cause for these disorders and their link to cilia may shed light on the 
molecular mechanisms behind these disorders and other human diseases 
(Tobin and Beales, 2009). Moreover, study of known OFD could be very 









Hyperplastic frenula, lobulated tongue, 
hypoplasia of nasal cartilage, alar hypoplasia, 
cutaneous milia, polycystic kidney disease, 
porencephaly, absence of lateral incisors, 
agenesis of corpus callosum 
OFDII 
Mohr syndrome 
252100 AR Bilateral bifidity of big toe, bifid tip nose, 
absence of medial incisors, short humerus 
OFDIII 
Sugarman syndrome 






Tabial dysplasia, short stature 
OFDV 
Thurston syndrome 





Tongue hamartoma, mesoaxial polydactyly, 
lingual, sublingual swellings, hypothalamic 




Facial asymmetry, tongue split, hydronephrosis 
OFDVIII 
Edwards syndrome 
300484 AR Short tibiae or radii, preaxial and postaxial 




Retinal abnormalities, non-median cleft lip, 









Postaxial polydactyly, ventriculomegaly, alar 
hypoplasia, Duplicated vomer, Cleft ethmoid 




NA AR Myelomeningocele, stenosis of aqueduct of 





Table 2: The pathognomonic features of OFD types. AR; autosomal recessive, AD; 
autosomal dominant, XR; X-linked recessive, XD; X-linked dominant. Source from 




1.12.3. The genetic aetiology of OFD 
OFD are genetically heterogeneous disorders and cause variable phenotypes 
among OFD patients and between patients within the same family. 
Subsequently, the mode of inheritance also should be different in these 
syndromes. Transmission of the majority of OFD is autosomal recessive, 
although many reported cases also display X-linked or autosomal dominant 
modes of inheritance. Only four genes have been identified so far; the 
causative genes for the rest of OFD are yet to be unraveled. The first gene is 
CXORF5. It is located on chromosome X and mutations in this gene causes 
OFDI (MIM 311200) (Ferrante et al., 2001). By linkage analysis for 7 cases 
present with OFDI followed by direct sequencing of the candidate region, 
Ferrante and coworkers found different causative mutations. CXORF5 codes 
for a protein localized at the basal body of primary cilia which plays a pivotal 
role in the ciliary formation and function (Ferrante et al., 2009; Ferrante et al., 
2006; Singla et al., 2010). The second OFD gene is TCTN3 (Tectonic 3) which 
when mutated causes OFDIV (MIM 258860) (Thomas et al., 2012). Several 
pathogenic mutations within TCTN3 gene were found in 8 unrelated patients 
diagnosed with OFD anomalies and dysgenesis of tabia without short ribs. 
Biochemical analysis revealed that TCTN3 is essential for ciliary function and 
is necessary for transduction of Shh signaling (Thomas et al., 2012). Few 
months ago, a new gene DDX59 was identified in two Arab families affected 
with OFDV. This gene is located in chromosome 1and encodes a member of 
DEAD-box-helicases family (DDX) which comprises more than 40 proteins 
(Shamseldin et al., 2013). The function of many of these proteins including the 
DDX59 remains unclear but most of them are involved in RNA processing 
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and ribosomal biogenesis. However, an interesting finding was observed in the 
affected patients; the ciliogenesis in patient‟s fibroblast cells was found to be 
unaffected. This suggests that DDX59 is not implicated in ciliary formation 
which is consistent with the absence of this protein in the available ciliome 
databases. Interestingly, the Shh signaling was markedly perturbed in the 
patients‟ cells (Shamseldin et al., 2013). 
The fourth gene named C5ORF42 has been recently identified and causes the 
Varadi-Papp syndrome (OFDVI; MIM 277170) (Lopez et al., 2013). This 
syndrome is autosomal recessive and differs from other OFD by tongue 
hamartoma, hypothalamic hamartoma and mesoaxial polydactyly (Lopez et 
al., 2013). Even though, mutations in the TMEM216 gene (MIM 613277) have 
been associated with known ciliopathies such as MKS2 (MIM 603194) and 
JBTS2 (MIM 608091) syndromes, were also identified in two patients 
diagnosed with OFDVI syndrome (Valente et al., 2010). The new study 
showed that C5ORF42 seems to be the major gene for this syndrome (Lopez 
et al., 2013). Moreover, C5ORF42 mutations have been reported in many 
patients with MKS and JBTS syndromes and causes atypical phenotypes of 
the disease (Alazami et al., 2012; Shaheen et al., 2013; Srour et al., 2012a; 
Srour et al., 2012b), providing evidence for allelic heterogeneity of OFDVI, 
MKS2 and JBTS2 syndromes. In support of this, TCTN3 mutations were also 
observed in subset of patients with MKS, JBTS and cystic kidney. (Thomas 
2012). Likewise, the spectrum of OFDI phenotypes have lately been extended 
and mutations in CXORF5 were found in patients with X-linked JBTS10 
(MIM 300804) (Bisschoff et al., 2013; Coene et al., 2009; Field et al., 2012), 
X-linked Retinitis pigmentosa (RP; MIM 268000) (Webb et al., 2012) and 
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Simpson-Golabi-Behmel syndrome Type 2 (SGBS2; MIM 300209) (Budny et 
al., 2006). OFDI mutations have also been established in a few patients with 
OFDVII and OFDVIII, a further indication of variable expressivity of OFD 
genes (Budny et al., 2006; Nowaczyk et al., 2003).  
Late last year, the two genes C6ORF170 (TBC1D32; MIM not available) and 
SCLT1 (MIM 611399) have been separately identified in two patients 
diagnosed with OFDIX (Adly et al., 2014). The two genes have been 
described as ciliary protein, found to play roles in ciliogenesis and 
centrosomal biology (Ishikawa et al., 2012; Ko et al., 2010; Tanos et al., 
2013). 
Finally, a very recent study has uncovered a new subtype of OFD (OFDXIV; 
MIM 615948) with severe microcephaly and cerebral malformations caused 
by mutations in C2CD3 gene (MIM 615944) (Thauvin-Robinet et al., 2014). 
This gene is localized to primary cilia and required for cilia biogenesis and 
centriole elongation (Hoover et al., 2008; Thauvin-Robinet et al., 2014; Ye et 
al., 2014). 
Taken together, the phenotypic overlaps between  many known ciliopathies 
and OFD suggesting that OFD could have ciliary involvement (Toriello, 
2009). In addition, the involvement of CXORF5, TMEM216 and TCTN3 in 
cilia biogenesis and function (Brugmann et al., 2010b; Singla et al., 2010; 
Thomas et al., 2012) and the recent identification of TBC1D32, SCLT1 and 
C2CD3 as ciliary players, support the hypothesis that the rest of 
uncharacterized OFD could be ciliopathies as well. We can therefore 
anticipate that the genes responsible for the other OFD including Mohr 
syndrome could have ciliary involvement. Since the genetic cause for most of 
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these conditions with the exception of OFDI, OFDIV, OFDV, OFDVI and 
OFDXIV are still unknown, and chromosomal analysis have generally been 
reported to be normal, the explanation for the other forms of OFD is yet to be 
determined. It is possible that the different phenotypes observed in the Mohr 
syndrome and the other OFD are caused by different mutations in the same 
gene (Toriello, 2009).  
Homozygosity mapping and next generation sequencing will be helpful to 
identify the causative gene responsible for Mohr syndrome. Furthermore, by 
means of downstream functional analysis using biochemical tools, patients‟ 
cells and animal models, we will be able to get a better understanding of the 
biological pathways and underlying mechanisms to explain the pathogenesis 
of this disorder. 
1.12.4. Clinical spectrum of Mohr syndrome 
Mohr syndrome is a very rare autosomal recessive disorder; with an estimated 
incidence rate of 1 to 300 000 live births. Like other OFD, Mohr syndrome is 
defined by malformations of the face, oral cavity as well as hand and foot 
digits. Craniofacial dysmorphisms include hypertelorism, microcephaly, 
micrognathia, broad nasal ridge and cleft upper lip. Defects of the oral cavity 
development including clefts of the palate and tongue together with oral 
frenula and dental abnormalities have been also reported in most cases. Digital 
anomalies are also common including brachydactyly, syndactyly, clinodactyly, 
and preaxial or postaxial polydactyly. Other minor features were reported in 
single families, such as tongue lipoma and a sacral dermal pit (Ghossaini et al., 
2002), muscular hypotonia and respiratory infections (Gustavson et al., 1971; 
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Haumont and Pelc, 1983; Prpic et al., 1995; Reardon et al., 1989); absence of 
the pituitary, epiglottis abnormalities, micropenis and adrenal hypoplasia 
(Shashi et al., 1995); choroid coloboma, jerky eye movement, hydrocephaly 
and zygomatic hypoplasia (Anneren et al., 1984; Kalyan et al., 2012). 
Additionally, absence of olfactory nerve, natal teeth, lung malformation, 
Dandy-Walker malformation, corpus callosum agenesis and tachypnea have 
also been observed in many cases (Balci et al., 1999; Gustavson et al., 1971; 
Haumont and Pelc, 1983). 
To date, tens of cases have been reported in the literature presenting with 
variable phenotypic manifestations in face, oral cavity, digits and other organs.  
1.13. Animal modeling for Mohr syndrome  
To understand the function of the disease causative gene, animal models have 
been helpful. Human ciliopathies have been well studied in different animal 
models including mouse, rat and zebrafish. Several mouse and zebrafish 
models have been used to study the role of primary cilia in various 
developmental and physiological disorders including ciliopathies (Hildebrandt 
et al., 2011; Leightner et al., 2013; Menezes and Germino, 2009; Perrault et 
al., 2012). Both mouse and zebrafish animals were also used to understand the 
function OFDI in the development of disease phenotypes (Ferrante et al., 
2009; Ferrante et al., 2006; Hunkapiller et al., 2011). These animal models 
gave interesting insights of the invaluable role of cilia in the development and 
function in human organ systems. For instance, skeletal system, craniofacial 
structures, eye, kidney, teeth, ear and other internal organs (Brugmann et al., 
2010a; Tasouri and Tucker, 2011; Tayeh et al., 2008; Tobin et al., 2008). In 
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addition to zebrafish, Xenopus, which is a common animal model in our lab, 
was used to study the aetiology of Mohr syndrome. There are two species 
of Xenopus that are widely used by researchers, Xenopus leaves (X. 
leaves) and Xenopus tropicalis (X. tropicalis). However, the African clawed 
frog, X. leaves has been well described and widely used as a vertebrate model 
system to study events during embryonic development. Moreover, X. leaves 
embryos are particularly applicable to address the function of many genes 
during vertebrate embryonic development (Bonnard et al., 2012). The female 
Xenopus can be stimulated to lay eggs by exogenous injection of Human 
gonadotropin hormone (HCG); each female can release more than 1000 eggs 
per day. Eggs are quite large (around 1.3 mm in diameter), easy to handle, 
allows for detailed visualization of developmental progress, and ease for 
microinjection and surgical manipulation. Frog embryos are relatively large 
compared to zebrafish embryos, and can be obtained by in vitro fertilization, 
therefore it is easy to manipulate the embryos as they grow. They undergo 
rapid embryonic development; taking 48 hours from fertilization to a 
swimming tadpole stage. For these reasons, X. leaves has emerged as another 
excellent organism to model human disease. For examples, Xenopus model 
helped to uncover the molecular mechanisms and the pathophysiology of 
many diseases, including, ciliopathies, and other developmental disorders 
(Bonnard et al., 2012; Pratt and Khakhalin, 2013). The process of craniofacial 
development is conserved between  Xenopus and mammals,  therefore 
Xenopus is a suitable animal model to study these events during embryonic 
development (DeSimone et al., 2005). Moreover, the “ex utero” development 
of frog embryos facilitates manipulation such as loss-of-function assays and 
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classical surgical experiments. Besides using zebrafish and frog embryos, an 
experiment in Drosophila will be performed to investigate the pathogenicity of 
the defective disease mutation I isolated.  
1.14. Animal modeling for Mohr syndrome  
In a period of time during early development of Xenopus, the epidermis 
normally processes three main cell types; mucus-secreting goblet cells (MSC), 
multi-ciliated cells (MCC) and ion-secreting cells, (ISC) (Figure 10b-e). MSC 
are the largest cells that occupy the majority of Xenopus skin, the 
ultrastructure of these cells revealed the presence of exocytic vesicles reside 
on their apical surface are responsible for the secretion of mucus (Billett and 
Gould, 1971; Hayes et al., 2007). The MCC bear multiple beating cilia that 
generate directional fluid flow from anterior to posterior throughout the 
Xenopus skin and decorate the epidermis with regular puncta patterns 
(Mitchell et al., 2007; Park et al., 2008; Wallingford, 2010). The ISC reside a 
long side MCC and MSC, and express large numbers of ion channels and 
display irregular scattered patterns throughout the embryonic epidermis 
(Dubaissi and Papalopulu, 2011; Hayes et al., 2007; Quigley et al., 2011). 
 The frog epidermis has been well used as powerful model system for 
epithelial development, biogenesis of cilia and studying planar cell polarity 
(PCP) signaling (Dubaissi and Papalopulu, 2011; Mitchell et al., 2009; 
Wallingford, 2010). 
The mature MCC of Xenopus originate from their ciliated cell precursors 
residing in the inner layer of the epidermis that undergo several changes 
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during embryonic development. Between stage 15-19, MCC as well as ISC are 
specified by Notch/Delta signaling. Activation of Notch-signaling prevents the 
formation of MCC and ISC, while inhibition of the pathway promotes the 
specification of these cells (Deblandre et al., 1999; Hayes et al., 2007; Stubbs 
et al., 2006; Tsao et al., 2009). After specification of these cells, they 
translocate from the deep layer and undergo intercalation into the outer layer 
(Quigley et al., 2011). By the end of stage 19, the ciliated cells become totally 
differentiated and spatially distributed in an even pattern, while, the ISC 
distributed in a scattered patterns (Stubbs et al., 2006) (Figure 10).  
The human respiratory epithelium comprises three cell types; the mucus-
secreting cells, the ciliated cells, and the serous acinar cells (ion-transporting 
cells). This cellular composition of human airway epithelium showed 
remarkable similarities with the cells of Xenopus epidermis (Hayes et al., 
2007; Werner and Mitchell, 2012). Because both patients we studied suffer 
from recurrent respiratory tract infection and cough, which also could be 
related to ciliary defects, therefore the Xenopus larval epidermis will be a good 
model for studying ciliogenesis and ciliary function. The possible defect in the 
Asun morphants epidermal cell types could potentially phenocopy the defects 






Figure 10: A diagram of Xenopus epidermal cells development. (a) During the 
embryo develops from gastrula stage to adult epidermal cells undergo rounds of 
differentiation and remodeling; MSC (blue), ISC (red), MCC (green). At neurula 
stage, MCC precursor cells and INC reside in the inner layer. From gastrula stage 
onward, cells start to migrate to the outer layer. At tailbud stage, cells become totally 
differentiated, MCC start to be ciliated; MSC and ISC become functional. (b-d) In 
situ hybridization for genes expressed in epidermal cells: (a) MCC marked with 
ccdc19, display regular spaced punctate pattern, (b) ISC marked with xema shows 
randomly scattered punctate pattern, (c) MSC labeled with xeel covers the whole 
epidermis. (e) SEM for the Xenopus epidermal cells.  (a) Modified from (Werner and 
Mitchell, 2012, 2013). (b-d) Adapted from (Hayes et al., 2007). (e) Our own work on 





1.15. Objectives and significance of this study 
As outlined in the above introduction, OFD are rare genetically heterogeneous 
disorders with different modes of inheritance. Most of OFD reported cases 
exhibit inter- and intra-familial phenotypic variability with variable degree of 
severity. These syndromes are supposed to be ciliary related disorders due to 
the ciliary related causative genes for OFD types I, IV, V, VI and XIV and 
their phenotype overlapping with other known ciliopathies. The molecular 
background for the rest of OFD is still unknown.  
Mohr syndrome is a well-defined disorder with phenotypes typical of OFDII. 
The gene(s) responsible for Mohr syndrome have yet to be found. Identifying 
the first gene responsible for this human disease was my prime objective for 
my thesis project. 
In one consanguineous family two girls were diagnosed with a likely 
autosomal recessive Mohr syndrome-like disorder. Therefore, the main aim of 
this study was to delineate the genetic aetiology of Mohr syndrome and to 
confirm or reject the hypothesis that Mohr syndrome is a ciliopathy.  
To identify the candidate locus or loci, I first used high density single 
nucleotide polymorphism (SNP)-array-based homozygosity mapping followed 
by high throughput sequencing to find the causative gene. The second step 
was to investigate the effect of the mutation on the encoded protein synthesis 
and function using patients and wild type cells and specific antibodies. The 
specific objectives of this study were to: 
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Investigate whether any ciliogenesis defects are detected in patient‟s cells. 
This was achieved using different biochemical approaches such as 
immunofluorescence staining, scanning electron microscopy (SEM) and small 
interference RNA (siRNA) techniques. 
I order to explore the role of the causative gene during embryogenesis; its 
expression patterns in animal models such as Xenopus and zebrafish were 
examined using whole mount in situ hybridization (WISH) and antibody 
staining at different stages of development. In order to recapitulate the human 
disease, the expression of the causative gene was knocked-down in the above 
mentioned animal models using morpholino antisense oligonucleotides. 
The variability of clinical features between the two patients and other reported 
cases, suggests a possible contribution of genetic modifiers that could 
modulate the severity of disease phenotypes. Therefore, I will attempt to 
uncover the possible interaction between the causative protein and other 
ciliopathy proteins using a combination of genetic and biochemical tools. 
Overall, studying of ciliopathies has exponentially increased since the 
discovery of cilia and their related disorders. Hundreds of genes have been 
reported so far that are linked to cilia biogenesis and function. However, the 
functions of many of ciliary proteins are well understood; the majority of them 
are poorly understood or generally unknown. Most ciliary proteins are linked 
directly or indirectly to each other and supposed to function collectively in 
complexes according to their genetic and structural properties and other 
unknown reasons. For these reasons, the identification of the causative gene of 
Mohr syndrome may shed light towards the identification of the other OFD 
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genes. Furthermore, the disease protein could be indispensable for cilia and it 
could also be linked with other ciliary proteins that are required for cilia 
function and/or formation. As such, many diseases could be unraveled as a 













Chapter 2: Materials and Methods 
2.1. Patients and samples  
The two affected (IV.6 and IV.7) sisters were initially evaluated at the 
age 5 and 3.5 years, respectively at the National center for Diabetes, 
Endocrinology and Genetics by Prof. Hanan Hamamy. Between the age of 1.5 
and 3 years the two patients underwent many surgical operations to correct the 
cleft lip/palate (CLP). The youngest affected girl had cardiac surgery to 
correct the pulmonary stenosis. During the last four years, patients have been 
carefully examined by ultrasound scanning, ear, nose and tracheal 
examination, ophthalmic evaluation, dental assessment, magnetic resonance 
imaging (MRI) and computer tomography in order to find out new phenotypes 
or congenital defects associated to this syndrome. Informed written consent 
was obtained from the parents of the family who gave their consent for the 
publication of photographs and to use their sample for diagnosis and research 
purposes. The study was approved by the respective local ethical commission 
in Jordan and Singapore. Saliva and blood samples were collected from the 
whole family in addition to 34 saliva samples collected from uncles, aunts and 
cousins (Supplementary Figure 1). Skin biopsies were also obtained from one 
of the affected, the unaffected mother. Blood and skin biopsy were also 
collected from age-matched healthy individual as a control. 
2.2. Sample collection and genomic DNA extraction 
Genomic DNAs (gDNAs) were extracted from saliva samples collected in 
Oragen
TM 
DNA self-collection kit (DNA Genotek, Ontario, Canada, Cat. No. 
63 
 
OG-500) using the manufacturer protocol. After incubation of Oragene kits 
containing saliva at 50°C overnight or at least 1 hour, 0.5-1 ml of mixed saliva 
was transferred in a 2 ml microcentrifuge tube. 40 µl of Oragene Purifier 
(DNA Genotek, Ontario, Canada, Cat. No. OGL2P-5) per 1ml of saliva was 
added in each tube and mixed by vortexing for few seconds. After that, tubes 
are incubated on ice for 10 minutes (min). Then, tubes are centrifuged at room 
temperature for 5 min at 13,000 rounds per min (rpm). The clear supernatant 
was carefully transferred into new 2 ml microcentrifuge tubes. Then, equal 
volume around 1ml of 95% to 100% ethanol was added to each sample and 
mixed gently by inversion 6-10 times. Samples were left on bench for 10 min 
for efficient precipitation of DNA. Samples were centrifuged at 13000 rpm, 2 
min, and the clear supernatants were carefully removed and discarded 
avoiding the disturbance of the light pellet. 500 μl of 70% ethanol was added 
to tube and centrifuged at 13000 rpm, 1 min. Finally, after removing the 
supernatant, DNA pellets were resuspended into 50 to 100 µl of Tris-EDTA 
(TE) buffer or H2O. Additional vigorous pipetting and vortexing, samples 
were incubated at 50°C for 1 hour with frequent vortexing or overnight at 
room temperature for better reconstitution. The purity and concentration of the 
extracted gDNAs were evaluated by measuring the absorbance at 260/280 nm 
ratio using Nanodrop 8000 spectrophotometer (Thermo Scientific, 
Wilmington, USA). The quality of DNA was further assessed on a 1% agarose 
gel. The double stranded DNA was also quantified using Quant-iT™ 
PicoGreen® dsDNA (Invitrogen, USA, Cat. No. P11496) for single nucleotide 
polymorphism (SNP) genotyping (Singer et al., 1997) and kept at -20°C or (-
80°C) until used. In this study we collected also saliva from both parents and 
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the healthy parent‟s siblings in addition to the affected patients. Skin biopsies 
were collected from the affected patients and the healthy mother. 
2.3. Genotyping and homozygosity mapping 
To identify the candidate loci for Mohr syndrome, homozygosity mapping was 
performed in this family.  
Saliva samples from parents (1, 2), unaffected (3, 4, 5) and affected (6, 7) 
children were collected after informed consent (Figure 12a) using Oragene 
DNA self-collection kits. After DNA extraction, the purity and quality of each 
gDNA were determined and confirmed to be appropriate for genotyping. 
For linkage analysis, we first genotyped all samples using SNPs array-based 
genotyping by Illumina 610k SNP (Illumina 610-Quad) Genotyping BeadChip 
(Illumina, CA, USA), with 500,000 SNP markers, according to the 
manufacturer‟s guidelines at the Genome Institute of Singapore (GIS). 
Genotype results were normalized using the Illumina BeadStudio software 
with a final call rate >99% for each sample.  
To test for possible deletion or supernumerary copies of a gene that may 
contribute to the etiology of this syndrome, the density of Mendelian genotype 
errors throughout the genome was examined and the signal intensity of each 
SNP probe presents in the Illumina Infinium array was analyzed. No deletion 
bigger than 10 SNPs or 30 kb was detected and no Copy Number Variation 
(CNV) was found to segregate with the disease. All genotyping analyses were 
done by Dr. Barry Merriman (Geffen School of Medicine, University of 




The principle of homozygosity mapping is to find the shared regions that are 
homozygous and identical-by-descent (IBD) in the 2 affected patients using 
custom programs written in the Mathematica (Wofram Research) data analysis 
software. The larger the regions of homozygosity were considered as 
candidate IBD homozygous blocks that are likely to harbor recessive disease 
gene. IBD blocks of 2 centiMorgan (cM) or above were taken to be significant 
and further investigated. The HapMap Phase II recombination rate map was 
used to determine the cM distances between SNPs. The homozygous or the 
identical but not homozygous regions shared by affected and unaffected 
siblings were excluded. Visual Genome Studio (VIGENOS) program 
(Hemosoft Inc, Ankara) allowed genome-wide haplotyping of SNP data 
(Kayserili et al., 2009). 
2.4. Genomic loci capture assay  
This technique is usually composed of 5 main steps (Figure 11). All 
experiments and analysis were performed at the University of California, Los 
Angeles (UCLA) following manufacturer‟s instructions. 
2.4.1. Genomic DNA sample and capture array preparation 
Samples were processed following the Illumina Library Generation Protocol 
version 2.3 (Figure 11). Around five µg of genomic DNA from each sample 
were diluted with water to a final volume of 150 µl. The DNA was sheared 
using a sonicator (Bioruptor, Diagenode) to generate short fragments between 
150 bp to 400 bp. After PCR purification using QIAquick PCR Purification 
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Kit (Qiagen, Germany, Cat. No. 28106), samples were concentrated in 30 µl 
of elution buffer. T4 and Klenow DNA polymerases, T4 PNK, dNTPs and T4 
DNA ligase buffer with 10 mM ATP were added to repair 3‟ and 5‟ overhangs 
and generate blunt ends for all the double stranded DNA fragments. The DNA 
solution was then purified and eluted in 32 µl of elution buffer. After elution, 
single „A‟ base was added to the fragments using Klenow exo- (3' to 5' exo 
minus) and incubated at 37°C for 30 min. After purification with MinElute 
PCR purification kit (Qiagen, Germany, Cat. No. 28004), and elution in 10 µl 
of elution buffer, the adaptors, supplied by Solexa, were ligated to the 
genomic fragments using T4 DNA ligase, adapter oligo mix and T4 DNA 
ligase buffer. The samples were incubated for 15 min at room temperature 
(RT) and then purified using QIAquick PCR Purification Kit. After that, 
templates were run on a 2% agarose gel and fragments with a size-range of 
150-200 bp were excised and gel extracted using Gel Extraction Kit (Qiagen, 
Germany, Cat. No. 28704) and eluted in 30 μl of elution buffer. Fragments 
with the right adaptors pairs ligated were amplified by PCR using Phusion 
DNA Polymerase (Finnzymes Oy, Espoo, Finland, Cat. No. F-530S) and 
primers complementary to the adaptors. To generate sufficient DNA to 
hybridize on the capture array, four replicates of PCR reactions were run to 
generate a yield ~4 µg of amplicon. Samples were purified, eluted in in 50 μl 
of elution buffer and quantified with Nanodrop spectrophotometer. 
2.4.2. Hybridization 
The experiment was performed according to Agilent CGH 244 K array 
protocol. Around 4 µg of amplified products were mixed with 50 µg of 
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Human Cot-1 DNA (Invitrogen, Carlsbad, USA, Cat. No. 15279-11), 52 µl of 
Agilent 10X Blocking Agent, 260 µl of Agilent 2X Hybridization Buffer and 8 
μl of each of the Illumina primer stock (100 μM each). The hybridization mix 
was then incubated at 95°C for 3 min and 37°C for 30 min. 490 µl of the 
hybridization mix was added to the array and hybridized in the Agilent 
Hybridization oven at 65°C for 65 hours, 20 rpm.  
2.4.3. Washing and stripping  
After hybridization, the arrays were washed to remove unbound DNA 
fragments following CGH wash procedure. To increase stringency the second 
wash was further extended to 5 min. After washing, the arrays were stored in a 
glass dish with Agilent Oligo aCGH wash buffer 1 until the next step was 
ready. The array was stripped by incubation with 1.09X Titanium Taq PCR 
Buffer in the 95°C rotating oven at 20 rpm for 10 min. The solution was 
collected and aliquoted into 4, 1.5 mL microcentrifuge tubes. 1 µl Illumina 
primer pair (final concentration 0.1 μM), 1 µl of Titanium Taq (final 
concentration 0.5X), and 1 µl of dNTPs (10 mM each) were added to a final 
volume 100 μl. The stripped DNA was amplified by 15 cycles of PCR and 
purified using QIAquick PCR Purification Kit and eluted in 50 µl of elution 
buffer. To confirm that the size of fragments matched the size extracted from 
the gel, the concentration of DNA was measured and the size was checked on 
a 2% agarose gel. After purification, the samples were diluted to 10 nM, the 




Figure 11: Sequence capture array re-sequencing in 5 steps: 
1. The genomic DNA sample is fragmented, followed by linker ligation 
2. The fragment pool is denatured and hybridized to a custom sequence capture array 
3. Array washing to remove unbound fragments  
4. The target-enriched fragment pool is eluted and amplified by ligation-mediated    
    PCR 




2.4.4. High-throughput re-sequencing and analysis 
Samples were loaded on the Solexa Flowcell and sequenced by Illumina 
Genome Analyzer (GAII) according to the manufacturer‟s standard protocol. 
The image data was processed through the Firecrest version 1.3.4 and Bustard 
version 1.3.4 algorithms.  A Blat-like Fast Accurate Search Tool (BFAST, 
https://secure.genome.ucla.edu/index.php/BFAST/) was used to align all 
sequence reads to the human reference genome (University of California, 
Santa Cruz, build 18, http://genome.ucsc.edu/). Variants were called using 
SAMtools pileup tool (SAMtools, http://samtools.sourceforge.net/) and 
submitted to an internal database for further filtration and annotation. 
Mismatches were further mapped to the dbSNP129 database to identify 
variants homozygous and to filter out known SNPs from de novo variants. An 
additional SeqWare tools and the "knownGene" gene model from the UCSC 
hg18 were used to identify the non-synonymous mutations. The open source 
SeqWare project which provides a LIMS tool for tracking samples (SeqWare 
LIMS) and a pipeline for sequence analysis (SeqWare Pipeline, 
http://seqware.sourceforge.net/) was used throughout this work (O'Connor et 
al., 2010). 
The sequence coverage at each position along the chromosome and the 
positional candidate genes were obtained from the GenBank 
(http://www.ncbi.nlm.nih.gov/mapview/) and Ensembl 
(http://www.ensembl.org/) databases. Flanking primers for each exon were 
manually designed and direct Sanger re-sequencing was performed with the 
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BigDye Terminator cycle sequencing kit (Applied Biosystems, UK, Cat. No. 
4337455). 
2.5. Culture and maintenance of human cell lines 
Skin biopsies were cut into pieces of 2 mm and washed with phosphate buffer 
saline (PBS). Skin pieces were then fixed in 10 cm Petri dish on scratches 
made by a sterile blade. After that, Dulbecco modified Eagle medium 
(DMEM) (HyClone, Thermo Scientific, USA, Cat. No. SH30022.01) 
supplemented with 10% fetal bovine serum (FBS) (HyClone, Thermo 
Scientific, USA, Cat. No. SH30070.03) and 10% 100 units/ml penicillin G and 
100 µg/ml streptomycin (Gibco, USA, Cat. No. 15140-122) was carefully 
added. Primary fibroblast cells usually take from 3-5 days to start growing out 
of the skin biopsies. The hTERT-RPE1 cells were cultivated in DMEM/Ham‟s 
F12 (1:1) (Gibco, USA, Cat. No. 11330-032), supplemented with 0.348% 
sodium bicarbonate solution; mouse primary fibroblast (NIH3T3) and human 
embryonic kidney (HEK293), cells in DMEM, all were supplemented with 
10% FBS, 100 units/ml penicillin, and 100 µg/ml streptomycin. Cells were 
maintained in a humidified 5% CO2 atmosphere at 37ºC till confluency. After 
that, cells were washed with PBS and harvested. Cells were either re-plated 
into a new flask at a dilution of 1:10 for further passages (culture starts at P0) 
or supplemented with 1:10 DMSO-FBS and transferred to 2 ml cryotubes for 
freezing in -80ºC overnight and then in liquid nitrogen tank for long storage.  
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2.6. Analysis of non-sense mediated decay (NMD) 
To examine the effect of NMD on mutant mRNA stability, cultured cells were 
treated with cycloheximide (CHX) (Sigma-Aldrich, USA, Cat. No. C4859) at 
100 mg/ml for 4 hours before RNA extraction. 
2.7. Transient transfection of mammalian cells  
To induce expression of appropriate proteins, transient transfection of cultured 
cells was performed using lipofectamine 2000 (Invitrogen, USA, Cat. No. 
11668-019) according to the manufacturer‟s protocol. Briefly, Cells were 
seeded 24 hours prior to transfection until they reach 70% to 80% confluency. 
Lipofectamine and plasmid DNA were mixed with the appropriate volume of 
Opti-MEM (Invitrogen, USA, Cat. No. 31985-070) in a 1:3 ratio and added 
drop wise to cells. After 4 hours of incubation in (5% CO2, 37ºC) condition, 
the growth media was then replaced using medium supplemented with 
penicillin/streptomycin and incubated for 48-72 hours to allow for expression 
before being processed. 
2.8. Small interference RNA (siRNA) knock-down  
To silence the expression of the putative gene, primary fibroblast and hTERT-
RPE1 cells were seeded the day before transfection so as to reach a confluency 
of ~70%. Cells were transiently transfected using RNAi MAX (Invitrogen, 
USA, Cat. No. 13778-075) using two different siRNA duplex oligonucleotides 
designed to specifically knock-down ASUN gene (see Appendix 1) following 
the manufacturer‟s instructions. 20 µM of siRNA oligos (Integrated DNA 
technology (IDT), Singapore) were mixed in separate microcentrifuge tubes 
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with 100 µl of serum free OPTI-MEM and incubated at room temperature 
(RT) for 5 min. The targeting sequences for siRNAs are listed in Appendix. 
The RNAi MAX-Opti-MEM mix was then added to each oligo mix in a final 
volume of 200µl and incubated for 20-30 min at RT. The mix was then added 
drop wise to the 6-well plate and incubated overnight (5% CO2, 37ºC). The 
media was then removed and replaced with 0.5% serum media for 48-72 
hours. After that, cells were harvested and investigated for ciliogenesis using 
immunofluorescence staining with the desired antibodies. Cells were also 
transfected with control siRNA. To confirm the transfection efficiency, cells 
were also co-transfected with siGLO Red (Dharmacon, USA, Cat. No. D-
001630-02).  
2.9. RNA isolation and cDNA synthesis 
Total RNA was extracted from cultured cells using the TRIzol (Invitrogen, 
USA, Cat. No. 15596-026) together with RNeasy mini kit (Qiagen, Germany, 
Cat. No. 74106) according to manufacturer‟s protocol. Cells were washed with 
PBS and then lysed directly in the culture Petri dish by adding 500 µl of 
TRIzol reagent, mixed up and down by pipette and transferred to 1.5 ml 
micro-centrifuge tubes. Samples in Trizol were incubated at RT for 5 min. 
After incubation, 200 µl of chloroform was added to the samples, vortexed for 
1 min at high speed and centrifuged at 4°C, max speed for 15 min. After 
centrifugation, the upper aqueous RNA-containing phase was transferred to a 
new 1.5 ml micro-centrifuge containing equal volume of isopropanol. The 
samples were mixed by gently inverting many times and centrifuged at 4°C, 
max speed for 15 min. The supernatant was then removed and the pellet 
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washed with 75% ethanol and re-suspended in 34 µl of sterile RNase free 
double distilled water (ddH2O). RNA cleanup was then performed using the 
RNeasy mini column clean up protocol. RNA was brought up to 100 µl total 
volume with RNase free ddH2O, to which 350 µl of buffer RLT was added 
and mixed thoroughly. 250 µl of absolute ethanol was then added to the lysate, 
mixed and passed through RNeasy spin column, centrifuged at 10000 rpm for 
15 sec. The column was then washed once with 350 µl of RW1 buffer. To 
remove any traces of genomic DNA contamination, DNase I (Qiagen, 
Germany, Cat. No. 79254) digestion was performed by adding 70µl of DNase 
I reaction buffer (RDD) and 10 µl of DNase I (2 units) to the column and 
incubating at RT for 15 min. After that, column was washed once with 350 µl 
of RW1 buffer and twice with 500 µl of RPE buffer, centrifuged at 10000 rpm 
for 2 min. The RNA was then eluted from the column in 30 µl of ddH2O. The 
amount and purity of the RNA was determined by measuring absorbance at 
260 nm (A260) and 280 nm (A280) with a Nanodrop spectrophotometer. An 
A260/A280 ratio of 1.8-2.0, indicating RNA free of contaminants, was 
obtained for all samples. RNA was stored at -80
o
C until use.  
Around 1 µg of isolated RNA was used for complementary DNA (cDNA) 
synthesis. cDNA was synthesized using iScript reverse transcriptase (Bio-Rad, 
USA, Cat. No. 170-8841). Firstly, RNA was added in PCR tubes containing 4 
µl of iScript reverse transcription master mix and adjusted to a total volume of 
20 µl with ddH2O. After incubation the mix for 5 min at room temperature 
was transferred to PCR machine and incubated at 42
o
C for 30 min and then at 
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C for 5 min, samples were then cooled to 4
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until required and then either used neat or diluted 1/10 depending on 
abundance of the transcript. 
2.10. Quantitative real-time PCR 
Real-time qRT-PCR was performed using SYBR Green (Fast Start Universal 
SYBR Green Master, Roche diagnostic, USA, Cat. No. 04913850001), the 
sequence of primers were used are detailed in Appendix 1, primers were 
designed using Primer 3 software. The housekeeping gene β-ACTIN was used 
for normalization. All primers were used at a concentration of 10 µM. qRT-
PCRs were performed in a total volume of 10 µl, 4 µl of 1:10 diluted cDNA 
mixed with 5 µl of SYBR Green and 1 µl of forward and reverse primers mix. 
QRT-PCR reactions were performed in Optical 234-Well Thermal Cycling 
plate (Applied Biosystems, USA, Cat. No. 4309849), sealed with optical 
adhesion film (Thermo Scientific, UK, Cat. No. AB-0558) and run on an ABI 
Prism 7900HT Fast Real-Time PCR System (Applied Biosystems, US). 
Reactions were run in biological triplicate under the following conditions: 
50
o
C for 2 min, 95°C for 10 min to activate the DNA polymerase, followed by 
40 cycles of 95°C for 20 sec and 60°C for 30 sec and 72°C for 1 min. A melt 
curve from 95°C to 60°C was used at the end of the run to ensure PCR product 
purity. Each amplicon was run in triplicate with the average values of Ct used 
in calculation. Relative transcripts expression of the gene was quantified using 
the comparative Ct method.  
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2.11. Rapid amplification of cDNA ends (RACE)  
In order to identify the missing sequence of the Xenopus pkhd1l1 gene, 
5‟RACE-PCR was carried out using a SMARTer RACE cDNA Amplification 
Kit (Clontech, USA, Cat. No. 634923) according to the manufacturer‟s 
instructions. The first strand DNA was synthesized from the RNA obtained 
from stage 38 embryos. PCR primers were designed from the closely related 
X. tropicalis sequence. Nested PCR was used to amplify the part of 5‟UTR 
and the beginning of 5‟ coding regions. 
2.12. Plasmid construction 
A full length ASUN cDNA was generated by specific primers with restriction 
sites. ASUN was tagged with PC tag at 5‟ end and cloned to pCS2+ 
expression vector. pCS2+-PC-ASUN construct was prepared from 
transformed bacterial cultures using Qiagen maxiprep kits (Macherey-Nagel, 
Düren, Germany, Cat. No. 740416.50) according to manufacturer‟s 
instructions. This construct was used for further experiments such as siRNA 
co-transfection, preparation of capped mRNA, synthesis of anti-sense RNA 
probe and co-immunoprecipitation. A mutated construct was also prepared 
using site specific mutagenesis kit (Stratagene, USA, Cat. No. 200522), 
following manufacturer‟s protocol. The sequence of primers were used are 
detailed in Appendix 1. 
2.13. Western blot analysis  
Protein was extracted from cells using protease inhibitor and phosphatase 
inhibitor cocktails-complete EDTA-free (Roche Diagnostics, Germany, Cat. 
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No. 12245300). Cells were grown until they become 70% to 80% confluent, 
around 2x10
6
 cells, and then incubated with 0.5% serum media for 72 hours. 
After washing with PBS, 500-1000 µl of lysis buffer was added to each 10 cm 
Petri dish and incubated on ice for 10 min. Lysed cells were retrieved by 
scraping with a cell scraper and transfer to 1.5 ml microcentrifuge tubes, 
mixed by pipetting and centrifuged for 1 min at maximum speed at 4°C to 
pellet cellular debris. Supernatant was removed and protein stored at -20
o
C 
until required. Protein concentration was measured using the Pierce BCA 
protein assay (Thermo Scientific, USA, Cat. No. 32225). The working reagent 
was freshly prepared by mixing of BCA reagent A and B (50:1). 5 µl of 
protein lysate and standards were loaded in triplicate to a 96-well plate. 200 µl 
of working reagent was then added into each well and incubated for 30 min at 
37°C or 2 hours at Room temperature. After that, samples were cooled at 
Room temperature and the absorption was then measured at 595 nm with the 
FluroSkan Ascent (Thermo Fisher). To obtain the protein concentration of 
lysates, absorption of samples were compared with those of a standard curve. 
Extracted proteins were mixed with 2X reducing loading buffer (1X stacking 
gel buffer; 4% sodium dodecyl sulfate (SDS); 20% Glycerol; 10 mg 
bromophenol blue; 1.65 g dithiothreitol (DTT); ddH2O to 50 ml) (Bio-Rad, 
USA, Cat. No. 161-0710), denatured by heating to 100
o
C for 10 min and 
allowed to cool, and separated by electrophoresis on sodium dodecyl sulfate 
polyacrylamide gels (SDS-PAGE)  with reducing DTT, followed by transfer 
on polyvinylidene fluoride (PVDF) membrane (Bio-Rad, USA, Cat. No. 170-
4157). All samples were made to the same volume with PBS. In addition, 10µl 
of protein molecular weight ladder (Bio-Rad, USA, Cat. No. 161-0374). 
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Protein was transferred onto mini and midi transfer packs containing the 0.2 
µm PVDF membrane and the stacks immersed in the transfer buffer. The 
transfer conditions were (25 V, 1.3 A for 7 min and 25 V, 1.3 A for 7 min) for 
mini and midi gels, respectively using a Trans-Blot Turbo system (Bio-Rad, 
USA, Cat. No. 170-4155). Membranes were then blocked in 5% milk blocking 
solution for at least 1 hour at room temperature. After that, membranes were 
incubated with 1µg/ml of primary antibody diluted in blocking solution, 
overnight at 4
o
C with rotation or at room temperature for 1 hour. All primary 
and secondary antibodies used in this experiment are found in Appendix 1. On 
the next day, membranes were washed three times for 10 min with rocking in 
PBS-Tween (5% (w/v) milk, 0.05% (v/v) Tween20 (Sigma-Aldrich, USA, 
Cat. No. P1379) in PBS at room temperature and then incubated with the 
horseradish peroxidase (HRP) conjugated secondary antibody, diluted in a 
final dilution 1:4000 in blocking solution for 1 hour at room temperature. 
After that, membranes were washed 3 times for 15 min with at room 
temperature. Bound antibody was then visualized using SuperSignal enhanced 
chemiluminescent substrate (Thermo Scientific, USA, Cat. No. 34080, 34076, 
34096) according to manufacturer‟s instructions. 
2.14. Immunofluorescence assay  
2.14.1. Immunofluorescence on cultured cells  
Around 15x10
3 
cells were seeded on 12 mm cover slips. Cells were grown to 
around 80% confluency and then incubated with 0.5% serum media for 72 
hours to induce cilia formation. Cells were then washed with PBS and fixed 
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with 4% paraformaldehyde (Sigma-Aldrich, USA, Cat. No. P6148) at room 
temperature for 15 min. Cells were then washed 3 times with PBS for 5 min 
and permeabilized with 300 µl of (10% bovine serum albumin (BSA)-PBS-
0.01% Triton-X100) (Sigma-Aldrich, USA, Cat. No. BSA, 05470; TritonX-
100, 93443) incubated at room temperature for 10 min. To block the non-
specific antibody binding, coverslips were maintained in permeablized 
solution / 1% BSA at room temperature for a minimum of 30 min. Cells were 
then washed 3 times with PBS and incubated with an appropriate volume 25 
µl of 1:200 to 1:1000 primary antibody at room temperature for 1 hour. After 
primary antibody incubation, cells were washed 3 times for 5 min with PBS 
and then incubated in the dark to protect the flurochrome from bleaching for 1 
hour at room temperature with the appropriate Fluorescein isothiocyanate 
(FITC)-conjugated secondary antibody; alexa Fluor 594 goat anti-rabbit 
immunoglobulin (IgG) (Invitrogen, USA, Cat. No. A-11012) and 488 goat 
anti-mouse IgG (Invitrogen, USA, Cat. No. A-11001) were used to detect the 
primary antibodies. Prior to mounting, cells were washed 3x with PBS, one 
drop of ProLong® Gold antifade reagent   with 4‟,6-diamidino-2-phenylindole 
(DAPI) (Molecular Probes, Eugene, USA, Cat. No. P36934) was added onto 
each slide, the cover-slips were then mounted on slides. Visualization was 
performed using a Zeiss Apotome Axiovert Z1 microscope or Olympus 
Fluoview 1000. Images were assembled in Adobe Photoshop. All primary 
antibodies and secondary used in this study are found in Appendix 1. 
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2.14.2. Immunofluorescence on nasal epithelial cells 
Human nasal epithelial cells were obtained by nasal-brush biopsy (Cytobrush 
Plus, Medscand, Sweden) and suspended in cell culture medium (RPMI) 
(Invitrogen, USA, Cat. No. 21870-076) without supplements to avoid artifacts 
caused by serum. The cytobrush was moved gently up and down for 5 min to 
detach ciliary cells from the brush. Samples were then spread onto non coated 
glass slides, air dried, and stored at
 
-80°C until use. Slides were then fixed, 
washed and stained using mouse anti-acetylated α-tubulin primary antibody 
following the same protocol above.  
 
2.15.  Xenopus leaves egg fertilization 
Xenopus leaves female frog ovulation was induced by injecting them 
subcutaneously with 800-1000 units of human chorionic gonadotropin (Sigma-
Aldrich, USA, Cat. No. CG10-IVL) into the dorsal lymph sacs, near the lateral 
line, “stitch” marks. Both pigmented and albino females with a big belly and a 
red cloaca were used. Frogs were kept in plastic tanks filled with water at 
room temperature until they started to lay about 9-10 hours later. After 
ovulation, female frogs were rested for at least 3 months before being used 
again.  
In the second day morning, the females were transferred to another tank with 
1X high salt Barth‟s solution (10X high salt Barth‟s solution: 1.095 M NaCl; 
10 mM KCl; 24 mM NaHCO3; 8 mM MgSO4.7H2O; 100 mM Hepes; 3.4 
mM Ca(NO3) 2.4H2O; 4 mM CaCl2.2H2O pH7.7; up to 4000 ml nanopure 
H2O). After 1-2 hours, eggs were collected gently using a 25 ml pipet set to 
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the slow speed to avoid any perturbations of the eggs and finely transferred 
into a 100 mm glass Petri dish (1/3 the surface of the plate). It is possible to 
collect eggs every 1 hour. 
To fertilize the eggs, testes were excised from a male frog and kept at 4⁰C in 
1.5 ml microcentrifuge tube. About 1 ml of Steinberg‟s solution (10X 
Steinberg‟s Solution: 581 mM NaCl; 6.7 mM KCl; 3.3. mM Ca(NO3)2.4H2O; 
8 mM MgSO4.7H2O;  0.01% Kanamycin; 50 mM Tris Base pH 7.45; up to 
1000 ml nanopure H2O) was added to the testes and crushed into small pieces 
with scissors in the tube. 5 to 10 drops of minced testes solution were then 
added onto the eggs after drawing off the 1X Barth‟s solution using a Pasteur 
pipet. Kimwipes were used to suck up extra buffer. The eggs were then 
incubated at room temperature for 5 min. After that, 0.1X Barth‟s solution 
(10X Barth‟s Solution: 889 mM NaCl;  10 mM KCl; 24 mM NaHCO3; 100 
mM Hepes; 8 mM MgSO4.7H2O; 3.3 mM Ca(NO3)2.4H2O; 4.1 mM 
CaCl2.2H2O pH7.6 ;  up to 500 ml pure H2O) was added to the eggs and 
incubated at room temperature for 20 min. Sperm enters the eggs once adding 
0.1X Barth‟s solution. Barth solution was then removed with Pasteur pipet and 
replaced with fresh 2% Cysteine Solution (800 ml with 0.1X Barth‟s; 16 g L-
Cysteine Hydrochloride Monohydrate (Sigma-Aldrich, USA, Cat. No. C7880-
500G) pH 7.8; up to 1000 ml pure H2O) and incubated for 8 min at room 
temperature. This step is required to complete removal of protective 
glycoprotein jelly surrounding the eggs. Floating eggs were gently submerged 
by the finger. After incubation, the Cysteine Solution was drawn off and 
replaced with fresh solution and incubated for 3 min. Eggs were then washed 
approximately 6 times with 0.1X Barth‟s solutions and incubated in 0.1X 
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Barth. The embryos were placed in the incubator under low temperature to 
slow down the development of the fertilized embryos. The embryos were 
finally cultured in 0.1X Barth‟s solution in 50 mm plastic petridish lined with 
1% agarose solution for injection.  
Note that chemicals used in this experiment, were purchased from Sigma-
Aldrich, USA unless otherwise stated. 
2.16. Xenopus morpholino design and microinjection 
Splicing and translation blocking morpholino antisense oligos were designed 
and synthesized by Gene Tools, LLC (Oregon, USA) were re-suspended in 
RNase free water to a concentration of 1 mM. MO was injected at 25, 123 ng 
per embryo at the 2-4 cell stage. Western blot and PCR analysis of protein and 
RNA extracted from morpholino-injected embryos (morphants) were carried 
out to confirm the efficiency of the gene knock-down. Sequences of 
morpholinos are given in Appendix 1.  
Embryos at desired stages of development were collected and fixed in 1X 
MEMFA (10 ml of 10X MEM (100mM MOPS (pH 7.4); 2mM EGTA; 1mM 
MgSO4; pH 7.4, filtered) + 10 ml of Formaldehyde + 80 ml dH2O) for at least 
2 hours at room temperature (or overnight at 4°C). After that, they were 
dehydrated through series of methanol (24%, 50%, 75%, and 100%) in 1X 
PBS (10X PBS: 80 g NaCl; 2 g KCl; 14.4 g Na2HPO4;  2.4 g KH2PO4; up to 
1000 ml ddH2O, pH 7.4, 0.1% DEPC) for 5 min each. Embryos were then kept 
in 100% methanol at -20°C until use. 
Note that chemicals used in the given work, were purchased from Sigma-
Aldrich, USA unless otherwise stated. 
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2.17. Whole mount antibody staining in Xenopus  
Embryos at desired stages of development were collected and fixed in 1X 
MEMFA for at least 2 hours at room temperature (or overnight at 4°C). After 
that, they were dehydrated through series of methanol (24%, 50%, 75%, and 
100%) in 1X PBS. Embryos were bleached in bleaching solution (2/3 
Methanol 100%; 1/3 Hydroxide Peroxide 31.5% (Calbiochem, Germany, Cat. 
No. 386790) for 2 hours to remove the melanin pigment, in order to get white 
embryos. Embryos were then stored in 100% Methanol at -20⁰C until use.  
On the first day, embryos were rehydrated in PBS-Methanol series (75%, 
50%, 25%), 5 min each and incubated for 30 min in 1M glycine pH7-8. After 
incubation, embryos were washed for 30 min in 1X PBS and incubated in PBS 
+ 3% H2O2 for 10 min. Embryos then washed 5 times in PBST (0.2% BSA, 
0.1% Triton X-100 in PBS) (fast wash, 2 times, 5 min and 2 times, 30 min) 
and incubate in PBSTN for 30 min. After that, PBSTN (5% normal goat serum 
in PBST) was replaced with appropriate amount of primary antibody diluted in 
PBSTN at 4°C overnight on rotator. 
On the second day, embryos were washed 8 times in PBST (fast wash, 3 
times, 5 min and 4 times, 30 min) and incubated in PBSTN for at least 30 min. 
An appropriate amount of secondary antibodies conjugated with peroxidase 
diluted in PBSTN in a final dilution 1:400 and incubated for 2 hours at 25°C 
or overnight at 4°C. After incubation, embryos were washed 7 times in PBST 




On the third day, embryos were incubated in fresh DAB Peroxidase Substrate 
(Sigma-Aldrich, Germany, Cat. No. D4418) (1 tab of each gold and silver in 
5ml water, vortex and use immediately). The color reaction must be check 
carefully within 1 to 5 min. After that, embryos were washed with PBS 
followed by PBS / 2mM EDTA to stop definitively the reaction. Embryos 
were then dehydrated through a methanol series (25%, 50%, 75% and 100%) 
in PBS, 5 min each and kept protected from light at 4ºC, rocking. 
2.18. Whole mount in situ hybridization (WISH) of Xenopus  
2.18.1. Synthesis of anti-sense RNA probe 
Around 20 µg of plasmids containing cDNA of interest were first linearization 
by digestion with 50 U of suitable restriction enzyme (50 µl total reaction). 
Digestion was run on 1% gel and purified using a PCR purification kit. 2 µg of 
the linearized DNA template were transcribed using 4 µl of 10X digoxigenin 
(DIG) RNA labeling mix (Roche Diagnostics, USA, Cat. No. 1277073), 2 µl 
DTT, 1 µl RNase inhibitor, 40 U of (SP6 or T7) RNA polymerase (Roche 
Diagnostics, USA, Cat. No. SP6, 810 274; T7, 881767), 4 µl transcription 
buffer and dH2O (40 µl total reaction). After 3 hours of incubation at 37⁰C, 
sample was treated with 2 µl of DNase I for 20 min at 37⁰C to remove any of 
DNA plasmid. Unincorporated, free nucleotides were removed by adding 100 
µl of isopropanol (100%) + 10 µl of LiCl (in ice), mixed, and incubated 
overnight at -20°C to allow precipitation of RNA. Sample was then 
centrifuged at 4°C, max speed for 30 min. The pellet was rinsed with 400 µl of 
iced ethanol 70% and spun down at 4°C, max speed for 10 min. The pellet was 
then air dried and resuspended in 30 µl of RNAse free water. Probe quality 
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was checked on agarose gel and quantified with Nanodrop spectrophotometer. 
Probe was stored at -80°C until use. Probes were used in Xenopus include 
ccdc19 for multi-ciliated cells (MCC), xeel  for mucus secreting cells (MSC), 
xema for ion-secreting cells (ISC), nkx2.5 for heart tissues, twist for cranial 
neural crest, asun and pkhd1l1. 
2.18.2. WISH 
Embryos were first rehydrated in PBS-methanol series (75%, 50%, 25%) in 
0.1% Tween-20 (PBSw) (10X PBS: 80 g NaCl; 2 g KCl; 14.4 g Na2HPO4;  
2.4 g KH2PO4; up to 1000 ml ddH2O, pH 7.4, 0.1% DEPC)  for 5 min each, 
followed by 3 washes in 1X PBSw, 5 min each. Subsequently, embryos were 
digested in 10 μg/ml Proteinase K (Invitrogen, USA, Cat. No. 25530-049) / 1X 
PBSw for 8 min at room temperature. Digestion was stopped by washing the 
embryos with 2 mg/ml of glycine in PBSw. After 3 subsequent washes in 1X 
PBSw, 5 min each, embryos were fixed in fresh 4% paraformaldehyde / 0.2% 
glutaraldehyde in PBSw for 15 min. After fixing, embryos were washed in 
PBSw again, 3 times 5 min each, followed by washing for 3 min with 50% 
PBSw / 50% hybridization solution (HS) (10 g Boehringer block; 500 ml 
formamide; 250 ml 20x SSC, heat at 65ºC for 1 hour. Add 120 ml DEPC 
treated water; 100 ml Torula RNA (10 mg/ml in filtered water); 2 ml Heparin 
(50 mg/ml in 1X SSC); 5 ml 20% Tween-20; 10 ml 10% CHAPS; 10 ml 0.5 
M EDTA). Then, embryos were again washed in HS (100%) for 3 min and 
then incubated with 400 µl of HS for 3 hours at 65ºC. Hybridization was 
started by replacing the HS with 2 µg of DIG-labeled RNA probes diluted in 
100 μl of HS. Embryos were then incubated for overnight at 70ºC. 
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On the second day, probes were replaced with 800 μl of HS for 5 min at 70ºC, 
followed by subsequent washing of embryos with 400μl of 2X SSC (pH4.5) 
(20X SSC: 175.3 g NaCl; 88.2 g Sodium Citrate; up to 1000 ml ddH2O DEPC 
treated), 3 washes for 5 min each at 70ºC; (final volume = 800 μl + 400 μl + 
400 μl + 400 μl = 2000 μl). The embryos were then washed with 2X SSC 
(pH7) / 0.1% CHAPS (2 times, 30 min, at 70ºC), MAB (100 mM Maleic Acid; 
150 mM NaCl pH 7.5) (2 times, 10 min, at room temperature), followed by (2 
times, 30 min, at 70ºC) in MAB, (2 times, 10 min, at room temperature) in 
PBS, and finally (1 time, 5 min, at room temperature) in PBSw. After that, 
embryos were incubated in 1ml Antibody Buffer (10% heat inactivated goat 
serum; 10% Boehringer blocking stock solution (Roche Diagnostics, USA, 
Cat. No. 1096176) / 80% PBSw. Heat at 70°C for 10 min, vortex, cool on ice 
and filter at 4ºC, on a rocking platform, for 2 hours. In the same time, the 
antibody anti-DIG-alkaline phosphatase (Roche Diagnostics, USA, Cat. No. 
1093274) diluted at 1:5000 from a stock of 150 units/200 µl was pre-blocked 
in antibody buffer at 4ºC, on a rocking platform. After 2 hours, the antibody 
buffer was replaced with 1.5 ml of pre-blocked antibody and incubated at 4ºC, 
overnight, rocking. 
On the third day, embryos were quickly washed with 0.1% BSA in PBSw, 
followed by washing (5 times, 1 hour, at room temperature, rocking) in 0.1% 
BSA in PBSw. Embryos were then washed (2 times, 30 min, at room 
temperature) in PBSw, (2 times, 10 min, at room temperature) in AP1 Buffer 
(0.1 M NaCl; 0.1 M Tris pH 9.5; 50 mM MgCl2). AP1 Buffer was then 
replaced with 1 ml BM Purple (Roche Diagnostics, USA, Cat. No. 1442074). 
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The reaction was developed in the dark until desired intensity (overnight) at 
4ºC with rocking. 
The color reaction was stopped by washing at least 2 times in Stop Solution 
(100 mM Tris pH 7.4; 1 mM EDTA) for 15 min each. Subsequently, embryos 
were dehydrated through a methanol series (25%, 50%, 75% and 100%), 5 
min each and kept at 4ºC. For better visualization of the signals, pigmentation 
or excess background were removed by incubating embryos in fresh bleaching 
solution (2/3 methanol 100%; 1/3 hydroxide peroxide 31.5%). Images of 
embryos were taken by a stereomicroscope M205 FA equipped with an ICD 
camera (Leica) and assembled using Adobe Photoshop (CS5). 
Note that chemicals used in this experiment, were purchased from Sigma-
Aldrich, USA unless otherwise stated. 
2.19. Assessment of ciliary beating on skin of live embryo 
At desired stages of development (Tadpole stages onward), live imaging of 
wild type and injected live embryos was taken by using high-speed cameras. 
On the other hand, drops of a diluted trypan blue dye (Sigma-Aldrich, USA, 
Cat. No. T8154) was applied on the surface of embryos. The visualization of 
fluid flow was observed under a dissecting microscope equipped with digital 
camera. Movie was edited using ImageJ (NIH). 
2.20. Scanning electron microscopy (SEM)  
Embryos at the desired stages were fixed in 3% PBS-glutaraldehyde, pH 7.4, 
for 4 hours with agitation. Embryos were then washed 3 times PBS buffer, 5 
min with agitation, followed by 3 washes with ddH2O, 5 min each, with 
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agitation. After that, embryos were dehydrated through series of ethanol 
concentrations in ddH2O (25%, 50%, 70%, 90%, 100%), 30 min each, with 
agitation. Embryos can be kept at 4°C in 70% for several days.  
Embryos were embedded in Epon 812. Sections (50-60 nm) were prepared and 
contrasted with 4% uranyl acetate in 50% EtOH and 2.6% lead nitrate in 1 M 
NaOH. Embryos were scanned using a Hitachi 7000 electron microscope 
(Hitachi, Tokyo, Japan). SEM scanning was performed at electron microscopy 
facility (Institute of molecular and cell biology (IMCB), A*STAR, Singapore). 
2.21. Morpholino injection and testing in zebrafish 
Splice blocking morpholinos were designed and synthesized by Gene Tools 
(Data S3). Variable amounts of diluted morpholinos were tested in 1-2 cell 
stage embryos to determine the maximum sub lethal dose. Sequences of 
morpholinos are given in Appendix 1.  
Morphant embryo phenotypes were analyzed at different developmental stages 
using a dissection stereomicroscope. Otolith defects were assessed at 20-22 
hours post fertilization (hpf). Hydrocephaly and curved body axis were 
detected at 48 hpf. Cardiac oedema was scored at 4-5 days post fertilization 
(dpf). Two independent injections were performed to assess the observed 
phenotypes. The number of embryos in each trial (wild-type, morpholino-a 
(MO-a), morpholino-b (MO-b) was as follows: Otolith defects, (60,160, 200) 
embryos; curved body and hydrocephaly (50, 130, 155) embryos; cardiac 
edema, (55, 90, 80) embryos. The Fisher‟s Exact Test (2 x 2 matrix, two-
tailed) was used to evaluate significance, by comparing the MO-injected 
88 
 
embryos to wild-type embryos. Morphants phenotypes were considered 
positives with a minimum percentage of affected embryos and a maximum p-
value compared to wild type embryos. For curved body: positives; >15% 
aberrant embryos, with a p-value < 3.0 x 10
-10
. For otolith defects: positives; 
>20% aberrant embryos, with a p-value < 4.0 x 10
-7
. For hydrocephaly: 
positives; >10% aberrant embryos, with a p-value < 3.0 x 10
-11
. For edema: 
positives; >20% aberrant embryos, with a p-value < 4.0 x 10
-5
. 
2.22. In situ hybridization in zebrafish 
Embryos at desired stages were fixed in 4% PFA overnight with rocking at 
4°C, followed by washing twice in PBST, 5 min each. Embryos were then 
dechorionated in PBST, dehydrated in methanol series in PBST (25%, 50%, 
75%, 100%), 10 min each and stored in 100% methanol at -20°C until use. In 
the first day, embryos were rehydrated in PBST-methanol series (75%, 50%, 
25%), for 5 min with rocking followed by washing 3 times in PBST for 5 min 
each. Embryos were then treated with Proteinase K in PBST at room 
temperature (~1 ml per tube) as follow: 24 hours embryos: 3-4 µg/ml 
Proteinase K in PBST, 5-6 min, <24 hour embryos: 3 µg/ml Proteinase K in 
PBST, 3-5 min, <100% epiboly embryos: 1 µg/ml Proteinase K in PBST, 2-3 
min. After that, embryos were fixed again in 4% PFA for 20 min at room 
temperature followed by washing 2 times in PBST for 5 min each. After 
washing, embryos were incubated in 200µl (50% PBST/50% HS) for 5 min at 
65°C followed by incubation at 65°C for 4 hours with fresh prehybridization 
buffer. Hybridization was started by replacing the prehybridization solution 
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with 2 µg of DIG-labeled RNA probes diluted in 100 μl of HS. Embryos were 
then incubated at 65ºC, overnight. 
On the second day, probes were removed and replaced with FS solution (50% 
Formamide, 5X SSC) and wash at 65°C for 10 min followed by subsequent 
washing of embryos through a FS series in 2X SSCT (75%, 50%, 25%) at 
65°C for 10 min each. The embryos were then washed with 3X SSSC at 65°C 
for 10 min and 2 times in 0.2X SSCT at 65°C for 30 min each. Embryos were 
then wash through 0.2X SSCT series in MABT (1 M Maleic Acid; 5 M NaCl 
pH 7.5; 0.1% Tween-20, up to 1000 ml ddH2O, pH 7.1-7.6)  (75%, 50%, 25%) 
at room temperature for 5 min each followed by washing 3 times in 100% 
MABT at room temperature, 5 min each. Embryos were then incubated with 
0.5% blocking solution at room temperature, for a minimum of 1 hour with 
rocking. After incubation, the blocking solution was replaced with antibody 
solution, anti-DIG-alkaline phosphatase or anti-fluorescent-alkaline 
phosphatase in blocking buffer and incubated with rocking at 4°C overnight.  
On the third day, embryos were quickly washed with 10X in MABT, for 10 
min each followed by washing 3 times in fresh NTMT (1 ml 100 mM NaCl; 
5ml 100 mM Tris (pH9.5); 2.5 ml 50 mM MgCl2; 50 µl 0.1% Tween-20; 41.5 
ml ddH2O), for 5 min each. The NTMT was then replaced with 500 µl of BM 
Purple substrate, covered with aluminum foil and incubated with rocking until 
desired staining is reached. The reaction was stopped by washing in PBST for 
10-15 min. Finally, embryos were fixed with 4% PFA overnight.  
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On the fourth day, embryos were washed 3 times with PBST, for 10 min each 
and then stored at 4°C with 50% Glycerol:PBST. WISH with an antisense 
probe for the asymmetrically expressed gene lefty2 was used in this study. 
Note that chemicals used in this experiment, were purchased from Sigma-
Aldrich, USA unless otherwise stated. 
2.23. Co-immunoprecipitation (co-IP) 
Co-IP technique is used to analyze protein interactions. Co-IP experiments 
were processed with anti-Protein C Affinity Matrix (Roche Diagnostics, USA, 
Cat. No. 11815024001). These agarose beads are coupled to the antibody anti-
Protein C (Roche Diagnostics, USA, Cat. No. 11814516001) that recognizes 
the epitope EDQVDPRLIDGK, also called PC-tag. 
To prepare cell lysate, HEK293T cells were transfected with full-length 
ASUN, INT5 and CEP170 cDNAs subcloned in pCS2+ plasmid tagged at the 
N-terminal with PC for ASUN and with heamaglutinin (HA) for both INT5 and 
CEP170. Cells were also transfected with empty vector as a negative control 
to assess whether the interaction observed between PC-tag protein and the 
target protein was specific. After 48 hours of expression, cells were lysed on 
ice using a lysis RIPA buffer (50 mM Tris HCl pH 7.5; 150 mM NaCl; 0.1% 
NP-40; 0.05% Na-deoxycholate) containing 1mM CaCl2 (Ca
2+
 increase the 
efficiency of binding of antibody to PC epitope) supplemented with complete 
Protease Inhibitor. In order to use the equivalent amount of proteins in the Co-




The immunoprecipitation was performed as follows: The PC-tagged protein 
was immunoprecipitated to PC-beads in 1.5 ml microcentrifuge tube 
(MAXYMum recovery tubes) (Axygen, USA, Cat. No. MCT-150-L-C) 
rotating for 4 hours at 4°C. After incubation, the PC-beads were washed on ice 
in lysis RIPA buffer, 3 times for 5 min each, and beads were spun down at 
4000 rpm. Then, 150 µl of target protein which was expected to bind was 
added on each immunoprecipitated complex. Samples were then incubated 
overnight at 4°C with rotating. After that, the samples were centrifuged at 4°C, 
3000 rpm for 1 min and washed 1 time in 1 ml of lysis RIPA buffer followed 
by 3 washes on ice with high salt wash buffer (20 mM Tris HCl pH 7.5; 0.5 M 
to 1 M NaCl; 1 mM CaCl2), 5 min each in order to remove the unspecific 
proteins from the beads. Then, the beads were denatured to dissociate the 
purified complexes from the PC-beads by addition of 200 µl of 2X reducing 
loading buffer (1X stacking gel buffer; 4% SDS; 20% Glycerol; 10 mg 
bromophenol blue; 1.65 g DTT; ddH2O to 50 ml) and heated at 95°C for 10 
min. After that, beads were precipitated by centrifugation at 4000 rpm for 1 
min and the supernatant was carefully collected and run on a NuPAGE Novex 
4% to 12% Bis-Tris SDS-PAGE gel. The interaction of proteins was assessed 
by immunoblotting. 
Note that chemicals used in this experiment, were purchased from Sigma-
Aldrich, USA unless otherwise stated. 
2.24. Statistical analysis  
Statistical analyses used are described in the figure legends. Calculations and 
graphing were compiled using Microsoft Excel software. Student's t-test was 
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used to calculate two-tailed „P‟ values. Values < 0.05 (*) or < 0.005 (**) were 
considered statistically significant unless otherwise specified in the legend of 




Chapter 3: Results and Discussion  
3.1. Detailed clinical manifestations in the two affected girls 
diagnosed with Mohr syndrome    
A consanguineous family from Jordan was diagnosed with Mohr 
syndrome. Out of five children, two females (patients IV.6 and IV.7) are 
affected and displayed typical features of Mohr syndrome, including 
craniofacial dysmorphisms, abnormalities in the oral cavity, digit 
malformations and heart defects, in addition to other medical problems (Table 
3). The two sisters were born at term with an uneventful pregnancy and via 
normal vaginal delivery. From medical records, birth weight was around 3.5 
kg for each. During infancy, patients were admitted to a neonatal intensive 
care unit (NICU) for about 1 month because of feeding difficulties. The 
unaffected parents are maternal first cousins whose parents are also first 
cousins (Figure 12a). Although, consanguineous marriages are common within 
the family relatives, there is no further history of congenital deformities or 
genetic diseases in the extended family. 
Upon physical examination, the two sisters displayed similar phenotypes 
consisting of craniofacial dysmorphisms including a bilateral CL, 
microcephaly, hypertelorism, epicanthal fold, broad nasal root with depressed 
nasal tip, large and low set ears, long philtrum and thick septum (Figure 12b). 
They presented with apparent bilateral CP, omega shape epiglottis, under 
developed epiglottic folds and hypertrophied false vocal cords. Oral frenula 
and tongue anomalies or tongue hamartomas were absent. Dental 
abnormalities were also observed such as central median upper incisor in one 
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girl and single central upper incisor in the other affected sister and dental 
caries. Supernumerary teeth were also observed only in one girl (IV.6) (Figure 
12b). Mild digit malformations were present such as short broad fingers, 




 fingers and toes in both hands and feet. Pre-axial 
polydactyly, was observed in one hand of one affected girl only (IV.6). 
Bilateral simian creases on both hands and rough hair were also observed in 
both patients (Figure 12j,k). Both patients underwent multiple surgical 
operations to correct the CL/P and to remove the extra finger. Hallux 
duplication, which is a common feature in Mohr syndrome was unremarkable 
in the two patients (Arroyo Carrera et al., 2013; Gurrieri et al., 2007; Pradhan 
et al., 2007; Siebert, 2008). Audiologic examination for the two girls revealed 
the presence of tympanic membrane retraction and calcification 
(myringosclerosis). Ear discharge was also frequently seen, which could be 
associated with impaired hearing and recurrent ear infections in the two girls. 
Physical examination of the eyes, showed the presence of racemose angioma 
(dilated retinal vessels) and crowded optic disk (Figure 22e,f). Patients were 
reported to have chronic urinary tract infection and recurrent respiratory tract 
infections with chronic cough. Interestingly, patient IV.7 had supravalvular 
pulmonary stenosis and partial anomalous pulmonary venous return, soon after 
birth, which is not a common feature of Mohr or OFDS. On the contrary, 
central nervous system (CNS) malformations, which are frequently observed 
in Mohr syndrome, were absent in the two patients (Balci et al., 1999; Liu et 
al., 2012). Both patients started to walk at 1.5 years old and started to make 
sentences after 3 years of age. Currently, patients have normal performance 
and development for their age despite their speech abnormality. Ultrasound 
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scan of abdomen revealed normal internal organs. Brain magnetic resonance 
imaging (MRI) and computer tomogram (CT) scan were done and revealed no 
abnormalities. Patient (IV.6) recently suffered from pancreatitis and chronic 
renal failure. These are new findings of Mohr syndrome which have not been 
seen in any other reported cases. 
Taken together, both patients share the cardinal features of Mohr syndrome 
and exhibit a wide range of clinical manifestations detailed in table 3. Inter- 
and intra- familial variations have been reported in Mohr syndrome and were 
clearly observed between the two probands. We therefore decided to study this 
family because many clinical features are unique to this family, suggesting 




Figure 12: Clinical features of the 2 Jordanian probands with Mohr syndrome. 
(a) Pedigree of the Jordanian family. Males and females are represented by squares 
and circles, respectively. Open and black symbols indicate normal and affected (IV.6, 
IV.7) individuals, respectively. Blue circle represents the same individual. Crossed 
symbols indicate deceased individuals. (b-d,k) Pictures of the patient IV.7 at different 
ages. (e-h) Pictures of the patient IV.6 at different ages. (b-f) Craniofacial 
dysmorphisms including bilateral cleft lip and palate (corrected after multiple surgical 
operations). (b,b‟,e,e‟) Hypertelorism and broad nasal bridge. (g) Flat philtrum. 
(c,d,f,g) Dental abnormalities. (h,i) Digit anomalies. (j) Simian creases. (k) Large low 






Table 3: Clinical phenotype of the two probands compared to other Mohr 
syndrome reported cases. n.d., not determined; +, affirmative; -, negative; M, male; 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.2. Identification of the Mohr syndrome causative gene 
We searched for genetic lesion by combining linkage analysis (GWL), using 
homozygosity mapping with exon capture and massively parallel sequencing. 
This approach has been successful to find the causative genes for many 
diseases in single and multiple families (Bonnard et al., 2012; Reversade et al., 
2009; Thiel et al., 2011; Thomas et al., 2012). 
3.2.1. SNP genotyping and homozygosity mapping of the family  
The 2 cases were born to consanguineous unaffected parents, suggesting an 
autosomal recessive mode of inheritance. To identify the homozygous and 
identical by descent (IBD) regions of the genome that may contain the 
causative allele for this disease, we first performed homozygosity mapping. 
We detected many segments of homozygosity located on autosomal 
chromosomes and shared between the family members, confirming 
consanguinity in the family. Homozygous segments shared by affected and 
unaffected siblings were excluded. As a result, five candidate IBD regions 
were defined as being homozygous and identical in the two affected 
individuals. None of these IBD blocks were found in unaffected family 
members (Figure 13). 
The 5 IBD loci with a total size of 45.7 Mb containing 395 genes (Appendix 
2) were as follow: 
- Ch6q27: (chr6:167,901,317-170,287,795)                             (~2.4 Mb) 
- Ch8q23.1-q24.12: (chr8:106,743,988-122,186,235               (~15.4 Mb) 
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- Ch12p13.2-p11.22: (chr12:12,129,350-28,091,505)              (~16 Mb) 
- Ch13q12.11-q12.13: (chr13:21,704,404-26,337,017)            (~4.6 Mb) 
- Ch16q21: (chr16:58,296,974-65,631,053)                             (~7.3 Mb) 
Mohr syndrome could be caused either by point mutations or indels or copy 
number variations present within these 5 loci particularly in the coding region 
of one of these 395 genes. After identifying the candidate regions, the next 
step was to sequence all genes present in the 5 IBD regions. 
 
Figure 13: Homozygosity mapping in the Jordanian family identifies 5 IBD 
regions. Homozygous blocks were found across all the autosomal chromosomes. The 
position of candidate loci on each chromosome is indicated along the y-axis. The size 
of each locus is given in centiMorgan (cM) and the respective chromosome is 
indicated on the x-axis. Five homozygous and identical regions were found in the two 
probands on chromosome 16 (Ch6q27), chromosome 8 (Ch8q23.1-q24.12), 
chromosome 12 (Ch12p13.2-p11.22), chromosome 13 (Ch13q12.11-q12.13) and 




3.2.2. Capture array and re-sequencing of 395 genes 
In order to find the causative gene, we sequenced all the 5 homozygous IBD 
regions in patient IV.6. A custom array (Agilent 610K) was designed to target 
all coding exons and exon-intron boundaries regions of the 395 genes present 
in the 5 regions. A DNA library from patient IV.6 was prepared and 
hybridized to the array according to the Agilent array protocol.  
After high-throughput sequencing, 2328 contigs found in the 5 common IBD 
regions were targeted, captured and sequenced.  A total of 894 mismatches 
were identified when aligned to the human reference genome (UCSC hg18) 
(Figure 14). Out of 849 mismatches, 735 variants were homozygous and 
reported in dbSNP129. The remaining 114 variants were homozygous novel 
and not reported in the dbSNP129. Of the 114 variants, 71 were novel and 
within transcribed regions. Of these, using SeqWare tools and the 
"knownGene" gene model from the UCSC hg18, we found that only 22 were 
localized in transcribed regions of UCSC known genes. Finally, we narrowed 
down the list of 22 to only 7 homozygous, non-synonymous mutations (Those 





Figure 14: Sequencing workflow and number of mismatches found following 
loci-capturing and re-sequencing of the five genomic candidate regions. Detail of 




Of the 7 mutations 5 were missense, 1 frameshift and 1 splice site mutations 
located in 6 distinct genes as summarized in Table 4.  
Ch. Gene Mutation Position Consequence 
6 MLLT4 c.3923A>T 168094827 Missense 
6 DACT2 c.515G>A 168453763 Missense 
6 THBS2 c.389T>C 169390657 Missense 
8 PKHD1L1 
c.6406T>G 110533684 Missense 
c.6507+1g>a 110533586 Splice site 
12 ASUN c.2004delA 26950579 Frameshift 
13 SAC2 c.4335A>T 22809430 Missense 
Table 4: The candidate genes list. Homozygosity mapping defined five candidate 
regions covering 395 genes. Using loci capture assay followed by high throughput re-





We validated the high-throughput results by Sanger sequencing of the family 
members. All unaffected siblings were found to be heterozygous or wild-type 
and the parents were heterozygous for all 7 mutations. Hence, all 7 mutations 
segregated with the disease in the family with an autosomal recessive mode of 
inheritance.  
To further narrow down the candidate gene list, we extended our sequencing 
to unaffected siblings of the parents. To this end, we collected saliva from 34 
parent‟s brothers, sisters and their children: 7 from the father‟s siblings, 27 
from the mother‟s side (Supplementary Figure 1). After sequencing the 7 
variants in each of these samples, we uncovered 4 unaffected siblings who 
were homozygous for one or two mutations found in DACT2, PKHD1L1, 
MLLT4 and THBS2, allowing us to exclude these four genes (Supplementary 
Table). We also eliminated SACS because it has been implicated in autosomal 
recessive spastic ataxia (MIM 604490) (Duquette et al., 2013; Synofzik et al., 
2013), a disease with distinct manifestations from Mohr syndrome. Finally, 
one candidate gene ASUN remains (Table 4). 
3.2.3. Identification of c.2004delA in ASUN as the disease-causing 
mutation 
We first verified that the ASUN mutation segregates with the disease status in 
all family members using Sanger sequencing. PCR primers are given in 
Appendix 1. The homozygous deletion c.2004delA in ASUN gene was 
confirmed in the two affected patients. Based on the autosomal recessive mode 
of inheritance of the causative allele, both parents and the unaffected sister 
were found to be heterozygous (unaffected carriers) (Figure 15). The other 34 
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family members were either heterozygous or homozygous non-carrier. The 
c.2004delA variant in ASUN is therefore most likely a disease-causing in the 





Figure 15: Electropherogram of the ASUN mutation in the family siblings 
obtained by Sanger sequencing. Electropherograms of the parents 
(heterozygous/carriers), the unaffected siblings (heterozygous/carriers), and the two 
affected cases (homozygous mutant) for c.2004delA mutation. The red arrowheads 
indicate the position of the mutation. 
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The one base pair (bp) deletion c.2004delA, located in exon 16 of ASUN 
(NM_018164.2), causes a frameshift (Table 4). In silico analysis using a 
computer prediction software SIFT (http://sift.bii.a-star.edu.sg/) predicted that 
this mutation may create a premature termination codon (PTC) 8 amino acids 
from the site of mutation, resulting in deletion of the remaining 31 amino acids 
of the ASUN protein (Figure 16a). This ASUN mutation led to the amino acid 
change p.K668Nfs*9. It is also predicted that c.2004delA in exon 16 may 





Figure 16: Overview of the chromosomal localization of the ASUN gene (hg 18), 
genomic structure and schematic representation of the frameshift mutation. (a) 
The ASUN gene is located in chromosome 12 (Ch12p13.2-p11.22) and consists of 17 
exons. A frameshift mutation is detected in ASUN gene as a disease causing mutation. 
The c.2004delA (p.K668Nfs*9) mutation caused by single base pair deletion in exon 
16 predicted to introduce a PTC which may disrupt the reading frame and deletes the 
rest of around 31 amino acids from mutated protein. (b) In silico analysis using SIFT 
software also predicted that this mutation could induce NMD.  
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3.2.4. ASUN gene and ASUN protein functions SNP genotyping  
ASUN, also known as a spermatogenesis regulator homolog, referred to its 
basic function in Drosophila and later it was given a name asunder (set apart 
in position or space) based on its phenotypes. ASUN is encoded by a 32.8 kb 
genomic region (12p11-p12) and comprises 17 exons (Figure 16a). ASUN has 
an open reading frame of 2.97 kb and encodes a 706 amino acids protein 
known as ASUNDER (ASUN) with predicted molecular weight of 76 kDa. 
This protein belongs to a cell cycle regulator Mat89Bb (Maternal transcript 
89Bb) family due to its maternal expression in Drosophila embryo (Lee et al., 
2005; Stebbings et al., 1998).  
Bourdon and colleagues found that ASUN was expressed in all normal human 
tissues with high expression in testicular seminomas (Bourdon et al., 2002). 
Using a genome scale in vitro expression cloning (IVEC) technique in 
Drosophila, Lee and her group identified several genes including asun, whose 
encoded proteins function as substrates for the PAN GU (PNG) kinase that 
regulates Drosophila cell cycles. Subsequent functional analysis of ASUN was 
then performed in Drosophila, Xenopus and human epithelial cervical cancer 
cells (HeLa), showed that ASUN plays a biological function in HeLa cell 
cycle as well as animal models embryonic development (Lee et al., 2005). 
Loss-of-function approach of Asun resulted in disruption of development in 
Xenopus and Drosophila and cell cycle defects in both models and cultured 
cells.  By these findings, authors suggested that ASUN has a conserved 




In 2009, functional analysis of ASUN in Drosophila revealed that asun 
regulates spermatogenesis, a process required to generate mature and 
functional sperm (Anderson et al., 2009). While, loss-of-function analysis had 
no defects in either spermatogonial cell proliferation or overall appearance of 
Drosophila males, the seminal vesicles of male testis had few mature sperm 
which were mostly immotile. Furthermore, most of the spermatocytes were 
arrested during prophase I and contained free centrosomes. The cells that 
escaped cell cycle arrest displayed severe defects such as spindle assembly, 
chromosome segregation, and cytokinesis. They also showed that the failure of 
nucleus-centrosome coupling at the onset of meiotic cell cycle caused by 
disruption of normal nuclear localization of dynein-dynactin in mutant 
spermatocytes and spermatids (Anderson et al., 2009). The mechanism by 
which asun regulates spermatogenesis through recruitment of dynein-dynactin 
to the nuclear surface however could not be determined.  
This work was followed by two more studies explaining the previous 
mechanism. The results showed that Drosophila asun co-localized and 
interacted with Drosophila lissencephaly 1 (lis1), a dynein adaptor (Sitaram et 
al., 2012). This interaction was found to be conserved between the mammalian 
homologues. Down-regulation of ASUN in cultured human cells resulted in 
reduction of perinuclear dynein during prophase of mitosis, nucleus-
centrosome uncoupling and downstream cell cycle defects (Jodoin et al., 
2012). These findings suggested that ASUN interaction with dynein in the 
cytoplasm via LIS1 required for the proper dynein-dynactin perinuclear 
localization, a step that is necessary for the nucleus-centrosome coupling at the 
onset of meiotic G2/M transition in Drosophila primary spermatocytes and 
110 
 
mitotic cell cycle in cultured human cells (Jodoin et al., 2012; Sitaram et al., 
2012). These studies suggested that besides asun and lis1 interaction, other 
unknown protein partners may be required for the proper function; a 
proposition that has yet to be determined.  
A genome-wide RNAi screen in Drosophila S2 cells performed by Chen and 
coworkers has elucidated a new function of asun. It was shown that asun is 
required for the formation of the 3‟-end of small nuclear RNAs (snRNAs), a 
process normally mediated by a complex of proteins known as integrator 
complex (INT) (Chen et al., 2012).  snRNAs are non-coding RNA molecules 
that play vital roles in pre-mRNA splicing via removing of introns and further 
processing of pre-mRNAs (Matera et al., 2007). Additional biochemical 
analysis demonstrated that ASUN is a core component of INT. 14 INT 
subunits (INT) were found to be evolutionarily conserved, including  ASUN, 
which is referenced as INT13 (Chen et al., 2012).  
Subsequent experiments were carried out on HeLa cells in order to understand 
the mechanism of dynein localization and to determine the precise role of 
ASUN and other INT in this process (Jodoin et al., 2013b). The experimental 
results showed that INT required for dynein enrichment at the nuclear 
envelope. Knock-down (KD) of several individual INT in HeLa cells resulted 
in similar reduction of perinuclear dynein as in ASUN-siRNA cells. Structural 
analysis of ASUN revealed the presence of a specific conserved sequence at 
the C-terminus that mediates the nuclear localization of ASUN. These findings 
confirmed that ASUN and many INT interact to regulate the recruitment of 
dynein to the nucleus at specific time of the cell division. Taken together, 
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these results established that INT complex is essential for nuclear dynein 
localization, possibly through snRNA processing. This discovery paved the 
way for the following studies of role of INT in ciliogenesis.  
Jodoin and colleagues found that several INT were essential for primary cilia 
formation (Jodoin et al., 2013a). Using siRNA-mediated KD of individual INT 
in human retinal pigmented epithelial (RPE) cells, led to the absence of 
primary cilia and defects in centriole coupling. These results were limited to a 
group of INT. Interestingly; depletion of several INT did not affect other 
proteins required for primary cilia formation or for dynein recruitment to the 
nuclear envelope. Subsequent siRNA-mediated down-regulation experiments 
of other proteins that regulate perinuclear dynein showed no defects in 
ciliogenesis, although one of these proteins (CENP) displayed longer cilia. 
These results have demonstrated that primary cilia formation is independent 
on dynein recruitment to the nuclear envelope even though both processes are 
regulated by INT (Jodoin et al., 2013a). A recent study in Drosophila has 
confirmed the role of asun in the regulation of dynein localization and 
subsequent processes during oogenesis (Sitaram et al., 2013). 
3.2.5. ASUN is highly conserved across vertebrate species  
Highly conserved protein sequence across different species indicates a crucial 
function of this protein and a high evolutionary significant (Giudice, 2001). 
By amino acid alignment of ASUN proteins found in amphibians, fish and 
mammals, we found a high degree of sequence similarity among these 
animals. Moreover, we found that mutated residues reside within a highly 
conserved sequence of ASUN protein (Figure 17), suggesting that alteration of 
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these amino acids may lead to a pathogenic function of ASUN protein. A full 






Figure 17: Amino acid sequence alignment of ASUN in different speicies. Partial 
amino acid alignment of ASUN proteins shows high homology across vertebrate 
species. The amino acid sequences were retrieved from 
http://www.ncbi.nlm.nih.gov/protein/ website, using the following accession 
numbers: Homo sapiens (NP_060634.2), Gallus gallus (XP_416439.2), Xenopus 
leaves (NP_001086192.1), zebrafish (NP_956177.1), Rattus norvegicus 
(NP_001103078.1). Alignment performed using 
http://multalin.toulouse.inra.fr/multalin/. Asterisk (*) referred to the position of the 





3.2.6. The c.2004delA mutation causes down-regulation of ASUN 
mRNA expression  
Quantitative reverse transcriptase PCRs (qRT-PCR) were performed using 
cDNAs generated from RNA extracted from patient and control cells. The 
level of ASUN transcripts was found to be significantly down-regulated in 
patient‟s fibroblast cells compared to control cells Figure 18a). This suggests 
that ASUN mRNA was targeted for degradation by a nonsense-mediated decay 
(NMD). NMD is an evolutionary conserved mRNA surveillance mechanism 
which selectively degrades mRNAs that carry premature termination codons 
(PTCs) (Chang et al., 2007; Culbertson, 1999). The qRT-PCR was repeated in 
other cell types derived from patients and controls such as Epstein Barr virus-
transformed B-lymphoblastoid (EBV-LYB) cells and peripheral blood 
mononuclear cells (PBMC). The expression level of ASUN mRNA was also 
down-regulated in EBV-LYB, while the level of mRNA transcripts was 
unchanged in PBMC (Figure 18b,c). This might be due to the differences of 
number of white blood cells between both patients and control; therefore the 
abundance of mRNA transcripts will be different. To test whether the 
reduction in mRNA level in patient‟s cells was caused by NMD, the cultured 
cells were treated with cycloheximide (CHX) (Sigma), a translational inhibitor 
that inhibits NMD. A qRT-PCR was then performed on total mRNA to 
determine the mutant transcript levels. The results showed that the level of 
mutant mRNA was increased in EBV-LYB cells following CHX treatment, 
while levels were unchanged in fibroblast cells. This suggests that the mutant 




Figure 18: Quantitative real time PCR (qRT-PCR) in different cell lines. (a,b) 
The ASUN expression is down-regulated in patient‟s primary dermal fibroblasts & 
EBV-LYB cells, respectively relative to control cells. (c) Whereas, there is no 
significant difference between the affected and control PBMC. (d) Primary dermal 
fibroblast and EBV-LYB were treated with cycloheximide (CHX) (100 g/ml) for 4 h. 
Following treatment with CHX, a transcript level is increased in EBV-LYB relative 





3.2.7. The c.2004delA mutation results in a truncated protein 
To evaluate the effect of ASUN gene mutation on the encoded protein, western 
blot of cell lysates made from patients and control fibroblasts was performed. 
We designed two high affinity purified polyclonal antibodies against N-
terminal and C-terminal peptides of human ASUN (rabbit anti-M and anti-C, 
respectively) (Jodoin et al., 2012) (Figure 19a). These antibodies were used to 
determine the presence or absence of a truncated protein, respectively. The 
results displayed the presence of a truncated protein in patient cells compared 
to control cells by anti-M antibody. No product however was observed by 
anti-C antibody, consistent with the genetic mutation we discovered (Figure 
19b). This result was further confirmed in RPE cells, these were generated 
using induced pluripotent stem (iPS) cells derived from patient‟s fibroblast 
cells (Figure 19b). This suggests that a truncated ASUN protein is made in the 





Figure 19: The c.2004delA mutation resulted in a truncated protein. (a) The 
position of peptide sequence of ASUN polyclonal antibodies. (b) Western blot 
analysis in primary dermal fibroblast and RPE cells using anti-ASUN (M & C) 
antibodies. The results show the presence of a truncated product of ASUN in the 
affected fibroblast cells (Lane 2) and RPE (Lane 4) when probed with the α-M 
antibody but there is no product is observed with the α-C antibody compared to the 






Using a homozygosity mapping and loci capture assay, we identified a single 
base pair deletion in ASUN gene that leads to a rare congenital disorder called 
Mohr syndrome or OFDII affecting the face, the oral cavity and the digits in 
addition to other organs. 
The ASUN mutation reported in the two patients leads to a frameshift that 
results in a PTC in the  ASUN mRNA; that should, in theory, detects the 
mutant mRNA to be degraded by NMD, thus the transcript level is predicted 
to be reduced. Therefore, we proposed that patient‟s phenotypes are primarily 
caused by changes in activity of the remaining truncated ASUN protein. 
Therefore, the next step was to investigate the impact of c.2004delA mutation 
experimentally. A quantitative real-time PCR (qPCR) and western blot 
analysis were carried out to examine the levels of both ASUN mRNA and the 
encoded protein as a result of this mutation. 
The qPCR, findings indicated the existence of tissue-specific NMD for ASUN 
gene, which was confirmed by CHX treatments. The western blot analysis 
revealed the presence of a truncated product of ASUN in the affected 
fibroblasts. These findings suggest that the disease phenotype could be either 
due to loss of ASUN protein or as a result of truncated protein. 
To investigate the function of ASUN and its encoded protein in patients‟ cells, 
we first need to determine the localization pattern of the endogenous protein. 
Moreover, Identification of a crucial role of several OFD genes (CXORF5, 
TCTN3, TBC1D32 and SCLT1) in cilia formation and function suggests that 
Mohr syndrome and even the other OFD could be ciliopathies as well. 
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Additionally, the fundamental role of several INT in ciliogenesis provides 
further evidence that is ASUN could be implicated in cilia formation and/or 
function. To investigate this hypothesis and to gain insight into the possible 
role of ASUN in ciliary processes, biochemical experiments on patients‟ cells 















3.3. Subcellular localization of ASUN 
3.3.1. ASUN is ubiquitously localized in human and mouse cell lines 
ASUN has been reported to localize in Drosophila spermatocytes and its 
localization ranges from predominantly nuclear to being apportioned between 
the nucleus and cytoplasm (Anderson et al., 2009; Jodoin et al., 2012). Similar 
patterns were also observed in cultured HeLa cells. To assess the subcellular 
localization of ASUN in cultured primary dermal fibroblasts, we carried out 
immunofluorescence staining using ASUN α-M and α-C, respectively and 
DAPI to visualize DNA. The results showed that ASUN is localized both to 
the nucleus, and to the cytoplasm by α-M, similar to which have been reported 
in Drosophila spermatocytes and HeLa cells (Figure 20a,b). Whereas, using α-
C antibody, ASUN localization was predominantly to the cytoplasm with a 
background of unspecific staining. We repeated the experiment using other 
cell lines such as mouse embryonic fibroblast cells (NIH3T3) and human 
embryonic kidney 293 (HEK293T) cells, which showed similar localization 
patterns of ASUN (Figure 20c-e). Both ASUN antibodies showed 
inconsistency between cells which could be due to a cross reactivity of these 
antibodies to non-specific antigens in immunofluorescence although these 
antibodies were successfully validated by immunoblotting 
3.3.2. ASUN is localized to primary cilia in primary dermal fibroblasts 
To investigate the possible role of ASUN in ciliogenesis, and whether the 
primary cilia are affected in patient‟s cells, immunofluorescence staining in 
primary fibroblast cells was undertaken using ASUN (α-M & α-C) and anti-
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acetylated α-tubulin antibodies that marks ciliary axoneme. Upon analysis, the 
results showed that the ASUN signal was overlapped with acetylated α-tubulin 
(Figure 20a-e). These findings suggest a conserved function of ASUN 





Figure 20: Cytoplasmic, nuclear and primary cilia localization of ASUN in 
different cell lines. ASUN localization in human and mouse cell lines. (a,b) 
Immunofluorescence staining for ASUN in human primary fibroblasts, (c,d) NIH3T3 
and (e) HEK293T cells. ASUN (α-C & α-M) and acetylated α-tubulin antibodies were 
used in this experiment. ASUN displays cytoplasmic and nuclear localization in all 
cell types. Additionally, ASUN is also co-localized with the acetylated α-tubulin that 




3.3.3. Primary cilia assembly is not affected in patient’s cells 
Given the localization of ASUN to primary cilia, we decided to examine 
whether its localization is affected in patient‟s cells as a result of a frameshift 
mutation. To test this, cultured fibroblasts derived from patient and from 
unaffected age-matched control were seeded until they become confluent, 
followed by incubation with serum free medium for 72 hours to promote 
ciliogenesis. We next performed immunofluorescence staining with ASUN 
antibodies and other antibodies against axonemal (acetylated α-tubulin) and 
centrosomal (pericentrin and CEP170) proteins. Unfortunately, we were 
unable to discern significant differences with respect to cilia formation, 
morphology and number in the patient‟s cells compared to control cells, 
although many patient‟s cells displayed either no cilia or longer cilia (Figure 
21a,b). Similarly, patient‟s RPE cells were normally ciliated compared to 
control cells (Figure 21c). The plausible explanation for this could be due to 
that ASUN mRNA escaped NMD leading to the production of truncated 
ASUN protein which might be hypomorphic or neomorphic rather than loss-
of-function. On other hand, there was a significant reduction in the nuclear 
expression of ASUN protein between patient and control fibroblast cells, using 
ASUN (α-M) antibody, while the cytoplasmic expression ASUN was 
unchanged (Figure 21a). Therefore, we sought to address primary cilia 








Figure 21: Normal primary cilia formation in patient’s cells. Immunofluorescence 
staining in control and patient‟s cells using acetylated α-tubulin, pericentrin, CEP170 
and ASUN antibodies. (a) Patient fibroblasts display normal cilia formation with 
marked reduction in a nuclear localization of ASUN, while no change in its 
localization to primary cilia. (b) Many individual patient‟s cells possess variable 
length of cilia compared to control cells. (c) Patient RPE cells show no significant 
difference in primary cilia morphology and number as well as ASUN localization 




3.3.4. ASUN depletion through RNA interference (RNAi) 
To gain insight into the function of ASUN in ciliogenesis, we performed 
siRNA-mediated depletion for ASUN in primary dermal fibroblasts and RPE 
cell as another cell line that normally form primary cilia when they become 
confluent. RNAi is a highly conserved pathway involving a gene silencing 
mediated by introduction of exogenous short double-stranded RNA (Campbell 
and Choy, 2005). By this technique, we examined the consequences of ASUN 
depletion in ciliogenesis in human cells. 
3.3.5. ASUN down-regulation shows no defect in primary cilia 
formation in cultured dermal fibroblasts  
Since we did not find ciliogenesis defects in patient‟s cells, we postulated that 
KD of ASUN in fibroblast cells could cause obvious ciliary defect compared to 
the patient mutation. Fibroblasts were transfected with ASUN-siRNA followed 
by immunofluorescence staining with anti-acetylated α-tubulin antibody to 
visualize primary cilia formation. Unfortunately, we found that reduction of 
ASUN levels had no overt effect on primary cilia formation; cilia were present 
and formed normally from the surface of fibroblast cells after 48 hours of 







3.3.6. ASUN depletion results in loss of primary cilia in retinal 
epithelial cells (RPE) 
To preclude the possibility of tissue-specific requirement of ASUN in primary 
cilia formation, we repeated these experiments in retinal epithelial cells (RPE). 
We chose RPE since ophthalmological assessment in both patients revealed 
the presence of racemose angioma (dilated retinal vessels) and crowded optic 
disk (Figure 22e,f), raising the possibility that these manifestations could be 
related to ciliary dysfunction as a result of ASUN mutation. Therefore, we 
addressed the consequence of ASUN depletion on ciliogenesis in RPE cells. 
Performing siRNA-down-regulation of ASUN, followed by incubation with 
low serum medium for 24 hours to promote ciliogenesis. For rescue 
experiment, cells were transfected with another ASUN-siRNA duplex 
designed against 3‟UTR together with wild-type and mutant ASUN-tagged 
with Myc epitope to detect fusion proteins. Immunofluorescence staining 
using antibodies against acetylated α-acetylated tubulin and γ-tubulin was then 
carried out which showed most of ASUN-siRNA transfected cells did not form 
cilia compared to the control cells (Figure 22a-d,g). The experiment was 
repeated four times and gave similar findings. Besides that ASUN is 
indispensable for primary cilia formation, these findings also indicate a tissue 
specific function of this protein. The plausible explanation for this 
heterogeneity between fibroblasts and RPE could be due to a difference in the 
level of ASUN expression between these cells. The level of ASUN protein 
was assessed by western blot analysis to validate the KD efficiency (Figure 
22h). ASUN depletion in RPE cells was carried out by our collaborator Dr. 
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Laura A. Lee lab, Department of Cell and Developmental Biology, Vanderbilt 





Figure 22: Loss of primary cilia in RPE cells following ASUN-KD. (a) RPE cells 
transfected with control siRNA plus vector DNA display primary cilia. (b,d) Cells 
transfected with ASUN-siRNA plus vector DNA display no cilia. Furthermore, loss 
of hASUN causes an even more sever degree of multinucleation. (c) Cells transfected 
with ASUN siRNA directed against 3‟UTR  plus a Myc tagged-ASUN expression 
construct (“Rescue”) show restored cilia. Cells were fixed and stained for acetylated 
α-tubulin (labels cilia) and γ-tubulin (labels basal bodies). Scale bars, 20 μm.  (e,f) 
Fundus appearance in both patients shows dilated retinal vessels and crowded optic 
disk. (g) Quantification of cells with primary cilia. Almost all control-siRNA cells 
had cilia compared to 30% of ASUN-siRNA cells. All experiments were performed a 
minimum of four times with at least 300 cells scored per condition. Error bars 
indicate SEM. „„NS‟‟ stands for not significant. Asterisk, p < 0.0001 (Student‟s 
unpaired t test). (h) Immunoblotting of cell lysates confirms the efficient KD of 
ASUN. Tubulin was used as loading control. 
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3.3.7. Multi-cilia are perturbed in patients’ nasal epithelia  
The epithelia lining the upper and lower respiratory tract are densely covered 
with motile cilia that are responsible for the clearance of the airway. 
Reduction of mucociliary clearance of the airway is related to cilia 
dysfunction, often resulting in recurrent respiratory tract infections. Both 
patients suffer from recurrent respiratory tract infection and chronic cough. 
We assumed the ciliary defect could be behind these phenotypes. So, we 
obtained respiratory epithelial cells from the two patients and the mother to 
assess the cilia formation and performance. Immunofluorescence staining was 
performed using anti-acetylated α-tubulin antibody. The average length of 
nasal cilia was then scored. The results revealed shorter, fewer and 
disorganized cilia compared to that of the heterozygous mother, which may 
explain the recurrent respiratory tract infections in the two affected patients 
(Figure 23).  
 
Figure 23: Immunofluorescence of multiciliated cells after nasal biopsies. (a-c) 
Morphological appearance of respiratory epithelial multi-cilia in the mother and the 
two patients‟ cells, respectively. (d) Average length of nasal cilia in 200 cells of both 
control and patient. Cilia look shorter, less dense and disorganized in most epithelial 




3.3.8. Alteration of Sonic hedgehog (SHH) signaling in patient’s cells  
Although the out-of-frame mutation of ASUN had no effect on primary cilia 
formation, the overall appearance of patients‟ phenotypes suggests a possible 
ciliary dysfunction. Example of these phenotypes including, hypertelorism, 
polydactyly and teeth duplication, all suggesting SHH defects. We postulate 
that in spite of normal ciliation in patients‟ cells, the effect of ASUN mutation 
could be restricted to cilia function. Therefore, we addressed whether a 
frameshift mutation alters the activity of SHH. Patient‟s and control 
fibroblasts were seeded till confluency and incubated with low serum media 
for 72h. At 48h incubation, cells were treated with hedgehog agonist (SAG) 
and further incubated for the last 24h. A qRT-PCR was carried out to examine 
the expression levels of Ptch1 and Gli1, SHH target genes to give a read out of 
SHH signaling pathway activity (Caspary et al., 2007). Interestingly, the 
results showed that SAG treatment was able to induce SHH signaling pathway 
in patient‟s cells to a level higher and comparable between control- and 
ASUN-siRNA transfected cells (Figure 24). We observed an up-regulation of 
Gli1 expression following SAG treatment in patient‟s cells more than either 
the control or the ASUN-depleted cells. For Ptch1, We did not observe a 
significant change of its level in both control and patient‟s cells. However, 
these findings suggest that the frameshift mutation could be a hypomorphic, 
which while allowing primary cilia formation, does not lead to fully functional 
cilia. Alternatively, the truncated ASUN mutant protein could have a 
neomorphic function in promoting SHH signaling, either directly or indirectly 
through molecular alterations to ciliary function activity of ASUN mutation, 




Figure 24: Disruption of SHH in patient’s cells. A qRT-PCR for SHH target genes, 
Ptch1 and Gli1 before and after Sonic hedgehog (SAG) treatment. (a) The level of 
Ptch1 transcript is not significantly changed after 1 µM SAG treatment. (b) The level 
of Gli1 transcript is markedly up-regulated after SAG treatment. (c)  The level of Gli1 
expression at higher dose of SAG (2 µM) in patient‟s cells compared to control- and 
ASUN-siRNA transfected cells, shows dosage dependent of Gli1. Surprisingly, Gli1 
transcript level in patient‟s cells is highly up-regulated compared to control-siRNA 





The ASUN depletion in human cell lines indicated the essential role of this 
protein in cilia formation, although insignificant effect of ASUN frameshift 
mutation in patient‟s cells. Despite normal ciliation of patient‟s cells, our 
findings showed alteration in SHH signaling pathway, which argued for us to 
characterize the function of this gene in animal models.  
To gain insight into the pathophysiological mechanism behind the clinical 
features of individuals with Mohr syndrome, different animal models such as 
zebrafish, Xenopus and Drosophila were utilized to investigate the role of 
ASUN during embryogenesis. My objective was to better understand how the 













3.4. In vivo animal modeling of ASUN 
3.4.1. ASUN c.2004delA failed to rescue asun-mutant Drosophila 
phenotypes 
This experiment was carried out by our collaborator Dr. Laura A. Lee. Her 
group had previously generated an asun-mutant Drosophila line (asun
f02815
 
males) carrying a truncated asun transcript in germ cells of the testes which 
displayed spermatogenesis phenotypes (Anderson et al., 2009; Jodoin et al., 
2012). The biochemical analysis of asun-mutant Drosophila revealed severe 
reduction of perinuclear dynein, loss of nucleus-centrosome coupling and 
multinucleation in the spermatids (Jodoin et al., 2012). ASUN protein is 
highly conserved from C. elegans to human. The human ASUN protein shares 
61% similarity and 36% identity with its Drosophila orthologue (Lee et al., 
2005). Drosophila asun mutants expressing the wild-type of either Drosophila 
asun or human ASUN were able to rescue the aforementioned phenotypes 
(Anderson et al., 2009). Given this functional conservation of ASUN, we 
therefore attempted to examine whether the ASUN c.2004delA mutation could 
restore the resulted Drosophila asun mutant phenotypes.  




) was generated by 
introducing a frameshift mutation into the wild type pCS
2+
-ASUN using site-
specific mutagenesis. Mutated construct was verified by sequencing (this part 
was performed by me in our lab). Both mutant and wild-type constructs were 
then subcloned into testis expression vector tv3 tagged with Cherry (CHY) at 
the N-terminal. Transgenic lines of asun mutants expressing either the wild-





generated. Then perinuclear dynein, nucleus-centrosome coupling and 
multinucleation in asun spermatocytes were assessed in each line. 
Rewardingly, the results showed that unlike the CHY-ASUN, the CHY-
ASUN
c.2004delA
 transgene failed to rescue Drosophila asun prototypical 
phenotypes (Figure 25). These findings strongly support that ASUN frameshift 





Figure 25: Mutant ASUN failed to rescue Drosophila asun-mutant phenotype. 
(a,b) Germline CHY-ASUN expression restored perinuclear dynein in asun primary 





not. (d,e) Representative G2 spermatocytes stained for dynein heavy chain (DHC) 
and DNA are shown with bar graphs describing percentages of spermatocytes or 
spermatids exhibiting properly localized DHC. (c,f) Germline CHY-ASUN expression 
restored nucleus-centrosome coupling in asun primary spermatocytes, while CHY-
ASUN
mut
 failed to. (c) Prophase I spermatocytes stained for -tubulin and DNA. (f) 
Quantification of nucleus-centrosome coupling in prophase spermatocytes. 
Arrowheads indicate centrosome positions, f.wt (asun-Drosophila wild-type). 




3.4.2. Modeling of Asun loss-of-function in zebrafish  
After we identified the causative gene for Mohr syndrome, the next step is to 
understand its function. In order to recapitulate the disease phenotypes and 
explore the role of ASUN in vivo, we chose to use a zebrafish model, which 
has been well established as a suitable vertebrate model system to explore 
ciliopathies (Bisgrove et al., 2005; Hildebrandt and Zhou, 2007; Otto et al., 
2010; Sayer et al., 2006; Simms et al., 2012; Valente et al., 2010). One asun 
paralogue has been annotated in zebrafish and showed high amino acid 
sequences similarity to other vertebrates. We first determined the expression 
pattern of asun at different developmental stages and then performed loss of 
function experiments. Zebrafish work was carried out by our collaborators Dr. 
Sudipto Roy and Dr. Semil Choksi, Institute of Molecular Cell Biology 
(IMCB), A*STAR, Singapore. 
3.4.2.1. Endogenous asun is expressed ubiquitously throughout 
zebrafish development 
Whole embryo in situ hybridization was performed to examine spatiotemporal 
expression pattern of asun in zebrafish at different embryonic developmental 
stages. We found that asun was constitutively and ubiquitously expressed 
throughout development. Figure 26 shows that the expression of asun at 24 
hours post fertilization (hpf) is ubiquitous, while being enriched in the anterior 
regions of the embryo, including the brain and the eye (Figure 26a). Whole 
mount immunofluorescence staining using ASUN (α-C, α-M) antibodies and 
GFP-tagged Asun protein revealed that the endogenous protein is mainly 
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expressed in the cytoplasm, while the exogenous proteins showed a nuclear 





Figure 26: Expression pattern of asun/Asun in zebrafish embryos. (a) In situ 
hybridization in zebrafish at 24 hpf revealed an ubiquitous expression of asun 
transcripts. The red box represents the position of cells, which were used for 
Immunofluorescence. (b-d) Immunofluorescence analysis using ASUN antibodies (α-
C, α-M) and an overexpression of a GFP-tagged Asun, respectively. The result shows 
cytoplasmic localization of Asun using α-C, α-M, whereas it is predominantly 





3.4.2.2. Loss of Asun function in zebrafish causes ciliary defects  
To assess whether the loss of Asun resulted in ciliary and embryonic defects in 
zebrafish, we performed transient depletion of Asun protein. Splice blocking 
morpholinos (MO), anti-sense oligonucleotide sequence, were designed 
against asun mRNA to disrupt its normal splicing. Two different splicing-MO 
(MOa & MOb) were injected separately into the animal pole of zebrafish 
embryos at the 1-cell stage. We observed that morphant embryos were 
severely malformed, displaying small head, shortened and curved body axis, 
hydrocephalus and otolith defects (fused) (Figure 27c,d,g) and cardiac oedema 
developed at 3 days post fertilization (dpf) (Figure 27f; Figure 28). Almost all 
morphants did not survive after 5 dpf due to a massive edema. Both MO gave 
similar phenotypes, but phenotypes were more severe with asun-MOa than 
with asun-MOb (Figure 27g). RT-PCR was performed to verify aberrant 
splicing for each MO (Figure 27h). These phenotypes are collectively 
considered as typical ciliary defects, suggesting a crucial role of Asun in 
ciliary function during early developmental stages (Austin-Tse et al., 2013; 









Figure 27: Morphological phenotypes of asun MO-injected zebrafish embryos. 
(a,c,e) Lateral views of 48 hpf controls. (b,d,f) Time-matched views of asun morphant 
embryos. (b) Embryo injected with asun-MO display small head, short and bent body 
axis. (c) In control embryos, two otoliths are found in the otic vesicle, whereas the 
two otoliths are often fused in morphant embryos (d). (e,f) Morphant embryos also 
display marked hydrocephaly compared to the control embryos (red arrow head). (g) 
The percentage of observed phenotypes using two different splicing-MO injected in 
100 embryos. (h) RT-PCR for splicing-MO (MOa & MOb) shows that MOa is more 




3.4.2.3. KD of asun in zebrafish causes craniofacial patterning defects   
Craniofacial development is conserved throughout different species and 
particularly between human and zebrafish as shown in several studies, 
zebrafish is thus, a suitable model to address craniofacial defects (Duldulao et 
al., 2009; Ferrante et al., 2009; Tobin and Beales, 2009; Tobin et al., 2008). 
Moreover, many developmental signaling pathways (e.g. Shh and Wnt) that 
are essential for the development of craniofacial structures were found to be 
conserved between fish and mammals. We therefore examined the craniofacial 
morphology in larval zebrafish Asun morphants using alcian blue (AB) 
staining. We observed severe craniofacial disruption; craniofacial cartilage 
was totally absent at majority of the injected embryos, and morphants 
exhibited a small head with variable severity of hypotelorism (Figure 28), 
consistent with the expression pattern of asun. Given that Asun is important 
for the formation of normal head structures, one can hypothesize that it is 
involved in cranial neural crest cells (CNCC) migration and suggests a 






Figure 28: Severe carniofacial defects in Asun-depleted embryos. Ventral view of 
representative wild-type and Asun-morphant embryos stained with AB at 4 dpf. (a) 
wild-type embryo with intact craniofacial structures. (b) Asun-morphant with sever 
craniofacial defects including small head, hypotelorism and complete absence 
craniofacial cartilage.  Branchial (BA), mandibular (M) and hyoid arches (H). Red 






3.4.2.4. Asun is required to establish normal left-right asymmetry in 
zebrafish  
The left-right (LR) axis specification in zebrafish is mainly controlled by the 
Kupffer‟s vesicle (KV). KV is equivalent to the mammalian node and is 
conserved among all teleost fish. Between 12 and 16 hpf, KV originates from 
a group of cells, the dorsal forerunner cells, which migrate at the posterior end 
of the embryo during gastrulation (Essner et al., 2002). This transient structure 
filled with cilia that rotate clockwise to generate a directional fluid flow, 
which is essential to determine the LR asymmetry in fish (Kramer-Zucker et 
al., 2005; Kreiling et al., 2007; Melby et al., 1996). Randomization of fluid 
flow as a result of defects in cilia formation and/or function has been shown to 
cause laterality defects in the internal organs of zebrafish (Ferrante et al., 
2009). Therefore, we sought to address whether the asun-MO would cause 
laterality defects. This can be examined by determining the position of heart 
looping with the ventricle and atrium in the right and left side of the embryo, 
respectively and the position of the pancreas, liver and gut looping (Levin, 
2005; McGrath and Brueckner, 2003). 
We performed in situ hybridization with an antisense probe for the 
asymmetrically expressed gene lefty2, a nodal pathway gene which is 
specifically expressed to the left side of zebrafish embryos (Bisgrove et al., 
1999; Liang et al., 2000; Long et al., 2003) (Figure 29). 
Upon analysis, we observed that lefty2 expression pattern was disrupted in the 
lateral plate mesoderm. The majority of uninjected embryos displayed normal 
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left-side expression, while around 45% of Asun-depleted embryos exhibited 
bilateral, absent or right-sided expression, indicating situs randomization 
(Figure 29). These findings indicate that a loss of Asun expression perturbs the 
establishment of LR asymmetry, which could be a result of malfunctioning 





Figure 29: KD of asun causes laterality defects in zebrafish embryos. In situ 
hybridization for lefty2 at 24 hpf embryos. (a) In wild-type embryos, the expression 
of lefty2 is observed on the left side of the embryos (b,c) Expression of lefty2 in Asun 
morphant, is detected either bilaterally or absent (b) or  at the right side only (c). (d) 
Percentage of embryos with laterality defect, around 45% of Asun morphants show 
randomization of lefty expression. Arrow in (a) indicates expression in the left lateral 




3.4.2.5. Asun is essential for normal formation of otoliths in the 
developing ear 
In addition to laterality defects, otoliths malformation was remarkably 
observed in zebrafish morphant embryos (Figure 28c,d,g). Functionally, 
zebrafish inner ear is analogous to the mammalian counterpart; they are 
important for hearing, gravity sensation and balance (Hughes et al., 2006; 
Malicki et al., 1996; Supatto and Vermot, 2011). Zebrafish otoliths usually 
develop at stages 18-24 hpf when the otic placode invaginates to form the 
otocyst; a fluid filled cavity (Hughes et al., 2006; Stooke-Vaughan et al., 
2012). Within each otic vesicle (OV), specialized mechanosensory hair cells 
are then formed. These hair cells harbor a single specialized long non-motile 
cilium, known as the kinocilium and cluster of actin-based protrusions, 
referred to as stereocilia that are densely packed and arranged to form a 
bundle. These hair cells kinocilia also known as mature tether cells, attach to 
otoliths at the poles of the OV. These cilia are non-motile, surrounded by 
clusters of motile cilia which undergo beating that contribute to the formation 
and correct nucleation of otoliths (Riley et al., 1997; Stooke-Vaughan et al., 
2012; Wu et al., 2011; Yu et al., 2011). The rest of the OV epithelia are lined 
with non-motile cilia (Stooke-Vaughan et al., 2012). Otoliths are equivalent to 
otoconia in mammals; both are mineral-rich structures composed mainly of 
calcium carbonate (CaCO3) and proteins. In the zebrafish at 18-22 hpf, they 
appear as irregular clumps with continuous deposition of mineralized 
precursors and by 24 hpf, two small round otoliths are formed, attached to 
tether cells. Defects in ciliary beating has been reported to cause abnormalities 
in the shape, number and formation of otoliths (Ferrante et al., 2009; Lee et 
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al., 2012; Neugebauer et al., 2009; Schibler and Malicki, 2007; Stooke-
Vaughan et al., 2012; Yu et al., 2011). 
Asun morphants displayed otoliths defects as early as 20-22 hpf. For most 
MO-injected embryos, otoliths were formed; however they were miss-
localized and fused to each other, as compared to the uninjected embryos 
(Figure 28c,d,g). Defects in otoliths formation and laterality as well as 
pericardial oedema indicated a ciliary disruption in zebrafish morphant 
embryos. 
3.4.2.6. Conclusions 
Expression analysis and Loss of function experiments of Asun in zebrafish 
revealed typical ciliary phenotypes. In situ hybridization analysis of lefty2 
expression confirms the laterality defects. We suggest that abnormal left-right 
asymmetry establishment and other ciliary related phenotypes including 
cardiac oedema, fused otoliths and hydrocephalus could be due to disruption 
of ciliary beating which in turn caused impairment of fluid flow in KV, inner 
ear, spinal cord and pronephric duct. Furthermore, examining the cartilage of 
morphant embryos showed marked defects in craniofacial structures.  
Because Asun is highly conserved among vertebrates, it is expected that this 
gene would play a similar function in embryogenesis. Therefore, we 
investigated the role of Asun in Xenopus as another model for studying 





3.4.3. Loss of ASUN function modeling in Xenopus 
3.4.3.1. Expression patterns of asun during Xenopus embryonic 
development 
To provide a complementary evidence for ASUN function in embryonic 
development, and ciliary function, we used Xenopus as another appropriate in 
vivo model to address ciliopathies (Fakhro et al., 2011; Hagenlocher et al., 
2013; Mitchell et al., 2009; Park et al., 2006; Schweickert et al., 2007; 
Vincensini et al., 2011a, b).  
We first characterized the spatial and temporal expression pattern of asun in 
developing embryos, using whole embryo in situ hybridization (WISH) with 
DIG-labeled antisense RNA probes.  
By examining the expression pattern of asun in Xenopus our aim was to get an 
overview about its functions during embryonic development. The expression 
of asun was found to be ubiquitous during early cleavage, gastrula and even in 
the late stages, suggesting both a maternal and zygotic expression of this gene 
in Xenopus (Figure 30a-f). At early cleavage stages, asun transcripts were 
restricted to the animal half, but they were absent in the vegetal hemisphere 
(Figure 30a). At these stages, only the maternal transcripts are present since 
the zygotic expression begins at the mid blastula transition (MBT) stage 9 
(Kerns et al., 2012; Newport and Kirschner, 1982; Tadros and Lipshitz, 2009). 
At gastrula (stage 12), the expression of asun was enriched in ectoderm cells 
with no expression in the endodermal cells (Figure 30b). At early neurula 
(stage 17), asun expression was enriched in the neural tube and the neural 
folds (Figure 30c). From tadpole stages onwards, asun transcripts were 
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abundantly observed in specific tissues including the brain, branchial arches, 
pronephros, eye vesicles, otic vesicles and a diffuse staining of the whole head 
was also observed (Figure 30d,e).  
Moreover, staining was also found to cover the whole skin of the embryos in a 
punctate pattern at stage 22 onward (Figure 30d,e). Punctate staining was also 
extended to the head tissues, including the brain regions, eye, and ear. This 
punctate pattern is demonstrative of ciliated cells located in the epidermis of 
the embryo, which are better observed with whole mount immunostaining, 
performed with our custom polyclonal ASUN (α-M) antibody (Figure 30f).  
To conclude, asun is a maternally expressed gene with ubiquitous expression 
at gastrula stage. At later stages, asun displays a tissue specific expression 
raising the possibility that asun could have a role in tissue morphogenesis. The 
expression pattern of asun in frog embryos significantly overlaps with the one 
observed in zebrafish embryos, suggesting a conserved function of Asun 
protein during evolution. The expression of asun overall the epidermis of skin 
embryos is overlapping with the expression of ciliated cells genes (Park et al., 
2006). These results provide further support to our hypothesis that ASUN 
could be involved in ciliogenesis. The similar expression pattern of asun in 
frog and zebrafish animal models was consistent with the ubiquitous 
expression of ASUN in human adult tissues (Bourdon et al., 2002), suggesting 
that ASUN is evolutionary conserved, and thus suggesting a role for Asun 
during vertebrate development. Therefore, to gain further insights into the role 
played by asun in these specific organs and tissues, we performed loss-of-





Figure 30: Detailed expression pattern of asun/Asun in Xenopus embryos 
analyzed by WISH and whole mount immunostaining. asun has both maternal and 
zygotic. (a) Stage 4, asun transcripts are localized within the animal half. (b) Stage 12, 
its expression covers the whole embryo except the blastopore. (c) Stage 17, asun is 
observed in neural tube and neural folds. Lateral view, anterior is right (d) Stage 22 
asun starts to be enriched in brain(b), branchial arches (ba), pronephros (pn), eye 
vesicles (ev), ear (e), skin cells (sk) and somites (so). Lateral view, anterior is right 
(e) Stage 32 asun expression is also detected in ear (e), skin cells (sk) and pronephros 
(pn). Lateral view, anterior is left. (f) Correlation of transcript localization of Asun 
protein by whole mount embryo antibody staining using a custom polyclonal ASUN 




3.4.3.2. Morpholino design, microinjection and validation 
In order to gain more insight into the precise function of ASUN during 
Xenopus embryonic development, anti-sense morpholino (MO) 
oligonucleotides against asun mRNA were designed either to block the 
translation or disrupt the normal splicing of asun mRNA.  
The ATG-targeted antisense MO was previously published (Lee et al., 2005) 
(Figure 31a). For a splicing MO, the DNA sequence of the exon-intron 
boundaries that mimic the position of patients‟ mutation was obtained by PCR 
amplification. Xenopus embryos were microinjected with 4 nl of pure asun-
MO (123 ng) into each blastomere of 2 to 4-cell stages (Figure 31b). 
The efficiency of the ATG-MO was verified by western blot analysis of lysate 
from wild-type and morphant embryos using human ASUN antibodies and 
confirmed the complete reduction of Asun protein in Asun morphant embryos 
(Figure 31c). For asun splicing-MO, we confirmed the splicing defects by RT-
PCR analysis of RNA extracted from wild-type and MO-injected embryos 
using pair of primers flanking the MO binding site. PCR products were run on 
1% agarose to confirm the splicing alteration (Figure 31d). Compared to 
control transcript, asun-MO injection significantly disrupted the normal 
splicing of asun mRNA. These results suggest that both ATG-MO and 
splicing-MO successfully block the translation and disrupt the normal splicing 






Figure 31: Morpholinos design, microinjection and validation. (a,b) The 
sequences of asun ATG-MO and the site of injection in 2- and 4-cell stage Xenopus 
embryo. (c) Immunoblotting for ATG-MO morphants and uninjected embryos lysate 
using ASUN (α-M) antibody shows effective depletion of Asun protein. Actin used as 




3.4.3.3. Knock-down (KD) of asun in Xenopus partially recapitulates 
human disease  
In the past 8 years, the functions of ASUN in vertebrates have already been 
addressed in Xenopus leaves. ASUN has a crucial function in cell cycle 
control and development (Lee et al., 2005). For instance, the asun gene is 
required for normal convergent extension (CE), a process involved in tissue 
movements during gastrulation and neurulation. Down-regulation of asun 
using MO injection resulted in developmental delay, shortened body axis, 
polyploidy and early developmental arrest in Xenopus morphants. These 
defects are consistent with disruption of gastrulation and cell cycle events. In 
this study, we confirmed gastrulation defects as a result of asun depletion in 
Xenopus that were discovered previously (Lee et al., 2005). More importantly, 
we describe for the first time that Asun was also involved in ciliogenesis and 
craniofacial, heart and muscle development. 
To further examine the loss of Xenopus Asun function phenotypes during 
Xenopus development, embryos were closely examined at different stages 
following MO injection. We observed that MO-injected embryos were 
severely affected and exhibited small head, big belly and convergent extension 
defects such as irregular somites, shortened and curved body axis and bent tail 
compared to wild-type embryos(Figure 32a‟,b‟,b‟‟,c'). Moreover, cardiac 
oedema and massive developmental delay were also noted in morphant 
embryos (Figure 32). These phenotypes were more severe with the ATG-MO. 
These results suggest that a translation-blocking MO causes phenotypes more 
consistent with loss-of-function interference, whereas the splice-blocking MO 
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generates hypomorphic phenotypes. The weaker defects observed in splicing-





Figure 32: Common phenotypes in asun-depleted Xenopus embryos. (a-c) Control 
embryos at tadpole stage (a, b) and stage 24 (c). (a‟-c‟) Xenopus embryos injected 
separately with asun ATG-MO and splicing-MO. Morphant embryos display severe 
developmental defects including a small head, big belly, short and down curved-body 








3.4.3.4. asun depletion affects heart morphogenesis 
Congenital heart defects (CHD) have been reported in many patients with 
Mohr syndrome, including aortic coarctation, aortic stenosis, atrial septal 
defect, atrioventricular canal defect, hypoplastic left ventricle, truncus 
arteriosus, mitral atresia, endocardial cushion defects and tetralogy of Fallot 
(Digilio et al., 1999; Digilio et al., 1996; Ghossaini et al., 2002; Orstavik et al., 
1992; Shashi et al., 1995). In the Jordanian family, one of the affected girls 
(IV.7) had supravalvular pulmonary stenosis. To our knowledge, this defect 
has never been observed in previously reported cases of Mohr syndrome. KD 
of asun in Xenopus showed cardiac edema; therefore it is worth it to examine 
the role of Asun in heart development. To examine this, we performed in situ 
hybridization using the nkx2.5 (transcription factor); a heart specific marker 
(Tonissen et al., 1994).  The results showed an increase in nkx2.5 expression 
in morphants heart tissues compared to control embryos, suggesting that asun 
is involved in Xenopus heart development (Figure 33b-c‟).  
3.4.3.5. Asun is required for CNCC migration in Xenopus embryos 
In addition to heart defects, craniofacial dysmorphisms were also observed in 
the two patients. The characteristic features of Mohr syndrome and other 
OFD, suggest that ASUN gene could have a specific role in the development of 
CNCC. CNCC and cranial mesoderm are known to responsible for the 
formation of the majority of craniofacial bones in vertebrates (Trainor, 2005). 
Tobin and colleagues have demonstrated that migrating CNCC of zebrafish 
bear primary cilia. They highlighted that, craniofacial features in patients with 
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Bardet-Biedl syndrome (BBS) could be due to defects in CNCC migration 
(Tobin et al., 2008). Similarly, Brugmann and his group showed that mouse 
CNCC also express primary cilia, which were missing in knock-out 
intraflagellar transport protein Kif3 mouse cells (Brugmann et al., 2010a). 
These findings suggest that the craniofacial dysmorphisms presented in the 
two patients could possibly be attributed to a deficit in the migration of CNCC 
secondary to primary cilia perturbation.  
In support of this, at Xenopus tailbud stage, we observed that Asun morphants 
displayed smaller heads compared to control embryos (Figure 32). During 
neurula stages, asun was found to be expressed in brachial arches, a neural 
tube and neural folds; at which CNCC undergo directional migration to form 
the craniofacial structures (Nichols, 1987; O'Rahilly and Muller, 2007).  
Therefore, it is advisable to examine whether asun depletion in frog embryos 
causes changes in head development. In situ hybridization for embryos at early 
tailbud stages was carried out using a tissue-specific antisense RNA probe for 
cranial neural crest marker; twist (Betters et al., 2010). We observed that 
abrogation of asun expression reduces the expression of twist (Figure 33a,a‟). 
This result demonstrates that asun depletion affects CNCC migration.  
To conclude, the pleiotropic expression of asun in the head, heart and skin as 
well as the phenotypic appearance following asun depletion in Xenopus 





Figure 33: Asun is required for CNCC and heart development. Whole embryo in 
situ hybridization using CNCC marker (twist) and heart marker (nkx2.5) at stage 28. 
(a) Expression of twist reveals the CNCC population in the 4 branchial arches. (a‟) 
ATG-MO injected embryos display defective CNCC migration, especially in the 
second branchial arch (b-c‟) Impairment of nkx2.5 expression is observed in both 
ATG-MO (b‟) and slicing-MO (c‟) injected embryos. The level of nkx2.5 expression 




3.4.3.6. Asun is also required for somites development in Xenopus 
embryos  
During Xenopus gastrulation, cells undergo morphogenic movements and cell 
fate determination that will lead to the formation of the three germ layers: 
ectoderm, mesoderm, and endoderm. As a result of these movements, the 
embryonic axes are determined. For instance, the dorsal mesoderm develops 
into the axial mesoderm that form the notochord and paraxial mesoderm that 
undergo segmentation at both sides of notochord to form the somites (Keller et 
al., 2000).   
In addition to heart defects and craniofacial dysmorphisms, Asun-depleted 
embryos displayed defects that were clearly observed in the developing 
somites from tadpole stages onwards. Whole mount antibody staining using 
anti-ASUN-M antibody showed disorganization and mislocalization in the 
majority of somites in ATG-MO injected embryos (Figure 34a). Whole mount 
antibody staining was further carried out for the somite specific marker 
(MyoD) (Rupp et al., 2002) to determine the role of Asun in somites 
development. The results showed that the expression of MyoD was reduced in 
the disrupted somite segments (Figure 34b). These results indicate that Asun is 





Figure 34: Asun is required for somites development in Xenopus. Whole mount 
antibody staining of Xenopus tailbud embryos (stage 32) using ASUN (α-M) antibody 
and a somite specific antibody, MyoD. (a) Expression of ASUN is observed in 
developing somites (black arrowhead) (b) MyoD immunostaining reveals that 
depletion of Asun affects both induction and segmentation of the somites in morphant 




3.4.3.7. Ciliary beating frequency is markedly reduced following asun 
depletion 
Based on the biological function of ASUN in ciliogenesis in mammalian cells 
and the ubiquitous expression of asun mRNA throughout the Xenopus skin, 
we next examined the possibility that asun also affect multi-cilia formation 
and beating in Xenopus embryos. 
Following MO injection, live imaging was performed to investigate whether 
Asun disrupts directional flow over the Xenopus epidermis, and to observe 
general embryonic development. In order to observe the flow across the 
epidermis of Xenopus embryos, both control and morphant embryos at desired 
stages, at which all multi-ciliated cells (MCC) are totally differentiated were 
collected in a Petri dish and a dye was added drop wise on the surface of 
embryos. A time-lapse movie was taken to assess for the performance of 
beating cilia in the skin of control and morphant embryos. In control embryos, 
the dye moved away very rapidly in one direction, from dorso-anterior region 
to ventral-posterior part. Interestingly, in ATG-MO injected embryos, the 
results showed that all morphants were completely unable to move liquid 
around their bodies. This suggests that ciliated cells were either unable to form 
cilia or that cilia were not functional in Asun morphants. However, when we 
used the splicing-MO, we observed disorganized movements of dye in 
different directions. Furthermore, the dye movement was significantly slower 
than controls suggesting that the fluid flow was disorganized. This also 
suggests that MCC either had few cilia or that cilia did not properly function 
in Asun-depleted embryos. To further observe the ciliary beating more clearly, 
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we recorded the cilia movement using a high-speed video microscopy. Images 
were taken at 200-250 frames per second. We found that MCC in morphant 
embryos seem to have fewer cilia with reduced beating frequency compared to 
control embryos (Figure 35). Moreover, the ciliary beating in Asun-depleted 
embryos was erratic and uncoordinated compared to control embryos.  
Taken together, these data indicate that Asun is necessary for cilia formation 
and coordination of ciliary beat of cilia within ciliated cells, and is thereby 
responsible for the generation of the directional flow of embryos by MCC. 
 
Figure 35: Ciliary formation and beating are disrupted following asun depletion. 
Time-laps pictures of multi-cilia beating using a high-speed video microscopy. MCC 
display less and disorganized cilia in morphant embryos. Moreover, cilia beating 
frequency is markedly reduced in Asun morphants compared to control embryos. 




3.4.3.8. Ciliogenesis is markedly perturbed in Asun morphants 
The reduced ciliary beating frequency in Asun morphants suggests that the 
morphology of cilia themselves could also be affected. Therefore, we 
performed in situ hybridization using specific MCC marker, ccdc19 (Hayes et 
al., 2007) which showed reduction in the expression of ccdc19 in Asun-
depleted embryos compared to control embryos (Figure 36a,a‟). To further 
investigate the effect of Asun on MCC, we also performed whole mount 
antibody staining for control and morphant embryos using acetylated α-
tubulin. We found that morphant embryos displayed punctate pattern similar 
to control embryos but more shiny in control embryos (Figure 36b-c‟), 
consistent with the ccdc19 expression pattern. Furthermore, the distances 
between puncta were higher and irregular in Asun-depleted embryos. This 
suggests that the epidermis of Asun morphants could have either less 
differentiated ciliated cells and/or these cells express less cilia, indicating the 





Figure 36: MCC differentiation and multi-cilia formation are affected in Asun-
Xenopus morphants. (a,a‟) In situ hybridization in control and Asun morphant 
embryos using a specific probe for the MCC marker (ccdc9) shows reduction in 
ccdc9 expression in morphants‟ MCC compared to control embryos. (b,b‟) whole 
mount antibody staining with acetylated α-tubulin antibody shows punctate pattern 
similar to ccdc9. The punctate look more condense and stronger in control embryos. 





To gain further insights into the impact of asun KD on Xenopus MCC, we 
performed a scanning electron microscopy (SEM) for both Asun morphants 
and wild-type embryos. In this experiment, we used both the splicing blocking 
MO and the ATG-MO. For ATG-MO, the results showed that the major defect 
was in the MCC. Most MCC in ATG-MO injected embryos exhibited variable 
reduction in number of cilia, while few individual cells displayed no cilia. 
However, the length of cilia seemed to be normal in many ciliated cells, 
inconsistency was also observed within and between MCC (Figure 37). 
Moreover, cilia exhibited abnormalities in morphology, protrusion and 
direction (Figure 37). Interestingly, at the low magnification view, we 
observed fewer differentiated cells in Asun-depleted embryos compared to 
control embryos (Figure 37a-d). For splicing-MO, MCC showed mild ciliary 
defects compared to ATG-MO, cilia were either twisted and clumped to each 
other or spread in irregular directions in the majority of MCC (Supplementary 
Figure. 3). Interestingly, we detected no abnormal cilia in many cells, while 
many expressed no cilia and variability in length of cilia on individual cells 
was also observed.  
Taken together, these data demonstrate that Asun is required for MCC 
differentiation as well as cilia formation and function which could explain the 
reasons behind the improper cilia motility in Asun-depleted embryos as 
documented by time-laps movies. On the other hand, the similarity between 
human airway lining cells and Xenopus skin cells suggest that the phenotypic 
appearance in patients‟ respiratory system could be due to defects in MCC that 





Figure 37: Multi-cilia are markedly perturbed in MCC of Xenopus morphants. 
Ultrastructure of the Xenopus MCC at different magnification using SEM at 
embryonic stage 28. (a,c,e) MCC of control embryo possess multiple, long cilia. 
(b,d,f) Asun morphant MCC display few, short and disorganized cilia. (c-f) At high 
magnification view, it seem that the length of cilia is not severely affected in Asun 
morphant, however MCC appear less differentiated in morphant embryo compared to 
control embryo. (g) The average number of cilia in individual MCC is markedly 




3.4.3.9. Loss of Asun affects the development of mucus secreted cells 
(MSC) and ion-secreting cells (ISC)  
In addition to MCC defects in frog morphants, SEM analysis also revealed 
marked defects in other epidermal cells. In control embryos, we clearly 
observed that Xenopus skin covered with extensive small round exocytic 
vesicles or empty vacuoles spread at the apical surface of MSC. The 
ultrastructure of MSC seemed to be affected and the number of secretory 
vesicles was remarkably reduced in the majority of morphants MSC (Figure 
38b,d,f). On the other hand, we also observed less ISC in morphants compared 
to control embryos (Figure 38b). 
To conclude, these findings demonstrate that beside the indispensable role of 
Asun for MCC development, it is also required for both MSC and ISC 
function and differentiation, respectively. Indeed, we were unable to interpret 
the precise effect of Asun in ISC by SEM because the small size of these cells 
compared to others. To gain a greater insight into the impact of asun depletion 
on epidermal cells, it would be interesting to carry out in situ hybridization 
using specific markers; xeel (Hayes et al., 2007) for MSC and xema (Mir et al., 






Figure 38: asun depletion results in variable defects in Xenopus skin MSC and 
ISC. Ultrastructure of the Xenopus MSC and ISC at different magnification using 
SEM at embryonic stage 28. (a,c,e) Control embryos possess numerous MSC with 
secretory vesicles (white arrow) and empty vesicles (black arrows) at their apical 
surface. (b,d,f) Asun morphants MSC display small and marked reduction in 




3.4.3.10. Conclusions  
Loss-of-function analysis of Asun in Xenopus showed typical ciliary 
phenotypes including irregular somites, shortened and curved body axis, bent 
tail and cardiac edema. Defects in multi-cilia formation and beating were also 
apparent; all are consistent with the expression analysis in embryonic tissues. 
These phenotypes are common in genes that are associated with cilia 
formation and function. First, in situ hybridization analysis showed an obvious 
overlap between the expression of asun and the ciliated cells marker (ccdc19). 
Additionally, whole mount antibody staining for Asun in Xenopus embryos 
also showed similar expression to the ciliary protein (acetylated α-tubulin). 
Depletion of asun confirmed the defect in these cells and the other epidermal 
cell types. Using in situ hybridization together with live imaging and SEM 
analyses showed apparent defects in cilia formation, morphology and beating, 
indicating that Asun is indispensable for MCC differentiation and multi-cilia 
biogenesis. Furthermore, SEM analysis in Xenopus revealed possible defects 
in MSC and ISC as well. These results indicated that Asun is required for the 
development and differentiation of epidermal cells especially the MCC. 
Beside ciliary defects in the MCC, Asun-depleted embryos displayed 
shortened and curved body axis, small head, bent tail and developmental 
delay. More severe phenotypes were also highlighted by in situ hybridization 
and immunohistochemistry experiments including defects in heart 
development, developing somites and craniofacial structures. These 
phenotypes were less severe in embryos injected with a splicing-MO as 
compared to ATG-MO.  
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Altogether, analysis of asun expression during embryonic development stages 
together with asun KD experiments in Xenopus confirmed that asun gene 
played a crucial role in the development of heart, somites craniofacial 
structures as well as playing a pivotal role in development, differentiation and 
function of MCC.  
To conclude, KD of asun in both Xenopus and zebrafish animal models 
recapitulate the patients‟ phenotypes to a reasonable extent. Additionally, 
functional analysis of Asun in Xenopus and zebrafish helped us to elucidate 
roles for this protein in the regulation of cilia function, and embryonic 
development. However, the molecular mechanism by which Asun controls 












3.5. A possible modifier affect on patients’ phenotypes 
Genetic and phenotypic overlaps have been widely observed among 
ciliopathies arguing strongly for the presence of genetic factors that could 
influence disease manifestations. In ciliopathies, it is not uncommon to find 
mutations in a given gene which can function as causal mutations for disease 
phenotypes or as modifying factors that modulate disease manifestations. 
These findings have provided further evidence for the contribution of second-
site genetic modifiers on the phenotypic variability of ciliopathies including 
OFD. For instance, the ciliary gene, Retinitis pigmentosa GTPase regulator 
interacting protein 1-like gene (RPGRIP1L; MIM 610937) mutated in JBTS, 
NPHP and MKS. However, the pathogenic effect of RPGRIP1L in these 
disorders, it has been shown that a common mutation that function as a 
second-site modifier allele of the retinal degeneration in patients with other 
ciliopathies (Delous et al., 2007; Fahim et al., 2012; Khanna et al., 2009). 
Mutations in OFDI gene resulted in variable phenotypes in X-linked JBTS10, 
X-linked RP and SGBS2 syndromes (Bisschoff et al., 2013; Coene et al., 
2009; Field et al., 2012). Similarly, mutations in CEP290 (MIM 610142) can 
cause SLSN, NPHP, LCA, JBTS, BBS, and MKS (Baala et al., 2007; 
Coppieters et al., 2010; Helou et al., 2007) and mutations in MKS3 are found 
to cause JBTS, MKS, BBS and NPHP (Cardenas-Rodriguez and Badano, 
2009; Leitch et al., 2008). Mutations in Abelson helper integration site 1 
(AHI; MIM 608894) have also been found to cause NPHP or JBTS but also 




Altogether, these data indicate that the phenotypic spectrum of ciliopathies is 
governed by mutation type, position, and the total mutational load within 
different ciliary genes that cause variable effects on gene and protein function. 
Furthermore, the phenotypic differences of the disease in the expression or 
penetrance also suggest the presence of disease modifying alleles that could 
exacerbate or modulate the disease phenotypes.  
 Among all reported Mohr syndrome cases, we observed intra- and inter-
familial phenotypic variability and severity, which were apparent in the two 
affected patients in this study. For instance, heart defect, polydactyly, 
duplicated teeth were only observed in one of either probands. Otitis media, 
bronchitis and urinary tract infection were more sever in one patient than 
another. Moreover, new manifestations like chronic renal failure and chronic 
pancreatitis have recently developed in patient IV.6, which could correspond 
to an age dependent phenotype.  
In this context, we asked whether mutations in other genes could be associated 
with the phenotypic variability observed in patients affected with Mohr 
syndrome.  Therefore, we first looked back at our candidate genes list and 
checked whether any of these genes could be involved in ciliary biogenesis. 
One of these genes, known as Polycystic Kidney and Hepatic Disease Like-1 
(PKHD1L1) as a potential good candidate. It is a very large and complex gene, 
located on chromosome 8q23.1-q23.2. It spans a genomic segment of ~168 kb, 
contains 79 exons and encodes a protein known as Fibrocystin-Like1 (Hogan 
et al., 2003). Human Fibrocystin-L is a large protein (4243 amino acids; 466 
kDa) and has homology to Fibrocystin (PKHD1, MIM 606702) over the 
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extracellular portion of the protein with overall identity of 25% and similarity 
of 41.5% (Hogan et al., 2003). The protein homolog Fibrocystin is localized to 
the basal bodies of primary cilia, and the loss of this protein is associated with 
cilia morphology and function defects (Masyuk et al., 2003; Wang et al., 2007; 
Zhang et al., 2004). Fibrocystin-L is predicted to be the ancestral Fibrocystin 
protein and this implies that Fibrocystin-L could have a similar function of 
Fibrocystin. 
In PKHD1L1 gene we found 1 missense mutation that leads to non-
conservative amino acid substitution in exon 42 and 1 splice site mutation 
located in intron 42  (Table 4). The c.6507+1g>a mutation predicted to disrupt 
the normal splicing of mRNA which in turn could create a PTC. We therefore 
sought to address the effect of c.6507+1g>a mutation on the function of 
PKHD1L1 in patients‟ cells and animal model using a combination of 
molecular and biochemical tools. 
3.5.1.  In silico splicing and qRT-PCR analyses 
In silico analysis using human splice site finder (HSF) 
(http://www.umd.be/HSF/), a tool which predicts the effects of splice site 
mutations on mRNA splicing, showed that this mutation generates various 
high score cryptic splice sites in both exon 42 and intron 42. These cryptic 
splice sites could be preferentially used as an alternative to the canonical 5‟ 
splice site, thereby resulting in partial exon deletion or partial intron retention. 
A qRT-PCR analysis showed that PKHD1L1 gene was not expressed in 
fibroblast cells of patient and control cells. We repeated qRT-PCR in different 
patient‟s cell lines including EBV-LYB and PBMC. Upon analysis, the 
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expression level of PKHD1L1 was significantly down-regulated in patients‟ 
EBV-LYB and PBMC compared to control cells (Figure 39). These findings 
indicate the NMD mechanism for PKHD1L1 gene. 
 
Figure 39: QRT-PCR for PKHD1L1 in different cell lines. (a) The PKHD1L1 is 
not expressed in primary fibroblasts. However, it is expression is down-regulated in 
patient‟s EBV-LYB (b) & PBMC (c) cells relative to control cells. Error bars indicate 




3.5.2.  pkhd1l1 is expressed in cilia related tissues in Xenopus 
To examine the endogenous pkhd1l1 expression pattern during development, I 
performed whole mount in situ hybridization in Xenopus embryos. The results 
showed that the pkhd1l1 expression exclusively zygotic and began at the end 
of neurulation. Its expression was confined to a subset of skin cells and was 
concentrated in gills, cement gland, proctodaeum and along the ventral fin. 
The results indicated that the expression of pkhd1l1 was overlapping with the 
expression of ciliated cells genes. These results give us complementary 





Figure 40: Expression pattern of pkhd1l1 during Xenopus developmental stages. 
In situ hybridization analysis shows the zygotic expression of pkhd1l1. This gene is 
not expressed in early stages:  cleavage (a), gastrula (b), and neurula stages (c). The 
expression is observed during early tailbud stages onward with majority in the 
epidermis particularly the MCC (d-g). pkhd1l1 transcripts are also seen in cement 




3.5.3. Loss-of-function analysis  
To investigate the precise role of pkhd1l1 gene in Xenopus, we next knocked- 
down its translation using MO-mediated down-regulation. A partial sequence 
of Xenopus leaves pkhd1l1 was identified using 5‟ RACE (Rapid 
Amplification of CDNA Ends) and specific primers were designed from the 
closely related Xenopus tropicalis sequence. 
3.5.4. Pkhd1l1 is required for Xenopus epidermal cells differentiation 
and multi-cilia formation 
Xenopus embryos were injected at the 2 to 4-cell stage. At a desired stage of 
embryonic development, live imaging was taken to assess the performance of 
beating cilia following pkhd1l1 depletion in Xenopus. The result showed that 
the Pkhd1l1 morphants were completely unable to move liquid around their 
bodies compared to wild-type embryos. This suggests that ciliated cells were 
either unable to form cilia or that cilia were not functional in Pkhd1l1-depleted 
embryos.  We further assessed the role of Pkhd1l1 in MCC and other cell 
types using in situ hybridization for epidermal cells markers for MCC, MSC 
and ISC. The results showed that the expression of all three epidermal cell 
types was markedly impaired in Pkhd1l1 morphants relative to controls 
(Figure 41). Moreover, we noted a developmental delay in morphants. These 
results were further confirmed by SEM (Figure 42) which showed that the 
major defect was in MCC. The multi-cilia were found to be absent compared 
to wild-type embryos. Moreover, MSC seem to be affected as well, there are 
an empty vesicles and vesicles with secretory granules in the wild type 
embryos, which are missing in the Pkhd1l1 morphants. Furthermore, ISC were 
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also affected; these cells are microvilli-rich cells, seemed to be compromised 
in the Pkhd1l1 morphants compared to the wild type embryos (Figure 42). 
 
Figure 41: Xenopus epidermal cells defects following pkhd1l1 depletion. In situ 
hybridization analysis for Xenopus skin markers following pkhd1l1 depletion at stage 
28. ISC mark by xema, (a), MSC mark by xeel (b) and MCC mark by ccdc19 and 
pkhd1l1 (c,d), all are markedly reduced in numbers in Pkhd1l1-MO injected embryos 





Figure 42: SEM skin surface of stage 28 Xenopus embryo upon pkhd1l1 
depletion. (a,b) View of Xenopus epidermal cell types at low magnification in control 
and morphant embryos, respectively. Ciliogenesis is severely compromised in overall 
MCC of Pkhd1l1 morphant. (c,d)  At high magnification view, cilia are nearly absent, 
the remaining cilia seem to be shorter and disturbed in the Pkhd1l1 morphants 
relative to control. Moreover, MSC in control embryos contain empty vesicles and 
vesicles with secretory granules (black arrows) which are missing in Pkhd1l1 





In conclusion, the PKHD1L1 splice site mutation causes aberrant splicing 
resulted in multiple illegitimate transcripts. These abnormal transcripts could 
lead to production of a truncated protein or could potentially be degraded by 
NMD pathway as anticipated from qRT-PCR results in PBMC and 
immortalized B-lymphocytes. Moreover, the pkhd1l1 causes an observable 
ciliary perturbation in Xenopus epidermis which gives us further evidence that 
PKHD1L1 is indispensable for ciliogenesis. However, the obvious effect of 
the donor splice site mutation in PKHD1L1 mRNA processing and protein 
function, we found this mutation unable to display disease phenotypes in the 
unaffected sibling who carries the homozygous alleles.  
Taken together, our work on PKHD1L1 suggests that it is not sufficient for 
pathogenesis although it may contribute to aggravating the phenotype caused 




Chapter 4: Conclusions and Perspectives 
4.1. Aims, results and significance 
The goal of this thesis was to identify the molecular genetics, 
biochemical and functional aetiology of a disorder known as Oral-facial-
digital syndrome type II (OFDII) or Mohr syndrome. The main aims of this 
study were to find the causative gene of this syndrome, to explore its function 
during the development and determine if the disease phenotypes are attributed 
to ciliary defects. In this chapter, I will give a summary and discussion of my 
findings and their implications, as well as future perspectives which stem from 
this study. 
A frameshift mutation in ASUN gene causes Mohr syndrome 
A single base pair deletion mutation in ASUN gene was identified in two 
affected girls of Jordanian family. ASUN is a core component of INT family 
and was found to be required for Drosophila spermatogenesis and oogenesis, 
snRNA processing, and dynein localization (Anderson et al., 2009; Chen et al., 
2012; Jodoin et al., 2013a; Jodoin et al., 2012; Jodoin et al., 2013b; Sitaram et 
al., 2012; Sitaram et al., 2013). In this study we identified an additional role of 
ASUN in ciliogenesis and embryonic development. To the best of my 
knowledge this is the first report of a human genetic disorder caused by 
mutations in ASUN. 
The out-of-frame mutation in ASUN gene found to introduce a premature 
termination codon (PTC) in the penultimate exon, resulting in the deletion of 
the last 31 amino acid residues of the protein. These residues are highly 
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conserved across both vertebrate and invertebrate species, suggesting that they 
are functionally indispensable. The corollary is a likely pathogenicity of this 
novel mutation. Based on qRT-PCR and western blot analyses, we confirmed 
that this mutation caused marked reduction in ASUN mRNA levels and 
produced a truncated protein. Rescue experiment analysis in Drosophila 
revealed that expression of the truncated ASUN allele in an asun-mutant line 
failed to restore the mutant phenotypes. These phenotypes include loss of 
dynein recruitment to the nuclear surface, loss of nucleus-centrosome coupling 
and cell cycle defects. Accordingly, this finding suggests that c.2004delA is 
most likely the causative mutation for Mohr syndrome and patients‟ 
phenotypes likely due to loss of function of ASUN protein as a result of this 
mutation.  
ASUN as a new player in cilia function and formation 
At the inception of this thesis project, the genetic aetiology of Mohr syndrome 
was unknown. However, the genetic lesions for many OFD syndromes 
including OFDI, OFDIV, OFDV, OFDVI OFDIX and OFDXIV had been 
identified. For OFDI, OFDIV, OFDIX and OFDXIV, their encoded proteins 
were found to be localized in primary cilia and essential for cilia formation 
and function. However, DDX59, the gene involved in OFDV does not have a 
role in primary cilia formation, but it was found instead to have an effect on 
SHH, a ciliary related signaling pathway. Lastly, the contribution of C5ORF42 
which causes OFDVI, to ciliary function, has yet to be confirmed or 
disproved. In addition to ciliary conspicuous link between cilia link and OFD 
syndromes, recent findings have established the role played by several INT in 
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ciliogenesis. These data, led us to hypothesize that ASUN could be involved in 
ciliary processes, and thus Mohr syndrome could therefore be a ciliopathy 
similar to other OFD syndromes. Besides being localized to the nucleus and 
cytoplasm in mammalian cells, we also found that ASUN is localized to 
primary cilia. Despite our finding that the mutation results in decreased ASUN 
mRNA in patient‟s cell compared to control cells, we were unable to observe a 
significant difference in its expression to primary cilia, using two different 
ASUN specific polyclonal antibodies. Conversely, we detect marked reduction 
in ASUN nuclear localization in patient‟s cells using ASUN (α-M) antibody. 
These findings showed absence of consistency of ASUN antibodies in 
immunostaining, which confounded the reliability of these results. One 
plausible explanation for this inconsistency is due to a cross reactivity of these 
antibodies to non-specific antigens in immunofluorescence although these 
antibodies were successfully validated by immunoblotting. Therefor in vivo 
animal modeling would hopefully provide clarification. We further assessed 
whether there are ciliary defects in patient‟s cells using immunofluorescence 
analysis with ciliary markers. Unexpectedly, we also did not detect overt 
differences in cilia formation and morphology, both fibroblasts and RPE cells 
from the affected individuals were normally ciliated. This result suggests that 
ASUN could be dispensable for cilia formation and it is role could be 
restricted to cilia function after the cilia have been formed. Alternatively, the 
frameshift mutation could behave as hypomorphic variant, and thus a 
truncated protein allows ciliogenesis in an in vitro setting. Conversely, we did 
detect dysgenesis of motile cilia in nasal biopsies of our patients. To 
investigate whether total loss of ASUN affects ciliogenesis, we performed 
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siRNA-based down-regulation of ASUN in primary fibroblasts. 
Immunofluorescence staining of these cells showed no overt defects in 
ciliogenesis. These results suggest even with low level of ASUN, cells are able 
to form cilia. In an attempt to explain these findings, we sought to deplete 
ASUN using siRNA in RPE cells, another human ciliated cell line. ASUN 
depletion in RPE cells revealed marked loss of primary cilia in ASUN-siRNA 
cells compared to control siRNA cells however primary cilia were formed in 
siRNA primary fibroblasts, suggesting the fundamental role of ASUN in 
primary cilia formation in RPE cells. The discordance between fibroblasts and 
RPE suggests a probable cell type-specific requirement of ASUN during 
ciliogenesis. Variation in cilia morphology between these cells also suggests 
that loss of ASUN proteins may have different effects in different ciliated cell 
types. In addition, normal ciliation does not always guarantee normal cilia 
function, differences in the rate of ciliary growth and turnover could lead to 
morphological and functional variation. On the other hand, ciliary related 
signaling defects could be observed even with normal cilia formation. Several 
studies on ciliary genes showed ciliary function defects despite normal cilia 
formation. For instance, a hypomorphic mouse model of intraflagellar 
transport 80 (Ift80) which causes autosomal recessive JATD and SRPIII 
(MIM: 263510) syndromes resulted in normal cilia formation accompanied 
with Shh pathway alteration in the embryonic fibroblast cells (Rix et al., 
2011). Moreover, mutation in CCDC65, which causes primary ciliary 
dyskinesia (PCD) syndrome, did not cause ciliary morphological defects but 
impaired cilia beating (Horani et al., 2013). Additionally, same scenario was 
recently observed in an OFDV gene (DDX59) which gives further support for 
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possible ciliary signaling defects even with normal primary cilia assembly 
(Shamseldin et al., 2013). 
 SHH signaling is potentially altered in patient’s cells 
For the reasons mentioned above, we asked if the cilia in patient‟s cells are 
functionally defective despite being normally formed. Since one of the main 
functions of primary cilia is to mediate signaling transduction pathways 
including SHH, we therefore assessed the response of our patient‟s ciliated 
fibroblasts to a Hedgehog agonist (SAG). Surprisingly, patient‟s cells 
displayed increased response toward SAG, suggesting an increase in SHH 
signaling. This was not observed in ASUN-depleted cells. These findings 
suggest a neomorphic activity of the truncated ASUN mutant protein encoded 
by the mutant ASUN allele in patient‟s cells. To validate this hypothesis, we 
will need to reproduce these results using patient‟s RPE cells and examine the 
localization and levels of SHH targets at the protein level. These findings 
indicate that a truncated ASUN does not affect ciliogenesis in patient‟s 
fibroblasts, but might be able to cause HEDGEHOG signaling defects. 
ASUN displays conserved expression patterns during Xenopus and 
zebrafish embryonic development 
Using whole embryo antibody staining in Xenopus and in situ hybridization in 
both Xenopus and zebrafish, we delineated the spatiotemporal expression of 
asun during early development. My results confirmed the maternal and 
zygotic expression of asun which was constitutive and ubiquitous throughout 
development. asun is specially expressed in tissues preferentially containing 
cilia or rely on cilia biogenesis to develop including neural tube, epidermal 
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multi-ciliated cells (MCC), ear, eye, brain, head, somite and pronephros. This 
broad expression pattern suggests that asun could play a fundamental role 
during embryonic development as well as ciliary processes. 
The pathophysiology of Mohr syndrome is partially recapitulated by in 
vivo animal modeling 
The phenotypes of Mohr syndrome patients suggest that it is a ciliopathy. 
Hence, ASUN probably function in ciliary biogenesis and/or function during 
embryogenesis in humans. To describe the function of the asun gene during 
embryonic development, in vivo animal modeling of this syndrome was 
performed using morpholino (MO)-based knock-down (KD) of asun in 
zebrafish and Xenopus leaves embryos. Embryos microinjected with different 
antisense MOs designed against asun displayed developmental defects 
partially reminiscent of the disease phenotypes in the affected patients. 
asun depletion in Xenopus and zebrafish resulted in morphological phenotypes 
not observed in wild-type embryos, including shortened and curved body axis, 
disrupted somites, cardiac edema, developmental delay and randomization of 
left-right (LR) asymmetry. Collectively, these phenotypes are similar to 
common phenotypes caused by mutations in genes that are involved in cilia 
biogenesis. Additionally, asun is expressed in the developing head, eye, ear, 
skin and heart in Xenopus, which are the tissues that exhibit defects in the 
human syndrome. This suggests that patients‟ phenotypes might be due to 
altered cilia formation and/or function as a consequence of impaired ASUN 
function.   
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First, the congenital heart defect diagnosed in one proband, could be 
phenocopied by Asun-depleted Xenopus embryos that displayed impaired 
expression of heart marker nkx2.5. asun depletion in zebrafish embryos also 
caused randomization of heart looping/jogging associated with pericardial 
oedema. These phenotypes provide support that Asun is required for 
establishment of LR asymmetry, which is directly dependent on normal cilia 
function. 
In addition to cardiac phenotypes, Asun-depleted Xenopus and zebrafish 
embryos also displayed a small head and dysmorphic head structures in 
zebrafish. These defects were previously found to be caused by migration 
defect of the cranial neural crest cells (CNCC) in branchial arches (BAs) 
similar to what we established in this study by a CNCC marker twist in 
Xenopus. This likely indicates defects in primary cilia that cover the migratory 
CNCC. 
Further investigation of craniofacial structures of zebrafish morphants 
revealed severe defects including lack of cartilage structures and variable 
degrees of hypotelorism. Additional ciliary-related phenotypes observed in 
Asun-depleted zebrafish embryos include otolith malformation and 
hydrocephaly. Furthermore, Xenopus morphants also exhibited somitic 
dysgenesis which was clearly observed by whole embryo immunostaining 
using ASUN (α-M) antibody and confirmed by the somites specific marker 
MyoD. All these phenotypes demonstrate the pivotal role of Asun in cilia 
biogenesis and function.  
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Asun is required for ciliary differentiation and proper motility in Xenopus 
epidermis  
Besides the fundamental role of ASUN in ciliogenesis in mammalian cells, our 
results also identified Asun as an essential player in cilia assembly and 
function in MCC of Xenopus. As described earlier, in situ hybridization 
analysis revealed ubiquitous expression of asun/Asun throughout embryonic 
skin in a punctate pattern reminiscent to a ciliary marker, acetylated α-tubulin 
and other MCC expressing genes (Dubaissi and Papalopulu, 2011; Hayes et 
al., 2007). KD of asun in Xenopus resulted in prominent defects in MCC. The 
majority of MCC in Asun-depleted embryos failed to express normal cilia, and 
showed an obvious perturbation of multi-cilia beating. Cilia were fewer in 
number, relatively shorter and lack a normal orientation. Immunofluorescence 
staining using acetylated α-tubulin together with live imaging delineated less 
cilia and abnormal beating frequency of MCC multi-cilia, respectively.  
To gain a further insight into the impact of asun depletion on the ultrastructure 
of the epidermal cells specifically the MCC, morphant embryos were then 
analyzed by scanning electron microscopy (SEM). We demonstrated that 
besides MCC defects, both mucus-secreting cells (MSC) ion-secreting cells 
(ISC) seemed to be affected as well. We found fewer secretory vesicles on the 
apical surface of MSC, which were also smaller in size compared to wild-type 
embryos. Moreover, the number of ISC was reduced in morphant embryos, 
suggesting that Asun affects normal differentiation of these cells. MSC and 
ISC defects could be secondary to MCC perturbation. Alternatively, a recent 
study on Xenopus epidermis showed that depletion of ISC resulted in strong 
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defect in MCC development and differentiation similar to what we observed in 
Asun-depleted embryos (Dubaissi and Papalopulu, 2011). These findings 
indicate a strong interaction between these cells.  
The observation of Xenopus epidermal cells might provide an explanation for 
the recurrent, respiratory tract infections and cough reported in Mohr 
syndrome patients, including the present two probands. This finding suggests 
the presence of ciliary defects in epithelial cells that line human airway 
particularly the ciliated cells. Immunofluorescence staining on patients‟ nasal 
epithelial cells revealed an alteration in cilia formation and morphology, 
consistent with the observed ciliary defects in MCC of Xenopus morphant 
embryos. The conserved structure of airway lining cells among vertebrates, 
suggesting a possible defect in the MSC and ISC as well. Moreover, Xenopus 
ISC were found to be analogous to those found in transporting epithelia of the 
collecting duct of mammalian kidney (α and β intercalated cells) (Batlle et al., 
2001; Wagner et al., 2009). These cells are ion secreting cells also known as 
ionocytes, proton-secreting cells, and mitochondria-rich cells that regulate 
ionic balance in order to control the epithelial surface liquid. Several human 
diseases arise as a result of defective ISC and MSC, including Inflammatory 
bowel disease, Pseudomyxoma peritonei, Cystic fibrosis and Distal renal 
acidosis (Dubaissi and Papalopulu, 2011; Kim and Ho, 2010). 
To gain a greater insight on the impact of Asun on epidermal cells, it would 
therefore be important to perform in situ hybridization of markers specifically 
expressed in these cells. Furthermore, it will be important to visualize the 
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entire ultrastructure of each of the cells by transmission electron microscopy 
(TEM), which is currently underway.  
PKHD1L1 splicing mutation as a modifier in Mohr syndrome 
In addition to the ASUN mutation, our probands were also homozygous for a 
splicing mutation in PKHD1L1 that was able to disrupt the normal splicing of 
PKHD1L1 mRNA. Consequently, the expression level of PKHD1L1 mRNA 
was significantly down-regulated and alternative transcript isoforms were 
produced as a result of defective splicing. However, this mutation was also 
found in a healthy, unaffected aunt with no signs of disease manifestations. As 
we described before, the phenotypic variability in patients affected by Mohr 
syndrome is notable within and between families, which is also very obvious 
in the two patients. These observations suggest the existence of modifier 
alleles that modulate the disease severity. Several studies have shown that 
splicing defects can influence the severity of the disease (Garcia-Blanco et al., 
2004; Nissim-Rafinia and Kerem, 2002, 2005). 
The phenotypic spectrum of Mohr syndrome could possibly be due to tissue-
specific PKHD1l1 splicing concomitant with ubiquitous expression of ASUN. 
We postulate that PKHD1L1 splicing could influence disease phenotypes 
caused by ASUN deficiency in certain tissues, thereby modifying the 
expressivity of ASUN mutation. In addition, reduction of nuclear localization 
of ASUN in patient‟s cells, suggesting that some of the clinical manifestations 





4.2. Future perspectives 
Searching for potential interactors with ASUN 
Mohr syndrome and other OFD syndromes are pleotropic disorders 
characterized by multiple organ defects. Inter- and intra-familial phenotypic 
variations have been described in patients with Mohr syndrome as well as in 
the two patients we studied. Moreover, the phenotypic overlap between OFD 
and other ciliopathies imply that a similar underlying aetiology may cause 
these pathologies.  
It has been shown that different genes that share spatio-temporal expression or 
that encode proteins with similar functional domains or motifs, may act in 
common pathways. Several proteomic analyses revealed that many ciliary 
proteins are components of multi-protein complexes. The dysfunction of any 
of these proteins may affect the function of the other complex components, 
which would therefore result in a variable degree of phenotypic severity 
(Adams et al., 2008; Cardenas-Rodriguez and Badano, 2009; Deltas and 
Papagregoriou, 2010). For instance, mutations in the OFDI (CXORF5) gene 
have been associated to a variety of diseases such as with X-linked JBTS10, 
X-linked RP and SGBS2 syndromes (Bisschoff et al., 2013; Coene et al., 
2009; Field et al., 2012). The phenotypic variability among OFDI was 
correlated with differences of interaction affinity between CXORF5 protein 
and its partner, the LCA protein (Lebercilin). This level of interaction was 
shown to depend on the types and the positions of mutation in CXORF5 gene 
(Coene et al., 2009). Likewise, mutations in the centrosomal protein CEP290 
resulted in variable phenotypic appearance among several ciliopathies such as 
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Senior-Loken syndrome (SLSN; MIM 266900), NPHP, LCA, JBTS, BBS, and 
MKS (Coppieters et al., 2010). This wide range of phenotypes caused by 
CEP290 was confirmed by its interaction with these disorder-associated 
proteins that are all localized at the TZ of cilium (Garcia-Gonzalo et al., 2011). 
As such, the phenotypic severity and variability could be explained by 
differences in binding of different mutated proteins with their interacting 
partners (Zaghloul and Katsanis, 2010). Further examples of protein-protein 
interactions were mentioned in section 1.10.  
To find possible proteins that interact with ASUN, we performed a mass 
spectrometry (MS) analysis in NIH3T3 cells followed by a pull down 
experiment using a specific ASUN antibody. Several proteins were enriched 
by immunoprecipitation, especially components of INT subunits (INT 1, 3, 5 
and 10) (Table 5). This confirms our finding that ASUN is a functional 
component of the integrator complex. 
 
Table 5: The list of proteins that are enriched with ASUN antibody using MS 
 
Concurrently, we also searched through, a web-based resource of Affymetrix 















479 Cep170 H7BX26 95% (5) 5 0 5
114 Int1 K3W4P2 95% (INF) 17 0 17
431 Int3 Q7TPD0 95% (4) 4 1 5
202 Int5 Q8CHT3 95% (3) 3 1 4
84 Int10 E9Q360 95% (2.6) 12 4 16
20 Snrnp200 Q6P4T2 95% (74) 47 1 48
13 Ddx5 Q61656 95% (13) 20 4 24
58 Ddx1 Q91VR5 95% (4) 17 6 23
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that were highly correlated in term of their expression. This tool gave us an 
estimation of genes that may act in similar biological pathways (Table 6). In 
order to verify whether these proteins are putative interactors of ASUN, co-
immunoprecipitation (co-IP) using tagged INT5 and CEP170 are currently 
being performed.  
 
Table 6: Correlation of ASUN gene with genes encoding CEP170, INT (1-10, 12) 
according to gene-gene correlation tool. 1: correlated, indicative of co-expression; 
0: not correlated. 











chr7:1476438-1500014 integrator complex subunit 1 INTS1 212210_at 0.135 0.12825
chr7:1476438-1500014 integrator complex subunit 1 INTS1 212212_s_at 0.1215
chr17:57297512-57360159 integrator complex subunit 2 INTS2 224308_s_at 0.3872 0.3872
chr1:152001922-152013179 integrator complex subunit 3 INTS3 202809_s_at 0.0798 0.0798
chr11:77267415-77383360 integrator complex subunit 4 INTS4 225169_at 0.3237 0.3237
chr11:62170898-62174171 integrator complex subunit 5 INTS5 221818_at 0.262 0.2934
chr11:62170898-62171381 integrator complex subunit 5 INTS5 53968_at 0.3248
chr13:50837642-50854200 integrator complex subunit 6 INTS6 222239_s_at 0.2455 0.2455
chr1:210181320-210275485 integrator complex subunit 7 INTS7 222250_s_at 0.65 0.35
chr1:210180367-210247362 integrator complex subunit 7 INTS7 218783_at 0.2401
chr1:210246976-210248475 integrator complex subunit 7 INTS7 1570173_at 0.1593
chr8:95930909-95961714 integrator complex subunit 8 INTS8 218905_at 0.3974 0.3974
chr8:28681098-28803398 integrator complex subunit 9 INTS9 203941_at 0.4748 0.4748
chr8:19752917-19753858 integrator complex subunit 10 INTS10 229632_s_at 0.2865 0.2865
chr4:106823235-106840620 integrator complex subunit 12 INTS12 218616_at 0.5445 0.5445
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4.3. Limitations and perspectives 
Although the expression of ASUN is ubiquitous in most tissues and cilia are 
widely spread, we may ask why that the loss of ASUN caused defects only in 
certain organs or body parts of Mohr syndrome patients. Chronic kidney 
failure and pancreatitis have been recently reported in the older patient, 
suggesting that additional phenotypes could be observed over age. Therefore, 
the possibility for the youngest patient to display these defects still remains. 
The potential role of ASUN protein in kidney and pancreas should therefore 
be investigated. 
Our results delineate ASUN as a causative gene for multi-organ phenotype 
ciliopathies. Gene augmentation therapy may be used to correct the genetic 
lesion by injecting an adenoviral-mediated expression of the wild-type gene to 
the affected target tissue. This technique was effective to restore vision of 
human and animal models with non-syndromic retinal ciliopathies as well as 
restoring of olfactory function in mouse model (Estrada-Cuzcano et al., 2012; 
Hufnagel et al., 2012; McIntyre et al., 2012) . Similarly, delivery of the wild-
type gene using the same approach was able to restore ciliary beating in 
patient with PCD whose airway epithelium cells express non-motile cilia 
(Estrada-Cuzcano et al., 2012). Although this technique is not accessible for 
multi-organ defects, it may be used to cure specific affected organs. 
Induced pluripotent stem cells (iPS) may also be a promising approach to 
examine the role of ASUN in vitro. We have already generated iPS from the 
patient‟s primary fibroblasts and different ciliated lineages such as neural 
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precursor cells (NPC), kidney and pancreatic cells are currently being 
generating. With the help of Institute of Medical Biology (IMB) Stem Cell 
Bank, Singapore, these reprogrammed cells were successfully differentiated 
into RPE cells. Besides disease modeling, the iPS cells generated from 
matched unaffected siblings can also be transplanted into the patient for 
therapy purpose (Phillips, 2012; Zou et al., 2011). The patients‟ respiratory 
tract defect could therefore be cured by this approach. 
Moreover, the role of ASUN during spermatogenesis and oogenesis in 
Drosophila drives us to examine the role of ASUN in human male and female 
reproductive system. Since ASUN is expressed in human testis and based on 
the essential role of asun for fertility in Drosophila male embryos, we could 
hypothesize that males present with Mohr syndrome may have reduced 
fertility. Unfortunately, this possible phenotype could not be investigated 
during my thesis since the two probands are females. Recently, the role of 
asun in Drosophila oogenesis has been also elucidated, suggesting a similar 
effect in human female‟s patients  (Sitaram et al., 2013). 
In line with this, ASUN showed high expression in testicular seminomas 
(Bourdon et al., 2002), suggesting a possible role of ASUN in cancer 
development that could be seen at late onset. 
Based on the medical examination of the two patients, laterality defects were 
not observed in these patients. In this work, we cannot exclude the probability 
of LR asymmetry randomization in humans as a result of ASUN mutation.    
Finally, since Asun-depleted Xenopus and zebrafish embryos displayed 
convergent extension (CE) defects, we suggest that the planar cell polarity 
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(PCP) pathway may be defective. As convergent extension (CE) movements 
are regulated by non-canonical / Wnt PCP signaling, it would therefore be 
interesting to investigate whether Asun plays a role in this signaling pathway. 
To conclude, I have in part achieved my initial objectives and successfully 
determined the genetic aetiology of Mohr Syndrome. I am well aware that it is 
critical that other cases diagnosed with this rare disease be sequenced in order 
to uncover distinct pathogenic variant in ASUN. This will provide independent 
confirmation of our findings which are for the moment most pertinent to this 
particular Jordanian family. Nonetheless, my functional studies and animal 
modeling lend support to the notion that ASUN is indeed involved in ciliary 
function in humans, fish and frogs. I trust that the results presented in my 
thesis lay a sound foundation for future investigations on the role of ASUN in 
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(a) The list of primers used for different experiments. 
 
  
Primer 5'>3' sequence Location
gDNA amplification of Exon 16 (human)
ASUN-E16 (Fwd) AGTCACTGAACTAGTGGTTGCTCTT Intron 16




PKHD1L1-P1 (Fwd) AGCTGAGCAAGCCTGTGAA   Exon 41
PKHD1L1-P1 (Rev) CATCAGGGAGTGTGACCGTA  Exon 47
PKHD1L1-P2 (Fwd) TGCATGACAGATGCCCATAC Exon 42
PKHD1L1-P2 (Rev) TGCCTGGAGTTCAATGTCAG Exon 44
QRT-PCR (human)
ASUN-q (Fwd) TTGCAGCAGTGGAAACTCTC Exon 3
ASUN-q (Rev) GTCTTCAAGCATTCGCACAT Exon 4
PKHD1L1-q8 (Fwd) AGGCCAGTTTAATCCTGTGG      Exon 63
PKHD1L1-q8 (Rev) GCTGGCATGTAAATCATTGG     Exon 65
PTCH1-q (Fwd) GCTGCACTACTTCAGAGACTGG Exon 15
PTCH1-q (Rev) CACCAGGAGTTTGTAGGCAAGG Exon 16
Gli1-q (Fwd) AGCCTTCAGCAATGCCAGTGAC Exon 9
Gli1-q (Rev)  GTCAGGACCATGCACTGTCTTG Exon 10
B-Actin (Fwd) CATGTACGTTGCTATCCAGGC Exon 4
B-Actin (Rev) CTCCTTAATGTCACGCACGAT Exon 4
GAPDH (Fwd) GGAGCGAGATCCCTCCAAAAT Exon 5
GAPDH (Rev) GGCTGTTGTCATACTTCTCATGG Exon 6
5'RACE-PCR primers (Xenopus)
PKHD1L1-p86-deg2 (Fwd) GCGCGGAATTC ATGTTYCARACNTAYGCN GA 5'UTR
PKHD1L1-p264-deg1 (Rev) GCGCGCAAGCTT YTCNGCRTANGTYTGRAACAT 5'UTR
PKHD1L1-5UTR GTGCAACAGGCAAGTGTGAG 5'UTR
PKHD1L1 (Rev) CCTGGAGTTCCAGAGAATGG Open reading frame
QRT-PCR (Xenopus & zebrafish)
asun-slpicing-MO (Fwd) GCCGAGGTGATCAAAGACTC Exon 15
asun-slpicing-MO (Rev) CCAGCGACAGAACAAAGTGA 3'UTR
asun_Moa  (Fwd) GGAAGCAGGAGGATCAAAATAC
asun_Moa  (Rev) TGTATGGTTTCCAGCACACAGT
asun_Mob  (Fwd) AGGATCCTGAATGCTGCAGTG
asun_Mob  (Rev) GTCTGAGACCAGAGTGTCATCC
Cloning in PCS2
EcoRI-ASUN (Fwd) CCGGAATTCCCAGGCACGAAAGTTAAAACA 5'UTR




ASUN-del2004delA (Fwd) AATAGAATCAATACTGCCAATTCCAGAAACATCAGGAATTTGCTG Exon 16
















INTS-5-XhoI-3 (Rev) CCGGAATTCCTACGTCCCCTGTCGAAGGAGAGTGG 3'UTR
222 
 
(b) The list of morpholino oligonucleotides (MO), siRNA and sequences. 
 











Name 5'>3' sequence Reference
Morpholino (MO)





ASUN-siRNA-5' ORF GGAAAUAGAGGACGAAUAA Jodoin et al., 2012
ASUN-siRNA-3' UTR cagcaagaugguataguua Jodoin et al., 2012
Antibodies Dillution Company
Immunofluorscent staining
Anti-Mouse‎Acetylated-α-tubulin 1:'500 Sigma-Aldrich, USA, (Cat. No. T6074)
Anti-Rabbit‎γ-tubulin 1:'500 Sigma-Aldrich, USA, (Cat. No. T5192)
Anti-Rabbit Pericentrin 1:'1000 Abcam, USA, (Cat. No. ab4448)
Anti-Rabbit Cep170 1:'1000 Abcam, USA, (Cat. No. ab84545)
Anti-Rabbit DHC 1:'120 Jodoin et al., 2013
Anti-Mouse MyoD 1:'500 Developmental Studies Hybridoma Bank, USA, (Cat. No. D7F2)
Immunoblotting
Anti-Mouse Actin 1:'1000 Sigma-Aldrich, USA, (Cat. No. A4700)
Anti-Mouse‎β-tubulin 1:'500 Developmental Studies Hybridoma Bank, USA, (Cat. No. AA12.1)
Monoclonal Anti-PC Tag 1:'1000 Roche Diagnostics, Germany, (Cat. No. 11-814-508-001)
Monoclonal Anti-myc Tag 1:'4000 Sigma-Aldrich, USA, (Cat. No. H4439)
Donkey Anti-Rabbit-HRP 1:'4000 Jackson ImmunoResearch Laboratories, USA, (Cat. No. 711-035-152)
Donkey Anti-Mouse-HRP 1:'4000 Jackson ImmunoResearch Laboratories, USA, (Cat. No. 715-035-150)




The list of the 395 genes in the 5 IBD regions found by homozygosity mapping of the 
family. The 5 candidate genes are highlighted in blue. 
 
# Gene Position Discription
1 LOC401286 6q27 uncharacterized LOC401286
2 LOC100422263 serine palmitoyltransferase, long chain base subunit 2 pseudogene
3 C6orf123 6q27 chromosome 6 open reading frame 123
4 LOC441179 6q27 uncharacterized LOC441179
5 MLLT4-AS1 6q27 MLLT4 antisense RNA 1 (head to head)
6 MLLT4 6q27 myeloid/lymphoid or mixed-lineage leukemia 
7 HGC6.3 6q27 uncharacterized LOC100128124
8 KIF25-AS1 6q27 KIF25 antisense RNA 1
9 KIF25 6q27 kinesin family member 25
10 FRMD1 6q27 FERM domain containing 1
11 LOC101929420 uncharacterized LOC101929420
12 CTAGE13P CTAGE family, member 13, pseudogene
13 DACT2 6q27 dishevelled-binding antagonist of beta-catenin 2
14 SMOC2 6q27 SPARC related modular calcium binding 2
15 LOC101929442 uncharacterized LOC101929442
16 LOC101929460 uncharacterized LOC101929460
17 LOC101929484 uncharacterized LOC101929484
18 LOC101929504 uncharacterized LOC101929504
19 LOC101929523 uncharacterized LOC101929523
20 THBS2 6q27 thrombospondin 2
21 WDR27 6q27 WD repeat domain 27
22 LOC101929569 uncharacterized LOC101929569
23 LOC101929543 uncharacterized LOC101929543
24 C6orf120 6q27 chromosome 6 open reading frame 120
25 PHF10 6q27 PHD finger protein 10
26 TCTE3 6q27 t-complex-associated-testis-expressed 3
27 ERMARD 6q27 ER membrane-associated RNA degradation
28 LINC00242 6q27 long intergenic non-protein coding RNA 242
29 LINC00574 6q27 long intergenic non-protein coding RNA 574
30 ZFPM2 8q23 zinc finger protein, FOG family member 2
31 RPL12P24 8q23 ribosomal protein L12 pseudogene 24
32 SLC16A14P1 8q23.1 solute carrier family 16, member 14 pseudogene 1
33 OXR1 8q23 oxidation resistance 1
34 TAGLN2P1 8q23.1 transgelin 2 pseudogene 1
35 RNU7-84P 8q23.1 RNA, U7 small nuclear 84 pseudogene
36 ABRA 8q23.1 actin-binding Rho activating protein
37 LOC100419978 high mobility group box 1 pseudogene 46
38 ANGPT1 8q23.1 angiopoietin 1
39 PGAM1P13 8q23.1 phosphoglycerate mutase 1 pseudogene 13
40 RNA5SP275 RNA, 5S ribosomal pseudogene 275
41 RSPO2 8q23.1 R-spondin 2
42 NRBF2P4 8q23.1 nuclear receptor binding factor 2 pseudogene 4
43 AURKBPS1 8q23.1 aurora kinase B pseudogene 1
44 EIF3E 8q22-q23 eukaryotic translation initiation factor 3, subunit E
45 RPS17P14 8q23.1 ribosomal protein S17 pseudogene 14
46 EMC2 8q23.1 ER membrane protein complex subunit 2
47 LOC101060000 dnaJ homolog subfamily B member 6-like
48 LOC101060002 tRNA methyltransferase 10 homolog B-like
49 TMEM74 8q23.1 transmembrane protein 74
50 LOC101927413 uncharacterized LOC101927413
51 TRHR 8q23 thyrotropin-releasing hormone receptor
52 NUDCD1 8q23 NudC domain containing 1
53 ENY2 8q23.1 enhancer of yellow 2 homolog (Drosophila)




# Gene Position Discription
55 LOC100420748 suppressor of cytokine signaling 5 pseudogene
56 MAPK6PS5 8q23.1 mitogen-activated protein kinase 6 pseudogene 5
57 EBAG9 8q23 estrogen receptor binding site associated, antigen, 9
58 SYBU 8q23.2 syntabulin (syntaxin-interacting)
59 LOC100132813 8q23.2 uncharacterized LOC100132813
60 LOC644335 8q23.2 SMG5 nonsense mediated mRNA decay factor pseudogene
61 RPL18P6 8q23.2 ribosomal protein L18 pseudogene 6
62 KCNV1 8q23.2 potassium channel, subfamily V, member 1
63 RPSAP48 8q23.2 ribosomal protein SA pseudogene 48
64 LOC100132280 8q23.2 ataxin 3 pseudogene
65 LOC100129370 8q23.2 NADH dehydrogenase 1 beta subcomplex, 9, 22kDa pseudogene
66 LOC101927459 uncharacterized LOC101927459
67 LOC101927487 uncharacterized LOC101927487
68 EEF1A1P37 eukaryotic translation elongation factor 1 alpha 1 pseudogene 37
69 CSMD3 8q23.3 CUB and Sushi multiple domains 3
70 RPL30P16 8q23.3 ribosomal protein L30 pseudogene 16
71 MIR2053 microRNA 2053
72 RPL18P7 8q23.3 ribosomal protein L18 pseudogene 7
73 LOC100420746 8q23.3 NADH dehydrogenase complex I, assembly factor 7 pseudogene
74 TRPS1 8q24.12 trichorhinophalangeal syndrome I
75 LINC00536 8q23.3 long intergenic non-protein coding RNA 536
76 EIF3H 8q24.11 eukaryotic translation initiation factor 3, subunit H
77 UTP23 8q24.11 UTP23, small subunit (SSU) processome component, homolog (yeast)
78 RAD21 8q24 RAD21 homolog (S. pombe)
79 RAD21-AS1 8q24.11 RAD21 antisense RNA 1
80 MIR3610 microRNA 3610
81 AARD 8q24.11 alanine and arginine rich domain containing protein
82 SLC30A8 8q24.11 solute carrier family 30 (zinc transporter), member 8
83 MED30 8q24.11 mediator complex subunit 30
84 RPS10P16 8q24.11 ribosomal protein S10 pseudogene 16
85 EXT1 8q24.11 exostosin glycosyltransferase 1
86 SAMD12 8q24.12 sterile alpha motif domain containing 12
87 SAMD12-AS1 8q24.12 SAMD12 antisense RNA 1
88 RPS26P35 8q24.12 ribosomal protein S26 pseudogene 35
89 TNFRSF11B 8q24 tumor necrosis factor receptor superfamily, member 11b
90 COLEC10 8q23-q24.1 collectin sub-family member 10 (C-type lectin)
91 LOC100286746 GABA(A) receptor-associated protein-like 2 pseudogene
92 LOC101927513 uncharacterized LOC101927513
93 MAL2 8q23 mal, T-cell differentiation protein 2 (gene/pseudogene)
94 NOV 8q24.1 OTTHUMP00000228107
95 LOC392264 8q24.12 zinc finger protein 532 pseudogene
96 ENPP2 8q24.1 ectonucleotide pyrophosphatase/phosphodiesterase 2
97 CYCSP23 8q24.12 cytochrome c, somatic pseudogene 23
98 TAF2 8q24.12 TAF2 RNA polymerase II
99 DSCC1 8q24.12 DNA replication and sister chromatid cohesion 1
100 DEPTOR 8q24.12 DEP domain containing MTOR-interacting protein
101 RNA5SP277 RNA, 5S ribosomal pseudogene 277
102 COL14A1 8q23 collagen, type XIV, alpha 1
103 MRPL13 8q22.1-q22.3mitochondrial ribosomal protein L13
104 MTBP 8q24.12 Mdm2, transformed 3T3 cell double minute 2, p53 binding protein
105 SNTB1 8q23-q24 syntrophin, beta 1 (dystrophin-associated protein A1, basic component 1)
106 LOC100421096 non-SMC condensin I complex, subunit G pseudogene
107 LOC101927561 uncharacterized LOC101927561
108 LOC101927543 uncharacterized LOC101927543
109 LOC100133147 8q24.12 glucosamine-phosphate N-acetyltransferase 1 pseudogene
110 LOC101928224 uncharacterized LOC101928224
111 BCL2L14 12p13-p12 BCL2-like 14 (apoptosis facilitator)
112 LOC100506248 prothymosin alpha-like
113 LRP6 12p13.2 low density lipoprotein receptor-related protein 6
114 RPL21P100 12p13.2 ribosomal protein L21 pseudogene 100





# Gene Position Discription
116 LOC101929053 ubiquitin-conjugating enzyme E2 variant 1-like
117 MANSC1 12p13.2 MANSC domain containing 1
118 RPL23AP66 12p12 ribosomal protein L23a pseudogene 66
119 LOH12CR2 12p13.2 loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)
120 LOH12CR1 12p12 loss of heterozygosity, 12, chromosomal region 1
121 DUSP16 12p13 dual specificity phosphatase 16
122 RPL19P17 12p13 ribosomal protein L19 pseudogene 17
123 CREBL2 12p13 cAMP responsive element binding protein-like 2
124 LOC100419521 ribosomal protein L21 pseudogene
125 GPR19 12p12.3 GPR-NGA
126 LOC101929220 caskin-2-like
127 CDKN1B 12p13.1-p12 cyclin-dependent kinase inhibitor 1B (p27, Kip1)
128 APOLD1 12p13.1 apolipoprotein L domain containing 1
129 MIR613 12p13.1 microRNA 613
130 LOC100423046 syntaxin 8 pseudogene
131 DDX47 12p13.1 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47
132 RPL37AP9 12p13.1 ribosomal protein L37a pseudogene 9
133 RPS6P1 12p13.1 ribosomal protein S6 pseudogene 1
134 RPL13AP20 12p13.1 ribosomal protein L13a pseudogene 20
135 GPRC5A 12p13-p12.3 G protein-coupled receptor, family C, group 5, member A
136 MIR614 12p13.1 microRNA 614
137 GPRC5D 12p13.3 G protein-coupled receptor, family C, group 5, member D
138 HEBP1 12p13.1 heme binding protein 1
139 LOC100506314 uncharacterized LOC100506314
140 HTR7P1 12p13.1 5-hydroxytryptamine (serotonin) receptor 7 pseudogene 1
141 RPS26P46 12p13.1 ribosomal protein S26 pseudogene 46
142 KIAA1467 12p13.1 KIAA1467
143 GSG1 12p13.1 germ cell associated 1
144 EMP1 12p12.3 epithelial membrane protein 1
145 C12orf36 12p13.1 chromosome 12 open reading frame 36
146 RNA5SP353 RNA, 5S ribosomal pseudogene 353
147 GRIN2B 12p12 glutamate receptor, ionotropic, N-methyl D-aspartate 2B
148 HMGN1P23 high mobility group nucleosome binding domain 1 pseudogene 23
149 MRPS18CP4 12p13.31 mitochondrial ribosomal protein S18C pseudogene 4
150 GNAI2L 12p13.1
guanine nucleotide binding protein , alpha inhibiting activity polypeptide 2 
pseudogene 1
151 RPL30P11 12p13.1 ribosomal protein L30 pseudogene 11
152 ATF7IP 12p13.1 activating transcription factor 7 interacting protein
153 PLBD1 12p13.1 phospholipase B domain containing 1
154 LOC101928317 uncharacterized LOC101928317
155 LOC101928290 uncharacterized LOC101928290
156 GUCY2C 12p12 guanylate cyclase 2C (heat stable enterotoxin receptor)
157 HIST4H4 12p12.3 histone cluster 4, H4
158 H2AFJ 12p12.3 H2A histone family, member J
159 WBP11 12p12.3 WW domain binding protein 11
160 C12orf60 12p12.3 chromosome 12 open reading frame 60
161 SMCO3 12p12.3 single-pass membrane protein with coiled-coil domains 3
162 ART4 12p13-p12 ADP-ribosyltransferase 4 (Dombrock blood group)
163 MGP 12p12.3 matrix Gla protein
164 ERP27 12p12.3 endoplasmic reticulum protein 27
165 ARHGDIB 12p12.3 Rho GDP dissociation inhibitor (GDI) beta
166 PDE6H 12p13 phosphodiesterase 6H, cGMP-specific, cone, gamma
167 LOC101928340 uncharacterized LOC101928340
168 RERG 12p12.3 RAS-like, estrogen-regulated, growth inhibitor
169 LOC728996 12p12.3 methyltransferase like 8 pseudogene
170 PTPRO 12p13-p12 protein tyrosine phosphatase, receptor type, O
171 RPS2P42 12p13.3-p13.2ribosomal protein S2 pseudogene 42
172 EPS8 12p12.3 epidermal growth factor receptor pathway substrate 8
173 MRPS7P2 12p13.1 mitochondrial ribosomal protein S7 pseudogene 2
174 STRAP 12p12.3 serine/threonine kinase receptor associated protein




# Gene Position Discription
176 LOC100420503 egl-9 family hypoxia-inducible factor 3 pseudogene
177 SLC15A5 12p12.3 OTTHUMP00000239482
178 LOC101928362 uncharacterized LOC101928362
179 MGST1 12p12.3-p12.1microsomal glutathione S-transferase 1
180 SUPT16HP1 12p12.3 suppressor of Ty 16 homolog (S. cerevisiae) pseudogene 1
181 LOC121520 12p12.3 glutamic-oxaloacetic transaminase 2 pseudogene 4
182 LMO3 12p12.3 LIM domain only 3 (rhombotin-like 2)
183 SKP1P2 12p12.3 S-phase kinase-associated protein 1 pseudogene 2
184 LOC387845 12p12.3 eukaryotic translation elongation factor 1 alpha 1 pseudogene 16
185 RPL7P40 12p12.3 ribosomal protein L7 pseudogene 40
186 PSMC1P8 12p12.3 proteasome (prosome, macropain) 26S subunit, ATPase, 1 pseudogene 8
187 LOC390298 12p12.3
translocase of inner mitochondrial membrane 17 homolog B (yeast) 
pseudogene
188 MIR3974 microRNA 3974
189 RERGL 12p12.3 RERG/RAS-like
190 PIK3C2G 12p12 phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
191 LOC100420792 Nedd4 family interacting protein 1 pseudogene
192 LOC100419827 zinc finger with KRAB and SCAN domains 7 pseudogene
193 PLCZ1 12p12.3 phospholipase C, zeta 1
194 PSMC1P9 12p12.3 proteasome (prosome, macropain) 26S subunit, ATPase, 1 pseudogene 9
195 CAPZA3 12p12.3 capping protein (actin filament) muscle Z-line, alpha 3
196 RPL7P6 12p12.3 ribosomal protein L7 pseudogene 6
197 LOC100128109 12p12.3 MEF2B neighbor pseudogene
198 PLEKHA5 12p12 pleckstrin homology domain containing, family A member 5
199 LOC100421296 serine/arginine-rich splicing factor 11 pseudogene
200 LOC100527946 programmed cell death 5 pseudogene
201 AEBP2 12p12.3 AE binding protein 2
202 EEF1A1P4 12p12.3 eukaryotic translation elongation factor 1 alpha 1 pseudogene 4
203 RPL34P25 12p12 ribosomal protein L34 pseudogene 25
204 LOC101928387 uncharacterized LOC101928387
205 TCP1P3 12p12.2 t-complex 1 pseudogene 3
206 LOC100506393 12p12 uncharacterized LOC100506393
207 PDE3A 12p12 phosphodiesterase 3A, cGMP-inhibited
208 UBE2L2 12q12 ubiquitin-conjugating enzyme E2L 2 (pseudogene)
209 hCG_23738 12p12.2 ubiquitin-like, containing PHD and RING finger domains, 1 pseudogene
210 SLCO1C1 12p12.2 solute carrier organic anion transporter family, member 1C1
211 SLCO1B3 12p12 solute carrier organic anion transporter family, member 1B3
212 SLCO1B7 12p12.2 solute carrier organic anion transporter family, member 1B7 (non-functional)
213 SLCO1B1 12p solute carrier organic anion transporter family, member 1B1
214 SLCO1A2 12p12 solute carrier organic anion transporter family, member 1A2
215 IAPP 12p12.1 islet amyloid polypeptide
216 PYROXD1 12p12.1 pyridine nucleotide-disulphide oxidoreductase domain 1
217 TCEB1P31 transcription elongation factor B (SIII), polypeptide 1 pseudogene 31
218 RECQL 12p12 RecQ protein-like (DNA helicase Q1-like)
219 GOLT1B 12p12.1 golgi transport 1B
220 C12orf39 12p12.1 chromosome 12 open reading frame 39
221 GYS2 12p12.2 glycogen synthase 2 (liver)
222 LDHB 12p12.2-p12.1lactate dehydrogenase B
223 KCNJ8 12p11.23 potassium inwardly-rectifying channel, subfamily J, member 8
224 ABCC9 12p12.1 ATP-binding cassette, sub-family C (CFTR/MRP), member 9
225 THEM4P1 12p12.1 thioesterase superfamily member 4 pseudogene 1
226 CMAS 12p12.1 CMP-N-acetylneuraminic acid synthetase
227 ST8SIA1 12p12.1-p11.2ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
228 LOC101928412 uncharacterized LOC101928412
229 C2CD5 12p12.1 C2 calcium-dependent domain containing 5
230 LOC100288378 12p12.1 leucine rich repeat containing 34 pseudogene
231 ETNK1 12p12.1 ethanolamine kinase 1
232 RPS27P22 12p12.1 ribosomal protein S27 pseudogene 22
233 LOC101928441 uncharacterized LOC101928441
234 SOX5 12p12.1 SRY (sex determining region Y)-box 5
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236 LOC101928471 uncharacterized LOC101928471
237 LINC00477 12p12.1 long intergenic non-protein coding RNA 477
238 KNOP1P1 12p12.1 lysine-rich nucleolar protein 1 pseudogene 1
239 RPL21P102 12p12.1 ribosomal protein L21 pseudogene 102
240 BCAT1 12p12.1 branched chain amino-acid transaminase 1, cytosolic
241 DAD1L 12p12.1 defender against cell death 1 pseudogene 1
242 BRI3P2 12p12.1 brain protein I3 pseudogene 2
243 C12orf77 12p12.1 chromosome 12 open reading frame 77
244 LOC645177 12p12.1 protein KASH5-like
245 LRMP 12p12.1 lymphoid-restricted membrane protein
246 LOC100419930 centromere protein U pseudogene
247 CASC1 12p12.1 cancer susceptibility candidate 1
248 LYRM5 12p12.1 LYR motif containing 5
249 KRAS 12p12.1 Kirsten rat sarcoma viral oncogene homolog
250 RPL39P27 12p12.1 ribosomal protein L39 pseudogene 27
251 LOC100421617 family with sequence similarity 133, member A pseudogene
252 IFLTD1 12p12.1 intermediate filament tail domain containing 1
253 LOC645233 12p12.1 thymine-DNA glycosylase pseudogene
254 MIR4302 microRNA 4302
255 RASSF8-AS1 RASSF8 atnisense RNA 1
256 RASSF8 12p12.3 Ras association (RalGDS/AF-6) domain family (N-terminal) member 8
257 BHLHE41 12p12.1 basic helix-loop-helix family, member e41
258 SSPN 12p11.2 sarcospan (Kras oncogene-associated gene)
259 LOC101928554 uncharacterized LOC101928554
260 ITPR2 12p11 inositol 1,4,5-trisphosphate receptor, type 2
261 RNA5SP354 RNA, 5S ribosomal pseudogene 354
262 LOC101929091 enoyl-CoA hydratase domain-containing protein 2, mitochondrial-like
263 ASUN 12p11.23 asunder spermatogenesis regulator
264 FGFR1OP2 12p11.23 FGFR1 oncogene partner 2
265 TM7SF3 12q11-q12 transmembrane 7 superfamily member 3
266 MED21 12p11.23 mediator complex subunit 21
267 LOC101928625 uncharacterized LOC101928625
268 C12orf71 12p11.23 chromosome 12 open reading frame 71
269 LOC729222 12p11.23 liprin-beta-1-like
270 STK38L 12p11.23 serine/threonine kinase 38 like
271 ARNTL2 12p12.2-p11.2aryl hydrocarbon receptor nuclear translocator-like 2
272 LOC101928646 uncharacterized LOC101928646
273 SMCO2 12p11.23 single-pass membrane protein with coiled-coil domains 2
274 LOC100419829 arginyl-tRNA synthetase pseudogene
275 PPFIBP1 12p12.1 PTPRF interacting protein, binding protein 1 (liprin beta 1)
276 LOC100506578 uncharacterized LOC100506578
277 REP15 12p11.22 RAB15 effector protein
278 LOC100420013 high mobility group box 1 pseudogene 49
279 MRPS35 12p11 mitochondrial ribosomal protein S35
280 MANSC4 12p11.22 MANSC domain containing 4
281 KLHL42 12p11.22 kelch-like family member 42
283 SAP18 13q12.11 Sin3A-associated protein, 18kDa
284 SKA3 13q12.11 spindle and kinetochore associated complex subunit 3
285 MRP63 13q12.11 mitochondrial ribosomal protein 63
286 ESRRAP2 13q12.11 estrogen-related receptor alpha pseudogene 2
287 LOC101928764 coiled-coil domain-containing protein 144C-like
288 MIPEPP3 13q12.11 mitochondrial intermediate peptidase pseudogene 3
289 LINC00539 13q12.11 long intergenic non-protein coding RNA 539
290 GRK6P1 13q12.11 G protein-coupled receptor kinase 6 pseudogene 1
291 GAPDHP52 glyceraldehyde 3 phosphate dehydrogenase pseudogene 52
292 RNA5SP25 RNA, 5S ribosomal pseudogene 25
293 ZDHHC20 13q12.11 zinc finger, DHHC-type containing 20
294 HIST1H2BPS3 histone cluster 1, H2b, pseudogene 3
295 MICU2 13q12.11 mitochondrial calcium uptake 2
296 FNTAP2 13q12.11 farnesyltransferase, CAAX box, alpha pseudogene 2




# Gene Position Discription
298 RPS7P10 13q12.11 ribosomal protein S7 pseudogene 10
299 FGF9 13q11-q12 FGF-9|HBGF-9|glia-activating factor|heparin-binding growth factor 9
300 LINC00424 long intergenic non-protein coding RNA 424
301 NME1P1 NME/NM23 nucleoside diphosphate kinase 1 pseudogene 1
302 MTND3P1 MT-ND3 pseudogene 1
303 LINC00540 long intergenic non-protein coding RNA 540
304 LOC101927298 uncharacterized LOC101927298
305 FTH1P7 13q12.11 ferritin, heavy polypeptide 1 pseudogene 7
306 DDX39AP1 13q12.11 DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A pseudogene 1
307 RPL7AP73 ribosomal protein L7a pseudogene 73
308 IPMKP1 13q12.12 inositol polyphosphate multikinase pseudogene 1
309 LOC100129167 13q12.12 Rieske (Fe-S) domain containing pseudogene 1
310 BASP1P1 13q12.12 brain abundant, membrane attached signal protein 1 pseudogene 1
311 NUS1P2 13q12.12
nuclear undecaprenyl pyrophosphate synthase 1 homolog 
(S. cerevisiae) pseudogene 2
312 LOC100130029 13q12.12 high mobility group AT-hook 1 pseudogene 6
313 SGCG 13q12 sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
314 RNU6-58P RNA, U6 small nuclear 58, pseudogene
315 TATDN2P3 TatD DNase domain containing 2 pseudogene 3
316 SDAD1P4 SDA1 domain containing 1 pseudogene 4
317 SACS 13q12 spastic ataxia of Charlevoix-Saguenay (sacsin)
318 RPLP1P13 ribosomal protein, large, P1 pseudogene 13
319 SACS-AS1 13q12 SACS antisense RNA 1
320 LINC00327 long intergenic non-protein coding RNA 327
321 LOC101928839 uncharacterized LOC101928839
322 TNFRSF19 13q12.11-q12.3tumor necrosis factor receptor superfamily, member 19
323 MIPEP 13q12 mitochondrial intermediate peptidase
324 MTCO3P2 MT-CO3 pseudogene 2
325 C1QTNF9B-AS113q12 C1QTNF9B antisense RNA 1
326 C1QTNF9B 13q12.12 C1q and tumor necrosis factor related protein 9B
327 ANKRD20A19P13q12.12 ankyrin repeat domain 20 family, member A19, pseudogene
328 SPATA13 13q12.12 spermatogenesis associated 13
329 RP11-309I15.2 13q12.12 importin 7 pseudogene 2
330 MIR2276 microRNA 2276
331 SPATA13-AS1 SPATA13 antisense RNA 1
332 C1QTNF9 13q12.12 C1q and tumor necrosis factor related protein 9
333 LOC100287275 13q12.12 protein PCOTH pseudogene
334 CEND1P2 13q12.12 cell cycle exit and neuronal differentiation 1 pseudogene 2
335 LOC101060086 cell cycle exit and neuronal differentiation protein 1-like
336 NUS1P3 13q12
nuclear undecaprenyl pyrophosphate synthase 1 homolog 
(S. cerevisiae) pseudogene 3
337 CYCSP33 13q12.12 cytochrome c, somatic pseudogene 33
338 PARP4 13q11 poly (ADP-ribose) polymerase family, member 4
339 LOC101927375 ankyrin repeat domain-containing protein 26-like
340 PSPC1P2 paraspeckle component 1 pseudogene 2
341 TPTE2P6 13q12.12
transmembrane phosphoinositide 3-phosphatase and tensin
homolog 2 pseudogene 6
342 ATP12A 13q12.1-q12.3ATPase, H+/K+ transporting, nongastric, alpha polypeptide
343 RPL26P34 13q12.12 ribosomal protein L26 pseudogene 34
344 LOC100418742 clustered mitochondria (cluA/CLU1) homolog pseudogene
345 IRX1P1 13q12.12 iroquois homeobox 1 pseudogene 1
346 LOC101928867 uncharacterized LOC101928867
347 ANKRD20A10P ankyrin repeat domain 20 family, member A10, pseudogene
348 RNF17 13q12.12 ring finger protein 17
349 CENPJ 13q12.12 centromere protein J
350 LOC101928898 uncharacterized LOC101928898
351 TPTE2P1 13q12.13
transmembrane phosphoinositide 3-phosphatase and tensin
homolog 2 pseudogene 1
352 LOC100422635
solute carrier family 25 (mitochondrial carrier; ornithine transporter) 
member 15 pseudogene 3
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354 LSP1P1 13q12.13 lymphocyte-specific protein 1 pseudogene 1
355 LOC100133284 13q12.13 striatin, calmodulin binding protein pseudogene
356 PABPC3 13q12-q13 poly(A) binding protein, cytoplasmic 3
357 AMER2 13q12.13 OTTHUMP00000018143
358 LOC101928922 uncharacterized LOC101928922
359 RPL23AP69 13q12.13 ribosomal protein L23a pseudogene 69
360 MTMR6 13q12 myotubularin related protein 6
361 NUPL1 13q12.13 nucleoporin like 1
362 TCEB2P1 13q12
transcription elongation factor B (SIII), polypeptide 2 
(18kDa, elongin B) pseudogene 1
363 ATP8A2 13q12 ATPase, aminophospholipid transporter, class I, type 8A, member 2
364 RNU6-78P RNA, U6 small nuclear 78, pseudogene
365 CCDC113 16q21 coiled-coil domain containing 113
366 PRSS54 16q21 protease, serine, 54
367 GINS3 16q21 GINS complex subunit 3 (Psf3 homolog)
368 NDRG4 16q21-q22.1 NDRG family member 4
369 SETD6 16q21 SET domain containing 6
370 CNOT1 16q21 CCR4-NOT transcription complex, subunit 1
371 SNORA46 16q21 small nucleolar RNA, H/ACA box 46
372 SNORA50 16q21 small nucleolar RNA, H/ACA box 50
373 SLC38A7 16q21 solute carrier family 38, member 7
374 GOT2 16q21 glutamic-oxaloacetic transaminase 2, mitochondrial
375 RNY5P9 16q21 RNA, Ro-associated Y5 pseudogene 9
376 GEMIN8P2 16q21 gem (nuclear organelle) associated protein 8 pseudogene 2
377 RPL12P36 16q21 ribosomal protein L12 pseudogene 36
378 RPS27P27 16q21 ribosomal protein S27 pseudogene 27
379 APOOP5 16q21 apolipoprotein O pseudogene 5
380 LOC101927580 uncharacterized LOC101927580
381 LOC100421258 NOP58 ribonucleoprotein homolog (yeast) pseudogene
382 LOC729159 16q21 UPF0607 protein ENSP00000381418-like
383 LOC101927605 uncharacterized LOC101927605
384 GNPATP 16q21 glyceronephosphate O-acyltransferase pseudogene
385 LOC100421593 family with sequence similarity 71, member A pseudogene
386 RPS27AP16 16q21 ribosomal protein S27a pseudogene 16
387 CDH8 16q22.1 cadherin 8, type 2
388 RNU6-21P RNA, U6 small nuclear 21, pseudogene
389 LOC101060189 ubiquitin-conjugating enzyme E2F (putative) pseudogene
390 RPS15AP34 16q21 ribosomal protein S15a pseudogene 34
391 LOC101927629 uncharacterized LOC101927629
392 LOC729217 16q21 emopamil binding protein-like pseudogene
393 CDH11 16q21 cadherin 11, type 2, OB-cadherin (osteoblast)
394 LOC101927650 uncharacterized LOC101927650




Supplementary Figures and Tables 
Supplementary Figure 1: Full pedigree of the Jordanian family. Empty red boxes 
and circles indicate to parents‟ siblings whom we collected saliva samples for 
genotyping. Solid circles with similar color represet the same individual. Numbers 










Supplementary Figure 3: A scanning electron microscopy for ciliated cells (MCC) 
of control and asun-splicing-MO injected embryos. (a,c,e) Low magnification view of 
control embryo MCC which display multiple, long cilia. (b,d,f) Low magnification 
view of Asun morphant MCC exhibit mild defect in multi-cilia although few MCC 
are not totally ciliated. (c-f) At high magnification view, it seems that the length of 
cilia is not affected in Asun morphant, however, few, malformed, disorganized and 




Supplementary Figure 4: Nested RT-PCR analysis for PKHD1L1 in lymphoblastoid 
cells of control, unaffected heterozygous brother and patients. (a) Primers position 
and the fragments size. Nested RT-PCR results display multiple and variable 
transcripts in both patients‟ cells. Wild-type transcript (Panels b and c, lane 1), 
heterozygous brother‟s transcripts (Panels b and c, lane 2), patients‟ transcripts 
carrying PTCs at different positions: patient IV.6 (Panel b, lanes 3-5); patient IV.7 






Supplementary Table: Mutation analysis of all candidate genes for 34 samples 




Gene MLLT4 DACT2 THBS2 SAC2 PKHD1L1 ASUN




Sample # Relation to patients
Father's siblings
1 Uncle -/+ -/- -/- +/+ -/+ +/+
2 Uncle -/+ -/+ -/+ -/+ -/+ -/+
3 Uncle -/- +/+ -/- -/+ -/+ +/+
4 Aunt +/+ -/+ +/+ -/+ -/+ +/+
5 Aunt -/+ +/+ -/+ +/+ -/+ +/+
6 Aunt -/+ +/+ -/+ +/+ -/+ +/+
7 Aunt +/+ +/+ +/+ +/+ -/+ +/+
8 Uncle -/- +/+ -/- -/+ -/+ +/+
Mother's siblings
9 Grandmother -/+ -/+ -/+ -/+ +/+ -/+
10 Uncle +/+ +/+ +/+ -/+ +/+ -/+
11 Uncle +/+ +/+ +/+ -/+ +/+ -/+
12 Aunt +/+ +/+ +/+ +/+ +/+ -/+
13 Aunt -/+ -/+ -/+ -/+ -/+ -/+
14 Aunt +/+ +/+ +/+ -/+ -/+ -/+
15 Aunt -/+ +/+ -/+ +/+ +/+ -/+
16 Uncle +/+ +/+ -/+ +/+ +/+ +/+
17 Uncle -/+ +/+ -/+ +/+ -/+ +/+
18 Cousin +/+ +/+ +/+ -/+ -/+ +/+
19 Cousin +/+ +/+ +/+ +/+ -/+ -/+
20 Cousin +/+ +/+ +/+ -/+ -/+ +/+
21 Cousin +/+ +/+ +/+ +/+ -/+ +/+
22 Cousin +/+ +/+ +/+ -/+ -/+ +/+
23 Cousin +/+ +/+ +/+ +/+ -/+ -/+
24 Cousin +/+ +/+ +/+ -/+ -/+ +/+
25 Cousin +/+ +/+ +/+ +/+ -/+ -/+
26 Uncle's wife +/+ +/+ +/+ +/+ -/- +/+
27 Cousin +/+ +/+ +/+ -/+ +/+ -/+
28 Cousin +/+ +/+ +/+ -/+ -/+ -/+
29 Cousin +/+ +/+ +/+ +/+ -/+ -/+
30 Cousin +/+ +/+ +/+ +/+ -/+ -/+
31 Cousin +/+ +/+ +/+ -/+ -/+ -/+
32 Cousin +/+ +/+ +/+ -/+ +/+ +/+
33 Uncle's wife +/+ +/+ +/+ +/+ -/+ +/+
34 Cousin +/+ +/+ +/+ +/+ -/+ +/+
                                                            Results
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Abstract Autosomal recessive forms of Charcot-Marie-
Tooth disease (ARCMT) are rare but severe disorders of the
peripheral nervous system. Their molecular basis is poorly
understood due to the extensive genetic and clinical heteroge-
neity, posing considerable challenges for patients, physicians,
and researchers. We report on the genetic findings from a
systematic study of a large collection of 174 independent
ARCMT families. Initial sequencing of the three most com-
mon ARCMT genes (ganglioside-induced differentiation pro-
tein 1—GDAP1, SH3 domain and tetratricopeptide repeats-
containing protein 2—SH3TC2, histidine-triad nucleotide
binding protein 1—HINT1) identified pathogenic mutations
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in 41 patients. Subsequently, 87 selected nuclear families
underwent single nucleotide polymorphism (SNP) genotyping
and homozygosity mapping, followed by targeted screening
of known ARCMT genes. This strategy provided molecular
diagnosis to 22 % of the families. Altogether, our unbiased
genetic approach identified pathogenic mutations in ten
ARCMT genes in a total of 41.3 % patients. Apart from a
newly described founder mutation in GDAP1, the majority of
variants constitute private molecular defects. Since the gene
testing was independent of the clinical phenotype of the
patients, we identified mutations in patients with unusual or
additional clinical features, extending the phenotypic spec-
trum of the SH3TC2 gene. Our study provides an overview
of the ARCMT genetic landscape and proposes guidelines for
tackling the genetic heterogeneity of this group of hereditary
neuropathies.
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Introduction
Charcot-Marie-Tooth disease (CMT) represents a group of
degenerative disorders of the peripheral nervous system,
characterized by progressive weakness and atrophy of distal
limb muscles and sensory abnormalities. CMT is the most
common type of inherited peripheral neuropathy affecting 1 in
2,500 individuals worldwide [1]. Autosomal recessive CMT
(ARCMT) is considered to be rare in the European CMT
population accounting for less than 10 % of patients. This
frequency is most likely underestimated due to the small size
of sibships, with many ARCMT patients being unrecognized
and considered as sporadic cases. ARCMT, similarly to other
rare recessive disorders, is more frequent (30–50 % of CMT
patients) in populations with high prevalence of consanguin-
eous marriages (e.g., in the Mediterranean basin or in the
Middle East) [2].
ARCMT can be divided into demyelinating (CMT4), axo-
nal (ARCMT2), or intermediate types based on clinical, elec-
trophysiological, and neuropathological criteria. Clinical pre-
sentation of patients is similar to that of other types of CMT;
however, it has a more severe disease course. The first symp-
toms are early in life (can be even congenital or in early
infancy) and result in delayed developmental milestones. Pro-
gression of muscle atrophy and weakness often leads to loss of
ambulation. The widespread involvement of peripheral nerves
is frequently associated with vocal fold paralysis, sensorineu-
ral deafness, bulbar, facial and diaphragmatic weakness, and
can lead to early death in the most severely affected patients.
Accompanying phenotypic features, like scoliosis, glaucoma,
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myelin outfoldings, or neuromyotonia, can guide the correct
genetic diagnosis of some ARCMT subtypes [3–6].
Up until now, 27 genes were causally associated with
ARCMT, which however explain only a small proportion of
cases. The known genes have been identified mainly by
linkage analyses and candidate gene screenings in large ped-
igrees or in specific ethnic minorities (e.g., Gypsies), while the
smaller families often remained undiagnosed. Furthermore,
there is no single gene or mutation accounting for the majority
of patients, and most of them carry private defects in rare
genes. This extensive non-allelic heterogeneity challenges the
molecular genetic diagnosis and follow-up of the ARCMT
patients and hampers the development of effective treatment
strategies.
In the current study, we analyzed a cohort of 174
nuclear families or isolated patients diagnosed with auto-
somal recessive Charcot-Marie-Tooth disease. Combining
gene-based screening with homozygosity mapping and
mutation analysis of positional CMT candidates, we were
able to provide a molecular diagnosis to 41.3 % of the
families. The gene screening was guided by genetic rather
than clinical criteria, and we were able to expand the
phenotypic spectrum of mutations in the SH3TC2 gene.
Also, homozygosity mapping allowed estimating the actual
degree of inbreeding and the corresponding size and num-
ber of homozygous regions in each patient or family,
which facilitated mutation identification. Our results pres-
ent an overview on the ARCMT genetic architecture and
provide guidelines for future gene screenings in ARCMT
patient cohorts.
Materials and methods
Standard protocol approvals, registrations, and patient
consents
All patients or their legal representatives signed an informed
consent form prior to enrolment. This study was approved by
the local institutional review boards.
Patient cohort
In this study, we included 174 index patients with peripheral
neuropathies either inherited in autosomal recessive fashion or
sporadic patients, descendants from consanguineous mar-
riages. Diagnosis of CMT in the probands was established
by an experienced physician and was based on neurological
examination and electrophysiological evaluation.
In 87 selected families, we performed SNP genotyping and
subsequent candidate gene sequencing. The patients in the
genotyped cohort were diagnosed with CMT1 (38), CMT2
(25), CMT-intermediate (2), hereditary motor neuropathy (2),
and hereditary neuropathy of unspecified type (20). Families
included in this part of the study were of Turkish (83 %), Arab
(5.7 %), Roma (4.5 %), or other (6.8 %) origin. We had data
on parental consanguinity for 34 pedigrees, including double
first cousins (2), first cousins (23), first cousins once removed
(6), second cousins (2), and second cousins once removed (1)
marriages. Other 23 families had unknown degree of related-
ness, for 12 no information on parental consanguinity was
available and for 18 no consanguinity was reported.
SNP genotyping and homozygosity mapping
Whole genome SNP genotyping on 155 individuals from
87 ARCMT families was performed with the Illumina
Human660W-Quad (42 families) or OmniExpress (45) plat-
forms. Data analysis was based on the human genome
reference hg18 and hg19, respectively. We used the
GenomeStudio software to calculate individual call rates
(CR) and prepare files for bioinformatics analysis. Our
quality filtering eliminated from further analysis samples
with CR<98 %. Subsequent filtering steps were conducted
with the PLINK software [7]. We excluded SNPs with low
genotyping rate (uncalled in more than 10 % of individ-
uals) and with low heterozygosity (minor allele frequency
<0.05). Runs of homozygosity (ROH) in PLINK scanned
the genome with a window of 50 consecutive SNPs, of
which 94 % had to be homozygous and allowing 3 hetero-
zygous SNPs. Overlap between sliding windows was 5 %.
Acceptable missingness was three SNPs that were not
called within the window. Allowed gap between SNPs
was 1,000 kb. Subsequently, we selected only regions
≥1 Mb in size and containing minimum 100 SNPs. In the
intra-familial analysis, overlapping homozygous segments
were compared pairwise and were considered to be shared
between individuals if allelic matching was declared for
95 % of all jointly homozygous and non-missing SNPs.
Individual homozygous regions and the shared ones were
visualized in Microsoft Excel using in-house developed
Perl scripts. We developed Microsoft Excel-based script
in order to automatically investigate the presence within
selected homozygous regions of known CMT genes and
genes involved in autosomal recessive forms of either
ataxia or hereditary spastic paraplegia associated with pe-
ripheral neuropathy symptoms.
Mutation analysis
Total genomic DNAwas isolated from peripheral blood sam-
ples and used as a template in the polymerase chain reactions
(PCR). All coding exons and exon–intron boundaries of
HINT1, GDAP1, SH3TC2, MTMR2, PRX, FGD4, MFN2,
SBF2, NEFL, LMNA, NDRG1, HK1, and LRSAM were am-
plified using primer oligonucleotides designed with Primer3
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(primer sequences and PCR conditions are available upon
request). Subsequently, PCR products were purified with the
exonuclease I-shrimp alkaline phosphatase enzymes (USB,
Cleveland, USA) and sequenced in both directions using the
BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems, Foster City, USA). Electrophoretic separation of
fragments was performed on an ABI3730xl DNA Analyzer
(Applied Biosystems, Foster City, USA). Sequences were
analyzed with SeqMan™ II (DNASTAR Inc., Madison,
USA) program. Mutations were described according to the
latest conventions of the HGVS nomenclature (http://www.
hgvs.org/mutnomen) with nucleotide numbering based on the
published online (www.ncbi.nlm.nih.gov/) protein and
mRNA sequences: HINT1 (NM_005340.5, NP_005331.1),
GDAP1 (NM_018972, NP_061845), SH3TC2 (NM_
024577.3, NP_078853.2), MTMR2 (NM_016156.5, NP_
057240.3), PRX (NM_181882, NP_870998.2), FGD4 (NM_
139241.2, NP_640334.2), MFN2 (NM_014874.3, NP_
055689.1), SBF2 (NM_030962.3, NP_112224.1), NDRG1
(NM_001135242.1, NP_001128714.1), and HK1 (NM_
033498.2, NP_277033.1). All sequence variants were
confirmed by an independent PCR and resequencing of the
original or newly obtained DNA samples. Segregation
analysis of the mutations with the disease phenotype was
performed in all available family members. For the newly
identified mutations, 100 ethnically (Turkish, Belgian,
Bulgarian) matched control individuals were screened.
Haplotype analysis
Haplotype sharing between families with the common
GDAP1 deletion was ascertained with four highly informa-
tive short tandem repeat (STR) markers surrounding the
gene (D8S286, D8S551, D8S1144, D8S548). STRs were
first PCR-amplified with fluorescently labeled primer pairs
(sequences are available at www.ncbi.nlm.nih.gov/), and
fragments were subsequently combined with a formamide
and GeneScanTM 500 Liz® Size Standard (Applied
Biosystems, Foster City, USA) mixture (ratio 1:30) and
size-separated on an ABI3730xl DNA Analyzer. Genotyp-
ing results were analyzed with Local Genotype Viewer, an
in-house developed software program (http://www.
vibgeneticservicefacility.be/).
Multiplex amplicon quantification assay (MAQ)
The presence of 3′-end partial deletion in GDAP1 was inves-
tigated by the MAQ assay (http://www.multiplicon.com/). In
this assay, we performed multiplex PCR of ten fluorescently
labeled amplicons targeting the genomic region of GDAP1
and six reference amplicons located at randomly selected
genomic positions outside the GDAP1 region and other
known copy number variations (CNVs). PCR fragments
were mixed with a formamide and GeneScanTM 500 Liz®
Size Standard (Applied Biosystems, Foster City, USA)
solution (ratio 1:30) and size-separated on ABI3730xl DNA
Analyzer. The ratio of peak areas between the target and the
reference amplicons was calculated. Comparison of the nor-
malized peak area values between patients and control indi-
viduals allowed determination of a dosage quotient (DQ) for
each target amplicon, calculated by the MAQ-S package
(http://www.multiplicon.com/). DQ values below 0.75 were
considered indicative for amplicon deletion.
Results
Mutation analysis of the most common ARCMT genes
Initially, we performed systematic analysis of 156 ARCMT
families with unknown molecular defects (Fig. 1). We
screened this cohort for the most frequently mutated ARCMT
genes known to date, independent of the clinical phenotype of
the patients. Mutation analysis of the coding regions and
exon–intron boundaries ofGDAP1 andHINT1 and the known
hotspot mutations (R954* and R1190*) in SH3TC2 identified
15, 17, and 9 molecular defects, respectively. Some of the
mutations were described previously [5, 8–12], and the novel
or known pathogenic defects in non-reported pedigrees are
presented in Table 1.
Additionally, 12 patients with known Roma ethnic back-
ground were screened for the private founder mutations in
NDRG1 (R148*) and HK1 (AltT2 G>C + G>A intron). We
identified ten individuals homozygous for the NDRG1 muta-
tion and two for the HK1 alterations.
Collectively, this analysis provided molecular diagnosis to
53 out of the 156 families (33.9 %).
Homozygosity mapping analysis
As the remaining known ARCMT genes have very low fre-
quency (<2 %) or are described in single families, we opted
for an approach that would allow identification of the under-
lying defects in the rest of the patients while respecting the
genetic heterogeneity of the CMT disease. To this end, we
selected 69 ARCMT pedigrees from the initial cohort, based
on the available genealogical information, reported consan-
guinity, ethnical, or geographic clustering. Additional 18 con-
sanguineous families were included only at this stage of the
study and therefore were not pre-screened for any gene
(Fig. 1).
We performed genotyping with high-density SNP arrays
of 155 individuals from these 87 families, followed by
homozygosity mapping. We determined the median num-
ber of homozygous segments ≥1 Mb in size per affected
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individual. This number progressively decreased from 61
for patients, whose parents were double first cousins, to 48
for first cousins, 35 for first cousins once removed, and to
40 for second cousins. The average sizes of the homozy-
gous SNP blocks were 7.1, 5.4, 4.7, and 2.6 Mb, respec-
tively (Supplementary Table 1).
We also correlated the proportion of homozygous autoso-
mal genome with the degree of consanguinity. In descendants
from first cousin marriages, the observed median genome
homozygosity was 8.2 %, while the theoretical predictions
suggest 6 % (1/16). Similarly, the calculated median values
were higher by at least 2–3 % than the expected ones for all
other consanguinity groups (Supplementary Table 1). Inter-
estingly, patients with ARCMTand no documented history of
consanguinity showed increased homozygosity of their ge-
nome that was often higher than the homozygosity observed
in descendants from second cousin marriages (Supplementary
Fig. 1).
To reduce the number and the size of homozygous regions
containing putative ARCMT-causing mutations, we included
the genotypes of additional sibs, available in 36 % of the
families. Combined analysis of two affected individuals de-
creased the number and size of homozygous blocks by ∼60%.
Inclusion of unaffected sibs also decreased the percentage of
homozygous genome (and number of homozygous blocks) by
12 (33) %, 48 (50) %, or 73 (68) %, respectively for one, two,
or three unaffected individuals.
Furthermore, we could not identify large autozygous
regions shared by two affected individuals in the Belgian
family cmt68, thus suggesting the presence of compound
heterozygous mutations. Subsequent linkage analysis com-
bined with whole genome sequencing revealed two com-
pound heterozygous mutations in the novel at that time
HINT1 gene [6].
Gene and mutation contribution to ARCMT
We used the homozygosity data, rather than clinical fea-
tures of the patients, to Sanger sequence any known
ARCMT gene located within a large (>1 Mb) homozygous
region. With this approach, we successfully identified mu-
tations in 19 out of 87 families (22.9 %) (Table 1). We found
mutations in SH3TC2 (four), HINT1 (two), GDAP1 (two),
FGD4 (two), MFN2 (two), PRX (two), SBF2 (two),
MTMR2 (two), and NDRG1 (one). Although NEFL, LMNA,
and LRSAM1 were located in large homozygous regions in
several families, we could not find mutations in the coding
regions of these genes.
In total, our screening efforts resulted in identification of 14
non-reported sequence variations in GDAP1 (five), SH3TC2
(three), SBF2 (two), MTMR2 (two), and FGD4 (two) (Ta-
ble 1). Importantly, we found a partial homozygous deletion
of GDAP1 in three presumably unrelated families originating
from different parts of Turkey (cmt131, cmt239, and
cmt1226). Haplotype analysis with flanking microsatellite
markers revealed a shared chromosomal region surrounding
GDAP1, suggesting a founder effect (Supplementary Fig. 2a).
The deleted genomic segment encompasses intron 5, exon 6,
and three prime untranslated region (3′ UTR) of the gene.
Heterozygosity of this deletion in the parents was confirmed
by the MAQ assay (Supplementary Fig. 2b).
For all variants, we confirmed segregation with the disease
phenotype in available family members. Presence of the new-
ly identified mutations in ethnically matched control individ-
uals was also excluded.
The phenotypic characteristics of the patients with newly
identified mutations are presented in Supplementary Table 2.
Our combined target- and homozygosity-based gene
screening approach identified disease-causing mutations in





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































73 ARCMT families and provided molecular diagnosis to
41.3 % of the 174 ARCMT index patients analyzed (Fig. 2).
Discussion
ARCMT is a disorder found in all ethnic groups; however, its
prevalence varies significantly between populations and is
rather low in the Western societies, when compared to auto-
somal dominant CMT forms. ARCMT patients are dispersed
among clinical and research centers and very few large patient
collections exist worldwide. Accordingly, the majority of
studies performed so far focused on single ARCMT genes,
specific phenotypes, or populations. Here, we present the
findings in 174 nuclear families and sporadic patients diag-
nosed with ARCMT. To our knowledge, this is the first
systematic study providing a general overview on the genetic
landscape of ARCMT in a large cohort of patients.
Considering the extensive clinical and genetic heterogene-
ity of ARCMT, we pursued a genetic approach to unravel the
molecular defects in our patients. Initially, we examined them
for GDAP1, SH3TC2, and the recently discovered HINT1,
followed by homozygosity-based CMT gene screening. In
the ARCMT field, application of homozygosity mapping
and/or linkage analyses have been proven successful in small
diagnostic studies [13] and in identification of novel genes [6,
14–16]. Therefore, we SNP-genotyped the affected patients of
87 families with high-density arrays, providing 550,000–
700,000 equally spaced genetic markers per individual. We
selected autozygous stretches ≥1 Mb in size and containing at
least 100 consecutive homozygous SNPs. We used the num-
ber of SNPs as an inclusion criterion, as in non-random
locations of the human genome with low recombination rates,
regions of increased homozygosity-by-state are present that
are characterized by low number of polymorphic markers
[17]. Using these parameters, the average size of a homozy-
gous block per ARCMT individual, whose parents are first
cousins, was 5.5 Mb and the average number of homozygous
regions was 48. These numbers could be further reduced by
including additional affected or non-affected family members,
when available.
We applied homozygosity mapping as an unbiased priori-
tization tool for analysis of the numerous known ARCMT
loci. We sequenced a total of 12 CMT genes located within
homozygous regions larger than 1 Mb and found mutations in
nine of them, i.e., SH3TC2, HINT1, GDAP1, FGD4, MFN2,
PRX, SBF2, MTMR2, and NDRG1. Genes with identified
mutations were residing in the largest shared homozygous
block in 35 % of families. In patients, whose parents were
first cousins, the average size of the disease-associated homo-
zygous region was 19 Mb (n=8, range 4.4–45 Mb). Notably,
in family cmt112, in which we detected high degree of relat-
edness of the parents (calculated autosomal genome homozy-
gosity of ∼5 %), the disease-associated region was only
1.7 Mb in size. This finding has important practical conse-
quences, particularly in light of the numerous reports
recommending the mutation search to be focused primarily
on genes residing in one of the largest homozygous regions
[18]. One should consider the genetic map density and the
Fig. 2 Gene contribution to
ARCMT in the studied cohort
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criteria for homozygosity in order not to miss small homozy-
gous stretches that could also contain a disease-causing
mutation.
Homozygosity analysis facilitated the molecular diagnosis
of 22% of patients in the genotyped cohort. Our success rate is
lower in comparison with a recently published study [13], in
which homozygosity mapping provided ARCMT diagnosis in
63 % of the cases. Fischer et al. however investigated only 24
index patients, while our cohort is substantially larger. Also,
the fact that 7/24 patients with known ARCMT mutations
were retrospectively analyzed for homozygosity could inflate
the detection rate. Despite the differences in sensitivity, out-
comes of both studies are complementary in showing that
homozygosity mapping is an efficient tool in providing mo-
lecular diagnosis for a highly heterogeneous genetic disease,
like ARCMT.
We identified 14 novel ARCMT mutations. New sequence
variations were found in GDAP1 (five), SH3TC2 (three),
SBF2 (two), FGD4 (two), and MTMR2 (two). Homozygous
partial deletion in GDAP1 was identified in three Turkish
families. STR marker analysis showed ancestral haplotype
sharing between them, thus revealing a new GDAP1 founder
mutation in the Turkish population. Importantly, since the
deletion encompasses intron 5, exon 6, and 3′UTR, this small
copy number variation can be easily missed if only parents are
analyzed (e.g., the index patient is deceased) or if it occurs in
transwith another heterozygous mutation. Thus, dosage anal-
ysis of exon 6 should be considered for ARCMT patients
having only one heterozygous GDAP1 mutation.
The probands carrying the GDAP1 deletion showed an
early onset phenotype and had walking difficulties requiring
supports. In cmt239, Pectus carinatum was present, which
could be considered as a skeletal deformity due to CMT, along
with hoarseness and hypophonia. Although the patients had
the same mutation, electrophysiological differences were ob-
served between them.While cmt1226 and cmt239 had severe-
ly reduced or unrecordable nerve conduction velocities,
cmt131 had considerably higher NCVs. Similar clinical het-
erogeneity was documented for other GDAP1 mutation, even
among patients within the same pedigree [10]. The peripheral
nerve biopsies were characterized by absence of large mye-
linated fibers and overt signs of demyelination and axonal
degeneration. Overall, this partial GDAP1 deletion was char-
acterized by mixed features, highlighting GDAP1 as a gene
causing an intermediate CMT phenotype.
Interestingly, our unbiased genetic approach allowed estab-
lishing of important genotype–phenotype correlations. In fam-
ily, cmt1224 with the novel p.L780P SH3TC2 mutation the
proband had median NCVs values ≥40 m/s. The conduction
velocities of patients with SH3TC2 mutations reported so far
are usually within the range 4–34 m/s (http://neuromuscular.
wustl.edu/time/hmsn.html). In the available literature, the
only two exceptions are a CMT patient with median
motor NCVs of 42.0 m/s, amplitude of 1.9 mV, and
unexcitable median sensory nerves [12] and a patient
reported by ref. [19] with median motor NCVs of 39.8 m/
s, amplitude of 6.6 mV and median sensory NCVs of 43.
0 m/s, and amplitude of 2.9 mV. Our findings extend the
electrophysiological spectrum of SH3TC2 mutations and
suggest that along with intermediate conduction
velocities, also patients with axonal electroneurographic
findings should be considered for testing of this gene.
In patient cmt1236 with the novel p.A639Pfs*6 SH3TC2
mutation, cerebellar dysfunction (tremor, bilateral horizontal
nystagmus, titubation of the head with cerebellar dysmetria)
was apparent. This type of central nervous system involve-
ment has not been associated with SH3TC2 mutations so far.
We cannot exclude, however, that an additional gene might
cause the cerebellar features in the patient.
The clinical phenotype of the remaining patients with
newly identified mutations was in agreement with the geno-
type–phenotype correlations reported in the literature.
Our extensive screening efforts could not identify genetic
defects in 58 % of the patients. Overall, there were no major
clinical differences between the CMT individuals with known
and unknown genetic causes. We cannot exclude that muta-
tions located in unknown regulatory regions or deep-intronic
sequences could have been missed by focusing on protein-
coding regions. Furthermore, mutations in genes associated
with other neuromuscular disorders that mimic CMT clinical-
ly could cause the disease in part of the families. Nevertheless,
our findings underscore the heterogeneous molecular etiology
of ARCMT and imply many unidentified disease-causing
genes to exist.
The findings in this large-scale study allow us to suggest
some guidelines for molecular genetic analysis of patients
with ARCMT. Three genes are distinguished as major players
in our ARCMT cohort, namely GDAP1 (10.9 %), HINT1
(10.3 %), and SH3TC2 (7.5 %). Sanger or panel sequencing
of these genes, which consist of only six, three, and two
hotspot exons, respectively, would provide molecular diagno-
sis in ∼25 % of the cases. It is also meaningful to first exclude
known population-specific founder mutations. For example,
the overall contribution of NDRG1 is only 6.3 %; however, it
reaches 17.9 % in the Gypsy population and should be tested
in any patient with this ethnicity and demyelinating type of
CMT [20]. The remaining known ARCMT genes have rather
limited contribution to this disease (∼1 %). Therefore, after
screening the three most common genes, in view of constantly
decreasing running costs, one could directly proceed with
whole exome sequencing (WES) of the index patient. WES
presents an interesting future alternative of the application of
CMT gene panels, provided that the capturing and coverage
will be improved. This way, finding of known genetic causes
and searching for variations in new candidate genes can be
performed simultaneously.
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Homozygosity mapping with extracted SNPs from whole
exome sequencing data can be used as a prioritization tool,
pointing the regions encompassing known or novel ARCMT
genes [21, 22]. WES-based homozygosity approach, howev-
er, will only identify autozygous loci that are located within
regions containing a sufficient number of informative SNPs.
Therefore, an alternative could be SNP genotyping of at least
one affected individual prior to whole exome sequencing. Our
data suggest that in patients originating from populations with
prolonged history of consanguinity, the percentage of homo-
zygous autosomal genomemight be at least 2–3% higher than
the theoretical predictions [23]. Woods et al. by studying
patients with autosomal recessive disorders originating from
Pakistani and Arab populations reported similar findings [18].
In their study, mainly patients from first cousin marriages (n=
38) were analyzed, and the percentage of homozygous auto-
somal genome was on average 11 %, while for us, this equals
to 8.6 % (n=27). Interestingly, among the ARCMT patients
with identified mutations, but no data or negative data for
consanguinity, the percentage of homozygosity was also in-
creased and could be as high as for descendants of a second
cousin marriage. Therefore, in sporadic patients with in-
creased degree of homozygosity, a recessive CMT inheritance
should primarily be suspected. Contrastingly, lack of large in
size (>1 Mb) or number of homozygous regions in any
ARCMT family will be indicative of most likely compound
heterozygous mutation underlying the phenotype.
In conclusion, our findings contribute to the knowledge on
the molecular basis of ARCMT by providing an overview of
the ARCMT genetic landscape, updating the ARCMT gene
frequencies and broadening the mutation and clinical spec-
trum of known genes, likeGDAP1, SH3TC2,MTMR2, SBF2,
and FGD4. Furthermore, we propose guidelines for molecular
investigation of ARCMT patients considering recent techno-
logical advances. Our findings have major implications for
future molecular diagnostics and research in the field of pe-
ripheral neuropathies and other disorders with extensive ge-
netic heterogeneity.
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Abstract Oral-facial-digital syndrome type VI (OFD VI)
is a recessive ciliopathy defined by two diagnostic criteria:
molar tooth sign (MTS) and one or more of the following:
(1) tongue hamartoma (s) and/or additional frenula and/or
upper lip notch; (2) mesoaxial polydactyly of one or more
hands or feet; (3) hypothalamic hamartoma. Because of the
MTS, OFD VI belongs to the ‘‘Joubert syndrome related
disorders’’. Its genetic aetiology remains largely unknown
although mutations in the TMEM216 gene, responsible for
Joubert (JBS2) and Meckel-Gruber (MKS2) syndromes,
have been reported in two OFD VI patients. To explore the
molecular cause(s) of OFD VI syndrome, we used an ex-
ome sequencing strategy in six unrelated families followed
by Sanger sequencing. We identified a total of 14 novel
mutations in the C5orf42 gene in 9/11 families with posi-
tive OFD VI diagnostic criteria including a severe fetal
case with microphthalmia, cerebellar hypoplasia, corpus
callosum agenesis, polydactyly and skeletal dysplasia.
C5orf42 mutations have already been reported in Joubert
syndrome confirming that OFD VI and JBS are allelic
disorders, thus enhancing our knowledge of the complex,
highly heterogeneous nature of ciliopathies.
Introduction
Oral-facial-digital syndrome type VI (OFD VI) or Varadi-
Papp syndrome (OMIM 277170) belongs to the hetero-
geneous group of 13 OFD syndromes defined by the
association of malformations of the face, the oral cavity,
and the extremities (Gurrieri et al. 2007) and has been
distinguished from other OFD subtypes by cerebellar
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malformation, metacarpal abnomalities with mesoaxial
polydactyly and severe intellectual disability (Doss et al.
1998; McPherson et al. 2006; Varadi et al. 1980).
Hypothalamic hamartomas have also been described
(Poretti et al. 2012; Stephan et al. 1994). Recently,
diagnostic criteria for OFD VI have been defined as:
molar tooth sign (MTS) and one or more of the following:
(1) tongue hamartoma and/or additional frenula and/or
upper lip notch; (2) mesoaxial polydactyly of one or more
hands or feet and (3) hypothalamic hamartoma (Poretti
et al. 2012).
The MTS on axial brain MRI argues in favor of OFD VI
being a Joubert syndrome related disorder (JSRD) (Gleeson
et al. 2004). To date, mutations in 20 genes (Brancati et al.
2010) (INPP5E [MIM613037], TMEM216 [MIM613277],
AHI1 [MIM608894], NPHP1 [MIM607100], CEP290
[MIM610142], TMEM67 [MIM609884], RPGRIP1L
[MIM610937], ARL13B [MIM608922]), CC2D2A
[MIM612013], OFD1 [MIM300170], KIF7 [MIM611254],
TCTN1 [MIM609863], TCTN2 [MIM613846], TMEM237
[MIM614423], CEP41 [MIM610523] (Lee et al. 2012a),
TMEM138 [MIM614459] (Lee et al. 2012b), C5orf42
[MIM614571] (Srour et al. 2012a), TCTN3 [MIM614815]
(Thomas et al. 2012), ZNF423 [MIM604557] (Chaki et al.
2012) and TMEM231 [MIM614949] (Srour et al. 2012b)
have been identified in patients with a JSRD. Most of the
encoded proteins are predicted or known to be involved in
the function of the primary cilium/basal body.
OFD VI usually follows an autosomal recessive mode of
inheritance with mainly unknown molecular basis. Indeed,
mutations in the TMEM216 gene, also responsible for
Joubert (JS) and Meckel (MKS) syndromes, have been
identified in only two JS patients with oral frenula and
polydactyly (Valente et al. 2010). A few mutations in the
X-linked OFD1 gene have also been reported in male JS
patients with oral defects (Coene et al. 2009) or female
patients with OFD syndrome and mild MTS (Bisschoff
et al. 2013; Darmency-Stamboul et al. 2013).
In this study, we used exome sequencing to identify
C5orf42 as the major gene responsible for OFD VI, and we




We ascertained eight cases (six males and six females)
from six unrelated sibships with clinical features meeting
OFD VI diagnostic criteria (Table 1) (Darmency-Stamboul
et al. 2013; Poretti et al. 2008). Informed consent for
research investigations was obtained from the affected
individuals, legal representatives, or relatives. The research
protocol was approved by the local ethics committees.
Among the eight cases, 4/8 were fetuses including one
deceased sibship and 4/8 were living including a second
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sibship. All living patients presented with MTS upon brain
MRI (Fig. 1). The phenotype also included oral abnor-
malities (tongue hamartoma(s) and/or an additional frenula
and/or upper lip notch) (5/7 cases), facial dysmorphism
(4/6 cases), mesoaxial polydactyly (4/8 cases), Y-shaped
metacarpal abnormality (2/5 cases), preaxial polydactyly
(7/7 cases), postaxial polydactyly (5/7 cases), and hypo-
thalamic hamartoma (4/8 cases) (Figs. 1, 2; Table 1).
Standard chromosomal analysis and array-CGH (Agilent
60, 105 or 244 K) were normal in all individuals. No
mutation or genomic rearrangement in the TMEM216 and
OFD1 genes was identified by Sanger sequencing of exons
and intron–exon boundaries and quantitative PCR (primers
and PCR conditions available on request).
An additional series of nine families was collected
including 5/9 with OFD VI positive diagnostic criteria and
possible atypical clinical features (short femurs, occipital
meningocele, right fibular agenesis, tibial bowing and
microphthalmia). One severe fetus (case 8) presented with
facial dysmorphism, microphthalmia, cerebellar vermis
hypoplasia, corpus callosum agenesis, bilateral hand and
feet preaxial and postaxial polydactyly, unilateral hand
mesoaxial polydactyly with Y-shaped metacarpal pha-
lange, and severe skeletal dysplasia with right fibular
agenesis and tibial bowing but absent oral manifestations.
The four other families presented with an overlapping
phenotype including polydactyly and at least one of the
following features: oral defects, cerebellar hypoplasia, and
hypothalamic hamartoma (3/4 with pituitary gland abnor-
mality with hypothalamic hamartoma, 1/4 with normal




Exome sequencing was performed by IntegraGen using the
Agilent SureSelect Human All Exon kit v2 (Agilent,
France). DNA samples were prepared according to the
platform recommendations. Genomic DNA was captured
with a biotinylated oligonucleotide probe library (Agilent,
France), followed by 75 bp paired-end massively parallel
sequencing on an Illumina HiSEQ 2000 (Gnirke et al.
2009). Briefly, 3 lg of each genomic DNA sample was
fragmented by sonication and purified to yield fragments of
150–200 bp. Paired-end adaptor oligonucleotides from
Illumina were then ligated to the shared genomic DNA.
Five hundred nanograms of these tailed fragments were
then hybridized to the SureSelect probe library. Each DNA
sample was sequenced on an Illumina HiSEQ 2000 as
paired-end 75 bp reads. Image analysis and base calling
were performed using Illumina real time analysis (RTA)
pipeline version 1.8 with default parameters.
Reads were aligned to the human reference genome
(GRCh37/hg19) with the burrows-wheeler aligner (BWA)
(Li et al. 2009) and potential duplicate paired-end reads were
removed with Picard v.1.22 (see Web Resources). The
Genome Analysis Toolkit (GATK) v.1.0.57 was used for
base quality-score recalibration and indel realignment as
well as for single-nucleotide-variant and indel discovery and
genotyping with the use of standard hard-filtering parameters
(DePristo et al. 2011). Variants with a quality score \30,
allele balance[0.75, sequencing depth\4, quality-to-depth
ratio\5.0, length of homopolymer run[5.0, and strand bias
[–0.10 were flagged and excluded from subsequent analy-
ses. We used the GATK depth of coverage tool to assess
coverage by ignoring reads with a mapping quality\20 and
by ignoring bases with a base quality \30. All variants
identified in the affected individuals were annotated with
SeattleSeq SNP annotation (see Web resources). Candidate
mutational events were then inspected with the integrative
genomics viewer (see Web resources) (Robinson et al. 2011).
The resulting variants were excluded when the frequency
was over 1/1,000 in exome variant server (EVS) (see web
Resources). The analyses were focused on genes with at least
two heterozygous variants (missense, nonsense, and splice-
site variants and coding indels).
Sanger sequencing
Exons containing the sequence variations of the C5orf42 gene
(NM_023073.3) were amplified using a 65–55 touchdown
protocol with primers designed to amplify all the 51 exons and
intron–exon boundaries (Supplementary Table 1). PCR
fragments were purified using the multiscreen Vacuum
Manifold system (Millipore, Merck, France) or Exosap (Af-
fymetrix, USB products, USA). Sequencing was performed
using an ABI BigDye Terminator Cycle Sequencing kit (v3.1)
(Applied Biosystems, France) in an ABI 3130 sequencer.
Sequence data were analyzed with SeqScape v2.7 (Applied
Biosystems, France) and Sequencer v4.1. The pathogenicity
of missense mutations was tested with PolyPhen-2 and SIFT
online software (see Web Resources) (Adzhubei et al. 2010).
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Results
To identify the molecular defect(s) underling this con-
dition, we performed exome analysis in six index cases
with OFD VI positive diagnostic criteria. After applying
variant calling filters, we identified two causal mutations
in the C5orf42 gene in three out of six cases: one
frameshift and one missense in patient 1, one nonsense
and one missense in fetus 2 and one homozygous splice
acceptor mutation in patient 3a. We also identified one
causal heterozygous mutation in the 3/6 other individu-
als: one splice-site mutation in fetus 4 and one missense
in fetus 5 and in case 6 (Table 1, Supplementary
Table 2).
Since 2 transcripts of C5orf42 are described in ensembl,
we checked the exome coverage and noticed that the first
18 exons of the C5orf42 (NM_023073) gene were not
covered by v2 of the Agilent SureSelect Human All Exon
library. C5orf42 Sanger sequencing analysis of the first 18
exons was performed in individuals 4, 5, 6 allowing the
identification of the same second causal mutation in cases 4
and 6 (p.Ile165Tyrfs*17) and one nonsense mutation in
case 5.
Screening of nine additional individuals with OFD VI or
overlapping phenotypes revealed three other families with
C5orf42 recessive mutations. In family seven, two mis-
sense mutations were found, including the same one as had
been identified in case 6. In fetus 8, one missense (the same
as that found in case 7) and one frameshift were found
(Table 1 and Supplementary Table 3), while two unique
mutations were identified in case 9. All variants were
confirmed in all individuals and affected sibs by Sanger
sequencing. Parental segregation analysis confirmed het-
erozygosity in parents in families 2, 3, 4, 5, 6 and 7. We
also analyzed 5 microsatellite markers at the C5orf42 locus
and found that cases 6 and 7 share a common haplotype for
D5S1994, D5S2021, D5S1964 and D5S2105 segregating
with Ser1127Leu, suggesting a founder effect for this
mutation. However, there was no evidence of linkage dis-
equilibrium around the Ile165Thrfs*17 mutation shared by
cases 4 and 6.
Altogether, a total of 14 distinct C5orf42 mutations
(four frameshift, three nonsense, five missense and two
splice site, Table 1 and Supplementary Table 3) were
identified in 9/11 unrelated families. Detailed clinical fea-
tures of 12 individuals are presented in Table 1.
Fig. 1 Clinical and neuroimaging features of individuals with
C5orf42 mutations (case 1 (e), case 2 (i), case 3b (a), case 4 (b, c,
f), case 5 (j), case 6b (g) and case 7b (d, h)), with facial dysmorphism
with hypertelorism (a, b), oral hamartoma (c), occipital encephalocele
(d), molar tooth sign (e, f), cerebellar hypoplasia (g, h) and
hypothalamic hamartoma (i, j)
372 Hum Genet (2014) 133:367–377
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Discussion
In this study, we identified causal C5orf42 mutations in
9/11 families meeting OFD VI diagnostic criteria, but no
mutation in individuals with partly overlapping features.
Thus, all presented the diagnostic criteria characterized by
MTS and one or more of the following: (1) tongue ham-
artoma and/or an additional frenula and/or upper lip notch;
(2) mesoaxial polydactyly of one or more hands or feet; (3)
hypothalamic hamartoma (Poretti et al. 2012). Common
distal limb abnormalities in the 12 cases with C5orf42
mutations included constant feet preaxial polydactyly (12/
12 cases) and frequent mesoaxial polydactyly (7/12 cases)
and at least one distal extremity with Y–shaped metacarpal
abnormality (6/9 cases) (Table 1; Fig. 2). Hypothalamic
hamartoma was frequent (5/12 cases). Intellectual disabil-
ity was constant (4/4 cases) in contrast with two other
frequent OFD subtypes, i.e., OFD I and II (Gurrieri et al.
2007). OFD VI belongs to the JSRD (Gleeson et al. 2004).
Remarkably, additional features usually reported in this
group of ciliopathies such as polycystic kidney disease and
retinal disease are absent in the cases with C5orf42
mutations.
C5orf42 mutations were also found in atypical cases,
such as fetus 7a with short femurs, fetuses 7b and 9 with
occipital meningocele and fetus 8 with microphthalmia and
severe skeletal dysplasia with right tibial bowing and fib-
ular agenesis (Table 1; Fig. 2). Occipital meningocele, a
feature of the lethal Meckel syndrome (MIM 249000) and
rarely JBS, was also previously described in two JBS
individuals with C5orf42 mutations, but without renal
involvement or polydactyly (Alazami et al. 2012; Shaheen
et al. 2012). The absence of characteristic renal involve-
ment seems, therefore, a discriminating feature of C5orf42-
mutated individuals reported thus far. Tibial bowing and
fibular agenesis have already been described in other cili-
opathies, including short ribs polydactyly, OFD IV or OFD
X syndromes (Figuera et al. 1993; Toriello et al. 1997).
Moreover, OFD VI was diagnosed in 4/9 cases because of
the association of mesoaxial polydactyly and MTS despite
the absence of oral abnormalities (Gurrieri et al. 2007).
Among the 15 previous reported cases with C5orf42
Fig. 2 Clinical and radiological distal limb abnormalities of individ-
uals with C5orf42 mutations (case 1 (a–f), case 2 (h–j), case 3b (k–n),
case 4 (g), case 5 (o–r), case 6b (s–v) case 7b (w–z) and case 8 (a-f)),
with hand polydactyly (h, o, s, w, a), hallux valgus or foot preaxial
polydactyly (d, g, j, m, q, u, y, c), Y-shaped metacarpal abnormality
(i, p, t, x, b), and right fibula agenesis with tibial incurvation (f)
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mutations, hypothalamic hamartoma and mesoaxial poly-
dactyly were absent. Oral examination has only been
described in one case presenting with cleft lip and palate,
and is therefore a rare but possible feature of OFD VI (2
cases of our series).
We identified a total of 14 novel C5orf42 mutations in 9
families, mostly truncating (4 frameshift, 3 nonsense, 5
missense and 2 splice) including 3 recurrent mutations in
unrelated cases. Thus far, 11 pathogenic C5orf42 mutations
have been reported in 15 patients (Table 2) (Alazami et al.
2012; Shaheen et al. 2012; Srour et al. 2012a, b). It is likely
that at least one truncating mutation is necessary to induce
JSRD or OFD VI as suggested by the high rate of mutations
of this type (16/23 mutations, i.e., 70 %), contrasting with
most JSRD causative genes (Mougou-Zerelli et al. 2009).
Missense mutations identified in the compound heterozy-
gous state are also predicted to alter splicing (Supplemen-
tary Table 3). While few patients with TMEM216 mutations
display OFD features, C5orf42 appears the major gene for
OFD VI in our series (9/11). Such genetic homogeneity will
be helpful for molecular analysis and genetic counseling of
patients with OFD VI diagnostic criteria.
The ciliopathy protein network implicated in the JSRD
clinical spectrum involves three distinct, but connected
modules: the ciliary transition zone, the centrosome and the
Hedgehog signaling pathway (Sang et al. 2011). This net-
work appears distinct from the BBsome and IFT complexes,
implicated in other ciliopathies (Wei et al. 2012). C5orf42
encodes a 3,198-amino acid protein, but very little is known
about its function (Srour et al. 2012a). The Gene Ontology
project suggests that it might be a transmembrane protein
and ProtoNet predicts a coiled-coil structure within the
protein. Analysis of EST, microarray, and other databases
predict widespread expression of C5orf42, including in
brain. The predicted protein sequence appears well con-
served as close C5orf42 orthologs are detected in several
vertebrates. Additional studies will be required to identify
the role of C5orf42 in the ciliopathy protein network.
Overall, we report the identification of C5orf42 as the
major gene responsible for OFD VI. Mutations are asso-
ciated with a broad clinical spectrum that extends from a
viable to severe, lethal phenotype with skeletal dysplasia.
These results also confirm that OFD VI and JBS are allelic
disorders, thereby improving our understanding of the
complex, frequently allelic and highly heterogeneous nat-
ure of ciliopathies.
Web resources
The URLs for data presented herein are as follows: Broad
Institute Integrated Genomics Viewer (IGV), http://www.
broadinstitute.org/igv/; NHLBI Exome Sequencing Project
(ESP) Exome Variant Server (EVS), http://evs.gs.
washington.edu/EVS/; Online Mendelian Inheritance in
Man (OMIM), http://www.omim.org/; Picard, http://picard.
sourceforge.net/; PolyPhen-2, http://genetics.bwh.harvard.
edu/pph2/; Primer3, http://frodo.wi.mit.edu/primer3/;
SeattleSeq Annotation 131, http://snp.gs.washington.edu/
SeattleSeqAnnotation131/; SIFT, http://sift.bii.a-star.edu.
sg/; Human Splicing Finder (HSF), http://www.umd.be/
HSF/.
Acknowledgments We thank the families for their participation.
We are grateful to the French Society of Fetal Pathology (SOFFOET)
for participating in the study. This work was supported by grants from
GIS-Institut des Maladies Rares and Fondation IMAGINE for high-
throughput-sequencing, the French Ministry of Health (PHRC
national 2010 and 2012), the Dijon University Hospital, Regional
Council of Burgundy, the project ANR (2010 FOETOCILPATH N
BLAN 1122 01 to T.A.B.), and A*STAR Singapore for a Strategic
Positioning Fund for Genetic Orphan Diseases. Finally, the authors
would like to thank the NHLBI GO Exome Sequencing Project and its
ongoing studies which produced and provided exome variant calls for
comparison: the Lung GO Sequencing Project (HL-102923), the WHI
Sequencing Project (HL-102924), the Broad GO Sequencing Project
(HL-102925), the Seattle GO Sequencing Project (HL-102926) and
the Heart GO Sequencing Project (HL-103010).
Conflict of interest The authors declare no competing financial
interest.
References
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A,
Bork P, Kondrashov AS, Sunyaev SR (2010) A method and
server for predicting damaging missense mutations. Nat Methods
7:248–249
Alazami AM, Alshammari MJ, Salih MA, Alzahrani F, Hijazi H,
Seidahmed MZ, Abu Safieh L, Aldosary M, Khan AO, Alkuraya
FS (2012) Molecular characterization of Joubert syndrome in
Saudi Arabia. Human mutation 33:1423–1428
Bisschoff IJ, Zeschnigk C, Horn D, Wellek B, Riess A, Wessels M,
Willems P, Jensen P, Busche A, Bekkebraten J, Chopra M, Hove
HD, Evers C, Heimdal K, Kaiser AS, Kunstmann E, Robinson
KL, Linne M, Martin P, McGrath J, Pradel W, Prescott KE,
Roesler B, Rudolf G, Siebers-Renelt U, Tyshchenko N, Wiecz-
orek D, Wolff G, Dobyns WB, Morris-Rosendahl DJ (2013)
Novel mutations including deletions of the entire OFD1 gene in
30 families with type 1 orofaciodigital syndrome: a study of the
extensive clinical variability. Hum Mutat 34:237–247
Brancati F, Dallapiccola B, Valente EM (2010) Joubert syndrome and
related disorders. Orphanet J Rare Dis 5:20
Chaki M, Airik R, Ghosh AK, Giles RH, Chen R, Slaats GG, Wang
H, Hurd TW, Zhou W, Cluckey A, Gee HY, Ramaswami G,
Hong CJ, Hamilton BA, Cervenka I, Ganji RS, Bryja V, Arts
HH, van Reeuwijk J, Oud MM, Letteboer SJ, Roepman R,
Husson H, Ibraghimov-Beskrovnaya O, Yasunaga T, Walz G,
Eley L, Sayer JA, Schermer B, Liebau MC, Benzing T, Le Corre
S, Drummond I, Janssen S, Allen SJ, Natarajan S, O’Toole JF,
Attanasio M, Saunier S, Antignac C, Koenekoop RK, Ren H,
Lopez I, Nayir A, Stoetzel C, Dollfus H, Massoudi R, Gleeson
JG, Andreoli SP, Doherty DG, Lindstrad A, Golzio C, Katsanis
N, Pape L, Abboud EB, Al-Rajhi AA, Lewis RA, Omran H, Lee
Hum Genet (2014) 133:367–377 375
123
EY, Wang S, Sekiguchi JM, Saunders R, Johnson CA, Garner E,
Vanselow K, Andersen JS, Shlomai J, Nurnberg G, Nurnberg P,
Levy S, Smogorzewska A, Otto EA, Hildebrandt F (2012)
Exome capture reveals ZNF423 and CEP164 mutations, linking
renal ciliopathies to DNA damage response signaling. Cell
150:533–548
Coene KL, Roepman R, Doherty D, Afroze B, Kroes HY, Letteboer
SJ, Ngu LH, Budny B, van Wijk E, Gorden NT, Azhimi M,
Thauvin-Robinet C, Veltman JA, Boink M, Kleefstra T, Cremers
FP, van Bokhoven H, de Brouwer AP (2009) OFD1 is mutated in
X-linked Joubert syndrome and interacts with LCA5-encoded
lebercilin. Am J Hum Genet 85:465–481
Darmency-Stamboul V, Burglen L, Lopez E, Mejean N, Dean J,
Franco B, Rodriguez D, Lacombe D, Desguerres I, Cormier-
Daire V, Doray B, Pasquier L, Gonzales M, Pastore M,
Crenshaw ML, Huet F, Gigot N, Aral B, Callier P, Faivre L,
Attie-Bitach T, Thauvin-Robinet C (2013) Detailed clinical,
genetic and neuroimaging characterization of OFD VI syndrome.
Eur J Med Genet
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl
C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna
A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K,
Gabriel SB, Altshuler D, Daly MJ (2011) A framework for
variation discovery and genotyping using next-generation DNA
sequencing data. Nat Genet 43:491–498
Doss BJ, Jolly S, Qureshi F, Jacques SM, Evans MI, Johnson MP,
Lampinen J, Kupsky WJ (1998) Neuropathologic findings in a
case of OFDS type VI (Varadi syndrome). Am J Med Genet
77:38–42
Figuera LE, Rivas F, Cantu JM (1993) Oral-facial-digital syndrome
with fibular aplasia: a new variant. Clin Genet 44:190–192
Gleeson JG, Keeler LC, Parisi MA, Marsh SE, Chance PF, Glass IA,
Graham JM Jr, Maria BL, Barkovich AJ, Dobyns WB (2004)
Molar tooth sign of the midbrain-hindbrain junction: occurrence
in multiple distinct syndromes. Am J Med Genet A 125:125–134
(discussion 117)
Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman
W, Fennell T, Giannoukos G, Fisher S, Russ C, Gabriel S, Jaffe
DB, Lander ES, Nusbaum C (2009) Solution hybrid selection
with ultra-long oligonucleotides for massively parallel targeted
sequencing. Nat Biotechnol 27:182–189
Gurrieri F, Franco B, Toriello H, Neri G (2007) Oral-facial-digital
syndromes: review and diagnostic guidelines. Am J Med Genet
A 143A:3314–3323
Lee JE, Silhavy JL, Zaki MS, Schroth J, Bielas SL, Marsh SE, Olvera
J, Brancati F, Iannicelli M, Ikegami K, Schlossman AM,
Merriman B, Attie-Bitach T, Logan CV, Glass IA, Cluckey A,
Louie CM, Lee JH, Raynes HR, Rapin I, Castroviejo IP, Setou
M, Barbot C, Boltshauser E, Nelson SF, Hildebrandt F, Johnson
CA, Doherty DA, Valente EM, Gleeson JG (2012a) CEP41 is
mutated in Joubert syndrome and is required for tubulin
glutamylation at the cilium. Nat Genet 44:193–199
Lee JH, Silhavy JL, Lee JE, Al-Gazali L, Thomas S, Davis EE,
Bielas SL, Hill KJ, Iannicelli M, Brancati F, Gabriel SB, Russ
C, Logan CV, Sharif SM, Bennett CP, Abe M, Hildebrandt F,
Diplas BH, Attie-Bitach T, Katsanis N, Rajab A, Koul R,
Sztriha L, Waters ER, Ferro-Novick S, Woods CG, Johnson
CA, Valente EM, Zaki MS, Gleeson JG (2012b) Evolutionarily
assembled cis-regulatory module at a human ciliopathy locus.
Science 335:966–969
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth
G, Abecasis G, Durbin R (2009) The sequence alignment/map
format and SAMtools. Bioinformatics 25:2078–2079
McPherson E, Zaleski C, Mascola M (2006) Prenatal diagnosis of
episodic tachypnea in an infant with OFD VI. Am J Med Genet
A 140:2146–2149
Mougou-Zerelli S, Thomas S, Szenker E, Audollent S, Elkhartoufi N,
Babarit C, Romano S, Salomon R, Amiel J, Esculpavit C,
Gonzales M, Escudier E, Leheup B, Loget P, Odent S, Roume J,
Gerard M, Delezoide AL, Khung S, Patrier S, Cordier MP,
Bouvier R, Martinovic J, Gubler MC, Boddaert N, Munnich A,
Encha-Razavi F, Valente EM, Saad A, Saunier S, Vekemans M,
Attie-Bitach T (2009) CC2D2A mutations in Meckel and Joubert
syndromes indicate a genotype-phenotype correlation. Hum
Mutat 30:1574–1582
Poretti A, Brehmer U, Scheer I, Bernet V, Boltshauser E (2008)
Prenatal and neonatal MR imaging findings in oral-facial-digital
syndrome type VI. AJNR Am J Neuroradiol 29:1090–1091
Poretti A, Vitiello G, Hennekam RC, Arrigoni F, Bertini E, Borgatti
R, Brancati F, D’Arrigo S, Faravelli F, Giordano L, Huisman
TA, Iannicelli M, Kluger G, Kyllerman M, Landgren M, Lees
MM, Pinelli L, Romaniello R, Scheer I, Schwarz CE, Spiegel R,
Tibussek D, Valente EM, Boltshauser E (2012) Delineation and
diagnostic criteria of Oral-facial-digital syndrome type VI.
Orphanet J Rare Dis 7:4
Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander
ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat
Biotechnol 29:24–26
Sang L, Miller JJ, Corbit KC, Giles RH, Brauer MJ, Otto EA,
Baye LM, Wen X, Scales SJ, Kwong M, Huntzicker EG,
Sfakianos MK, Sandoval W, Bazan JF, Kulkarni P, Garcia-
Gonzalo FR, Seol AD, O’Toole JF, Held S, Reutter HM, Lane
WS, Rafiq MA, Noor A, Ansar M, Devi AR, Sheffield VC,
Slusarski DC, Vincent JB, Doherty DA, Hildebrandt F, Reiter
JF, Jackson PK (2011) Mapping the NPHP-JBTS-MKS protein
network reveals ciliopathy disease genes and pathways. Cell
145:513–528
Shaheen R, Faqeih E, Alshammari MJ, Swaid A, Al-Gazali L,
Mardawi E, Ansari S, Sogaty S, Seidahmed MZ, Almotairi MI,
Farra C, Kurdi W, Al-Rasheed S, Alkuraya FS (2012) Genomic
analysis of Meckel-Gruber syndrome in Arabs reveals marked
genetic heterogeneity and novel candidate genes. Eur J Human
Genet EJHG
Srour M, Hamdan FF, Schwartzentruber JA, Patry L, Ospina LH,
Shevell MI, Desilets V, Dobrzeniecka S, Mathonnet G, Lemyre
E, Massicotte C, Labuda D, Amrom D, Andermann E, Sebire G,
Maranda B, Rouleau GA, Majewski J, Michaud JL (2012a)
Mutations in TMEM231 cause Joubert syndrome in French
Canadians. J Med Genet 49:636–641
Srour M, Schwartzentruber J, Hamdan FF, Ospina LH, Patry L,
Labuda D, Massicotte C, Dobrzeniecka S, Capo-Chichi JM,
Papillon-Cavanagh S, Samuels ME, Boycott KM, Shevell MI,
Laframboise R, Desilets V, Maranda B, Rouleau GA, Majewski
J, Michaud JL (2012b) Mutations in C5ORF42 cause Joubert
syndrome in the French Canadian population. Am J Hum Genet
90:693–700
Stephan MJ, Brooks KL, Moore DC, Coll EJ, Goho C (1994)
Hypothalamic hamartoma in oral-facial-digital syndrome type
VI (Varadi syndrome). Am J Med Genet 51:131–136
Thomas S, Legendre M, Saunier S, Bessieres B, Alby C, Bonniere M,
Toutain A, Loeuillet L, Szymanska K, Jossic F, Gaillard D,
Yacoubi MT, Mougou-Zerelli S, David A, Barthez MA, Ville Y,
Bole-Feysot C, Nitschke P, Lyonnet S, Munnich A, Johnson CA,
Encha-Razavi F, Cormier-Daire V, Thauvin-Robinet C, Veke-
mans M, Attie-Bitach T (2012) TCTN3 mutations cause Mohr-
Majewski syndrome. Am J Hum Genet 91:372–378
Toriello HV, Carey JC, Suslak E, Desposito FR, Leonard B, Lipson
M, Friedman BD, Hoyme HE (1997) Six patients with oral-
facial-digital syndrome IV: the case for heterogeneity. Am J Med
Genet 69:250–260
Valente EM, Logan CV, Mougou-Zerelli S, Lee JH, Silhavy JL,
Brancati F, Iannicelli M, Travaglini L, Romani S, Illi B, Adams
376 Hum Genet (2014) 133:367–377
123
M, Szymanska K, Mazzotta A, Lee JE, Tolentino JC, Swistun D,
Salpietro CD, Fede C, Gabriel S, Russ C, Cibulskis K, Sougnez
C, Hildebrandt F, Otto EA, Held S, Diplas BH, Davis EE,
Mikula M, Strom CM, Ben-Zeev B, Lev D, Sagie TL, Michelson
M, Yaron Y, Krause A, Boltshauser E, Elkhartoufi N, Roume J,
Shalev S, Munnich A, Saunier S, Inglehearn C, Saad A, Alkindy
A, Thomas S, Vekemans M, Dallapiccola B, Katsanis N,
Johnson CA, Attie-Bitach T, Gleeson JG (2010) Mutations in
TMEM216 perturb ciliogenesis and cause Joubert, Meckel and
related syndromes. Nat Genet 42:619–625
Varadi V, Szabo L, Papp Z (1980) Syndrome of polydactyly, cleft lip/
palate or lingual lump, and psychomotor retardation in endog-
amic gypsies. J Med Genet 17:119–122
Wei Q, Zhang Y, Li Y, Zhang Q, Ling K, Hu J (2012) The BBSome
controls IFT assembly and turnaround in cilia. Nat Cell Biol
14:950–957
Hum Genet (2014) 133:367–377 377
123
The snRNA-processing complex, Integrator, is
required for ciliogenesis and dynein recruitment to the
nuclear envelope via distinct mechanisms
Jeanne N. Jodoin1, Mohammad Shboul2, Todd R. Albrecht3, Ethan Lee1, Eric J. Wagner3, Bruno Reversade2,4
and Laura A. Lee1,*
1Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232-8240, USA
2Institute of Medical Biology, A*STAR, Singapore138648, Singapore
3Department of Biochemistry and Molecular Biology, The University of Texas Medical School at Houston, Houston, TX 77030, USA
4Department of Pediatrics, National University of Singapore, Singapore 119228
*Author for correspondence (laura.a.lee@vanderbilt.edu)
Biology Open 2, 1390–1396
doi: 10.1242/bio.20136981
Received 21st October 2013
Accepted 28th October 2013
Summary
We previously reported that the small nuclear RNA
processing complex, Integrator, is required for dynein
recruitment to the nuclear envelope at mitotic onset in
cultured human cells. We now report an additional role for
INT in ciliogenesis. Depletion of INT subunits from
cultured human cells results in loss of primary cilia. We
provide evidence that the requirements for INT in dynein
localization and ciliogenesis are uncoupled: proteins
essential for ciliogenesis are not essential for dynein
recruitment to the nuclear envelope, while depletion of
known regulators of perinuclear dynein has minimal
effects on ciliogenesis. Taken together, our data support
a model in which INT ensures proper processing of distinct
pools of transcripts encoding components that
independently promote perinuclear dynein enrichment
and ciliogenesis.
 2013. Published by The Company of Biologists Ltd. This
is an Open Access article distributed under the terms of
the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution and reproduction in any
medium provided that the original work is properly
attributed.
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Introduction
Cytoplasmic dynein is a large, multimeric, minus-end-directed
motor complex that associates with the dynein-activating
complex, dynactin. (Holzbaur and Vallee, 1994; Kardon and
Vale, 2009; Schroer, 2004). Two forms of cytoplasmic dynein
exist within cells: dynein-1 and dynein-2. Dynein-1 is required
for a variety of essential functions such as cargo transport along
microtubules, centrosome assembly, organelle positioning,
mitotic spindle positioning, and ciliogenesis, whereas dynein-2
is required for retrograde transport of cargo along primary cilia
(PC) and maintenance of PC length (Palmer et al., 2011;
Rajagopalan et al., 2009). Dynein complexes are subject to
multiple layers of regulation, including binding of accessory
proteins, phosphorylation, variations in subunit composition, and
subcellular localization (Kardon and Vale, 2009).
During G2/M of cell division in multiple species, a pool of
dynein anchored to the nuclear envelope (NE) facilitates nucleus-
centrosome coupling, an essential step for proper mitotic spindle
formation (Anderson et al., 2009; Bolhy et al., 2011; Go¨nczy
et al., 1999; Jodoin et al., 2012; Malone et al., 2003; Robinson
et al., 1999; Sitaram et al., 2012; Splinter et al., 2010; Vaisberg
et al., 1993). Three components are known to be required for
dynein accumulation on the NE and subsequent nucleus-
centrosome coupling in human cells. The first two components,
Bicaudal D2 (BICD2) and Centromere protein F (CENP-F),
independently bind dynein subunits/adaptor proteins and
nucleoporins to stably tether dynein complexes to the NE
(Bolhy et al., 2011; Splinter et al., 2010). The third recently
identified component, the small nuclear RNA (snRNA) complex,
Integrator (INT), likely regulates dynein recruitment to the NE in
an indirect manner distinct from that of BICD2 and CENP-F
(Jodoin et al., 2013).
INT, a highly conserved nuclear complex consisting of 14
subunits, interacts with the C-terminal tail of the largest subunit
of RNA-polymerase II to promote 39-snRNA processing (Baillat
et al., 2005; Chen and Wagner, 2010). These processed snRNAs
play critical roles in gene expression via intron removal and
further pre-mRNA processing (Matera et al., 2007). Analysis of
INT has revealed that the complex must be intact to perform its
RNA processing function: loss of individual INT subunits, with
the exception of IntS10, leads to a nonfunctional complex (Chen
et al., 2012). Various cellular functions have been ascribed to
INT in cultured mammalian cells. IntS4 is required for formation
of Cajal bodies (Takata et al., 2012) and IntS6 and IntS11 ensure
proper differentiation of adipocytes (Otani et al., 2013). INT has
additionally been reported to be required for developmental
functions in vivo. IntS7 is essential for normal craniofacial











abdominal formation in Drosophila (Golling et al., 2002; Kamath
et al., 2003; Rutkowski and Warren, 2009). In zebrafish, IntS5,
IntS9, and IntS11 are required for smad1 and smad5 mRNA
processing (Tao et al., 2009). We recently reported an essential
role for INT in recruitment of dynein to the NE at G2/M (Jodoin
et al., 2013).
PC are non-motile appendages that form in the majority of
vertebrate cells. These structures act as sensory organelles and
play essential roles in sensing and processing signals from the
extracellular environment (Basten and Giles, 2013; Ko, 2012;
Salisbury, 2004). To initiate primary ciliogenesis during G1, one
of the two centrioles migrates to the plasma membrane, where it
will dock and mature into a basal body (BB) that nucleates the PC
(Kim and Dynlacht, 2013). Prior to mitotic entry, the PC is
resorbed to allow for the formation of the bipolar spindle (Wang
et al., 2013). Across phyla, dynein has been shown to be required
for ciliogenesis (Kim and Dynlacht, 2013; Kim et al., 2011; Kong
et al., 2013). Loss of dynein heavy chain, which results in decay
of the complex, hinders PC formation (Draviam et al., 2006;
Rajagopalan et al., 2009). Additionally, dynein is required for
retrograde movement of proteins along the PC and regulation of
PC length (Rajagopalan et al., 2009). While many centrosomal
and interflagellar trafficking proteins are known to be critical for
PC formation, more are hypothesized to exist (Graser et al., 2007;
Kim and Dynlacht, 2013).
In this work, we sought to determine if INT is required for
additional dynein-dependent events within cultured human cells.
We herein report a role for INT in promoting ciliogenesis. We
propose a model in which INT regulates dynein localization
during G2/M and ciliogenesis during G1 through distinct
mechanisms.
Results and Discussion
Individual INT subunits are required for PC formation
Given the role of INT in dynein recruitment to the NE at G2/M,
we asked whether INT plays a broader role in regulating dynein-
related functions. Specifically, we sought to determine if INT is
required for PC formation, another dynein-dependent process.
We performed siRNA-mediated down-regulation of individual
INT subunits in human retinal pigment epithelial (RPE) cells and
assessed PC formation. Prior to fixation and immunostaining for
acetylated tubulin and c-tubulin (to mark cilia and centrioles,
respectively), the confluent monolayer of cells was subjected to
serum starvation for 24 hours to stimulate PC formation.
Under these conditions, the frequency of non-targeting (NT)-
siRNA cells with PC ranged from ,60–80% (data not shown).
Primary ciliogenesis data are presented as the percentage of NT-
siRNA cells. As a positive control, cells were depleted of
Centrin-2 (CETN2), a centriolar component required for
ciliogenesis (Graser et al., 2007; Salisbury, 2004). Following
individual knockdown of most INT subunits tested (IntS1, 3, 4, 9,
11, or 12), we observed loss of PC to a degree comparable to that
of CETN2-siRNA cells, suggesting that INT plays a critical role
in PC formation (Fig. 1). We observed essentially identical
results using a second independent siRNA for a subset of INT
subunits, confirming that the loss of PC is not due to an off-target
effect (supplementary material Fig. S1). Knockdown of IntS10,
which is dispensable for both snRNA processing and dynein
localization, similarly had no effect on PC formation, further
confirming that this subunit is not a critical component of the INT
complex. Data are conflicting for only one INT subunit, IntS7,
which was previously reported to be required for snRNA
processing, but not for dynein localization; we found that
depletion of IntS7 had no effect on PC formation (Chen et al.,
2012; Ezzeddine et al., 2011; Jodoin et al., 2013) (Fig. 1). A
possible explanation for this discrepancy is that the snRNA-
processing assay might be more sensitive than the assays
designed to assess cytoplasmic events (perinuclear dynein
accumulation and PC formation) that are presumably downstream
of RNA processing. Efficient knockdown of all siRNA-targeted
endogenous proteins in experiments presented herein was
confirmed by immunoblotting (supplementary material Fig. S2).
To test whether the loss of PC in INT-depleted cells is specific
to disruption of INT-mediated snRNA processing, and not
secondary to a general disruption of RNA processing, we
down-regulated Cleavage Polyadenylation Specificity Factor 30
(CPSF30) in cells and assessed PC formation. CPSF30 is a
component of a complex required for the recruitment of
machinery that mediates 39-mRNA cleavage and poly(A) tail
synthesis; depletion of CPSF30 leads to a deficiency, but not a
complete loss, of poly(A) 39-end formation in cells (Barabino
et al., 1997). We found no significant effect on PC formation,
however, in CPSF30-siRNA cells, suggesting a specific role for
INT-mediated snRNA processing in PC formation (Fig. 1).
In addition to loss of PC, we observed increased centriole
separation following individual knockdown of most INT subunits
tested (IntS1, 3, 4, 9, 11, or 12) (results for IntS4 and IntS11
shown in supplementary material Fig. S3; data not shown for
other listed subunits). This phenotype has been reported in cells
depleted of a subset of ciliogenesis regulators, although a strict
correlation between the separation of centrioles and loss of PC
has not been observed; hence, the functional significance of this
Fig. 1. Loss of PC following INT depletion. RPE cells were transfected with
siRNA, serum-starved, fixed, and stained for acetylated tubulin, c-tubulin, and
DNA. (A–J) Representative images show decreased PC formation after
knockdown of most INT subunits tested. Scale bars, 10 (A,B) or 5 (C–J) mm.
(K) Quantification of PC formation (normalized to NT-siRNA) in INT-depleted
cells. Gray, P,0.0001; black, not significant (both relative to CETN2-siRNA,
red). (L) Comparison of INT subunit requirements in snRNA processing (Chen
et al., 2012), dynein localization, and ciliogenesis (presented herein). (+),
required; (2), not required; (N.D.), not determined.










phenotype is unclear (Graser et al., 2007; Salisbury, 2004). As for
PC formation, we did not observe defects in centriole coupling
following IntS7 or IntS10 depletion (results for IntS10 shown in
supplementary material Fig. S3; data not shown for IntS7).
We considered the possibility that the lack of PC in INT-
depleted cells could be secondary to a failure of these cells to
arrest in G1 upon serum starvation. We previously showed that
down-regulation of individual INT subunits does not lead to any
gross defects in cell-cycle phasing under normal growth
conditions (Jodoin et al., 2013). To confirm that INT-depleted
cells respond normally to serum starvation by arresting in G1, we
performed fluorescence-activated cell sorting analysis. In
contrast to INT-depleted cells growing asynchronously in 10%
fetal bovine serum, INT-depleted cells arrested in G1 following
serum starvation in the same manner as control cells
(supplementary material Fig. S4). Taken together, these data
reveal that INT is required for PC formation and centriole
coupling, thereby adding to the growing list of INT-dependent
cellular processes. We propose a model in which INT mediates
processing of snRNA required for normal production of mRNA
encoding a critical regulator of ciliogenesis.
INT depletion does not affect a subset of proteins required for
BB maturation and assembly
We considered the possibility that loss of PC following INT depletion
could result from failure of BB maturation and/or abnormal BB
composition. The process of BB maturation includes assembly of the
distal appendage, which projects radially from the distal end of the
cilium, serving to anchor the BB and cilium to the plasma membrane.
Centrosomal protein 164 (Cep164), Centrosomal protein 89 (Cep89),
and Fas-binding factor 1 (FBF-1) are distal appendage components
required for PC production (Sillibourne et al., 2011; Tanos et al.,
2013). We observed normal localization of these proteins to the base
of the PC in INT-depleted cells (Fig. 2A–C, quantified in
supplementary material Fig. S5A–C). We next evaluated several
core BB proteins essential for PC formation: CETN2, Pericentrin
(PCTN), and Ninein (Graser et al., 2007; Salisbury, 2004). We found
their localizations and intensities to be comparable in INT-depleted
and control cells (Fig. 2D–F; quantified in Fig. S5D–F). We also
found that c-tubulin localized normally to BB in INT-siRNA cells
(Fig. 1A–I). Taken together, these data suggest that loss of PC in
INT-depleted cells is unlikely to be secondary to defective processing
of transcripts encoding the studied proteins.
PC formation is not required for dynein recruitment to the NE
We have identified two dynein-mediated processes that require
INT: PC formation during G1 and dynein recruitment to the NE
at G2/M (Fig. 1) (Jodoin et al., 2013). We reasoned that INT
might ensure production of a single transcript encoding a
common regulator of these processes or distinct transcripts that
independently regulate each process. To help distinguish between
these two possibilities, we sought to determine whether dynein
enrichment on the NE and PC formation are interdependent or
uncoupled events.
We first asked whether proteins essential for PC formation are
also generally required for dynein recruitment to the NE. We
performed siRNA-mediated knockdown of CETN2 and PCTN in
HeLa cells and assessed dynein localization during prophase. We
used the following criteria to identify prophase cells: positively
immunostained for phosphorylated histone H3 (PH3) with an
intact NE. HeLa cells have commonly been used to study the
regulation of perinuclear dynein due to their highly enriched pool
of dynein on the NE at G2/M (Bolhy et al., 2011; Jodoin et al.,
2012; Jodoin et al., 2013; Splinter et al., 2010). Prior to fixation
and immunostaining for dynein intermediate chain (DIC) and
PH3, siRNA-treated cells were incubated with 5 mM nocodazole
to stimulate recruitment of dynein-dynactin complexes and their
accessory proteins to the nuclear surface. This brief nocodazole
Fig. 2. Normal BB composition following INT
depletion. RPE cells were transfected with siRNA, serum-
starved, fixed, and stained for acetylated tubulin, BB
markers, and DNA. Representative images show normal
localization of BB markers in INT-depleted cells. Higher-
magnification views (bottom micrographs) of BB
correspond with regions enclosed by white boxes. Scale
bars, 10 mm.










treatment has been documented to enrich for functional dynein
complexes on the NE in non-G1 cells (Beswick et al., 2006;
Bolhy et al., 2011; Hebbar et al., 2008; Jodoin et al., 2012; Jodoin
et al., 2013; Splinter et al., 2010).
Consistent with our previous report, we observed drastic
reduction of the fraction of cells with dynein accumulation on the
NE following INT depletion: only 24% of IntS11-siRNA
prophase cells exhibited perinuclear dynein compared to 92%
of NT-siRNA prophase cells (Fig. 3A,C) (Jodoin et al., 2012).
We chose to focus on IntS11 for this experiment based on its role
as the catalytic subunit of the INT complex (Chen and Wagner,
2010). In contrast, the fraction of prophase cells with perinuclear
dynein following depletion of other ciliogenesis regulators,
CETN2 or PCTN, was comparable to that of NT-siRNA cells
(90% and 88%, respectively; Fig. 3A,C). We have previously
reported that this NE-anchored pool of dynein is found in RPE
cells (Jodoin et al., 2012). To determine if INT is required for
dynein recruitment (in addition to primary ciliogenesis) in RPE
cells, we assessed perinuclear dynein following down-regulation
of IntS11. Dynein accumulation on the NE was found in 77% of
NT-siRNA RPE prophase cells following treatment with 10 mM
nocodazole (Fig. 3B,D). Similar to our results with HeLa cells,
we observed a severe reduction in the percentage of RPE
prophase cells with NE-anchored dynein (down to 7%) following
Fig. 3. Ciliogenesis regulators are not required for
perinuclear dynein recrutiment. HeLa cells (A,C) or RPE
cells (B,D) were transfected with siRNA, nocodazole-
treated, fixed, and stained for dynein (DIC) and PH3.
(A,B) Representative images show perinuclear dynein in
prophase HeLa (A) or RPE cells (B) after indicated
knockdowns. Yellow bars represent line scans that span the
cytoplasm (C), nuclear envelope (NE), and nucleus (N) to
measure peak DIC intensity on the NE; corresponding plots
are shown below each micrograph. (C,D) Quantification of
perinuclear dynein in HeLa (C) or RPE (D) prophase cells
(PH3-positive with intact NE). Scale bars, 10 mm. Gray,
P,0.0001; black bar, not significant (both relative to NT-
siRNA, red).










depletion of IntS11 (Fig. 3B,D). This finding suggests that the
role for INT in promoting perinuclear dynein is conserved and is
not a consequence of the transformed nature of HeLa cells. As for
HeLa cells, we found that the primary ciliogenesis regulators
tested were not required for perinuclear dynein in RPE cells: loss
of CETN2 or PCTN recapitulated what was observed in NT-
siRNA cells (with PC formation in 76% and 78%, respectively, of
siRNA-treated cells; Fig. 3B,D).
As further confirmation of these findings, we quantified DIC
immunofluorescence signals on the NE versus the cytoplasm and
the average peak DIC intensity on the NE in both cell lines and
found them greatly reduced in IntS11 cells as previously
described, but unchanged in cells depleted of CETN2 or PCTN
compared to NT-siRNA cells (supplementary material Fig. S6)
(Jodoin et al., 2012; Jodoin et al., 2013). These data reveal that
INT differs from CETN2 and PCTN, two other proteins essential
for ciliogenesis, in that it has a dual function in promoting
perinuclear accumulation of dynein.
Perinuclear dynein is not required for PC formation
We next asked whether other proteins essential for perinuclear
dynein accumulation are, like the INT complex, also required for
primary ciliogenesis. BICD2 and CENP-F directly anchor dynein
motors to the NE, whereas RanBP2 serves as the binding site for
BICD2 within the nuclear pore complex; depletion of any of
these proteins results in loss of perinuclear dynein in HeLa cells
(Bolhy et al., 2011; Splinter et al., 2010). We confirmed that
these known regulators of perinuclear dynein in HeLa cells are
similarly required for NE-anchoring of dynein in cells capable of
forming PC: depletion of BICD2, CENP-F, or RanBP2 in RPE
cells resulted in a marked loss of perinuclear dynein compared to
NT-siRNA cells (Fig. 4A,C).
We disrupted the pool of dynein anchored on the NE in RPE
cells by depleting proteins required for this process and assessed
PC formation. Following siRNA treatment, cells were serum-
starved and evaluated for the presence of PC. Loss of BICD2,
CENP-F, or RanBP2 resulted in only a slight reduction in the
fraction of cells with PC (80%, 91%, and 81% of NT-siRNA
cells, respectively) compared to loss of INT subunits (e.g. 38% of
NT-siRNA cells for IntS11; Fig. 1K; Fig. 4B,D). Additionally we
confirmed the previously reported requirement for dynein in PC
formation: down-regulation of DHC resulted in the absence of PC
in a majority of cells (Fig. 4B,D) (Rajagopalan et al., 2009).
These data suggest that, in contrast to the INT complex, other
Fig. 4. Perinuclear dynein regulators are not required
for primary ciliogenesis. RPE cells were transfected with
siRNA and either nocodazole-treated, fixed, and stained for
dynein (DIC) and PH3 (A,C) or serum-starved, fixed, and
immunostained for acetylated tubulin and c-tubulin
(B,D,E). (A) Representative images show perinuclear
dynein in prophase cells (PH3-positive and intact NE) after
indicated knockdowns. Yellow bars represent line scans
that span the cytoplasm (C), nuclear envelope (NE), and
nucleus (N) to measure peak DIC intensity on the NE;
corresponding plots are shown below each micrograph. (B)
Representative images show PC after indicated
knockdowns. Percentages in the DHC-siRNA micrographs
indicate frequency at which each phenotype (no cilium,
left; elongated cilium, right) was observed. (C–E)
Quantification of prophase cells with perinuclear dynein
(C), PC presence (D), or average PC length (E) after
indicated knockdowns. Gray, P,0.0001; black bar, not
significant (relative to IntS11-siRNA (C,D) or NT (E), red).
Scale bars, 10 mm (A) or 5 mm (B).










known regulators of perinuclear dynein accumulation are not
strictly required for generation of PC.
For the subset of cells with PC, we also assessed PC length in
these experiments. As previously reported, we observed increased
PC length following depletion of dynein when the PC was present
(Fig. 4B,E) (Palmer et al., 2011). Similarly, CENP-F-siRNA cells
exhibited longer PC compared to NT-siRNA cells, although
BICD2 or RanBP2 depletion had no effect (Fig. 4B,E). These data
suggest that CENP-F, while not required for PC formation, has a
role in regulating PC length; a role for CENP-F in this process has
not been previously reported to our knowledge. We speculate that
CENP-F may influence PC length through its regulation of
cytoplasmic dynein-2, which is essential for maintaining normal
PC length (Palmer et al., 2011; Rajagopalan et al., 2009). No
change in PC length, however, was observed in cells depleted of
IntS11 (Fig. 1B; Fig. 4E). This finding suggests that INT promotes
PC formation via a dynein-independent mechanism.
Taken together, the data presented herein showing that the pool
of dynein anchored on the NE at the G2/M transition is not
required for promoting primary ciliogenesis in G1, and vice
versa, supports our hypothesis that dynein recruitment to the NE
and PC formation are regulated by distinct INT-dependent
mechanisms (Figs 3, 4; Fig. 5A). We propose the following
model to explain how INT may regulate these two cytoplasmic
events that occur at different cell-cycle stages. INT is required for
proper processing of snRNAs, which in turn are required for
efficient processing of mRNAs encoding at least two critical
proteins that independently promote ciliogenesis in G1 and
dynein recruitment to the NE at G2/M (Fig. 5B1). We cannot,
however, exclude an alternative model in which INT functions
through a common critical target required to mediate both of
these events. In this case, INT would ensure efficient processing
of transcripts encoding a single (as yet unidentified) protein that
plays essential roles in promoting both ciliogenesis during G1
and perinuclear dynein accumulation at G2/M (Fig. 5B2). Further
studies will be required to identify the critical target(s) of the INT
complex that mediate these and other important cellular
processes.
Materials and Methods
Cell culture, immunostaining, and microscopy
Cell lines were maintained at 37 C˚ and 5% CO2 in DMEM (Life Technologies,
Carlsbad, CA) containing 10% FBS, 1% L-glutamine, 100 mg/ml streptomycin,
and 100 U/ml penicillin. siGENOME NT siRNA#5 (Dharmacon, Lafayette, CO)
was used as negative control. siRNA oligonucleotides used herein for specific
knockdowns have been previously described as follows: INT subunits (Jodoin
et al., 2012), CETN2 and PCTN (Graser et al., 2007), BICD2 and RanBP2
(Splinter et al., 2010), CENP-F (Bolhy et al., 2011), and DHC (Rajagopalan et al.,
2009). siRNA oligonucleotides were obtained from Dharmacon or Sigma-Aldrich
(St. Louis, MO). Independent siRNA oligonucleotides used to silence IntS3 (IntS3
#2; SASI_Hs01_00063141), IntS4 (IntS4 #2; 59-CAG CAU UGU UCU CAG AUC
A-39), IntS9 (IntS9 #2; 59-GUG AAC UCU GCC CUU AGU A-39), and IntS11
(IntS11 #2; SASI_Hs02_00350804) were obtained from Sigma-Aldrich.
Immunoblot signals for INT subunit protein levels following siRNA treatment
were quantified relative to tubulin using ImageJ.
Cells were transfected with siRNA oligonucleotides using DharmaFECT 1
transfection reagent (Dharmacon) and analyzed at 72 h post-siRNA treatment in
all cases. To stimulate PC formation under conditions of serum starvation, cells at
100% confluence and at 48 h post-siRNA treatment were incubated in DMEM plus
0.5% FBS for 24 h prior to fixation. Where indicated, siRNA-treated cells in
normal growth medium were incubated in 5 mg/ml (16.6 mM) nocodazole (Sigma-
Aldrich) for 3 h (HeLa cells) or 10 mg/ml (33.2 mM) nocodazole for 1 h (RPE
cells) prior to fixation at 72 h post-siRNA treatment to enhance perinuclear
localization of dynein. Primary antibodies were used as follows: acetylated tubulin
(6-11B-1, 1:500, Sigma-Aldrich), c-Tubulin (ab16504, 1:500, Abcam, Cambridge,
MA), CEP164 (NBP-77006, 1:100, Novus Biologicals, Littleton, CO), CEP89
(HPA040056, 1:100, Sigma), FBF-1 (HPA023677; 1:100, Sigma), CETN2 (N-17-
R, 1:200, Santa Cruz Biotechnology, Dallas, TX), PCTN (ab4448, 1:2000,
Abcam), Ninein (ab4447, 1:500, Abcam), dynein intermediate chain (74.1, 1:500,
Abcam), and PH3 (Mitosis Marker, 1:1000, Millipore, Billerica, MA). Wide-field
and confocal fluorescence microscopy methods were previously described (Efimov
et al., 2007; Jodoin et al., 2013).
PC length (visualized by acetylated tubulin staining) was measured from base to
tip using ImageJ (National Institutes of Health, Bethesda, MD); at least 100 cells
were scored per condition. For determination of the percentage of cells with PC or
perinuclear dynein, experiments were performed§3 times with§200 cells scored
per condition. For quantification of perinuclear dynein intensity, 10 representative
cells were measured per condition; for each cell, 12 line scans distributed equally
around the nuclear circumference were obtained. Line scan analyses were
performed using ImageJ. Line scans presented within figures are 50 pixels in
length and are oriented with the cytoplasmic end of each line to the left and the
intranuclear end of each line to the right. Statistical analyses of data were
performed using Student’s unpaired t-test. For bar graphs, error bars indicate s.e.m.
Immunoblotting
Immunoblotting of cell lysates was performed as previously described (Jodoin
et al., 2013). The following primary antibodies were used: c-Myc (9E10, 1:1000),
b-tubulin (E7, 1:1000, Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA), CENP-F (14C10 1D8, 1:500, Abcam), BICD2 (1:2500; gift
from A. Akhmanova) (Splinter et al., 2010), dynein intermediate chain (74.1,
1:500, Santa Cruz Biotechnology), PCTN (ab4448, 1:2000, Abcam), CETN2 (N-
17-R, 1:200, Santa Cruz Biotechnology), RanBP2 (ab64276, 1:1000, Abcam),
IntS1, IntS4, IntS7, IntS9, IntS10, IntS11, IntS12, and CPSF30 (1:1000, Bethyl
Labs, Montgomery, TX).
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Fig. S1. Loss of PC following INT down-regulation by independent siRNA
sequences. RPE cells were transfected with indicated siRNAs, serum-starved,
fixed, and stained for acetylated tubulin, c-tubulin, and DNA. Quantification of
PC formation (normalized to NT-siRNA) in siRNA-depleted cells. Gray,
P,0.001; black, not significant (relative to CETN2-siRNA, red).
Fig. S2. Confirmation of efficient knockdown of proteins by siRNA. RPE or
Hela cells were transfected with siRNA as indicated. Immunoblots of cell
lysates were probed with antibodies against INT subunits, perinuclear dynein
regulators, ciliogenesis regulators, or related controls corresponding to data
presented in Figs 1 and 3 (A) or Figs 3 and 4 (B). Depletion of each protein
targeted by siRNA was confirmed. Tubulin was used as loading control.
Percent of protein depletion following targeted knock down indicated next to
each antibody.
Fig. S3. Increased frequency and degree of centriole pair separation
following loss of INT activity. RPE cells were transfected with siRNA as
indicated. Following siRNA treatment, PC formation was stimulated by serum
starvation. After fixation, cells were stained for acetylated tubulin, g-tubulin,
and DNA. (A) Separation of centriole pairs was observed following INT
subunit-siRNA treatment. (B) Higher magnification of region enclosed within
white box shows scoring system used to measure distance between centriole
pairs (yellow bars). (C) Quantification of the average distance between
centriole pairs following indicated siRNA treatment. Gray bars, P,0.0001;
black, not significant (both relative to NT-siRNA, red). Distance between the
outer borders of basal body pairs (marked by g-tubulin staining) was measured
using ImageJ. Basal body pairs in at least 100 cells were scored per condition.










Fig. S4. Confirmation of G1 arrest in serum-starved
RPE cells following INT subunit knockdown. RPE cells
were transfected with siRNA as indicated, serum-starved,
fixed, and stained with propidium iodide. DNA content was
analyzed by FACS as previously described (Jodoin et al.,
2013). (A) Cell-cycle profile of NT-siRNA cells grown
under normal medium conditions (plus 10% FBS). (B) Cell-
cycle profiles of NT-siRNA and INT-depleted cells
following serum starvation revealed a similar degree of
G1 arrest.
Fig. S5. Characterization of basal body markers.
Quantification of distal appendage (A–C) and basal body
(D–F) signals for indicated markers (normalized to signals
for acetylated tubulin). No significant changes in intensity
were observed following depletion of individual INT
subunits. Intensity of antibody signals on basal bodies was
determined using ImageJ. Basal bodies in at least 100 cells
were scored per condition. Black bar, not significant
(relative to NT-siRNA, red).










Fig. S6. Quantification of perinuclear dynein following
knockdown of ciliogenesis regulators. Bar graphs
correspond to representative images of immunostained
HeLa (A) or RPE (B,C) cells presented in Fig. 3A,B and
Fig. 4A. Line scans were drawn from the cytoplasm to
inside the nucleus. Ratios of the intensity of the dynein
signal on the NE to the cytoplasm (top) and average peak
intensities of perinuclear dynein (bottom) are shown.
Samples with P,0.0001 are shown in gray; black, not
significant (relative to NT-siRNA (A,B) or IntS11-siRNA
(C), red).
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Nuclear-localized Asunder regulates cytoplasmic 
dynein localization via its role in the Integrator 
complex
Jeanne N. Jodoina, Poojitha Sitarama, Todd R. Albrechtb, Sarah B. Mayb, Mohammad Shboulc, 
Ethan Leea, Bruno Reversadec,d, Eric J. Wagnerb, and Laura A. Leea
aDepartment of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232-8240; 
bDepartment of Biochemistry and Molecular Biology, University of Texas Medical School at Houston, Houston, TX 
77030; cInstitute of Medical Biology, A*STAR, Singapore 138648; dDepartment of Pediatrics, National University of 
Singapore, Singapore 119228
ABSTRACT We previously reported that Asunder (ASUN) is essential for recruitment of dy-
nein motors to the nuclear envelope (NE) and nucleus–centrosome coupling at the onset of 
cell division in cultured human cells and Drosophila spermatocytes, although the mechanisms 
underlying this regulation remain unknown. We also identified ASUN as a functional compo-
nent of Integrator (INT), a multisubunit complex required for 3′-end processing of small nu-
clear RNAs. We now provide evidence that ASUN acts in the nucleus in concert with other INT 
components to mediate recruitment of dynein to the NE. Knockdown of other individual INT 
subunits in HeLa cells recapitulates the loss of perinuclear dynein in ASUN–small interfering 
RNA cells. Forced localization of ASUN to the cytoplasm via mutation of its nuclear localiza-
tion sequence blocks its capacity to restore perinuclear dynein in both cultured human cells 
lacking ASUN and Drosophila asun spermatocytes. In addition, the levels of several INT sub-
units are reduced at G2/M when dynein is recruited to the NE, suggesting that INT does not 
directly mediate this step. Taken together, our data support a model in which a nuclear INT 
complex promotes recruitment of cytoplasmic dynein to the NE, possibly via a mechanism 
involving RNA processing.
INTRODUCTION
Dynein, a minus end–directed molecular motor, is a large multimeric 
complex that can be divided into distinct regions (Holzbaur and 
Vallee, 1994; Kardon and Vale, 2009). Protruding from the head re-
gion are two microtubule-binding domains that allow the motor to 
walk processively along the microtubule toward its minus end. This 
movement is driven by the force-generating ATPase activity of the 
catalytic domains found within the head region of the motor. The 
stem region, consisting of multiple light, light intermediate, and in-
termediate chains, is the most variable and is widely considered to 
serve as the binding site for dynein adaptors.
Within the cell, dynein exists in association with its activating 
complex, dynactin (Schroer, 2004). The dynein–dynactin complex 
performs diverse functions within the cell, ranging from cargo trans-
port, centrosome assembly, and organelle positioning to roles in 
chromosome alignment and spindle positioning during mitosis 
(Holzbaur and Vallee, 1994; Kardon and Vale, 2009). Dynein–dynac-
tin complexes are subject to multiple layers of regulation, including 
binding of accessory proteins, phosphorylation, subunit composi-
tion, and subcellular localization (Kardon and Vale, 2009). Localized 
pools of dynein were identified and shown to be required for critical 
processes in the cell, although the mechanisms underlying the con-
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function, a cell-based assay was developed in which generation of 
a green fluorescent protein (GFP) signal due to incomplete process-
ing of a reporter U7 snRNA served as a readout of INT activity (Chen 
et al., 2012). With this approach, dASUN was identified as a func-
tional component of INT: down-regulation of dASUN led to increase 
misprocessing of U7 and spliceosomal snRNA, indicating its re-
quirement for activity of the complex (Chen et al., 2012). Further-
more, dASUN was shown to biochemically interact with INT in a 
stoichiometric manner, an association that it is conserved in humans 
(Malovannaya et al., 2010; Chen et al., 2012). Collectively these 
data provide compelling evidence that ASUN is a core Integrator 
subunit.
Given the divergent nature of the known activities of ASUN—
critical regulator of cytoplasmic dynein localization and essential 
component of a nuclear snRNA-processing complex—we sought to 
determine whether these roles are independent of each other or 
derived from a common function. We find that depletion of indi-
vidual INT components from HeLa cells results in loss of perinuclear 
dynein, recapitulating the phenotype observed in hASUN-siRNA 
cells (Jodoin et al., 2012). In addition, we find that forced localiza-
tion of either hASUN or dASUN to the cytoplasm inhibits its capacity 
to recruit dynein to the NE in the absence of endogenous ASUN. 
We present a model in which ASUN acts within the nucleus in con-
cert with other subunits of the Integrator complex, likely via process-
ing of a critical RNA target(s), to promote recruitment of cytoplasmic 
dynein motors to the NE at G2/M.
RESULTS
Multiple INT subunits are required for dynein recruitment 
to the NE
Two ASUN-dependent cellular functions have been reported: dy-
nein recruitment to the NE at G2/M, and proper processing of 
snRNA by INT (Chen et al., 2012; Jodoin et al., 2012). We hypoth-
esized that other components of the INT complex, such as hASUN, 
may be required to promote dynein recruitment to the NE. To test 
this hypothesis, we performed siRNA-mediated knockdown of indi-
vidual INT subunits in HeLa cells and assessed dynein localization. 
Before fixation and immunostaining for dynein IC (DIC), siRNA-
treated cells were incubated briefly with 5 μM nocodazole to stimu-
late recruitment of dynein–dynactin complexes to the NE. This treat-
ment has been documented to recapitulate, in non-G1 cells, the 
enrichment of functional dynein–dynactin complexes on the NE that 
normally occurs at G2/M, making this an ideal assay for identifying 
factors involved in dynein localization (Beswick et al., 2006; Hebbar 
et al., 2008; Splinter et al., 2010; Bolhy et al., 2011; Jodoin et al., 
2012).
Consistent with our previous report, we found that 78% of non-
targeting (NT) control siRNA cells had a striking enrichment of dy-
nein on the NE after brief nocodazole treatment (Figure 1, A and O); 
in contrast, the percentage of cells with perinuclear dynein was re-
duced to 20% after hASUN depletion (Figure 1, C and O; Jodoin 
et al., 2012). In most cases, we found that treatment of cells with 
siRNA targeting individual INT subunits (IntS, each followed by a 
unique identifying number) resulted in a similar reduction of cells 
with perinuclear dynein (Figure 1, D–I, K, M, and N). Of importance, 
we did not observe any overt effect on cellular health or growth after 
treatment with INT-targeting siRNAs, arguing against any potential 
reduction in cellular fitness as the cause of reduced perinuclear dy-
nein. To further quantify the dynein phenotype, we compared the 
DIC immunofluorescence signals on the NE to that of the cytoplasm 
and also determined the average peak DIC intensity on the NE for 
each knockdown as previously described (Supplemental Figure S1; 
Across phyla, a stably anchored subpopulation of dynein exists 
on the nuclear envelope (NE) of cells (Gonczy et al., 1999; Robinson 
et al., 1999; Salina et al., 2002; Payne et al., 2003; Anderson et al., 
2009). This pool of dynein is required for both stable attachment of 
centrosomes to the NE before nuclear envelope breakdown (NEBD) 
and migration of centrosomes to opposite sides of the nucleus, 
thereby ensuring proper positioning of the bipolar spindle (Vaisberg 
et al., 1993; Gonczy et al., 1999; Robinson et al., 1999; Malone 
et al., 2003; Anderson et al., 2009; Splinter et al., 2010; Bolhy et al., 
2011; Jodoin et al., 2012; Sitaram et al., 2012). In addition, this pool 
of dynein appears to facilitate NEBD by forcibly tearing the NE, al-
though the precise mechanism remains unknown (Beaudouin et al., 
2002; Salina et al., 2002).
Two proteins, Bicaudal D2 (BICD2) and centromere protein F 
(CENP-F), have been shown to directly anchor dynein to the nuclear 
surface at the G2/M transition in HeLa cells (Splinter et al., 2010; 
Bolhy et al., 2011). BICD2, a dynein adaptor protein, directly binds 
dynein and nucleoporin RanBP2, thereby anchoring the motors to 
the NE (Splinter et al., 2010). CENP-F directly interacts with dynein 
adaptor proteins NudE/EL and nucleoporin Nup133 to effectively 
anchor dynein to the NE (Bolhy et al., 2011). In both Drosophila 
spermatocytes and cultured human cells, we previously identified 
ASUN as an additional regulator of dynein recruitment to the NE at 
G2/M of meiosis and mitosis, respectively, although physical inter-
action between ASUN and dynein has not been demonstrated (An-
derson et al., 2009; Jodoin et al., 2012).
Spermatocytes within the testes of Drosophila asun males arrest 
at prophase of meiosis I with a severely reduced pool of perinuclear 
dynein and centrosomes that are not attached to the nuclear surface 
(hence the name “asunder”; Anderson et al., 2009). Spermatocytes 
that progress beyond this arrest exhibit defects in spindle assembly, 
chromosome segregation, and cytokinesis during the meiotic divi-
sions. Using cultured human cells, we found that small interfering 
RNA (siRNA)–mediated down-regulation of the human homologue 
of Asunder (hASUN) similarly resulted in reduction of perinuclear 
dynein during prophase of mitosis (Jodoin et al., 2012). Additional 
defects observed after loss of hASUN included nucleus–centrosome 
uncoupling, abnormal mitotic spindles, and impaired progression 
through mitosis.
In either Drosophila or cultured human cells, a direct mechanism 
for promotion of perinuclear dynein by ASUN has not been eluci-
dated, although localization changes in ASUN coincide with the ac-
cumulation of dynein on the NE. Drosophila ASUN (dASUN) is 
largely restricted within the nucleus of early G2 spermatocytes and 
first appears in the cytoplasm during late G2, roughly coincident 
with the initiation of dynein recruitment to the nuclear surface 
(Anderson et al., 2009). Similarly, in prophase HeLa cells, when a 
perinuclear pool of dynein forms transiently at G2/M, hASUN is dif-
fusely present in the cytoplasm (Jodoin et al., 2012). On the basis of 
these temporal associations of the localizations of ASUN and peri-
nuclear dynein, we previously proposed that the cytoplasmic pool 
of ASUN likely mediates recruitment of dynein motors to the NE 
(Anderson et al., 2009; Jodoin et al., 2012).
Integrator complex (INT) is an evolutionarily conserved complex 
consisting of 14 subunits, although its biology is poorly understood 
(reviewed in Chen and Wagner, 2010). INT was originally identified 
due to its association with the C-terminal tail of RNA polymerase II 
and was subsequently shown to be required for 3′-end processing 
of small nuclear RNAs (snRNAs; Baillat et al., 2005). These pro-
cessed snRNAs play roles in gene expression via intron removal and 
further processing of pre-mRNAs (Matera et al., 2007). To discover 
novel components of INT that are required for its snRNA-processing 
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analysis of DNA-stained HeLa cells after 
knockdown of individual INT subunits (Sup-
plemental Figure S3). We observed no dif-
ferences between the cell cycle profile of 
hASUN- or other INT subunit-siRNA cells 
and that of control NT-siRNA cells (Supple-
mental Figure S3A). We previously reported 
that hASUN depletion from HeLa cells re-
sults in a slightly increased mitotic index 
(Jodoin et al., 2012); we show here that de-
pletion of other INT subunits has a similar 
effect (Supplemental Figure S3B). We also 
found that the percentage of prophase cells, 
the stage at which dynein normally accumu-
lates on the NE, is slightly increased upon 
knockdown of ASUN or other INT subunits 
from HeLa cells (Supplemental Figure S3C). 
These results indicate that loss of dynein re-
cruitment to the NE in cells depleted of INT 
is not due to any substantial cell cycle 
perturbation.
Table 1 summarizes our observations of 
the requirements for INT subunits in dynein 
localization and the previously reported re-
quirements for INT subunits in snRNA pro-
cessing (Ezzeddine et al., 2011; Chen et al., 
2012). The two data sets compare favorably 
in that, for both processes, most INT sub-
units are required, whereas IntS10 is ex-
pendable. IntS7, however, was the sole ex-
ception, in that it is required for snRNA 
processing, yet we found no effect of its 
down-regulation on dynein recruitment to 
the NE (Chen et al., 2012). Overall these 
data are consistent with a model in which 
hASUN regulates dynein localization in an 
INT complex–dependent manner.
To show that loss of dynein localization is 
specific to disruption of an INT-mediated 
RNA processing event and not secondary to 
a general disruption of RNA processing, we 
depleted cells of cleavage polyadenylation 
specificity factor 30 (CPSF30) and assessed 
perinuclear dynein. CPSF30 is involved in 
the recruitment of machinery that mediates 
3′-mRNA cleavage and poly(A) tail synthesis 
(Barabino et al., 1997). We found that siRNA-
mediated down-regulation of CPSF30 had no effect on perinuclear 
dynein accumulation, suggesting a specific role for INT in this pro-
cess (Figure 1, B and O, and Supplemental Figure S1).
hASUN levels are normal after depletion of INT
Given the established role of INT in snRNA processing, we consid-
ered the possibility that hASUN could be a downstream target (i.e., 
formation/splicing of mature hASUN transcripts might require a 
functional INT complex). In this case, lack of perinuclear dynein in 
cells with INT down-regulation would be secondary to a reduction in 
hASUN levels. To test this idea, we used previously generated anti-
hASUN antibodies to probe immunoblots of lysates of HeLa cells 
after depletion of individual INT subunits (Jodoin et al., 2012). We 
found that hASUN protein levels remained largely unchanged in all 
lysates tested, with the exception of a slight reduction after IntS11 
Jodoin et al., 2012). Depletion of IntS1–6, 9, 11, or 12 resulted in a 
marked decrease in both the ratio of NE to cytoplasmic dynein and 
the peak intensity of DIC on the NE, comparable to that observed 
for hASUN. IntS7 and IntS10 were the two exceptions: depletion of 
either of these INT subunits had no effect on perinuclear dynein ac-
cumulation compared with control cells (Figure 1, J, L, and O, and 
Supplemental Figure S1). We confirmed that all targeted proteins 
were efficiently depleted by immunoblotting of cell lysates after 
siRNA treatment or by a second, nonoverlapping, siRNA (Supple-
mental Figure S2). Taken together, these data show that the majority 
of the individual INT subunits are required for dynein recruitment to 
the NE.
We considered the possibility that loss of dynein accumulation 
on the NE upon INT depletion could be secondary to cell cycle 
arrest. We performed fluorescence-activated cell sorting (FACS) 
FIGURE 1: INT subunits are individually required for dynein recruitment to the NE. HeLa cells 
were transfected with siRNA as indicated. (A–N) After siRNA treatment, cells were incubated in 
nocodazole, fixed, and stained for DIC and DNA. Loss of perinuclear dynein was observed upon 
individual knockdown of the majority of INT subunits. Scale bar, 10 μm. (O) Quantification of 
perinuclear dynein in cells after knockdown of individual INT subunits. *p < 0.0001 (compared 
with NT control). (P) hASUN immunoblot analysis of cell lysates after knockdown of individual 
INT subunits. Tubulin was used as loading control.
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required for recruitment of dynein motors to the NE at G2/M 
(Jodoin et al., 2012).
We considered the possibility that the INT complex might func-
tion within the cytoplasm to promote dynein recruitment to the NE 
in a manner independent of its role in snRNA processing within the 
nucleus. A broad survey of subcellular localization patterns of INT 
subunits has not been previously reported. To address whether the 
INT complex exists in the cytoplasm, we expressed GFP fusions of 
the majority of individual INT subunits in HeLa cells to visualize their 
localizations. We confirmed by immunoblotting for GFP that fusion 
proteins of the predicted sizes were stably expressed in transfected 
cells (Figure 2M).
We divided the INT subunits into three categories based on their 
localization: predominantly nuclear (hASUN; IntS4, 6, 9, 10, and 12), 
predominantly cytoplasmic (IntS2 and 7), or evenly distributed be-
tween the nucleus and cytoplasm (IntS3, 5, and 11; Figure 2, C–L; 
quantified in Table 2). Given these complex patterns, we could not 
exclude the possibility that the INT complex (or perhaps INT sub-
complexes) could have potential roles in the cytoplasm in addition 
to its established role in snRNA processing in the nucleus. It is inter-
esting to note, however, that knockdown of any of several INT sub-
units that localized predominantly to the nucleus (hASUN; IntS4, 6, 
9, or 12; excluding the nonessential IntS10) resulted in loss of 
perinuclear dynein in HeLa cells; these observations suggest that a 
nuclear pool of INT might be required to promote recruitment of 
cytoplasmic dynein to the NE (Figures 1 and 2 and Table 2).
Reduced levels of several INT subunits at G2/M
We further considered the possibility that a cytoplasmic pool of the 
INT complex might be required for dynein localization. In this case, 
the simplest model would be that INT acts in the cytoplasm at G2/M 
to mediate dynein recruitment to the NE. As a test of this model, we 
asked whether INT subunits are present at G2/M. HeLa cells ex-
pressing tagged INT subunits were either left untreated (asynchro-
nous population) or treated with an inhibitor of cyclin-dependent 
kinase 1 (CDK1; to obtain a G2/M-arrested population), followed by 
immunoblotting of cell lysates to assess fusion protein levels 
(Vassilev, 2006). Treated cells acquired a rounded morphology con-
sistent with a G2/M arrest, confirming efficacy of CDK1 inhibition. 
We found that the levels of 60% (6 of 10) of the INT subunits tested 
were markedly decreased in G2/M-arrested cells compared with 
asynchronously dividing cells (Figure 3A). In contrast, levels of 4 INT 
subunits, including hASUN (both endogenous and tagged), were 
unchanged at G2/M (Figure 3B). Other known regulators of dynein 
recruitment, BICD2 (tagged) and CENP-F (endogenous), as well 
as a GFP control, showed no change in levels at G2/M (Figure 3C). 
Of note, four subunits required for dynein localization (IntS2, IntS5, 
IntS6, and IntS9) were present at relatively low levels at G2/M 
(Figures 1 and 3A). These data led us to conclude that INT is unlikely 
to directly mediate dynein recruitment to the NE at this stage. 
Instead, we propose that INT functions earlier in the cell cycle, 
possibly at the level of RNA processing during interphase, to subse-
quently affect dynein localization at G2/M.
Mammalian ASUN homologues contain a functional nuclear 
localization sequence
To determine whether dynein recruitment to the NE is promoted by 
cytoplasmic ASUN, as we originally hypothesized, or by nuclear 
ASUN, as suggested by data presented here, we needed a method 
to direct the localization of ASUN within cells to either of these two 
compartments (Jodoin et al., 2012). To identify critical regions of 
ASUN required for its nuclear localization, we began by performing 
depletion (Figure 1P). We next assessed the reciprocal possibility 
that hASUN might be required for stability of the INT complex. By 
immunoblotting, we observed decreased levels of IntS3, 4, 7, 10, 
and 11 in lysates of hASUN-siRNA HeLa cells relative to control cells 
(Supplemental Figure S2). This observation is consistent with a re-
cent report showing that levels of Drosophila IntS1 and 12 are inter-
dependent, which may be due to their direct association within the 
complex (Chen et al., 2013). Taken together, these data indicate that 
failure of dynein localization in INT-depleted cells is not due to de-
creased hASUN production and hASUN is required for the stability 
of several other subunits of the INT complex.
INT subunits exhibit a range of subcellular localizations
We previously showed that Drosophila ASUN exhibits a dynamic lo-
calization pattern: in the Drosophila testes, mCherry-tagged dASUN 
(CHY-dASUN) expressed via a transgene shifts from exclusively 
nuclear in early G2 to diffusely present throughout the spermatocyte 
by late G2 (Anderson et al., 2009). Similar localizations (ranging from 
nuclear to cytoplasmic to diffuse throughout the cell) were observed 
when GFP-tagged dASUN was expressed in HeLa cells (Anderson 
et al., 2009). Similarly, we find in the present study that Myc-tagged 
hASUN expressed in HeLa cells localizes to the nucleus and/or cyto-
plasm, albeit with a predominantly nuclear pattern in most cells 
(Figure 2, A1–A3; quantified in Table 2 and later in Figure 4D).
In both fly testes and HeLa cells, we previously observed a tem-
poral correlation in which a pool of cytoplasmic ASUN is present at 
the onset of dynein accumulation on the NE at G2/M (Anderson 
et al., 2009; Jodoin et al., 2012). In fly spermatocytes, dASUN 
undergoes a shift from nuclear to first appearing in the cytoplasm 
during late G2, roughly coinciding with dynein recruitment to the 
NE (Anderson et al., 2009). In HeLa cells, hASUN localizes to the 
cytoplasm at prophase, a cell cycle stage at which dynein is en-
riched on the NE (Jodoin et al., 2012). Owing to this correlation, 
we previously hypothesized that a cytoplasmic pool of ASUN is 














+, Required; –, not required; N.D., not determined.
aAnalysis of requirements for INT subunits in U7 snRNA processing was previ-
ously reported (Chen et al. 2012).
bAnalysis of requirements for INT subunits in dynein recruitment to the NE is 
presented here (Figure 1).
TABLE 1: Comparison of INT subunit requirements in snRNA 
processing versus dynein localization.
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constructs used here, fusion proteins of the 
predicted sizes were observed by immuno-
blotting transfected HeLa cell lysates (Sup-
plemental Figure S4B).
We used nuclear localization sequence 
(NLS) prediction software to identify a pu-
tative NLS in the C-terminal region of 
mASUN (Supplemental Figure S4A). We 
generated Myc-mASUNmutNLS by perform-
ing site-directed mutagenesis to alter 
several charged residues to alanines within 
this region (Supplemental Figure S4A). 
When expressed in transfected HeLa cells, 
Myc-mASUN was predominantly nuclear, 
whereas Myc-mASUNmutNLS was predomi-
nantly cytoplasmic, confirming functional-
ity of the candidate NLS (Supplemental 
Figure S4, F and G).
We also used NLS prediction software to 
identify a putative NLS in the C-terminal re-
gion of the human ASUN homologue that 
was 100% identical to the verified NLS of 
mASUN (Figure 4A and Supplemental 
Figure S4A). We performed site-directed 
mutagenesis to change several charged 
residues in this sequence to alanines, 
thereby generating Myc-hASUNmutNLS 
(Figure 4A). When expressed in HeLa cells, 
Myc-hASUN was predominantly nuclear, 
with some cytoplasmic or diffuse localiza-
tion (Figure 2, A1–A3; quantified in Table 2 
and Figure 4D). In contrast, Myc-hASUNmutNLS 
was predominantly cytoplasmic, confirming 
that we had identified a functional NLS 
(Figure 4, C and D). For experiments pre-
sented later in Figure 6, we also generated 
constructs for addition of a strong exoge-
nous NLS (PKKKRKV; derived from SV40 
large T antigen) to both hASUN and 
hASUNmutNLS (C-terminal to the Myc tag) to 
produce Myc-NLS-hASUN and Myc-NLS-
hASUNmutNLS, respectively (Figure 4A; 
Kalderon et al., 1984). As expected, both fu-
sion proteins were predominantly nuclear 
when expressed in HeLa cells (Figure 4, C 
and D). We performed immunoblotting of lysates of transfected 
cells to confirm that all Myc-hASUN constructs used here produced 
fusion proteins of the predicted sizes (Figure 4B).
Drosophila ASUN contains a functional NLS
We also identified a putative NLS in the C-terminal region of dASUN 
by using NLS prediction software (Supplemental Figure S5A). We 
previously showed that GFP-tagged dASUN expressed in trans-
fected HeLa cells localizes in the nucleus, cytoplasm, and between 
these two compartments, and we obtained similar results here using 
Myc-tagged dASUN (Supplemental Figure S5, A and B; Anderson 
et al., 2009). By site-directed mutagenesis, we changed several 
charged residues to alanines within the candidate NLS of Myc-
dASUN to generate Myc-dASUNmutNLS (Supplemental Figure S5A). 
Introduction of these mutations resulted in a significant shift of the 
fusion protein from the nucleus to the cytoplasm of transfected 
HeLa cells, verifying functionality of the putative NLS in this system 
a structure–function analysis of the mouse ASUN homologue 
(mASUN). Full-length Myc-tagged mASUN expressed in transfected 
HeLa cells was concentrated in the nucleus, with some cells showing 
diffuse or cytoplasmic localization (Supplemental Figure S4, A and 
G). We divided full-length mASUN into three overlapping fragments 
(F1–F3) and generated constructs for expression of each fragment 
fused to GFP at its N-terminal end (Supplemental Figure S4A). On 
expression in transfected HeLa cells, we found that the three GFP-
tagged mASUN fragments had distinct localization patterns. GFP-
mASUN-F1 (N-terminal fragment) was present throughout the cell, 
with slight enrichment in the nucleus (Supplemental Figure S4, C 
and G), whereas GFP-mASUN-F2 (middle fragment) was predomi-
nantly cytoplasmic, with slight perinuclear enrichment (Supplemen-
tal Figure S4, D and G). GFP-mASUN-F3 (C-terminal fragment) ap-
peared to be exclusively nuclear, suggesting that it likely contains 
critical sequences that mediate nuclear localization of full-length 
mASUN (Supplemental Figure S4, E and G). For all mASUN 
FIGURE 2: INT subunits localize to the nucleus, cytoplasm, or both. HeLa cells were transfected 
with the indicated expression constructs encoding tagged versions of INT subunits. (A–L) After 
fixation, cells were stained with phalloidin and DAPI; cells expressing Myc-hASUN were also 
immunostained for Myc. (A) Myc-hASUN was either exclusively nuclear (A1), predominantly 
cytoplasmic (A2), or distributed throughout the cell (A3). (B) GFP (control) was diffusely present 
throughout the cell. (C–L) GFP-tagged versions of other INT subunits localized to the nucleus 
(E, G, I, J, L), cytoplasm (C, H), or both (D, F). Scale bar, 10 μm. (M) Immunoblot analysis of 
lysates of transfected cells using antibodies against Myc or GFP tags revealed fusion proteins of 
the predicted sizes. Tubulin was used as loading control.
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endogenous hASUN. Cells treated with NT or hASUN siRNA and 
transfected with Myc, Myc-hASUN, or Myc-hASUNmutNLS constructs 
(refractory to hASUN siRNA) were analyzed using our dynein local-
ization assay (Figure 6, A and B). As expected, we found that Myc-
hASUN rescued the loss of perinuclear dynein caused by endoge-
nous hASUN depletion (Figure 6A; quantified in Figure 6B). In 
contrast, dynein remained diffuse in the cytoplasm upon expression 
of Myc-hASUNmutNLS in cells lacking endogenous hASUN, suggest-
ing that hASUN may function in the nucleus to regulate dynein local-
ization (Figure 6, A and B).
To further confirm that a nuclear pool of hASUN is required for 
dynein localization and rule out the trivial possibility that mutation of 
the NLS of hASUN might interfere with its activity in other ways (e.g., 
improper protein folding), we asked whether forced localization of 
Myc-hASUNmutNLS to the nucleus via addition of an exogenous NLS 
would render it competent to restore perinuclear dynein in cells de-
pleted of endogenous hASUN. Indeed, we found that dynein local-
ized normally upon expression of Myc-NLS-hASUN or Myc-NLS-
hASUNmutNLS in hASUN-siRNA cells (Figure 6, A and B). These 
findings suggest that the mutations we introduced into the endog-
enous NLS of hASUN were not deleterious per se to the protein, but 
rather that nuclear residence is required for hASUN to exert its effect 
on dynein localization. Immunoblotting of cell lysates for endoge-
nous hASUN and the Myc tag confirmed efficient depletion of hA-
SUN by siRNA treatment and expression of all Myc-tagged hASUN 
fusions used here (Figure 6C).
We next used our dASUN constructs to test whether dASUN acts 
within the cytoplasm or nucleus of transfected HeLa cells to promote 
dynein localization. We previously reported that loss of perinuclear 
dynein in hASUN-depleted HeLa cells was rescued by expression of 
Cherry-dASUN, and similar results were obtained here by express-
ing Myc-dASUN in hASUN-siRNA cells (Supplemental Figure S5C; 
Anderson et al., 2009). Consistent with our hASUN results, we found 
that expression of cytoplasmic-localized Myc-dASUNmutNLS in 
hASUN-siRNA cells failed to restore perinuclear dynein, whereas 
FIGURE 3: Levels of a subset of INT subunits are reduced at G2/M. 
HeLa cells were transfected with the indicated GFP- or Myc-fusion 
constructs and either left untreated (asynchronous population; –) or 
treated with a CDK1 inhibitor (G2/M-arrested population; +) for 16 h. 
Immunoblot analysis of lysates of transfected cells using antibodies 
against GFP or Myc tags revealed decreased levels of several INT 
subunits at G2/M (A), whereas no changes were observed for other 
subunits (B). hASUN antibodies were used to assess endogenous 
hASUN levels. (C) No changes were observed in the levels of GFP 
(control), GFP-BICD2, or endogenous CENP-F at G2/M. Tubulin was 
used as loading control.
Subunit Nuclear Cytoplasmic Diffuse
Myc-hASUN 87 ± 2.2 4 ± 1.9 9 ± 2.4
GFP-IntS2 — 100 ± 0 —
GFP-IntS3 — — 100 ± 0
GFP-IntS4 97 ± 2.1 — 3 ± 2.1
GFP-IntS5 — — 100 ± 0
GFP-IntS6 93 ± 1.4 — 7 ± 1
GFP-IntS7 — 93 ± 1 7 ± 1
GFP-IntS9 85 ± 2.5 — 15 ± 2.5
IntS10-GFP 81 ± 6.5 — 19 ± 6
GFP-IntS11 — 4 ± 0.5 96 ± 0
GFP-IntS12 100 ± 0 — —
HeLa cells were transfected with the indicated expression constructs encoding 
GFP- or Myc-tagged versions of human INT subunits, fixed, and stained with 
phalloidin and DAPI. Cells expressing Myc-hASUN were also immunostained 
for Myc. Immunofluorescence microscopy was performed to assess localization 
patterns of INT fusion proteins (representative images presented in Figure 2, 
with quantification shown here). Localizations were scored as the percentage of 
cells with nuclear, cytoplasmic, or diffuse localization.
TABLE 2: Quantification of localizations of tagged INT subunits in 
transfected HeLa cells.
(Supplemental Figure S5B). For experiments presented later in this 
study, we also generated constructs encoding Myc-NLS-dASUN 
and Myc-NLS-dASUNmutNLS (each containing a strong exogenous 
NLS placed C-terminal to the Myc tag) and confirmed that both of 
these fusion proteins were predominantly nuclear when expressed 
in HeLa cells (Supplemental Figure S5, A and B).
We next tested whether the NLS that we identified in dASUN 
using transfected HeLa cells was also functional in vivo. We previ-
ously established transgenic Drosophila lines with testes-specific 
expression of CHY-tagged dASUN and introduced a copy of this 
transgene into the asun background (Figure 5A; Anderson et al., 
2009). In G2 spermatocytes, CHY-dASUN was predominantly nu-
clear, with some diffuse localization (Figure 5, C and D). We used the 
same approach to express CHY-tagged dASUNmutNLS (carrying mu-
tations in the predicted NLS as described earlier) in asun testes 
(Figure 5A). CHY-dASUNmutNLS was tightly localized to the cytoplasm 
of G2 spermatocytes, a pattern not observed for wild-type CHY-
dASUN; thus, the NLS sequence we identified in dASUN using cul-
tured human cells was also functional in vivo (Figure 5, C and D). For 
experiments presented later in Figure 7, to enrich for dASUN in the 
nucleus, we used the same approach to express CHY-dASUN with a 
strong exogenous NLS (NLS-CHY-dASUN) in asun testes (Figure 
5A). The NLS-CHY-dASUN fusion was even more tightly localized to 
the nucleus of G2 spermatocytes than CHY-dASUN (Figure 5, C and 
D). For all CHY-dASUN constructs described here, fusion proteins of 
the predicted sizes were observed by immunoblotting of transgenic 
testes lysates (Figure 5B).
A nuclear pool of ASUN is required in HeLa cells for dynein 
localization
We used our hASUN expression constructs to address whether hA-
SUN functions in the cytoplasm or nucleus of HeLa cells to promote 
dynein recruitment to the NE. We tested the capacity of cytoplasmic 
Myc-hASUNmutNLS to restore perinuclear dynein to cells depleted of 
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of asun spermatocytes lacking a transgenic 
rescue construct (Figure 7, A and B). Expres-
sion of NLS-CHY-dASUN in asun spermato-
cytes restored perinuclear dynein to nearly 
wild-type levels, suggesting that a nuclear 
pool of dASUN is responsible for regulating 
the localization of cytoplasmic dynein mo-
tors in this system.
In addition to the failure of dynein local-
ization, asun mutants display a range of de-
fects: spermatocytes arrested at prophase I 
with unattached centrosomes, impaired 
sperm bundling, and male sterility (Anderson 
et al., 2009). This constellation of asun phe-
notypes is likely secondary to loss of perinu-
clear dynein in G2 spermatocytes, an event 
that occurred upstream of these defects. To 
determine whether restoration of dynein on 
the NE of asun spermatocytes by NLS-CHY-
dASUN expression was sufficient to rescue 
the most downstream defect, male sterility, 
we scored the number of live progeny per 
fertile male. We found that NLS-CHY-dASUN 
could restore fertility to asun males to the 
same degree as the CHY-dASUN control, 
whereas only partial rescue was achieved 
with CHY-dASUNmutNLS (Figure 7C).
Taken together, these data suggest that 
a nuclear pool of ASUN plays a conserved 
role, from Drosophila to humans, in the re-
cruitment of cytoplasmic dynein motors to 
the NE at G2/M. Combined with evidence 
presented here that additional INT subunits 
likewise play an essential role in this recruit-
ment step, we hypothesize that the Integra-
tor complex mediates the processing of a 
critical RNA target(s) required for the production of a cytoplasmic 
protein that is directly involved in the regulation of dynein 
localization.
DISCUSSION
A newly identified role for Integrator in promoting dynein 
recruitment to the NE
We previously described an essential role for ASUN in regulating 
dynein localization in Drosophila spermatogenesis and cultured hu-
man cells (Anderson et al., 2009; Jodoin et al., 2012). Recent studies 
identified a second role for ASUN as an Integrator subunit required 
for snRNA-processing activity of the complex (Baillat et al., 2005; 
Malovannaya et al., 2010; Chen et al., 2012). Owing to the seem-
ingly divergent nature of these two roles, we initially speculated that 
ASUN might “moonlight” by performing cellular functions within 
the cytoplasm independently of INT. To disprove this model, we 
here asked whether additional INT subunits, such as ASUN, are re-
quired for dynein localization. Our finding that depletion of individ-
ual INT subunits recapitulates the loss of perinuclear dynein in 
hASUN-siRNA cells argues that ASUN functions within the Integra-
tor complex to mediate this process as opposed to working inde-
pendently. Given the established role of INT in snRNA processing, 
we considered that loss of perinuclear dynein in INT-depleted cells 
could be an indirect consequence of a failure to produce mature 
ASUN transcripts; our data, however, do not support this idea. Con-
versely, we find that ASUN is required for stability of several INT 
nuclear-localized Myc-NLS-dASUN or Myc-NLS-dASUNmutNLS were 
both competent to promote dynein localization (Supplemental 
Figure S5C). Immunoblotting of cell lysates for endogenous hASUN 
and the Myc tag confirmed efficient depletion of hASUN by siRNA 
treatment and expression of all Myc-tagged dASUN fusions used 
here (Supplemental Figure S5D). Taken together, these data provide 
further support for a model in which a nuclear pool of ASUN is re-
quired for recruitment of cytoplasmic dynein to the NE in cultured 
human cells and suggest that this mechanism might be conserved in 
Drosophila.
A nuclear pool of dASUN is required in Drosophila 
spermatocytes for dynein localization
We previously identified ASUN as a critical regulator of dynein lo-
calization during Drosophila spermatogenesis (Anderson et al., 
2009). We used this system to determine whether the requirement 
for nuclear ASUN in regulating cytoplasmic dynein localization that 
we observed in HeLa cells is conserved in vivo. Using transgenic 
Drosophila lines that we established (Figure 5A), we assessed the 
capacity of cytoplasmic CHY-dASUNmutNLS or nuclear NLS-CHY-
dASUN expressed in asun testes to promote dynein localization. 
As previously reported, we found that CHY-dASUN rescued loss 
of perinuclear dynein in asun spermatocytes (Figure 7, A and B; 
Anderson et al., 2009). asun spermatocytes expressing 
CHY-dASUNmutNLS, however, lacked perinuclear dynein; instead, 
dynein remained diffuse in the cytoplasm, similar to the phenotype 
FIGURE 4: Identification of a functional NLS in human ASUN. (A) Schematic of Myc-tagged 
hASUN with predicted NLS (yellow box) in the C-terminal region of the protein. Letter A (red) 
indicates each charged residue of the endogenous NLS mutated to alanine in Myc-hASUNmutNLS 
and Myc-NLS-hASUNmutNLS. An exogenous NLS (blue box) was added between the Myc tag and 
either hASUN or hASUNmutNLS to generate Myc-NLS-hASUN and Myc-NLS-hASUNmutNLS, 
respectively. (B) Myc immunoblot analysis of lysates of transfected HeLa cells revealed Myc-
hASUN fusion proteins of the predicted sizes. Tubulin was used as loading control. 
(C) Representative images showing predominant localizations of Myc-hASUN fusions in 
transfected HeLa cells. Scale bars, 10 μm. (D) Quantification of localization patterns of 
Myc-hASUN fusion proteins in transfected HeLa cells.
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lates on the NE, suggests that Integrator 
may exert its effect on dynein by acting ear-
lier in the cell cycle. We cannot exclude the 
possible existence of a subcomplex com-
posed of a subset of INT subunits that are 
stable at G2/M; however, based on our find-
ing that four subunits (IntS2, 5, 6, and 9) 
present at reduced levels at G2/M are none-
theless required for dynein localization, it is 
unlikely that any such subcomplex alone 
would be sufficient to mediate dynein re-
cruitment to the NE.
We propose a model in which nuclear-
localized Integrator complex, including 
ASUN, mediates 3′-end processing of 
snRNA, which in turn is required for normal 
processing of mRNA encoding a key 
regulator(s) of cytoplasmic dynein localiza-
tion. When Integrator activity is compro-
mised (e.g., by knockdown of an essential 
subunit), production of critical transcript(s) 
during interphase is impaired, leading to re-
duction of perinuclear dynein at G2/M. To 
further elucidate mechanisms underlying 
the temporal and spatial control of dynein, it 
will be important to identify critical target(s) 
of INT involved in this process.
What are the critical targets of 
Integrator that mediate dynein 
localization?
On the basis of data presented here, we 
hypothesize that transcripts encoding a key 
regulator(s) of dynein localization would be 
misprocessed after down-regulation of INT. 
In a preliminary effort to identify such a 
target(s), we performed a high-throughput 
RNA-seq screen using both control siRNA 
cells and IntS11-siRNA HeLa cells (T.R.A. and E.J.W., unpublished 
observations). We compared mRNA isolated from both populations, 
with an emphasis on identifying transcripts that were aberrantly 
spliced in the absence of functional INT. Although we observed sev-
eral thousand alterations in splicing throughout the genome, 
we found no evidence for misprocessing of transcripts encoding 
1) dynein–dynactin subunits or adaptor proteins or 2) components
of the BICD2-RanBP2 or NudE/EL-CENP-F-Nup133 dynein-binding 
cassettes. We speculate that novel regulators of dynein localization 
could be the critical mRNA targets of INT involved in this process. 
The identification of Drosophila ASUN (also known as Mat89Bb) as 
a positive regulator of siRNA, endo-siRNA, and microRNA pathways 
in three high-throughput screens, however, suggests that the Inte-
grator complex may impinge on other classes of small RNAs and 
highlights the need for further studies of its activities (Zhou et al., 
2008).
When comparing the list of individual INT subunits required for 
U7 snRNA processing and those required for dynein localization, 
only one discrepancy emerges (Table 1). IntS7 was previously shown 
to be essential for processing of U7 and spliceosomal snRNA using 
a cell-based reporter and through measurement of endogenous 
transcripts, but we find here that it is dispensable for dynein recruit-
ment to the NE (Ezzeddine et al., 2011; Chen et al., 2012). Given 
that we observed significant RNA interference-mediated depletion 
subunits, further underscoring its importance for functioning of the 
complex.
A model for regulation of dynein localization by integrator
We previously hypothesized that ASUN functions in the cytoplasm 
to promote redistribution of dynein from diffuse in the cytoplasm to 
NE anchored at G2/M (Anderson et al., 2009; Jodoin et al., 2012). 
We considered that a pool of Integrator might exist in the cytoplasm 
that could mediate dynein recruitment to the NE via a mechanism 
independent of its snRNA-processing role in the nucleus. Our find-
ing that INT subunits exhibit a range of localization patterns in HeLa 
cells (predominantly nuclear to predominantly cytoplasmic) neither 
strongly supports nor refutes this model.
Our identification of a functional NLS in Drosophila and mam-
malian ASUN homologues allowed us to manipulate the subcellular 
compartmentalization of ASUN and assess effects on dynein local-
ization. We find that forced cytoplasmic localization of ASUN (via 
endogenous NLS mutation) hinders its capacity to promote dynein 
recruitment to the NE, whereas redirection of this mutant protein 
into the nucleus (via exogenous NLS addition) restores its function. 
These data indicate that Integrator likely acts from within the nu-
cleus to control dynein localization in the cytoplasm. Furthermore, 
our observation that levels of several INT subunits are paradoxically 
decreased at G2/M, the stage at which dynein normally accumu-
FIGURE 5: Functional NLS is conserved in Drosophila ASUN homologue. (A) Schematic of 
CHY-tagged dASUN with predicted NLS (yellow box) in the C-terminal region of the protein. 
Letter A indicates each charged residue of the endogenous NLS mutated to alanine in CHY-
dASUNmutNLS. An exogenous NLS (blue box) was added to the N-terminal end of CHY-tagged 
dASUN to generate NLS-CHY-dASUN. (B) CHY immunoblot analysis of testes lysates from asun 
males with or without germline expression of CHY-dASUN fusions revealed proteins of the 
predicted sizes. An intervening lane just left of the last lane was removed. Wild-type (WT) males 
and asun males lacking a transgene were used as negative controls. Tubulin was used as loading 
control. (C) Representative images showing localizations of CHY-dASUN fusions in transgenic G2 
spermatocytes. Scale bar, 10 μm. (D) Quantification of localization patterns of CHY-dASUN 
fusion proteins in transgenic G2 spermatocytes.
2962 | J. N. Jodoin et al. Molecular Biology of the Cell
splicing of smad1 and smad5 transcripts, 
generating a dominant-negative form of 
Smad that disrupts erythrocyte differentia-
tion (Tao et al., 2009).
What remains to be elucidated is how 
perturbations in snRNA 3′-end formation 
generate phenotypes so specific and yet so 
diverse. Although the favored hypothesis is 
that global reduction in snRNA biosynthesis 
negatively affects splicing of a subset of 
transcripts, the criteria for defining this set 
are unclear. It is likely that these sensitive 
transcripts will be enriched for either subop-
timal splice sites, alternative splice sites, 
or minor spliceosome-dependent introns. 
Regardless of the root cause, our discovery 
of a new role for the Integrator complex in 
regulating dynein localization adds to the 
growing list of INT-dependent processes.
MATERIALS AND METHODS
Drosophila spermatocyte experiments
Flies were maintained at 25°C using stan-
dard techniques (Greenspan, 2004). y w flies 
obtained from Bloomington Drosophila 
Stock Center (Indiana University, Blooming-
ton, IN) were used as the “wild-type” stock. 
The asunf02815 allele (Exelixis Collection, 
Harvard Medical School, Boston, MA) and a 
transgenic line with male germline–specific 
expression of CHY-tagged wild-type dASUN 
were previously described (Anderson et al., 
2009). Transgenic lines for male germline–
specific expression of CHY-tagged dASUN 
fusion proteins (constructs described later) 
were generated by P-element–mediated 
transformation via embryo injection (Rubin 
and Spradling, 1982). For each transgene, a single insertion map-
ping to the X chromosome was crossed into the asunf02815 back-
ground using standard genetic crosses.
To test male fertility, individual adult males (2 d old) were placed 
in vials with five wild-type females (2 d old) and allowed to mate for 
5 d. The average number of live adult progeny produced per fertile 
male was scored (≥10 males tested per genotype). Statistical analy-
sis was performed using an unpaired Student’s t test.
Protein extracts were prepared by homogenizing dissected tes-
tes from newly eclosed males in SDS sample buffer. The equivalent 
of eight testes pairs was loaded per lane. After SDS–PAGE, immu-
noblotting was performed as described later.
Live testes cells were prepared for examination by fluorescence 
microscopy as described previously (Kemphues et al., 1980). Briefly, 
testes were dissected from newly eclosed adult males, placed in a 
drop of phosphate-buffered saline (PBS) on a microscopic slide, and 
gently squashed under a glass coverslip after making a small inci-
sion near the stem cell hub. Formaldehyde fixation was performed 
as described previously (Gunsalus et al., 1995). Briefly, slides of 
squashed testes were snap-frozen, immersed in 4% formaldehyde 
(in PBS with 0.1% Triton X-100) for 7 min at −20°C after coverslip 
removal, and washed three times in PBS. Mouse anti–dynein heavy 
chain primary antibody (P1H4, 1:120; gift from T. Hays, University of 
Minnesota, Minneapolis, MN) and Cy3-conjugated secondary anti-
body (Invitrogen, Carlsbad, CA) were used (McGrail and Hays, 
(Supplemental Figure S2), one possible explanation for this differen-
tial requirement is that the assays used to measure RNA processing 
might be more sensitive to perturbations of INT function than the 
dynein localization assay, perhaps because the latter is a more 
downstream event.
Additional cellular and developmental roles of integrator
The Integrator complex mediates 3′-end processing of snRNAs that 
play essential roles in global gene expression. Given that Integrator 
is likely required for accurate production of a plethora of proteins, it 
is not surprising that loss of its activity is associated with a wide 
range of cellular and developmental phenotypes. It was recently 
reported that siRNA-mediated down-regulation of IntS4 leads to 
defects in formation of nuclear structures known as Cajal bodies 
(Takata et al., 2012). Another group found that IntS6 and IntS11 are 
required for proper differentiation of adipocytes in a cultured cell 
system; although the underlying mechanism is unknown, the au-
thors hypothesized that U1 and U2 snRNAs are involved (Otani 
et al., 2013). In large-scale screens performed in zebrafish and 
C. elegans, IntS7 homologues were shown to be required for nor-
mal craniofacial development (Golling et al., 2002; Kamath et al., 
2003). Mutation of Drosophila IntS7 (deflated) results in abdominal 
phenotypes due to cell cycle and signaling defects (Rutkowski and 
Warren, 2009). Integrator is also essential for hematopoiesis in 
zebrafish: down-regulation of IntS5, IntS9, or IntS11 causes aberrant 
FIGURE 6: Nuclear pool of hASUN is required for dynein recruitment to the NE in HeLa cells. 
HeLa cells were transfected with NT or hASUN siRNA plus Myc (vector control) or Myc-hASUN 
expression constructs as indicated. (A) After nocodazole treatment, cells were fixed and stained 
for DIC and DNA. Representative images of cells. Perinuclear dynein was restored only by 
expression of hASUN fusion proteins with nuclear localization. Scale bar, 10 μm. 
(B) Quantification of cells with perinuclear dynein after the indicated siRNA and DNA 
transfections. *p < 0.0001 (pairwise comparisons indicated). N.S., nonsignificant statistical 
differences. (C) hASUN immunoblot of lysates of transfected HeLa cells confirmed depletion of 
hASUN in hASUN-siRNA cells, and Myc immunoblot confirmed expression of Myc-hASUN fusion 
proteins of the predicted sizes. Tubulin was used as loading control.
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CUG AGU UCA GAU A-3′), IntS4 (5′-CAG 
CAU UGU UCU CAG AUC A-3′), IntS5 (5′-
CAA GUU UGU CCA GUC ACG A-3′), IntS6 
(#1: 5′-CAC UAA UGA UUC GAU AAU A-3′ 
and #2: 5′-CCA UGA AGA GGU CAA UAC 
U-3′), IntS7 (5′-GGC UAA AUA GUU UGA 
AGG A-3′), IntS9 (5′-GAA AUG CUU UCU 
UGG ACA A-3′), IntS10 (5′-GGA UAC UUG 
GCU UUG GUU A-3′), IntS11 (Albrecht and 
Wagner, 2012), IntS12 (5′-GUC AAG ACA 
UCC ACA GUU A-3′), and CPSF30 (5′-GUG 
CCU AUA UCU GUG AUU U-3′) were ob-
tained from Sigma-Aldrich (St. Louis, MO).
Cells were transfected with siRNA du-
plexes using DharmaFECT 1 transfection 
reagent (Dharmacon) and analyzed 3 d post-
transfection. FuGENE HD transfection re-
agent was used for cotransfection of cells 
with siRNA and DNA constructs. Where in-
dicated, cells were incubated in 5 μg/ml 
(16.6 μM) nocodazole (Sigma-Aldrich) for 
3 h before fixation to enhance perinuclear 
localization of dynein. For G2/M arrest, cells 
were incubated for 16 h in 10 μM RO-3306 
(Cdk1 inhibitor; Enzo Life Sciences, 
Plymouth, PA).
Cell fixation, immunostaining, 
and microscopy
Cells were fixed in methanol (5 min at −20°C 
followed by washing with Tris-buffered sa-
line [TBS] plus 0.01% Triton X-100) and 
blocked in TBS plus 0.01% Triton X-100 and 
0.02% bovine serum albumin before immu-
nostaining. Primary antibodies were used as 
follows: DIC (clone 74.1, 1:500; Abcam, 
Cambridge, MA) and c-Myc (9E10, 1:1000). 
Alexa Fluor 546–conjugated phalloidin 
(1:1000; Invitrogen) was used to stain F-
actin. Appropriate secondary antibodies 
conjugated to Alexa Fluor 488 or Cy3 were 
used (1:1000; Invitrogen). Cells were 
mounted in ProLong Gold Antifade Reagent 
with DAPI (Invitrogen). Wide-field fluorescence images were ob-
tained using an Eclipse 80i microscope (Nikon) with Plano-Apo 
100× objective.
Line scan analyses to quantify perinuclear dynein accumula-
tion in HeLa cells were performed using ImageJ (National 
Institutes of Health, Bethesda, MD). Ten representative cells were 
measured per condition; for each cell, 12 line scans distributed 
equally around the nuclear circumference were obtained. To 
quantify the ratios of perinuclear to diffusely cytoplasmic DIC in 
stained HeLa cells, the average intensity of the DIC signal within 
a small rectangular region was sampled near the nuclear surface 
and in the surrounding cytoplasm using ImageJ. The ratio of the 
intensities was determined. At least 20 cells were scored per 
condition.
Statistical analyses of data from cultured cell experiments re-
ported here were performed using Student’s unpaired t test. Error 
bars indicate SEM for all bar graphs. All experiments were per-
formed a minimum of three times with at least 200 cells scored per 
condition.
1997). Fixed samples were mounted in PBS with 4′,6-diamidino-2-
phenylindole (DAPI) to visualize DNA. Wide-field fluorescence 
images were obtained using an Eclipse 80i microscope (Nikon, 
Melville, NY) with Plan-Fluor 40× objective. In experiments to deter-
mine the percentage of late G2 spermatocytes with perinuclear dy-
nein, at least 200 cells were scored per genotype. Statistical analysis 
was performed using Fisher’s exact test.
Cell culture and treatments
HeLa cells were maintained at 37°C and 5% CO2 in DMEM contain-
ing 10% fetal bovine serum, 1% l-glutamine, 100 μg/ml streptomy-
cin, and 100 U/ml penicillin (Life Technologies, Carlsbad, CA). Plas-
mid DNA was transfected into cells using FuGENE HD (Promega, 
Madison, WI). siGENOME NT siRNA#5 (Dharmacon, Lafayette, CO) 
was used as negative control. siRNA used to silence hASUN (3′-UTR 
region; 5′-CAG CAA GAU GGU AUA GUU A-3′) was obtained from 
Dharmacon. siRNAs used to silence IntS1 (5′-CAU UUC UCC GUC 
GAU UAA A-3′), IntS2 (#1: 5′-CUC GUU UAG CUG UCA AUG U-3′ 
and #2: 5′-CCU UAA UCA GCG UUU CAG U-3′), IntS3 (5′-GAA GUA 
FIGURE 7: Nuclear pool of dASUN is required for dynein recruitment to the NE in Drosophila 
spermatocytes. (A, B) Testes dissected from wild-type (WT) or asun males with or without 
germline expression of CHY-tagged dASUN fusion proteins were stained for dynein heavy chain 
and DNA. (A) Representative images of G2 spermatocytes. Perinuclear dynein was restored to 
asun G2 spermatocytes only by expression of dASUN fusion proteins with nuclear localization. 
Scale bar, 10 μm. (B) Quantification of G2 spermatocytes with perinuclear dynein. (C) Fertility 
assay shows the average number of progeny per fertile male. *p < 0.0001 (compared with 
wild-type control).
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1:1000), β-tubulin (clone E7, 1:1000; Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA), mCherry (1:500; 
Clontech, Mountain View, CA), CENP-F (clone 14C10 1D8, 1:500; 
Abcam), C-hASUN (1:300; Jodoin et al., 2012), GFP B-2 (1:1000; 
Santa Cruz Biotechnology, Dallas, TX), and IntS1, IntS4, IntS7, IntS9, 
IntS10, IntS11, IntS12, and CPSF30 (1:1000; Bethyl Labs, Montgom-
ery, TX). Horseradish peroxidase–conjugated secondary antibodies 
(1:5000) and chemiluminescence were used to detect primary 
antibodies.
FACS analysis
siRNA-treated HeLa cells (∼107) were fixed with 70% ethanol at 
4°C for 24 h and incubated in PBS containing propidium iodide 
(20 μg/ml) and RNase A (0.2 mg/ml; Sigma-Aldrich) at 4°C for 24 h. 
FACS analysis was performed to determine propidium iodide inten-
sity levels (a measure of DNA content). Gating was used to exclude 
cell debris and doublets from the DNA analysis. FACS experiments 
were performed in the Flow Cytometry Shared Resource of 
Vanderbilt University Medical Center.
DNA constructs
cDNA clones encoding mASUN and dASUN were previously de-
scribed (Jodoin et al., 2012). The full-length hASUN open reading 
frame (ASUN; National Center for Biotechnology Information Refer-
ence Sequence, NM_018164 [gene], NP_060634.2 [protein]) was 
amplified from a human primary skin fibroblast cDNA library. The 
following forward and reverse primers were used to incorporate 
EcoRI and StuI restriction sites into the 5′ and 3′ ends, respectively, 
of the hASUN coding region, followed by subcloning of the di-
gested, purified fragment into expression vector pCS2: 5′-CCG 
GAA TTC CCA GGC ACG AAA GTT AAA AC-3′ (ASUN-EcoRI-5′) 
and 5′-AAA AGG CCT TTC TTC AAG TCA CTC TTC ACT GC-3′ 
(ASUN-StuI-3′).
Constructs for expression in HeLa cells of the following N-termi-
nally tagged proteins were generated by subcloning into vector 
pCS2-Myc: Myc-dASUN, Myc-mASUN (previously described in 
Jodoin et al. 2012), and Myc-hASUN. To generate pCS2-Myc-NLS 
vector, the following nucleotide sequence was engineered into the 
pCS2-Myc vector to add a strong exogenous NLS (PKKKRKV; de-
rived from SV40 large T antigen) C-terminal to the Myc tag: CCC 
AAG AAG AAG CGC AAG GTC (Kalderon et al., 1984). hASUN and 
dASUN were subcloned into pCS2-Myc-NLS for production of Myc-
NLS-hASUN and Myc-NLS-dASUN, respectively, in transfected cells. 
We used a PCR-based approach to generate mASUN fragments for 
subcloning into pCS2-GFP expression vector (N-terminal tag; 
illustrated in Supplemental Figure S4).
Vector tv3 (gift from J. Brill, The Hospital for Sick Children, 
Toronto, Canada) containing the testes-specific β2-tubulin promoter 
was used to make constructs for Drosophila transgenesis (Wong 
et al., 2005). Sequence encoding a strong exogenous NLS 
(described earlier) was engineered into a previously described 
tv3-CHY vector to generate tv3-NLS-CHY. dASUN was subcloned 
into modified tv3 vector to produce NLS-CHY-dASUN in transgenic 
fly testes.
We used NLStradamus software to identify putative NLS motifs 
in hASUN, mASUN, and dASUN (Nguyen Ba et al., 2009). We used 
the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Tech-
nologies, Santa Clara, CA) to mutate charged residues to alanines 
within these motifs of hASUN (Figure 4A), mASUN (Supplemental 
Figure S4A), and dASUN (Figure 5A and Supplemental Figure S5).
GFP-Integrator subunits were subcloned into pcDNA4/myc-His 
A (Invitrogen) using purchased cDNA templates (Open Biosystems/
Thermo Scientific, Huntsville, AL). The GFP-BICD2 expression con-
struct was a gift from A. Akhmanova (Erasmus Medical Center, 
Rotterdam, Netherlands; Hoogenraad et al., 2001).
Immunoblotting
HeLa cell lysates were prepared using nondenaturing lysis buffer 
(50 mM Tris-Cl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% Triton 
X-100). After SDS–PAGE, proteins were transferred to nitrocellulose 
for immunoblotting using standard techniques. Immunoblotting 
was performed using the following primary antibodies: c-Myc (9E10, 
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ABSTRACT Recruitment of dynein motors to the nuclear surface is an essential step for 
nucleus–centrosome coupling in prophase. In cultured human cells, this dynein pool is anchored 
to nuclear pore complexes through RanBP2–Bicaudal D2 (BICD2) and Nup133– centromere 
protein F (CENP-F) networks. We previously reported that the asunder (asun) gene is required 
in Drosophila spermatocytes for perinuclear dynein localization and nucleus–centrosome cou-
pling at G2/M of male meiosis. We show here that male germline expression of mammalian 
Asunder (ASUN) protein rescues asun flies, demonstrating evolutionary conservation of func-
tion. In cultured human cells, we find that ASUN down-regulation causes reduction of peri-
nuclear dynein in prophase of mitosis. Additional defects after loss of ASUN include nucleus–
centrosome uncoupling, abnormal spindles, and multinucleation. Coimmunoprecipitation and 
overlapping localization patterns of ASUN and lissencephaly 1 (LIS1), a dynein adaptor, sug-
gest that ASUN interacts with dynein in the cytoplasm via LIS1. Our data indicate that ASUN 
controls dynein localization via a mechanism distinct from that of either BICD2 or CENP-F. We 
present a model in which ASUN promotes perinuclear enrichment of dynein at G2/M that 
facilitates BICD2- and CENP-F-mediated anchoring of dynein to nuclear pore complexes.
INTRODUCTION
Cytoplasmic dynein plays critical roles in many cellular processes 
by carrying out minus end–directed transport along micro-
tubules (Holzbaur and Vallee, 1994). Dynein is a multimeric 
complex composed of heavy, intermediate, light intermediate, 
and light chains. Each heavy chain contains six ATPase domains 
that power the motor. Noncatalytic subunits regulate dynein by 
linking the complex to its cargo and adaptor proteins. Dynein 
complexes approach 2 MDa in size, making dynein the largest of 
all known motor complexes. The composition of dynein com-
plexes and the cellular events requiring these complexes have 
been defined, although a comprehensive understanding of the 
mechanisms by which these complexes are regulated within 
cells is lacking.
Dynein complexes are subject to several modes of regulation, 
including phosphorylation, subunit composition, subcellular local-
ization, and binding of accessory proteins. Dynactin, another large 
multimeric complex, was identified through in vitro studies as an 
activator of dynein; subsequent work suggested that dynein re-
quires dynactin to perform its cellular functions (Schroer, 2004). 
A dynein adaptor protein, lissencephaly 1 (LIS1), binds directly to 
dynein heavy chains and is essential for multiple dynein functions, 
including coupling of centrosomes to the nucleus during neuronal 
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A dynein subpopulation stably anchored to the nuclear enve-
lope (NE) at the G2/M transition is essential for proper nucleus–
centrosome coupling in multiple systems (Malone et al., 2003; 
Anderson et al., 2009; Splinter et al., 2010; Bolhy et al., 2011). 
Minus end–directed movement of anchored dynein motors along 
astral microtubules has been hypothesized to draw centrosomes 
toward the nuclear surface to facilitate their attachment to the 
NE before nuclear envelope breakdown (NEBD; Burgess and 
Knight, 2004). This anchored pool of dynein has also been impli-
cated in the process of NEBD (Beaudouin et al., 2002; Salina 
et al., 2002).
Although promotion of nucleus–centrosome coupling is a dy-
nein-dependent function that is evolutionarily conserved, the exact 
molecular mechanisms appear to vary (Salina et al., 2002). Dynein is 
anchored to the nuclear surface via KASH and SUN domain–
containing proteins in Caenorhabditis elegans embryogenesis and 
during neuronal migration in mice (Malone et al., 2003; Zhang et al., 
2009). In a cultured mammalian cell line (HeLa), at least two distinct 
pathways are required to ensure proper execution of this critical 
event. These pathways both employ nuclear pore complex (NPC) 
interactions to anchor dynein motors to the nuclear surface. The first 
pathway uses RanBP2, a nucleoporin that associates with the cyto-
plasmic face of NPCs, as the docking site for Bicaudal D2 (BICD2; 
Splinter et al., 2010). BICD2, directly bound to dynein, moves in a 
minus-end direction toward the nuclear surface just before the G2/M 
transition, thereby anchoring dynein at the NE. The second pathway 
uses another nucleoporin, Nup133, as a docking site for centromere 
protein F (CENP-F; Bolhy et al., 2011). Before G2/M, CENP-F directly 
binds dynein-bound NudE/EL; CENP-F then simultaneously binds 
Nup133 to anchor dynein, NudE/EL, and ultimately the centrosomes 
to the NE.
We previously identified asunder (asun; formerly known as 
Mat89Bb) as an essential regulator of dynein localization during 
Drosophila spermatogenesis (Anderson et al., 2009). Spermatocytes 
of asun mutant testes arrest at prophase of meiosis I with cen-
trosomes unattached to the nucleus. asun spermatocytes that prog-
ress beyond this arrest exhibit defects in meiotic spindle assembly, 
chromosome segregation, and cytokinesis. The severe loss of peri-
nuclear dynein in asun spermatocytes is the likely basis for this con-
stellation of defects. Our studies revealed that Drosophila ASUN 
(dASUN) plays a key role in recruiting dynein to the nuclear surface 
at G2/M, a critical step in establishing nucleus–centrosome coupling 
and fidelity of meiotic divisions.
The human homologue of asun (also known as GCT1 or 
C12ORF11) was originally identified in a screen for genes up-regu-
lated in testicular seminomas (Bourdon et al., 2002). Whereas ex-
pression of Drosophila asun is limited to male and female germline 
cells, transcripts of the mouse homologue were detected in both 
germlines and all somatic cells surveyed (Stebbings et al., 1998; 
Bourdon et al., 2002). These findings suggested that Asunder 
(ASUN) might play a broader role in mammals.
To further investigate the mechanism by which ASUN regu-
lates dynein, we examined the function of the human homologue 
of ASUN (hASUN) in this study. We find that, like BICD2 and 
CENP-F, hASUN is required in cultured cells for enrichment of dy-
nein on the nuclear surface at the onset of mitosis. hASUN deple-
tion leads to mitotic defects, which are likely secondary to failure 
of dynein localization. We present a model in which hASUN acts 
via a mechanism distinct from that of BICD2 and CENP-F to pro-
mote dynein recruitment to the nuclear surface at G2/M, a critical 
step to establishing nucleus–centrosome coupling and fidelity of 
mitotic divisions.
RESULTS
Mammalian ASUN can functionally replace dASUN 
during spermatogenesis
The predicted hASUN and mouse ASUN (mASUN) proteins are 95% 
identical and 97% similar to each other; comparison of the predicted 
mammalian and Drosophila ASUN proteins revealed that they are 
43% identical and 64% similar. We sought to determine whether a 
mammalian form of ASUN could functionally replace dASUN in vivo. 
Using the Drosophila model system, we established transgenic lines 
expressing mCherry-tagged mASUN (CHY-mASUN) exclusively in 
the male germline (Figure 1A). We found that the presence of a 
single copy of the CHY-mASUN transgene significantly increased 
the percentage of asunf02815 males (hypomorphic allele) that pro-
duced adult progeny (Figure 1B; Anderson et al., 2009). We also 
observed a significant increase in the number of adult progeny pro-
duced per fertile male, albeit not to the level of wild-type controls 
(Figure 1C). We previously reported that germline expression of 
CHY-tagged dASUN fully rescued the sterility of asun males; the 
partial rescue obtained by germline expression of the mouse homo-
logue might be due to the relatively low level of expression of this 
fusion protein in the fly testes (Figure 1A; Anderson et al., 2009).
We previously identified a critical role for dASUN in recruitment 
of dynein motors to the nuclear surface and nucleus–centrosome 
coupling in Drosophila male germline cells (Anderson et al., 2009). 
We next asked whether a mammalian form of ASUN could similarly 
regulate these events. The severe reduction of perinuclear dynein 
heavy chain (DHC) that is a hallmark feature of asun G2 spermato-
cytes and immature spermatids was almost fully restored to wild-
type levels by transgenic CHY-mASUN expression (Figure 1, D–H). 
We also observed a significant increase in the degree of nucleus–
centrosome coupling at prophase in asun spermatocytes harboring 
the CHY-mASUN transgene (Figure 1, I and J). Together these find-
ings reveal that mASUN can functionally replace its Drosophila ho-
mologue in vivo to regulate dynein localization during spermato-
genesis and suggest that the molecular function of ASUN is 
conserved across phyla.
hASUN is required for dynein anchoring 
to the NE at prophase
On the basis of the role of dASUN during male meiosis and the 
broader expression pattern of mASUN, we reasoned that vertebrate 
homologues of ASUN might promote dynein recruitment to the NE 
of somatic cells at the onset of mitosis. To test this hypothesis, we 
performed small interfering RNA (siRNA)–mediated knockdown of 
hASUN in HeLa cells. We confirmed that ASUN was efficiently de-
pleted from cells by immunoblotting with antipeptide antibodies 
(M-hASUN antibody [Ab] and C-hASUN Ab) directed against dis-
tinct epitopes in the C-terminal region of hASUN (Supplemental 
Figure S1A). siRNA-treated cells were briefly incubated with no-
codazole to enhance perinuclear localization of dynein–dynactin 
complexes and accessory proteins before fixation and immunos-
taining for dynein intermediate chain (DIC; Beswick et al., 2006; 
Hebbar et al., 2008; Splinter et al., 2010; Bolhy et al., 2011). We 
found that ∼91% of NT-siRNA (nontargeting control) prophase cells 
showed strong perinuclear dynein staining (Figure 2, A and D–F). 
After hASUN knockdown, however, only ∼30% of cells exhibited this 
pattern; instead, the majority of prophase cells displayed diffuse 
localization of dynein in the cytoplasm (Figure 2, B and D–F). Using 
a second independent hASUN-siRNA sequence that efficiently de-
pleted ASUN from cells, we observed a similar reduction in the per-
centage of prophase cells with perinuclear dynein (Supplemental 
Figure S1, B–D).
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We considered the possibility that 
hASUN might function to destabilize micro-
tubules; in that case, down-regulation of 
hASUN could inhibit nocodazole-induced 
depolymerization of microtubules, thereby 
blocking access of dynein to the NE. We 
performed immunostaining experiments to 
assess whether microtubules undergo a nor-
mal degree of nocodazole-induced depo-
lymerization after loss of hASUN. We ob-
served essentially identical tubulin staining 
patterns for NT-siRNA versus hASUN-siRNA 
cells in response to nocodazole treatment, 
suggesting that the lack of perinuclear dy-
nein observed in hASUN-siRNA cells is not 
secondary to gross alterations of the micro-
tubule network (Supplemental Figure S2).
To further confirm that loss of perinuclear 
dynein in hASUN-siRNA HeLa cells was due 
to depletion of endogenous hASUN, we per-
formed a rescue experiment by transiently 
expressing CHY-tagged dASUN (refractory to 
hASUN siRNA). CHY-dASUN restored peri-
nuclear dynein in hASUN-siRNA prophase 
cells to levels similar to that of control cells 
(Figure 2, C–F). These results confirmed that 
loss of perinuclear dynein in hASUN-siRNA 
cells was specifically caused by hASUN de-
pletion and demonstrated that dASUN can 
replace its human homologue to promote 
dynein recruitment to the NE at prophase.
We considered an alternative possibility 
that hASUN is required for stability of dy-
nein–dynactin complexes rather than to pro-
mote their enrichment on the NE. Depletion 
of individual dynein–dynactin components 
can destabilize other subunits of these com-
plexes (Schroer, 2004; Mische et al., 2008). 
We immunoblotted for DIC and dynamitin 
(DMN; dynactin subunit) in extracts of HeLa 
cells after hASUN knockdown and found no 
changes in their cellular levels (Supplemen-
tal Figure S3A). We also performed sucrose 
density gradient analysis to assess whether 
dynein complexes remained intact after 
hASUN knockdown and found no change in 
migration profiles (Supplemental Figure 
S3B). Taken together, these data suggest 
that hASUN is not required to maintain the 
integrity of dynein–dynactin complexes.
hASUN is required for proper coupling 
of centrosomes to the NE at prophase
Perinuclear dynein is essential for proper 
tethering of centrosomes to the NE at G2/M 
(Splinter et al., 2010; Tanenbaum et al., 
2010; Bolhy et al., 2011). On the basis of the 
loss of perinuclear dynein we observed in 
hASUN-siRNA HeLa cells at prophase, we 
predicted that nucleus–centrosome cou-
pling defects would ensue. We used the hu-
man osteosarcoma U2OS cell line for these 
FIGURE 1: mASUN partially rescues spermatogenesis defects of Drosophila asun mutants. 
(A) Anti-CHY immunoblot of testes extracts from Drosophila wild-type (WT) males with or 
without germline expression of CHY-dASUN or CHY-mASUN; a relatively low expression 
level of a fusion protein of the expected size was observed for the latter. Tubulin was used 
as loading control. (B, C) Male fertility assays. “Rescue” indicates asun males with germline 
expression of CHY-mASUN, which increased the percentage of asun males producing 
progeny (B) and the average number of progeny per fertile male (C). (D–H) Germline 
CHY-mASUN expression restored perinuclear dynein in asun primary spermatocytes and 
spermatids. (D–F) Representative G2 spermatocytes stained for DHC and DNA are shown 
(D) with bar graphs depicting percentages of spermatocytes exhibiting perinuclear 
DHC (E) and average ratios of perinuclear to diffusely cytoplasmic DHC signal intensities (F). 
(G, H) Representative immature spermatids stained for DHC and DNA are shown (G) with 
bar graph depicting percentages of spermatids exhibiting perinuclear DHC (H). 
(I, J) Germline CHY-mASUN expression restored nucleus–centrosome coupling in asun 
primary spermatocytes. (I) Prophase I spermatocytes stained for β-tubulin and DNA. 
(J) Quantification of nucleus–centrosome coupling in prophase spermatocytes. **p < 0.0001, 
*p < 0.001. Scale bars, 50 μm.
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fidelity of subsequent mitotic events 
(Splinter et al., 2010; Tanenbaum et al., 
2010). If centrosomes are improperly cou-
pled to the NE at prophase, their separa-
tion to prospective poles before NEBD may 
be random, leaving room for errors in 
mitotic spindle assembly and chromosome 
segregation (Tanenbaum et al., 2010). 
Given our identification of a role for hASUN 
in dynein recruitment and centrosomal teth-
ering to the NE at mitotic prophase, we as-
sessed whether loss of hASUN in HeLa cells 
would induce downstream mitotic defects.
We tested the capacity of HeLa cells to 
form normal bipolar spindles after hASUN 
knockdown. To enrich for cells with mitotic 
spindles, we treated siRNA-transfected 
cells with a Cdk1 inhibitor (RO-3306) and 
released them into media containing a pro-
teasome inhibitor (Vassilev, 2006). We 
found that ∼35% of hASUN-siRNA meta-
phase cells exhibited mitotic spindle de-
fects, including scattered chromosomes 
and broadened spindles; these pheno-
types, which were seen in ∼9% of NT-siRNA 
metaphase cells, were fully rescued by 
CHY-dASUN expression (Figure 4, A–C and 
G). Similarly, in the absence of drug treat-
ment, we observed a nearly fourfold higher 
incidence of spindle defects in hASUN-
siRNA metaphase cells compared with con-
trol cells (Supplemental Figure S4A). We 
found that hASUN-siRNA cells concomi-
tantly exhibited a ∼50% increase in the 
mitotic index (12.1 vs. 8.1% for control 
cells), suggesting that loss of hASUN can 
lead to a mild delay in progression through 
mitosis (Supplemental Figure S4B).
We also assessed DNA content after 
loss of hASUN by microscopic examination 
of DNA-stained HeLa cells. We previously 
noted the presence of multinucleated HeLa 
cells after hASUN down-regulation; this 
phenotype, however, was not quantified or 
further characterized (Lee et al., 2005). To quantify the multinucle-
ation phenotype, we scored cells only if they contained more than 
two nuclei due to the common occurrence of binucleation in 
control HeLa cells. We found that ∼37% of hASUN-siRNA cells 
were multinucleated (typically containing three nuclei), compared 
with ∼9% of control cells, and this defect was fully rescued by 
CHY-dASUN expression (Figure 4, D–F and H). Furthermore, loss 
of hASUN caused an even more severe degree of multinucleation: 
∼6% of hASUN-siRNA cells contained more than four nuclei, which
we never observed in control cells (12 of 177 and 0 of 165 cells, 
respectively; Figure 4F). Using a second independent siRNA 
sequence, we also observed multi nucleation of HeLa cells after 
hASUN knockdown (Supplemental Figure S1E).
A common cause of multinucleation involves successful comple-
tion of chromosome segregation during mitosis, followed by a lack 
of cell division; increased centriole number is another indicator of 
cytokinesis failure (Godin and Humbert, 2011; Lacroix and Maddox, 
2012). In addition to multinucleation, we observed supernumerary 
studies. Owing to the relatively decreased density of the microtubule 
network in these cells, centrosomes undergo a more dramatic migra-
tion from the nucleus to the cortex at interphase and back to the 
nuclear surface at G2/M (Akhmanova and Hammer, 2010).
We found that ∼19% of hASUN-siRNA U2OS cells exhibited loss 
of coupling of one or both centrosomes to the NE at prophase, com-
pared with a baseline rate of ∼4% in control cells (Figure 3, A–E, and 
Supplemental Figure S1A). We measured an average distance of 
∼8 μm between the nucleus and centrosomes in hASUN-siRNA cells,
compared with a baseline distance of ∼3 μm in control cells (Figure 
3F). These data indicate that hASUN is required for normal linkage of 
centrosomes to the NE during prophase, and they further demon-
strate evolutionary conservation of function of ASUN homologues.
hASUN is required for proper spindle formation 
and fidelity of mitotic divisions
The evidence suggests that the perinuclear pool of dynein mediat-
ing nucleus–centrosome coupling at G2/M is also required for the 
FIGURE 2: hASUN is required for localization of dynein to the NE at mitotic entry. (A–C) HeLa 
cells were transfected with NT siRNA, hASUN siRNA, or hASUN siRNA plus a CHY-dASUN 
expression construct (“Rescue”). After nocodazole treatment, cells were fixed and stained for 
DIC, PH3, and DNA. Both the percentage of prophase cells with perinuclear DIC and the ratio of 
perinuclear to cytoplasmic DIC signal intensity were reduced by hASUN knockdown (compare B 
to A); CHY-dASUN expression rescued these defects (C). Note that CHY-dASUN cannot be 
visualized in C because its signal intensity was much weaker than that of PH3 (visualized with 
Cy3-conjugated secondary antibodies). (D–F) Quantification of dynein localization defects in 
hASUN-siRNA cells. Representative line scans (corresponding to blue, black, and red lines in 
A– C, respectively) of DIC intensity centered at the NE (marked by arrows) are shown below 
each micrograph with average peak intensities plotted in F. C, cytoplasmic; IN, intranuclear. 
*p < 0.0001. Scale bars, 20 μm.
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tent with a possible role for hAUN in mitotic 
events downstream of nucleus–centrosome 
coupling: proper spindle formation and ex-
ecution of cytokinesis.
hASUN is required for dynein 
anchoring to the NE at prophase in 
nontransformed cells
To confirm that the observed loss of NE-
bound dynein after knockdown of hASUN 
is independent of the transformed nature 
of HeLa cells, we performed a similar 
analysis using human retinal pigment epi-
thelial (RPE) cells, which are nontrans-
formed. We detected strong perinuclear 
localization of dynein after nocodazole 
treatment in 59% of control RPE cells; in 
contrast, we observed this staining pat-
tern in only 12% of cells after knockdown 
of hASUN (Figure 5, A–D). We observed 
an increased frequency of multinucleation 
in RPE cells after hASUN knockdown, pos-
sibly due to downstream mitotic defects 
caused by loss of perinuclear dynein: 
∼35% of hASUN-siRNA cells had more
than one nucleus, compared with ∼10% of control cells (Figure 5, 
E–G). These data suggest that the role of hASUN in regulating 
recruitment of dynein to the nuclear surface is not limited to 
transformed cells.
hASUN is cytoplasmic at G2/M
We previously reported that a tagged form of dASUN exhibited a 
meiotic stage–specific localization pattern in Drosophila spermato-
cytes: intranuclear in early G2 and appearing in the cytoplasm in late 
G2, coincident with dynein recruitment to the nuclear surface 
(Anderson et al., 2009). Tagged versions of dASUN and hASUN co-
expressed in HeLa cells exhibited similar localization patterns during 
mitosis (Anderson et al., 2009).
To further understand the mechanism by which ASUN controls 
dynein localization at G2/M, we sought to determine the localiza-
tion pattern of the endogenous protein in cultured human cells dur-
ing prophase. Using C-hASUN Ab for immunostaining of HeLa cells, 
we found endogenous hASUN to be localized to the cytoplasm in 
∼98% of prophase cells (85 of 87 cells; Figure 6A). We used the fol-
lowing criteria to identify prophase cells: phosphorylated histone 
(PH3)-positive DNA and intact NE.
To further confirm that this localization pattern reflects that of 
endogenous hASUN, we transfected HeLa cells with either control 
or hASUN siRNA, followed by immunostaining with C-hASUN Ab. 
The hASUN signal present in control cells was lost in hASUN-siRNA 
cells, demonstrating specificity (Figure 6, B and C). We confirmed 
these results with a second hASUN-siRNA sequence (Supplemental 
Figure S1C). We found that Myc-tagged mASUN transiently ex-
pressed in HeLa cells tightly colocalized with endogenous hASUN, 
indicating a conserved localization pattern of the human and mouse 
homologues, which are ∼95% identical at the amino acid level 
(Figure 6D).
Two dynein-recruiting proteins, BICD2 and CENP-F, have re-
cently been reported to bind NPCs at prophase via direct interac-
tions with the NPC components RanBP2 and Nup133, respectively 
(Splinter et al., 2010; Bolhy et al., 2011). Owing to their similar 
functions in recruiting dynein complexes to the NE, we considered 
centrosomes in ∼24% of prophase cells after hASUN knockdown, 
compared with ∼5% of control cells; this defect was corrected by 
expression of CHY-dASUN (Figure 3, D and G). Our data are consis-
FIGURE 3: hASUN is required for recruitment of centrosomes to the NE at mitotic entry. 
(A–D) U2OS cells were transfected with NT or hASUN siRNA, fixed, and stained for pericentrin 
(centrosomal marker), PH3, and DNA. hASUN knockdown yielded an increased percentage of 
prophase cells with loss of coupling of one (B) or both (C) centrosomes to the NE compared 
with control cells (A) as well as supernumerary centrosomes (arrows in D). (E–G) Quantification 
of centrosome defects in hASUN-siRNA cells. Expression of CHY-dASUN in hASUN-siRNA cells 
(“Rescue”) corrected these defects. ***p < 0.0001, **p < 0.005, *p < 0.02. Scale bar, 20 μm.
FIGURE 4: Loss of hASUN causes mitotic spindle defects and 
multinucleation. (A–F) HeLa cells were transfected with NT or 
hASUN siRNA, fixed, and stained for tubulin and DNA. (A–C) Mitotic 
spindles. To enrich for mitotic spindles, cells were arrested in 
metaphase before fixation. NT-siRNA cells had bipolar spindles with 
tight alignment of chromosomes at metaphase (A). hASUN-siRNA 
cells had an increased percentage of abnormal spindles with defects 
such as scattering of chromosomes along spindles (B) and 
broadened spindles (C). (D–F) Interphase cells. An increased 
percentage of hASUN-siRNA cells (E, F) were multinucleated (more 
than two nuclei) compared with NT-siRNA cells (D). We occasionally 
observed a more severe degree of multinucleation (more than four 
nuclei) in hASUN-siRNA cells (F). (G, H) Quantification of spindle 
morphology defects (G) and multinucleation (H) in hASUN-siRNA 
cells. Expression of CHY-dASUN in hASUN-siRNA cells (“Rescue”) 
corrected these defects. * p < 0.0001. Scale bars, 20 μm.
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precipitation of human LIS1 and Drosophila 
ASUN proteins, further indicating evolution-
ary conservation of this interaction (Supple-
mental Figure S6). In further support of 
these data, we found that CHY-LIS1 colocal-
izes with endogenous hASUN in the peri-
nuclear region of ∼70% of nocodazole-
treated HeLa cells (Figure 7, C and E). Line 
scans confirmed that hASUN and CHY-LIS1 
have overlapping staining patterns, al-
though tight colocalization was not consis-
tently observed (Figure 7D). Despite the in-
teraction observed between ASUN and 
LIS1, we did not detect coimmunoprecipita-
tion of ASUN and dynein–dynactin subunits 
(Supplemental Figure S7A).
To further explore the nature of the re-
lationship between ASUN and LIS1, we 
tested whether hASUN is required for 
perinuclear enrichment of LIS1 at G2/M. 
After nocodazole treatment, perinuclear 
CHY-LIS1 was detected in <25% of cells 
with loss of hASUN, compared with ∼80% 
of control cells (Figure 7, F and G). Immu-
noblot analysis revealed no change in 
CHY-LIS1 levels after hASUN knockdown, 
suggesting that ASUN is not required to 
maintain steady-state levels of LIS1 within 
cells (Figure 7H). These data are consis-
tent with a model in which hASUN acts via 
LIS1 to recruit dynein complexes to the 
NE at prophase. The localization of ASUN 
at G2/M, however, was not dependent on 
LIS1 (Figure 7, I and J, and Supplemental 
Figure S8).
hASUN, BICD2, and CENP-F localize 
independently of each other 
at prophase
Two pathways, BICD2–RanBP2 and NudE/
EL–CENP-F–Nup133, have been described 
that appear to operate independently to 
anchor dynein to the NE and facilitate 
proper positioning of centrosomes at the 
G2/M transition (Splinter et al., 2010; Bolhy et al., 2011). We con-
firmed that BICD2 and CENP-F colocalize to the NE of prophase 
HeLa cells as we would predict on the basis of independent reports 
of their localization patterns (Figure 8A; Splinter et al., 2010; Bolhy 
et al., 2011). As expected from our demonstration that the hASUN 
immunostaining pattern excludes the NE, we observed essentially 
no overlap of endogenous hASUN and GFP-BICD2 signals (Figure 
8B). Furthermore, we observed no coimmunoprecipitation from 
cell lysates of ASUN with either BICD2 or CENP-F (Supplemental 
Figure S7, B and C).
We asked whether knockdown of hASUN, BICD2, or CENP-F in 
HeLa cells would globally disrupt the structure of NPCs in such a 
way that docking of dynein motors to the nuclear surface might be 
blocked. In hASUN-siRNA cells exhibiting loss of dynein at the NE, 
nuclear pore morphology as assessed by immunostaining for an 
NPC marker resembled that of control cells; similarly, depletion of 
BICD2 or CENP-F caused loss of dynein at the NE without grossly 
disrupting NPCs (Figure 8C and Supplemental Figure S9).
the possibility that hASUN might also bind to NPCs at prophase. 
We observed minimal colocalization, however, of endogenous 
hASUN and a marker for NPCs in costained cells (Figure 6E).
hASUN interacts with the dynein adaptor LIS1
We recently demonstrated a strong genetic interaction between 
Drosophila asun and Lis-1, coimmunoprecipitation and colocaliza-
tion of dASUN and Drosophila LIS-1 proteins in cultured cells, and 
dependence of LIS-1 localization on dASUN during spermato-
genesis (Sitaram et al., 2012). On the basis of these findings, we 
considered the possibility that this interaction might be conserved 
between the mammalian homologues.
We showed coimmunoprecipitation of Myc-tagged mASUN and 
hemagglutinin (HA)-tagged human LIS1 after their coexpression in 
HEK293 cells, suggesting that these proteins exist within a complex; 
the capacity of these two proteins to coimmunoprecipitate was 
maintained when the affinity tags were switched (Figure 7, A and B, 
and Supplemental Figure S5). We also demonstrated coimmuno-
FIGURE 5: Loss of hASUN causes reduction of perinuclear dynein and multinucleation in 
nontransformed cells. (A–C) Dynein localization defects in hASUN-siRNA RPE cells. RPE cells were 
transfected with NT or hASUN siRNA. After nocodazole treatment, cells were fixed and stained 
for DIC, PH3, and DNA. The percentage of prophase cells with perinuclear DIC was reduced after 
hASUN knockdown (B) compared with control cells (A; quantified in C). (D) Immunoblotting of 
lysates confirmed down-regulation of hASUN. Tubulin was used as loading control. (E–G) A higher 
percentage of hASUN-siRNA RPE cells (F) were multinucleated (more than one nucleus per cell) 
compared with control cells (E; quantified in G). *p < 0.0005. Scale bars, 20 μm.
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properly localize BICD2 or CENP-F. We observed no alteration in 
the localization patterns of BICD2 or CENP-F in prophase HeLa 
cells, providing further confirmation that functional dynein motors 
are not reciprocally required to recruit these proteins to the NE 
(Supplemental Figure S10).
hASUN, BICD2, and CENP-F cooperatively regulate dynein 
recruitment to the NE at prophase
We investigated possible cross-talk between hASUN, BICD2, and 
CENP-F in their regulation of dynein recruitment to the NE and nu-
cleus–centrosome coupling at prophase. After knockdown of these 
three proteins, either individually or in combination, we assessed 
perinuclear dynein localization in nocodazole-treated HeLa cells 
and average nucleus–centrosome distances in U2OS cells (Figure 8, 
E and F). We did not observe additive or synergistic effects on these 
phenotypes in the double- or triple-knockdown cells. Bolhy et al. 
(2011) reported similar findings for the average nucleus–centrosome 
distances in U2OS cells with double knockdown of BICD2 and 
CENP-F. These observations suggest that hASUN, BICD2, and 
CENP-F operate via distinct molecular mechanisms but converge to 
regulate dynein localization and centrosomal tethering to the NE in 
prophase.
DISCUSSION
Proposed mechanism for hASUN-mediated recruitment 
of dynein to the NE during mitotic prophase
Two recent studies advanced our understanding of the mechanisms 
underlying the recruitment of dynein motors to the NE of cultured 
human cells at the onset of mitosis (Splinter et al., 2010; Bolhy et al., 
2011). BICD2–RanBP2 and NudE/EL–CENP-F–Nup133 were identi-
fied as separate cassettes of proteins that provide sites to anchor 
dynein to the NE. We report here our findings that hASUN is a third 
protein required for this critical event in cultured cells. In contrast to 
the BICD2 and CENP-F cassettes, however, which can bind directly 
to components of dynein complexes, our data suggest that hASUN 
regulates the localization of dynein in an indirect manner via LIS1, an 
accessory protein of the motor. Another distinction is that BICD2 
and CENP-F localize to NPCs within the NE, whereas hASUN local-
izes to the cytoplasm with exclusion of the NE.
We propose a model in which hASUN works in a manner distinct 
from that of BICD2 and CENP-F to mediate dynein recruitment to 
the NE at G2/M, a critical event required for nucleus–centrosome 
coupling before NEBD and faithful execution of mitotic divisions. 
Our data lead us to hypothesize that cytoplasmic hASUN transiently 
interacts with LIS1, which is bound to dynein heavy chains, to pro-
mote the enrichment and/or proper orientation of dynein com-
plexes in the vicinity of the nuclear surface at G2/M. The BICD2–
RanBP2 and NudE/EL–CENP-F–Nup133 cassettes then capture and 
stably anchor dynein complexes to NPCs. In the absence of hASUN, 
BICD2 and CENP-F are not sufficient to carry out the early steps in 
the process of dynein recruitment to the NE at G2/M; similarly, 
when either BICD2 or CENP-F is depleted from cells, hASUN can 
promote the enrichment/orientation of dynein complexes near the 
nuclear surface, but the complexes do not become stably anchored 
to the NE.
Why are so many factors required to carry out this important cel-
lular process? A network of proteins might be required to move and 
properly orient dynein complexes at G2/M, given their large size 
and multisubunit composition. NudE, in addition to directly interact-
ing with dynein motors, facilitates the interaction between LIS1 
and dynein, suggesting that both ASUN and the NudE/
EL–CENP-F–Nup133 cassette might converge on dynein through 
We next assessed whether hASUN, BICD2, or CENP-F is local-
ized within HeLa cells in an interdependent manner (Figure 8D). 
We observed no change in the cytoplasmic localization pattern of 
hASUN after depletion of BICD2 or CENP-F. Conversely, BICD2 
and CENP-F localized normally to the NE in hASUN-siRNA cells. 
We confirmed the previous observations of Bolhy et al. (2011) 
that BICD2 and CENP-F are not reciprocally required for their 
anchoring to the NE. Taken together, these data suggest that 
hASUN, BICD2, and CENP-F localize independently of each other 
at G2/M.
It was previously reported that inhibition of dynein function (via 
dynein antibody injection or dynactin subunit overexpression) does 
not disrupt the recruitment of BICD2 or CENP-F to the NE at G2/M 
(Splinter et al., 2010; Bolhy et al., 2011). We used siRNA-mediated 
knockdown to test whether the dynein adaptor LIS1 is required to 
FIGURE 6: Subcellular localization of ASUN. HeLa cells were 
immunostained for endogenous hASUN using antipeptide antibodies 
(C-hASUN Ab). (A) PH3 costaining revealed endogenous hASUN 
localizes to the cytoplasm of prophase cells. (B, C) The hASUN signal 
of NT-siRNA cells (B) was lost in hASUN-siRNA cells (C), thereby 
demonstrating specificity. (D) Colocalization of endogenous hASUN 
and transiently expressed Myc-tagged mASUN. (E) Costaining of 
endogenous hASUN revealed no significant overlap with the NPC 
marker Mab414. Scale bars, 20 μm.
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logue plays a role during embryonic devel-
opment (Lee et al., 2005). Down-regulation 
of ASUN in Xenopus embryos via morpholino 
oligonucleotide injection resulted in disrup-
tion of gastrulation and polyploidy; the lat-
ter phenotype suggested that ASUN might 
regulate the mitotic cell cycles of early blas-
tomeres during vertebrate embryogenesis. 
We also showed conservation of function 
between Xenopus and human ASUN homo-
logues by restoring proper developmental 
progression in Xenopus ASUN morphants 
via coinjection of mRNA encoding hASUN.
Drosophila asun mutants and HeLa 
cells depleted of ASUN exhibit strikingly 
similar disruptions of male meiosis and mi-
tosis, respectively. These shared pheno-
types underscore the likelihood that the 
transformed nature of the HeLa cell line is 
not responsible for the defects we ob-
served. The reduction of dynein localized 
to the NE of prophase RPE cells after 
hASUN knockdown as reported here further 
validates this conclusion. One difference in 
the meiotic versus mitotic phenotypes is 
that asun spermatocytes exhibit delayed 
progression through meiosis, as evidenced 
by a large increase in the prophase fraction, 
whereas we report here that hASUN-siRNA 
HeLa cells have only a slightly increased mi-
totic index compared with control cells 
(Anderson et al., 2009). We speculate that 
dynein localized to the nuclear surface 
might play a more important role in facilitat-
ing nuclear envelope breakdown at the end 
of prophase in Drosophila spermatocytes 
than in HeLa cells.
In contrast to Drosophila asun, which is 
expressed exclusively in germline tissues, 
mouse ASUN transcripts have been de-
tected in all tissues, both somatic and ger-
mline, surveyed in a study by another group 
(Stebbings et al., 1998; Bourdon et al., 
2002). The data we present here indicate 
that hASUN plays an important role in 
human somatic cells during mitosis. The hu-
man ASUN gene is located within a ge-
nomic region that is amplified in testicular 
seminomas, raising the possibility that 
ASUN may also regulate division of male germline cells in verte-
brates as it does in Drosophila (Bourdon et al., 2002).
Why might ASUN expression be limited to germline cells in flies? 
The absence of dASUN expression within somatic cells may be re-
lated to the lack of an absolute requirement for centrosomes during 
most life cycle stages of Drosophila. Centrioles, although important 
for the formation of centrosomes (as well as cilia and flagella), play 
nonessential roles in development from an embryo to an adult fly, 
with the exception of early embryogenesis (Basto et al., 2006; Stevens 
et al., 2007). The process of spermatogenesis in adult male flies is also 
exceptional in that centrioles are required to form the cilium of sper-
matocytes and the axoneme of spermatids (Bettencourt-Dias et al., 
2005). Centrioles within G2 spermatocytes undergo major changes in 
LIS1 at the onset of mitosis (McKenney et al., 2010). It will be inter-
esting to test in future experiments whether ASUN plays a role in 
promoting the interaction between CENP-F tethered to the NE and 
cytoplasmic NudE/EL–LIS1–dynein complexes at G2/M, a possible 
mechanism of action that would be consistent with our model.
Meiotic versus mitotic roles of ASUN
Whereas ASUN remained largely uncharacterized in human cells be-
fore this study, we previously showed that it has cell cycle and devel-
opmental roles in other organisms. In Drosophila, dASUN regulates 
dynein localization and centrosomal tethering to the nucleus during 
spermatogenesis, and it is required for male fertility (Anderson et al., 
2009). In Xenopus, we previously reported that the ASUN homo-
FIGURE 7: Interactions between ASUN and LIS1. (A, B) Coimmunoprecipitation experiments. 
(A, B) Lysates of HEK293 cells coexpressing the indicated tagged versions of mASUN and 
human LIS1 were used for Myc immunoprecipitation. Immunoblots of whole-cell lysates (WCL) 
and Myc immunoprecipitates (IP) were probed with HA and Myc antibodies. Representative 
blots are shown. (C–E) Overlapping localizations of hASUN and CHY-LIS1. Transfected HeLa cells 
expressing CHY-LIS1 were treated with nocodazole, fixed, and stained for hASUN. 
(C) Representative cell with partial overlap of hASUN and CHY-LIS1 in the perinuclear region is 
shown. (D) Line scans centered at the NE (corresponding to blue and red lines in D) confirmed 
colocalization of hASUN and CHY-LIS1 in some but not all areas. C, cytoplasmic; IN, intranuclear. 
(E) Quantification of overlap of perinuclear CHY-LIS1 (but not CHY) and hASUN in a majority of 
transfected cells. (F–H) Perinuclear localization of CHY-LIS1 is hASUN dependent. HeLa cells 
cotransfected with NT or hASUN siRNA plus CHY-LIS1 expression construct were treated with 
nocodazole and fixed. (F) Representative hASUN-siRNA cell with loss of perinuclear CHY-LIS1 
compared with control. (G) Quantification of the loss of perinuclear CHY-LIS1 after hASUN 
knockdown. (H) Immunoblotting revealed no change in steady-state levels of CHY-LIS1 protein 
after hASUN knockdown. Tubulin was used as loading control. (I, J) ASUN localization at G2/M is 
independent of LIS1. HeLa cells transfected with NT or LIS1 siRNA were stained for PH3 and 
ASUN. (I) NT-siRNA and LIS1-siRNA cells showed comparable ASUN staining patterns. 
(J) Quantification of cytoplasmic ASUN localization in PH3+ cells after LIS1 knockdown. 
*p < 0.0001. Scale bars, 20 μm.
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surface of G2 spermatocytes; our database searches, however, re-
vealed no CENP-F homologues in flies.
Evolved mechanisms for dynein regulation 
in multicellular organisms
Cytoplasmic dynein, most commonly studied for its roles in traffick-
ing of organelles and directed cell movement, is also required in 
their positioning, moving to the cortex during the extensive growth 
phase to elaborate a cilium and then back toward the nucleus at 
G2/M; the necessity to reestablish nucleus–centrosome coupling at 
the time of meiotic entry may impose a stringent requirement for 
dynein-localizing proteins such as ASUN in these cells (Fuller, 1993). 
Bicaudal, the Drosophila homologue of BICD2, is a potential candi-
date to cooperate with dASUN in dynein recruitment to the nuclear 
FIGURE 8: Relationship between hASUN, CENP-F, and BICD2 in recruiting dynein and centrosomes to the NE at 
mitotic entry. (A, B) HeLa cells were nocodazole treated, fixed, and immunostained as indicated. Endogenous CENP-F 
and BICD2 colocalized on the NE (A), but no colocalization was observed for GFP-BICD2 and endogenous hASUN (B). 
Higher-magnification views (micrographs on far right) of costained cells in the vicinity of the NE correspond to regions 
enclosed by yellow boxes. Line scans centered at the NE (corresponding to yellow lines in higher-magnification views) 
confirmed significant overlap of CENP-F and BICD2 signals but not hASUN and GFP-BICD2 signals. C, cytoplasmic; IN, 
intranuclear. (C–F) HeLa (C–E) or U2OS (F) cells were transfected with siRNA as indicated to down-regulate hASUN (A), 
BICD2 (B), and/or CENP-F (C). Transfected cells were nocodazole treated, fixed, and immunostained. (C) Perinuclear 
DIC was lost after hASUN, BICD2, or CENP-F knockdown without changes in the gross morphology of NPCs. (D) No 
change in hASUN, BICD2, or CENP-F localization was observed after knockdown of either of the other proteins. 
(E) Cells were immunostained for PH3, DIC, and DNA. Bar graph displays the percentage of prophase cells with 
perinuclear DIC for each knockdown condition. (F) Cells were immunostained for PH3, pericentrin, and DNA. Bar graph 
displays the mean nucleus–centrosome distance for each knockdown condition. *p < 0.0001. Scale bars, 20 μm.
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drop of phosphate-buffered saline (PBS) on a microscopic slide, and 
gently squashed under a glass coverslip after making a small inci-
sion near the stem cell hub. Formaldehyde fixation was performed 
as described previously (Gunsalus et al., 1995). Briefly, slides of 
squashed testes were snap-frozen, immersed in 4% formaldehyde 
(in PBS with 0.1% Triton X-100) for 7 min at −20°C after coverslip 
removal, and washed three times in PBS. Primary antibodies were 
used as follows: mouse anti-DHC (P1H4, 1:120; a gift from T. Hays, 
University of Minnesota, Minneapolis, MN; McGrail and Hays, 1997) 
and rat anti–α-tubulin (Mca77G, 1:300; Accurate Chemical & 
Scientific, Westbury, NY). Fixed samples were mounted in PBS with 
4′,6-diamidino-2-phenylindole (DAPI) to visualize DNA. Wide-field 
fluorescence images were obtained using an Eclipse 80i microscope 
(Nikon, Melville, NY) with Plan-Fluor 40× objective.
In experiments to determine the percentage of late G2 sperma-
tocytes or immature spermatids with perinuclear dynein or the per-
centage of prophase I spermatocytes with nucleus–centrosome 
coupling, at least 200 cells were scored per genotype; statistical 
analyses were performed using Fisher’s exact test. To quantify the 
ratios of perinuclear to diffusely cytoplasmic dynein in late G2 sper-
matocytes (testes stained for DHC), after image acquisition, the av-
erage intensity of the DHC signal within a small rectangular region 
was sampled near the nuclear surface and in the surrounding cyto-
plasm using Photoshop (Adobe, San Jose, CA). The ratio of the in-
tensities was determined. At least 30 cells from a minimum of three 
testes pairs were scored per genotype. Statistical analysis was per-
formed using an unpaired Student’s t test.
Cell culture and treatments
Cell lines were maintained at 37°C and 5% CO2 in DMEM (Life 
Technologies, Carlsbad, CA) containing 10% fetal bovine serum, 
1% l-glutamine, 100 μg/ml streptomycin, and 100 U/ml penicillin. 
U2OS and RPE cells were cultured in antibiotic-free media. Plas-
mid DNA was transfected into cells using Lipofectamine 2000 
(Invitrogen, Carlsbad, CA) or FuGENE HD (Promega, Madison, 
WI). siRNA duplexes were purchased from Dharmacon (Lafayette, 
CO). siGENOME NT siRNA#5 was used as negative control. siRNA 
sequences were designed to target human ASUN at its 5′-end 
(#1: 5′-GGAAA UAGAGG ACGAAUAAUU-3′) or its 3′-end (#2: 
5′-CAGAAGAGGAAGAACGAAA-3′; LIS1 (5′-GAGTTGTGCTGAT-
GACAAG-3′; Shu et al., 2004); CENP-F (5′-CAGAATCTTAGTAGT-
CAAGTA-3′; Bolhy et al., 2011); or BICD2 (5′-GGUGGACUAU-
GAGGCUAUC-3′; Splinter et al., 2010). hASUN siRNA#1 was used 
for all experiments in this study unless otherwise indicated. Cells 
were transfected with siRNA duplexes using DharmaFECT 1 trans-
fection reagent (Dharmacon) in two successive rounds and ana-
lyzed 3 d later. Lipofectamine 2000 transfection reagent was used 
for cotransfection of cells with siRNA and DNA constructs. Where 
indicated, cells were incubated in 5 μg/ml (16.6 μM) nocodazole 
(Sigma-Aldrich, St. Louis, MO) for 3 h before fixation to enhance 
perinuclear localization of dynein. For metaphase arrest, cells were 
incubated for 16 h in 10 μM RO-3306 (Cdk1 inhibitor; Enzo Life 
Sciences, Plymouth, PA), followed by incubation for 3 h in 10 μM 
MG-132 (proteasome inhibitor; Calbiochem, La Jolla, CA). Approx-
imately 80% of cells were arrested in metaphase under these 
conditions.
Fixation, immunostaining, and microscopy
Cells were fixed in either methanol (5 min at −20°C, followed by 
washing with Tris-buffered saline [TBS] plus 0.01% Triton X-100) or 
4% formaldehyde (20 min at room temperature, followed by 20-min 
permeabilization step with TBS plus 0.05% Triton X-100). Cells were 
multicellular organisms for coordination of mitotic entry and exit 
(Dujardin et al., 2003). Specifically, dynein promotes the coupling of 
centrosomes to the NE, has been hypothesized to assist in NEBD, 
and functions along the mitotic spindle to facilitate chromosome 
segregation at anaphase (Lippincott-Schwartz, 2002; Dujardin et al., 
2003; Tanenbaum et al., 2010). In contrast, only one role for dynein 
has been identified in budding yeast: proper positioning of the spin-
dle during mitosis (Stuchell-Brereton et al., 2011).
It is interesting to note that none of the three proteins needed 
for localization of dynein to the NE of prophase HeLa cells (BICD2 
and CENP-F as previously reported; hASUN as reported herein) 
have predicted homologues in either budding or fission yeast. The 
centrosome-like structure in yeast, known as the spindle pole body, 
is embedded into the nuclear surface throughout interphase and 
mitosis in budding yeast (Jaspersen and Winey, 2004). Similarly, in 
fission yeast, the spindle pole body is tethered to the nuclear sur-
face throughout interphase and will embed at mitosis (Lim et al., 
2009). In both cases, dynein is not required for the process of spin-
dle pole body–nucleus embedding (Jaspersen and Winey, 2004; 
Lim et al., 2009). Thus metazoans appear to have evolved a finely 
tuned mechanism for regulating the localization of dynein com-
plexes at the onset of mitosis, with at least three proteins required 
to execute the recruitment and docking of these motors to the NE.
MATERIALS AND METHODS
Drosophila experiments
Flies were maintained at 25°C using standard techniques 
(Greenspan, 2004). y w was obtained from the Bloomington 
Drosophila Stock Center (Indiana University, Bloomington, IN) and 
used as the “wild-type” stock. The asunf02815 allele (Exelixis Collec-
tion, Harvard Medical School, Boston, MA) and transgenic line 
with male germline–specific expression of CHY-dASUN were previ-
ously described (Anderson et al., 2009). cDNA encoding mASUN 
(clone details provided later) with an N-terminal CHY tag was sub-
cloned into vector tv3 (a gift from J. Brill, Hospital for Sick Children, 
Toronto, Canada) for expression of CHY-tagged mASUN under 
control of the testes-specific β2-Tubulin promoter (Wong et al., 
2005). Transgenic lines were generated by P-element–mediated 
transformation via embryo injection (Rubin and Spradling, 1982). A 
single transgene was mapped to the X chromosome and crossed 
into the asunf02815 background using standard genetic crosses.
To test male fertility, individual adult males (2 d old) were placed 
in vials with five wild-type females (2 d old) and allowed to mate for 
5 d. The percentage of males producing adult progeny and the av-
erage number of live adult progeny produced per fertile male were 
scored (≥10 males tested per genotype). Statistical analyses were 
performed using Fisher’s exact test (percentage of males producing 
progeny) or an unpaired Student’s t test (average number of prog-
eny per fertile male).
Protein extracts were prepared by homogenizing dissected tes-
tes from newly eclosed males in SDS sample buffer. The equivalent 
of eight testes pairs was loaded per lane. After SDS–PAGE, proteins 
were transferred to nitrocellulose for immunoblotting using stan-
dard techniques. Primary antibodies were used as follows: mCherry 
(1:500, Clontech, Mountain View, CA) and mouse anti–β-tubulin (E7, 
1:5000; Developmental Studies Hybridoma Bank, University of Iowa, 
Iowa City, IA). Horseradish peroxidase (HRP)–conjugated secondary 
antibodies and chemiluminescence were used to detect primary 
antibodies.
Live testes cells were prepared for examination by fluorescence 
microscopy as described previously (Kemphues et al., 1980). Briefly, 
testes were dissected from newly eclosed adult males, placed in a 
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amino acid residues of hASUN: IIKDSPDSPEPPNKKPLVEC (619–637) 
and CSVNNRAELYQHLKEENG (678–694), respectively. Exogenous 
cysteine residues were added for conjugation and affinity purifica-
tion purposes. After exsanguination, enzyme-linked immunosorbent 
assay–positive antisera were antigen-affinity purified to a final con-
centration of ∼1 mg/ml.
Immunoblotting and coimmunoprecipitation
Lysates were prepared using nondenaturing lysis buffer (50 mM 
Tris-Cl, pH 7.4, 300 mM NaCl, 5 mM EDTA, 1% Triton X-100). After 
SDS–PAGE, proteins were transferred to nitrocellulose for immuno-
blotting using standard techniques. Immunoblotting was performed 
using the following primary antibodies: c-Myc (9E10, 1:1000), HA 
(CAS 12, 1:1000), β-tubulin (clone E7, 1:1000; Developmental Stud-
ies Hybridoma Bank), mCherry (1:500; Clontech), CENP-F (clone 
14C10 1D8, 1:500; Abcam), DIC (clone 74.1, 1:500; Abcam), DMN 
(clone 25, 1:250; BD Biosciences, San Diego, CA), M-hASUN (1:300), 
and C-hASUN (1:500). BICD2 antibody (1:2500) was a gift from A. 
Akhmanova (Hoogenraad et al., 2001). HRP-conjugated secondary 
antibodies (1:5000) and chemiluminescence were used to detect 
primary antibodies. For coimmunoprecipitation experiments, anti–
c-Myc agarose beads (40 μl; Sigma-Aldrich) were incubated with 
lysates of transfected HEK293 cells (500 μg) for 1 h at 4°C with shak-
ing and washed 3× in lysis buffer. Samples were boiled in 6× sample 
buffer, resolved by SDS–PAGE, and analyzed by immunoblotting.
Sucrose density gradients
HeLa cells were transfected with either NT or hASUN siRNA. At 3 d 
posttransfection, lysates were prepared using nondenaturing lysis 
buffer (as described earlier). Lysates were layered on top of sucrose 
gradients (5 ml) with equal volumes of 30, 20, 10, and 5% sucrose in 
PBS (137 mM NaCl, 7 mM Na2HPO4, and 3 mM NaH2PO4, pH 7.2). 
Samples were centrifuged at 46,000 rpm for 16 h in a swinging-
bucket rotor (SW55ti; Beckman Coulter, Brea, CA). After centrifuga-
tion, fractions (167 μl) were collected and analyzed by immunoblot-
ting. Molecular weight standards were obtained from Bio-Rad 
(Hercules, CA).
blocked in TBS plus 0.01% Triton X-100 and 0.02% BSA before im-
munostaining. Primary antibodies were used as follows: C-hASUN 
(1:500), PH3 (Mitosis Marker, 1:1000, Millipore, Billerica, MA; or 
1:2000, Abcam, Cambridge, MA), DIC (clone 74.1, 1:500; Abcam), 
pericentrin centriolar marker (clone 28144, 1:2000; Abcam), c-Myc 
(9E10, 1:1000), β-tubulin (clone E7, 1:1000; Developmental Studies 
Hybridoma Bank), CENP-F (clone 14C10 1D8, 1:200; Abcam), BICD2 
(1:300; a gift from A. Akhmanova, Erasmus Medical Center, Rotter-
dam, Netherlands), and NPC marker (Mab414, 1:1000; Abcam). 
Appropriate secondary antibodies conjugated to Alexa Fluor 488 or 
Cy3 were used (1:1000; Invitrogen). Cells were mounted in ProLong 
Gold Antifade Reagent with DAPI (Invitrogen).
Wide-field fluorescence images were obtained using an Eclipse 
80i microscope (Nikon) with Plano-Apo 100× objective. Confocal 
stacks were taken by a Yokogawa QLC-100/CSU-10 spinning disk 
head (Visitec assembled by Vashaw [Norcross, GA]) attached to a 
Nikon TE2000E microscope using a CFI PLAN APO VC 100× oil 
lens/numerical aperture 1.4, with or without 1.5× intermediate mag-
nification, and a back-illuminated Cascade 512B electron-multiply-
ing charge-coupled device camera (Photometrics, Tucson, AZ) driven 
by IPLab software (Scanalytics, Rockville, MD). A krypton–argon laser 
(75 mW 488/568; Melles Griot, Albuquerque, NM) with acousto-
optic tunable filters was used for two-color excitation. Custom dou-
ble dichroic mirror and filters (Chroma, Bellows Falls, VT) in a filter 
wheel (Ludl, Hawthorne, NY) were used in the emission light path. 
The Z-steps (0.2 μm) were driven by a Nikon built-in Z motor.
Line-scan analyses were performed using ImageJ (National 
Institutes of Health, Bethesda, MD). Ten representative cells were 
measured per condition; for each cell, 12 line scans distributed 
equally around the nuclear circumference were obtained. Lines 
scans presented within figures are 100 pixels in length and are 
oriented with the cytoplasmic end of each line to the left and the 
intranuclear end of each line to the right. To quantify the ratios of 
perinuclear to diffusely cytoplasmic DIC in stained HeLa cells, we 
sampled the average intensity of the DIC signal within a small rect-
angular region near the nuclear surface and in the surrounding cyto-
plasm using ImageJ. The ratio of the intensities was determined. 
At least 30 cells were scored per condition.
Statistical analyses of experiments reported here were performed 
using Student’s unpaired t test unless otherwise noted. Error bars 
indicate SEM for all bar graphs. All experiments were performed a 
minimum of three times, with at least 100 cells scored per condition 
unless otherwise noted.
DNA constructs
cDNA clone LD33046 encoding ASUN was obtained from the 
Drosophila Gene Collection. IMAGE cDNA clones encoding 
mASUN (#4459471) and human LIS1 (#5786560) were obtained 
from the American Type Culture Collection (Manassas, VA). 
Constructs for expression of the following N-terminally tagged pro-
teins were generated by subcloning into vector pCS2: HA- and 
CHY-dASUN; HA- and Myc-mASUN; and HA-, Myc-, and CHY-LIS1. 
The HA-LIS1 expression construct was a gift from Deanna Smith 
(University of South Carolina Biological Sciences, Columbia SC). 
The GFP-BICD2 expression construct was a gift from A. Akhmanova 
(Hoogenraad et al., 2001). Mobyle@Pasteur, version 1.0.4, was used 
to determine the percentage identities and similarities between 
ASUN proteins from different species.
Anti-ASUN antibody production
Two rabbit polyclonal antibodies (M-hASUN Ab and C-hASUN Ab) 
were raised using synthetic peptides corresponding to the following 
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Palmoplantar keratoderma (MIM 148600) describes a group of 
hereditary skin disorders characterized by thickening (hyperkera-
tosis) of the epidermis of the palms and soles1. Historically, PPKs 
have been classified according to the pattern of lesions (diffuse, focal, 
punctate and striate), as well as by histopathological changes (epider-
molytic, non-epidermolytic and porokeratotic). Molecular genetics 
now allows for improved classification and diagnosis and for per-
sonalized approaches to treatment. Three distinct types of inherited 
punctate PPK are recognized by Online Mendelian Inheritance in 
Man (OMIM)2: PPKP1 (also known as the Buschke-Fischer-Brauer 
type; MIM 148600), for which the associated locus mapped to 15q22 
(refs. 4–6); PPKP2 (porokeratotic type; MIM 175860), for which no 
locus has been mapped yet; and PPKP3 (also known as acrokera-
toelastoidosis; MIM 101850), for which preliminary linkage sug-
gests a possible associated locus at 2p25–p12 (ref. 7). An additional 
disease-associated locus was identified at 8q24.13–8q24.21 in two 
Chinese families whose phenotypes resemble PPKP1 clinically and 
histologically8. Here we studied a collection of 18 kindreds with 
PPKP1 from Scotland, Ireland, Japan and Tunisia, 11 of whom had 
a family history consistent with autosomal dominant inheritance 
(Supplementary Fig. 1). In our PPKP1 case collection, there was 
considerable phenotypic variation (Fig. 1). In all families, onset was 
typically during the first to second decade of life, with the appearance 
of small circumscribed lesions on the palms and soles. These lesions 
consistently increased in number with advancing age and coalesced 
later to form larger lesions. In some families, lesions remained subtle 
(Fig. 1a,b), whereas the phenotype in other families, resembling 
human papilloma virus (HPV)-induced papilloma-like lesions, was 
much more severe, painful and debilitating (Fig. 1c,d). Histology of 
lesional palmar epidermis from three unrelated kindreds (families 1, 
Haploinsufficiency for AAGAB causes clinically 
heterogeneous forms of punctate palmoplantar keratoderma
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11 and 15) all showed very similar findings 
of a well-defined central epidermal depres-
sion associated with hypergranulosis and a 
prominent layer of overlying orthokeratosis 
(Fig. 1e). Immunohistochemical staining for 
the cell proliferation marker Ki67 showed 
continuous staining of the basal cell (prolifer-
ative) compartment of the epidermis beneath 
the hyperkeratotic lesions (Fig. 1f), indicative 
of a hyperproliferative form of hyperkeratosis 
rather than a retention hyperkeratosis due to 
defective desquamation.
Microsatellite linkage to the previously reported 15q22 locus was 
observed in a large Tunisian kindred originating from Saudi Arabia 
(Supplementary Fig. 2), with a maximum two-point logarithm of 
odds (LOD) score of 8.18 at recombination frequency (θ) = 0 obtained 
for D15S983 (Supplementary Table 1). The family was reported 
previously9. A 6.24-Mb key interval containing 80 RefSeq genes was 
defined by visible recombination with markers D15S993 (proximal) 
and D15S977 (distal). This locus overlaps the previously reported 
intervals associated with PPKP1 (Supplementary Table 2). In parallel, 
the proband in family 1 (of Scottish ancestry) was subjected to whole-
exome sequencing. Of the 28,513 SNPs identified, we elected to con-
centrate on loss-of-function variants located within the key interval 
defined by our linkage data and that previously reported. Of 106 unique 
stop-gain SNPs in the exome data set, only 3 SNPs, all heterozygous 
in the proband, were located on chromosome 15 (Supplementary 
Table 3). Two were located well outside the interval, including a 
known SNP, rs57809907, in DYX1C1, c.1617C>T, predicted to cause 
a p.Glu417* alteration, and a second previously unreported variant of 
unknown consequence in GABRG3, c.1316T>A, predicted to cause a 
p.Leu439* alteration. The remaining variant, c.481C>T in AAGAB,
predicted to cause a p.Arg161* alteration (mRNA, NM_024666; 
protein, NP_078942), fell within our linkage interval and that ini-
tially reported5 but was just outside the interval reported in a Chinese 
kindred6. This variant was absent from current dbSNP and 1000 
Genomes Project data sets (1 June 2012). The mutation was con-
firmed by conventional sequencing and cosegregated with the PPKP1 
phenotype in family 1 (Supplementary Fig. 3a,b). By conventional 
sequencing, a second loss-of-function mutation, c.346_347delAG, 
was identified and found to fully cosegregate with disease in the 
linked kindred and two additional Tunisian families (Supplementary 
Fig. 3c,d). Sequencing of the remaining 16 families identified a total of 
8 mutations in AAGAB (2 nonsense, 5 frameshift and 1 splice-site muta-
tion, as detailed in Supplementary Table 4). AAGAB, consisting of ten 
exons spanning 53,708 bp of genomic DNA, encodes α- and γ-adaptin– 
binding protein p34, which was identified in a yeast two-hybrid 
screen using a subunit of the adapter protein (AP)-1 complex as bait10. 
The positions of the predicted alterations in relation to the protein 
organization of p34 are shown (Fig. 2).
Conventional RT-PCR showed expression in palmoplantar epi-
dermis comparable to that in abdominal skin (data not shown). 
By quantitative RT-PCR (qRT-PCR), we confirmed that AAGAB 
is expressed at broadly comparable levels in skin, HeLa cells, pri-
mary epidermal keratinocytes and the commonly used keratinocyte 
cell line, HaCaT11 (Fig. 3a). Using qRT-PCR, we also showed that 




Figure 1 Clinical and histological features of 
punctate PPK. (a) The palm of the proband in 
family 1 with PPKP1 shows numerous small, 
hard, slightly indented hyperkeratotic lesions 
(arrow). Inset, magnified view of the lesion 
indicated by the arrow. (b) On the soles, lesions 
tend to coalesce at pressure points, and the 
presentation can therefore resemble a focal 
form of keratoderma. (c,d) In some cases, the 
phenotype is much more severe, as seen with 
the hand (c) and feet (d) of the proband from 
family 15. (e) Hematoxylin and eosin staining 
of a section showing a punch sample of skin 
incorporating a well-defined central epidermal 
depression associated with hypergranulosis and 
a prominent layer of overlying orthokeratosis. 
Scale bar, 500 µm. (f) Staining for the 
proliferation marker Ki67 highlights an increase 
in the number of keratinocytes in the cell cycle 
within the floor of the epidermal depression 
(arrowheads) compared to perilesional 
epidermis (arrow). Scale bar, 100 µm.








Figure 2 Identification of mutations in AAGAB in families with PPKP1. 
Protein domain organization of the p34 protein encoded by AAGAB, 
showing the positions of all eight alterations identified. Further details 
on the mutations are provided in supplementary table 4. Examples of 



















































1274	 VOLUME 44 | NUMBER 11 | NOVEMBER 2012 Nature GeNetics
l e t t e r s
in the skin (Supplementary Fig. 4). Two independent small inter-
fering RNAs (siRNAs) were developed that resulted in almost com-
plete reduction of the amount of p34 protein in HaCaT cells (Fig. 3b). 
Treatment of HaCaT cells with either of these potent siRNAs resulted 
in an approximately twofold increase in cell number over time com-
pared to cells transfected with a negative control siRNA (Fig. 3c), 
thus mirroring the high epidermal proliferation observed in lesional 
epidermis (Fig. 1f).
The coating of clathrin-coated vesicles consists of clathrin and 
adaptor complexes, both of which have to be recruited to the appro-
priate membrane from the cytoplasm12,13. The two most abundant 
types of adaptor protein complexes are AP-1, which is responsible 
for sorting proteins between the trans-Golgi network (TGN) and 
endosomes, and AP-2, which is responsible for sorting proteins at 
the plasma membrane. Both are heterotypic complexes, with AP-1 
containing a γ-adaptin subunit and AP-2 containing an α-adaptin 
subunit. Although cDNA encoding p34 protein was the predomi-
nant species cloned from the original yeast two-hybrid screen10, 
difficulty in obtaining antibodies specific to the p34 protein meant 
that further biochemical confirmation of these protein-protein inter-
actions were not presented. Here, using two independent antibodies 
to p34 that were made in house, we confirmed by immunoprecipita-
tion combined with protein blotting that this protein indeed inter-
acts with both AP-1 and AP-2 complexes in the cytosol (Fig. 4a). 
Cytosolic localization was confirmed by immunocytochemistry using 
constructs encoding p34 fused to green fluorescent protein (GFP) 
at either the N or C terminus (Fig. 4b), although fusion of GFP at the C 
terminus also led to some nuclear accumulation of the fusion protein. 
Cell fractionation studies showed that p34 protein is found in the 
cytosol but not in the membrane or clathrin-coated vesicle fractions 
in HeLa cells (Fig. 4c). Almost complete siRNA-mediated knock-
down of AAGAB (Fig. 4d) did not lead to an obvious change in the 
plasma membrane or TGN localization of AP-2 or AP-1, respectively 
(Fig. 4e). Neither AP-1 nor AP-2 colocalized with the N- or C-terminal 
GFP fusions of p34 (Supplementary Fig. 5). Essentially identical 
diffuse cytoplasmic localization data were obtained in the keratino-
cyte cell line HaCaT (data not shown). Overall, these data confirm 
that p34 is a cytosolic protein that binds to AP-1 and AP-2; however, 
p34 does not follow these protein complexes into their membrane-
associated vesicle populations on intracellular membranes or at 
the plasma membrane, respectively. This finding is consistent with 
a possible chaperone function for p34, as previously suggested10. For 
example, p34 might either prevent soluble clathrin from assembling 
with soluble adaptor complexes in the cytosol, be involved in vesicle 
uncoating or aid recruitment of soluble adaptors to membranes10. 
Bioinformatics analysis identified a GTPase domain in p34, which is 
most closely related to the Rab superfamily of vesicular trafficking 
proteins (Fig. 2 and Supplementary Fig. 6). It is not known whether 
this GTPase domain is functional. If this is the case, our finding may 
be indicative of a role for p34 in the active transport of cytosolic adap-
tor complexes rather than a more passive chaperone function14.
Ultrastructural analysis of lesional plantar skin showed mild 
acanthosis, a reduction in the granular cell layer and compact 
orthokeratosis (Supplementary Fig. 7). In basal keratinocytes 
(Fig. 5), there was a large increase in the number of small vesicles 
Figure 3 AAGAB is expressed in skin and 
keratinocytes and its depletion leads to increased 
cell numbers over time. (a) qRT-PCR showed that 
AAGAB mRNA is expressed in skin and is present 
at broadly comparable levels in primary epidermal 
keratinocytes. HeLa cells and the epidermal 
keratinocyte cell line HaCaT. (b) Protein blot 
showing that two independent siRNAs (designated 
AAGAB 1239 and 2164) potently lower p34 
expression in HaCaT cells. NSC4, nonspecific 
control siRNA (inverted lacZ sequence).  
(c) AAGAB knockdown by either siRNA leads to 
an approximate twofold increase in HaCaT cell 














































































































































































Figure 4 p34 associates with AP-1 and AP-2 in the cytosol. (a) Native 
immunoprecipitation of HeLa cytosolic extracts was performed with 
antibodies against p34, α-adaptin (detecting the AP-2 complex) and 
γ-adaptin (detecting the AP-1 complex). (b) HeLa cells were transiently 
transfected with constructs encoding p34 fused with GFP either at the 
C terminus (p34-GFP) or N terminus (GFP-p34). Both fusion proteins 
show a mainly cytosolic localization, consistent with the staining pattern 
(albeit faint) observed using antibody against p34 in either transfected or 
untransfected cells (*). (c) HeLa cell lysates were subjected to fractionation 
into cytosol, membrane and clathrin-coated vesicle (CCV) fractions, and 
protein blot analysis was performed for clathrin heavy chain (CHC), AP-1 
and p34. *, cross-reacting band. (d) HeLa cells were treated with siRNA 
(SMARTpool, Thermo-Fisher) to reduce expression of p34, and protein blot 
analysis was performed for CHC and p34. *, cross-reacting band. The amount 
of p34 protein was reduced by >95% in cells transfected with AAGAB siRNA. 
(e) Localization of AP-1 and AP-2 visualized by immunofluorescence after 
knockdown of AAGAB. AP-2–containing membrane-associated vesicles and 
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close to the cell membrane and prominent dilatation of the Golgi 
apparatus in lesional epidermis compared to normal, control skin 
(Supplementary Fig. 7). These ultrastructural features are consist-
ent with a defect in vesicle transport.
We hypothesized that a mechanism whereby perturbation of 
vesicle trafficking could lead to increased epidermal proliferation 
might involve recycling of EGFR. EGFR is known to undergo rapid 
turnover in a process that requires a number of sorting steps, includ-
ing clathrin- and AP-2–dependent endocytosis15,16. Internalized 
ligand-bound EGFR is either shuttled to late endosomes/lysosomes 
for degradation or into recycling endosomes, where, after removal 
of the bound ligand and dephosphorylation, the receptor is returned 
to the plasma membrane via vesicle fusion. Knockdown of AAGAB 
in HaCaT cells led to a modest ~2.5-fold increase in EGFR mRNA 
levels relative to cells transfected with control siRNA, as determined 
by qRT-PCR (data not shown); however, the amount of total EGFR 
protein was >10-fold higher in protein blot analysis (Fig. 6a), con-
sistent with decreased EGFR turnover. Notably, phosphorylation of 
EGFR at Tyr992, indicating active EGFR signaling17, was increased 
by >20-fold in cells with AAGAB knockdown (Fig. 6b). The regula-
tion of EGFR signaling via clathrin-mediated endocytosis is a com-
plex process mediated by Rab proteins15, dynamin18, AP-2 and the 
Grb2 adaptor protein that involves multiple mechanisms relating to 
post-translational modification of the receptor itself19. Disruption of 
EGFR endocytosis by double knockout of the Dnm1 and Dnm2 genes 
encoding the motor proteins dynamin-1 and dynamin-2, respectively, 
in mouse has been shown to result in decreased protein turnover with 
increased EGFR signaling18, very similar to what we observed with 
knockdown of AAGAB.
Here, using a combination of genetic linkage analysis and whole-
exome sequencing, we have identified mutations in the AAGAB gene, 
encoding p34, that cause the autosomal dominant form of punctate 
PPK that was previously linked to 15q22 known as PPKP1 (MIM 
148600)5,6,9. AP-2 is known to be involved in EGFR endocytosis19, and 
we confirmed here that p34 binds cytosolic AP-2 (Fig. 4) and show 
that p34 deficiency results in increased epidermal cell proliferation 
(Fig. 1f and Fig. 3). Overall, p34 seems to have a hitherto unrecog-
nized role in the control of cell division, possibly by contributing 
to normal endocytic recycling of receptor tyrosine kinases, such as 
EGFR15,16,18,19. Other genes involved in intracellular vesicle traffick-
ing have been linked to inherited skin diseases where hyperkeratosis 
and/or keratoderma form part of the phenotypic constellation. These 
genes include SNAP29 in cerebral dysgenesis, neuropathy, ichthyo-
sis and keratoderma (CEDNIK) syndrome20 and VPS33B in arthro-
gryposis, renal dysfunction and cholestasis (ARC) syndrome21, both 
of which encode proteins required for vesicle membrane fusion in the 
epidermis and other tissues. Moreover, loss-of-function mutations in 
AP1S1, which encodes the small σ1A subunit of the AP-1 complex, 
have been shown to cause the recessive neurocutaneous disorder 
mental retardation, enteropathy, deafness, peripheral neuropathy, 
ichthyosis and keratodermia (MEDNIK)22. Similarly, defects in mul-
tiple proteins involved in melanosome transport and fusion lead to 
the pigmentation disorder Griscelli syndrome23, and mutations in 
the gene encoding the AP-3 subunit protein β3A have been linked 
to Hermansky-Pudlak syndrome type 2, which consists of oculocu-
taneous albinism and other features24. Thus, mutations in a growing 
number of genes involved in vesicle transport have been linked to 
genetic skin disease, with or without extracutaneous phenotypes.
Disruption of EGFR signaling is a feature of neoplasia. There are 
anecdotal reports of cancer occurring in association with punc-
tate PPK25; however, without genetic testing, we cannot determine 
whether the AAGAB gene was involved in those cases. Although a 
few cases of cancer were reported in the larger families studied here, 
we did not observe cosegregation with the AAGAB mutations, and, 
therefore, any causal link between AAGAB mutations and cancer 
remains unproven.
It remains unclear why haploinsufficiency for this widely expressed 
gene leads to a phenotype limited to palm and sole epidermis, although 
this is not unusual in hereditary skin disease. For example, haplo-
insufficiency for the DSP or DSG1 genes encoding the desmosomal 
proteins desmoplakin and desmoglein-1, respectively (refs. 26,27), 
both of which are structural proteins expressed throughout the epi-
dermis, lead to striate palmoplantar keratoderma28. Another unan-
swered question relates to why the hyperkeratotic lesions are focal. 
These lesions are late in onset, appearing in the first or second dec-
ade of life, and increase in number with advancing age. This pat-
tern of appearance might be explained by a ‘second hit’ mutation in 
AAGAB, and we therefore sequenced the gene using genomic DNA 
derived from microdissected lesional tissue from more than one 
affected individual. We found neither loss of heterozygosity nor a 
Figure 5 Transmission electron microscopy of lesional plantar skin shows 
vesicle abnormalities within basal keratinocytes. Transmission electron 
microscopy of a basal epidermal keratinocyte (E) within PPKP1 lesional 
epidermis shows an abnormal abundance of membrane-bound vesicles 
abutting the plasma membrane (arrows), close to the cutaneous basement 
membrane (*). D, dermis. Scale bar, 0.2 µm. Additional electron micrographs 




















Figure 6 Knockdown of AAGAB greatly increases EGFR protein 
expression. (a) Knockdown of AAGAB with siRNA 1239 leads to greatly 
increased EGFR protein expression relative to cells transfected with 
NSC4. Part of the blot was stained for β-actin for a loading control and 
to normalize EGFR quantification. Using the LI-COR Odyssey system, the 
observed upregulation of EGFR was found to be greater than tenfold.  
(b) Knockdown of AAGAB with siRNA 1239 also leads to greatly increased 
phosphorylation of Tyr992 on the EGFR protein compared to transfection 
with NSC4. Using the LI-COR Odyssey system, the observed increase in 
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second compound heterozygous AAGAB mutation (data not shown). 
We also attempted immunohistochemistry; however, neither the 
in-house nor commercially available antibody to p34 gave a signal on 
fixed abdominal tissue from a normal control. It is also possible that a 
second somatic mutation might occur in a gene other than AAGAB.
In conclusion, this study expands the molecular diagnostic repertoire 
for keratodermas and shows that the p34 protein, which is associated 
with AP-1 and AP-2, is involved in regulating epidermal cell division.
URLs. The Eastern Sequence and Informatics Hub (EASIH), http://
www.easih.ac.uk/; Pachyonychia Congenita Project, http://www.
pachyonychia.org/.
METhods
Methods and any associated references are available in the online 
version of the paper.
Note: Supplementary information is available in the online version of the paper.
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Affected individuals and phenotypes. Individuals from 18 apparently 
unrelated families presented with PPK at dermatology clinics in Scotland, 
Ireland, Japan and Tunisia. Clinical examination and histological analysis of 
affected persons was consistent with a diagnosis of the Buschke-Fischer-Brauer 
type of punctate PPK (PPKP1; MIM 148600)2. In severely affected cases, where 
keratoderma resembled plantar warts, the presence of HPV was excluded in 
the clinical work-up. Blood samples were obtained in tubes containing the 
anticoagulant EDTA from the affected individuals with written informed con-
sent and approval from the institutional ethics committee (Tayside Committee 
on Research Ethics, Dundee, UK) that complied with the Declaration of 
Helsinki Principles. DNA was extracted using standard procedures.
Linkage analysis. Microsatellite genotypes were generated for members 
of family 15 using standard protocols. LOD scores were calculated using 
FASTLINK29,30, assuming a mutant allele frequency of 1 in 50,000. The 
LOD scores were recalculated assuming a 10% chance of non-penetrance 
because of difficulty in obtaining a definitive clinical ascertainment in some 
individuals in family 15 (the family resides in a remote mountainous area 
of Tunisia).
Exome sequencing. Exome enrichment was performed using the Agilent 
SureSelect 50Mb exome enrichment system, using the protocol for Applied 
Biosystems SOLiD (Protocol version 1.0, May 2010). Sequencing was then 
performed on the ABI SOLiD platform (Applied Biosystems), with an aver-
age sequencing depth of >30× across the exome. Next-generation sequencing 
and SNP calling were performed by The Eastern Sequence and Informatics 
Hub (EASIH; see URLs). To simplify filtering of the exome data, all SNP calls 
were put into a MySQL database and queried via an in-house web-based 
django front-end.
Histology. Routine hematoxylin and eosin staining of paraffin-embedded tis-
sue was performed using standard protocols. Immunohistochemical staining 
for the cell proliferation marker Ki67 was performed using polyclonal antibody 
HPA000451 (Sigma-Aldrich).
Mutation analysis of the AAGAB gene. The individual exons of AAGAB were 
amplified by PCR using genomic primers (sequences listed in Supplementary 
Table 5) and the following cycling conditions: 1 cycle at 94 °C for 5 min; 
35 cycles at 94 °C for 30 s, 55 °C for 30 s and 72 °C for 1 min; and 1 final exten-
sion at 72 °C for 5 min.
Cell culture. HaCaT keratinocytes were maintained in a monolayer in 5% 
CO2 in DMEM (Invitrogen) supplemented with 10% FCS. Normal human 
keratinocytes were obtained from CELLnTECH and cultured in the defined 
growth medium CnT57 (TCS Cellworks). HeLa cells were cultured in DMEM 
supplemented with 10% FCS, 2 mM L-glutamine, 50 U/ml penicillin and 
50 µg/ml streptomycin (Sigma-Aldrich).
RT-PCR. Total RNA was extracted from cultured HaCaT cells and primary 
keratinocytes using the RNeasy Mini kit (Qiagen). RNA (1 µg) was reverse 
transcribed using AMV Reverse Transcriptase (Promega) and oligo(dT)15 
(Roche Diagnostics). We used 1 µl of the reaction mix in subsequent PCR 
with Expand High Fidelity PCR buffer containing 1.5 mM MgCl2 and 0.5 U of 
High Fidelity DNA Polymerase (Roche Diagnostics). Primers AAGAB5intFor 
and AAGAB8intRev (see Supplementary Table 5) were used to amplify a 
292-bp fragment with the following cycling conditions: 1 cycle at 94 °C for 
5 min; 35 cycles at 94 °C for 30 s, 52 °C for 30 s and 72 °C for 30 s; and a final 
extension at 72 °C for 5 min.
Isolation of RNA and gene expression analysis. RNA was isolated from 
abdominal skin, primary keratinocytes, and HaCaT and HeLa cells using the 
RNeasy Mini kit and was treated with RNase-Free DNase (Qiagen) to remove 
any contaminating genomic DNA. We reverse transcribed 1 µg of each using the 
High-Capacity cDNA Reverse Transcription kit (Applied Biosystems). Then, 
1 µl of each reaction was used in quantitative PCR performed with Perfecta 
qPCR ToughMix, ROX (Quanta Biosciences) on a 7900HT Fast Real-Time 
PCR system (Applied Biosystems). TaqMan Gene Expression Assays 
(Life Technologies) for AAGAB (Hs01027607_m1) and GAPDH (4310884E) 
were used according to the manufacturer’s recommendations.
Multiple-tissue expression analysis. A cDNA clone was generated and used 
to produce a standard curve for copy-number estimation by qRT-PCR. To 
make this construct, cDNA was generated by reverse transcription of RNA 
from HaCaT cells and was used as a template for the amplification of a 
940-bp AAGAB cDNA fragment using the primers P34clone1 and P34clone2 
(Supplementary Table 5). The cDNA was cloned as a fragment flanked 
by EcoRI and HindIII restriction endonuclease sites and was inserted into 
pcDNA3.1(-)/myc-His A (Life Technologies). A normalized cDNA panel from 
48 different human tissues (Origene Technologies) was quantified by TaqMan 
Gene Expression Assay Hs01027607_m1. The standard used in this assay was 
plasmid DNA encoding wild-type AAGAB. The standard curve was calculated 
using the formulae described by Applied Biosystems.
siRNA knockdown of AAGAB in HaCaT cells. siRNA oligonucleotides 
targeting AAGAB and a scrambled negative control were obtained from 
Eurofins MWG Operon. The sequences of the siRNAs specific for AAGAB 
(designated AAGAB1239 and AAGAB2164) and the non-specific control 
siRNA (designated NSC4; a scrambled bacterial lacZ sequence) are shown in 
Supplementary Table 5. We plated 1.2 × 105 HaCaT cells in each well of a 
6-well dish containing DMEM supplemented with 10% FCS and transfected 
the cells with siRNA at a final concentration of 5 nM using Lipofectamine 
RNAiMAX Reagent (Invitrogen). Cells were incubated for 72 or 96 h 
before harvesting for RNA extraction and protein isolation and for cell 
proliferation analysis.
Cell proliferation analysis. HaCaT cells were transfected with siRNA and 
incubated for 96 h. Cells were washed with PBS and detached from the dishes 
using 0.05% trypsin-EDTA. Counts of viable cells (after trypan blue staining) 
were obtained using a hemocytometer.
Antibodies to a- and g-adaptin–binding protein p34. Two affinity-purified 
rabbit polyclonal antibodies, p34-1 and p34-2, were raised using a gluta-
thione S-transferase (GST) fusion protein consisting of residues 142–315 
(the C terminus) of rat α- and γ-adaptin–binding protein p34 (85% identical 
and 91% similar to the human protein). These antibodies were used for the 
HeLa cell experiments (protein blot analysis and immunofluorescence). For 
the HaCaT cell experiments, rabbit polyclonal antibody to α- and γ-adaptin– 
binding protein p34 was used (HPA040174, Sigma-Aldrich). Protein blotting 
and immunofluorescence of HeLa cells was repeated using the Sigma-Aldrich 
antibody with very similar results (data not shown). Similarly, protein 
blotting and immunofluorescence of HaCaT cells was repeated using p34-2 
with similar results (data not shown).
Protein blotting of HaCaT lysates and EGFR quantification. Cells were 
rinsed in ice-cold PBS, lysed in SDS lysis buffer (1% SDS, 20 mM Tris-HCl, 
pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM EDTA) with added protease 
inhibitor cocktail (Sigma-Aldrich), phosphatase inhibitor cocktail (Sigma-
Aldrich) and 25 U/ml Benzonase (Merck) and incubated at room temperature 
for 10 min with agitation. Lysates were cleared by centrifugation at 10,000g 
for 10 min at 4 °C, and protein concentration was determined using the Bio-
Rad Protein Assay. For each sample, 10 µg of total protein was separated 
on NuPAGE 4–12% Bis-Tris polyacrylamide gels (Invitrogen) in NuPAGE 
MOPS running buffer (Invitrogen) and blotted onto Hybond-C Extra 
(GE Healthcare). Membranes were probed with a 1:1,000 dilution of the 
appropriate primary antibody (rabbit antibody to α- and γ-adaptin–binding 
protein p34, Sigma-Aldrich), rabbit antibody to EGFR (4267P, Cell Signaling 
Technology) or a 1:10,000 dilution of mouse antibody to β-actin (A5441, 
Sigma-Aldrich). Membranes were then incubated with a 1:1,000 dilution of 
horseradish peroxidase (HRP)-conjugated goat secondary antibody to rabbit 
or HRP-conjugated rabbit secondary antibody to mouse (Dako). Immobilon 
Western Chemiluminescent HRP substrate (Millipore) was used for visualiza-
tion. For detection of phosphorylated EGFR, blots were blocked in 3% BSA in 




















































1 h at room temperature and incubated overnight in a 1:1,000 dilution of 
antibody to phosphorylated EGFR (Tyr992; 2235, Cell Signaling Technology) 
in PBST containing 10 mM β-glycerophosphate at 4 °C. Blots were washed in 
three changes of PBST containing 10 mM β-glycerophosphate and incubated 
in a 1:1,000 dilution of HRP-conjugated goat secondary antibody to rabbit in 
PBST containing 10 mM β-glycerophosphate for 1 h at room temperature. 
After washing, blots were developed using enhanced chemiluminescence 
(ECL). For detection of β-actin, blots were blocked and antibodies were diluted 
in 5% non-fat milk in PBST under the same conditions as described above. 
A dilution of 1:10,000 was used for the antibody to actin (Sigma-Aldrich), and 
a 1:1,000 dilution was used for the secondary HRP-conjugated rabbit antibody 
to mouse. Quantification of protein bands on blots was performed using a 
LI-COR Odyssey infrared imaging system.
HeLa cell transfection. Transfection of HeLa cells with siRNA was achieved 
with Oligofectamine (Invitrogen) following the manufacturer’s instruc-
tions, using 25 mM siRNA and incubating for 72 h. Knockdown of AAGAB 
was achieved using an siGENOME SMARTpool (M-0159891), and control 
knockdown was performed with a non-targeting siRNA (D-001810-10) (both 
from Thermo-Fisher). Transient transfections with plasmid DNA encoding 
GFP-tagged protein was achieved using HeLa Monster transfection reagent 
(Cambridge Bioscience) following the manufacturer’s instructions and trans-
fecting 48 h before imaging. For immunofluorescence, cells were grown on 
glass-bottom coverslips (MatTek), fixed in 3% formaldehyde in PBS at room 
temperature and permeabilized with 0.1% Triton X-100. Cells were imaged 
with a Zeiss Axiovert 200 inverted microscope using a Zeiss Plan Achromat 63× 
oil immersion objective, a Hamamatsu ORCA-ER2 camera and Improvision 
Openlab software (PerkinElmer).
Protein blot, immunofluorescence and immunoprecipitation in HeLa 
cells. These experiments were performed with antibodies raised in 
house, including to α- and γ-adaptin–binding protein p34 (p34-1, p34-2), 
AP-2α, AP-1γ and clathrin heavy chain10. Antibody p34-2 was used to detect 
α- and γ-adaptin–binding protein p34 unless otherwise specified. Constructs 
encoding N- and C-terminally tagged α- and γ-adaptin–binding protein p34 
were constructed from rat cDNA10 (human and rat AP-1γ share 99% amino-
acid identity) by PCR amplification and cloned in frame into pEGFP-N3 
(p34-GFP) or pEGFP-C1 (GFP-p34) (plasmids from Takara Bio Europe/
Clontech) using HindIII and KpnI restriction sites. The sequences of both 
constructs were verified by Sanger sequencing analysis.
Immunoprecipitation and clathrin-coated vesicle isolation in HeLa cell 
extracts. For immunoprecipitation, cells were lysed in PBS containing 1% 
IGEPAL (Sigma-Aldrich). Lysates were cleared of debris by centrifugation, 
and antibody-protein complexes were captured using Protein A Sepharose 
(Pharmacia). Samples were then analyzed by PAGE and protein blotting. Blots 
were probed with various antibodies, and signals were visualized with the ECL 
Plus Western Blotting Detection System (GE Healthcare). Control clathrin-
coated vesicle–enriched fractions were prepared as described previously31, 
except that the final pelleting step was performed at 86,900g for 30 min to 
improve yield.
Ultrastructural analysis. Skin biopsy specimens were cut into small pieces 
(of <1 mm3) and fixed in half-strength Karnovsky fixative for 4 h at room 
temperature. After washing in 0.1 M sodium phosphate buffer (pH 7.4), 
samples were immersed in 1.3% aqueous osmium tetroxide (TAAB 
Laboratories) for 2 h. Samples were then incubated in 2% uranyl acetate 
(Bio-Rad) and dehydrated in a graded ethanol series. We embedded the 
samples in epoxy resin via propylene oxide (TAAB Laboratories). Ultra-thin 
sections were stained with uranyl acetate and lead citrate and examined on a 
Philips CM10 transmission electron microscope.
29. Cottingham, R.W. Jr., Idury, R.M. & Schaffer, A.A. Faster sequential genetic linkage 
computations. Am. J. Hum. Genet. 53, 252–263 (1993).
30. Schäffer, A.A., Gupta, S.K., Shriram, K. & Cottingham, R.W. Jr. Avoiding 
recomputation in linkage analysis. Hum. Hered. 44, 225–237 (1994).
31. Hirst, J., Miller, S.E., Taylor, M.J., von Mollard, G.F. & Robinson, M.S. EpsinR is 




































































Development and evolution of craniofacial structures are driven by 
a transient cell population of embryonic origin known as cranial 
neural crest cells (NCCs). Changes in their proliferation or migration 
have led to diverse head shapes among living or extinct species of 
fish, amphibians, reptiles, birds and mammals1,2. This phylogenetic 
plasticity is limited, however, by the need to develop cardinal organs 
in the head region for cognition, sight, smell, taste, hearing, balance 
and touch. NCCs also contribute to the morphogenesis of secondary 
organs such as dental, lacrimal, salivary and thyroid structures3. As a 
result, even small alterations in craniofacial morphogenesis can lead 
to substantial structural or functional congenital anomalies of the 
human head4.
Here we report on the genetic, molecular and developmental etiol-
ogy of a new autosomal recessive human syndrome5 (MIM611174) 
that is marked by defective craniofacial morphogenesis and heart, 
blood, bone and germ cell ontogeny. In two consanguineous families, 
we diagnosed five probands (Fig. 1a) with a unique set of craniofacial 
dysmorphisms, including severe telecanthus, myopia, hypoplasia 
of the lacrimal-salivary apparatus, frontonasal anomalies, protrud-
ing ears and sensorineural hearing impairment (Fig. 1b–e and 
Supplementary Fig. 1). Skeletal anomalies with repeated fractures of 
long bones (Fig. 1f and Supplementary Fig. 1), hypodontia (Fig. 1g), 
microcytic hypochromic anemia (Fig. 1h,i) and congenital heart 
defects with intraventricular conduction delay (Fig. 1j) were also 
documented in all affected individuals. This syndrome includes a 
wide range of clinical symptoms (Supplementary Table 1).
Assuming a common etiology in both families, we carried out 
identical-by-descent (IBD) homozygosity mapping and delineated a 
single candidate locus of 9.2 Mb on chromosome 16. We used targeted 
genomic locus capturing followed by high-throughput resequenc-
ing6,7 to screen the 73 candidate genes in this region (Fig. 1k). In the 
Jordanian family, we identified 204 genomic mismatches in subject 1; 
only two of these were newly identified homozygous and nonsyn-
onymous in the SLC12A3 and IRX5 (c.498C>A) genes (Fig. 1k 
and Supplementary Table 2). In the Turkish family, we identified 
a distinct homozygous mutation (c.448G>C) in the IRX5 gene 
(NM_005853.5) segregating with the disease. The Iroquois (IRX) 
genes encode a family of six conserved transcription factors (IRX1 
to IRX6) that specify the identity of precise body parts via spatial 
and temporal regulation of target genes8. The IRX5 variants, which 
were homozygous in the index cases but not in the unaffected rela-
tives, led to the amino acid alterations p.Ala150Pro and p.Asn166Lys, 
altering two residues that are phylogenetically invariant in all known 
IRX paralogs and orthologs (Fig. 2a and Supplementary Fig. 2). 
Taken together, these results show that biallelic mutations in the IRX5 
homeobox cause a congenital disorder affecting the ontogeny and 
homeostasis of multiple organs.
To examine the allelic strength of these IRX5 missense variants, 
we carried out in vitro luciferase assays using mouse Irx5 expression 
constructs and a rat Kcnd2 promoter reporter9. Behaving like an Irx5 
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construct lacking its homeobox9, the two Irx5 missense variants could 
not transactivate Kcnd2, in contrast with wild-type Irx5 (Fig. 2b). 
Whereas wild-type Irx5 and the p.Asn166Lys variant were stable, the 
p.Ala150Pro variant was rapidly degraded via ubiquitin-mediated
proteolysis in cultured 10T1/2 cells (Fig. 2c). This is in agreement 
with earlier reports on alterations affecting the same homeodomain 
residues of helices 2 and 3, which affect protein stability and DNA 
binding, respectively10.
To investigate the role of Irx5 during craniofacial development, we 
examined whether its depletion in X. laevis embryos could partly model 
the human syndrome. Irx5 knockdown by morpholino injection11 
showed that blood, heart, germ cell and craniofacial anomalies could 
be recapitulated in vivo (Fig. 3 and Supplementary Fig. 3). In particu-
lar, Irx5 morphant embryos showed defective cranial NCC migration 
in the first branchial arch; this could be rescued by injection of wild-
type mouse Irx5 DNA but not p.Ala150Pro Irx5 DNA (Fig. 3a–d). 
However, the p.Asn166Lys variant, as compared with wild-type Irx5, 
allowed partial repopulation of NCCs to the first branchial arch of 
Irx5 morphants (Fig. 3c,e). With all constructs being equally tran-
scribed, the p.Ala150Pro Irx5 variant was unstable in embryos relative 
to wild-type Irx5 and the p.Asn166Lys Irx5 variant (Fig. 3f), in agree-
ment with results obtained in cultured cells (Fig. 2c). Taken together, 
these data suggest that the p.Ala150Pro and p.Asn166Lys variants 
do not behave as null alleles. Rather, owing to their altered protein 
stability and DNA binding activity, these missense IRX5 variants may 
act as hypomorphic alleles.
To gain mechanistic insight into the etiology of NCC defects 
observed in Irx5 morphants, we conducted an exploratory micro-
array experiment comparing Irx5 morpholino–injected and con-
trol embryos at neurulation. Sdf1 (also known as Cxcl12), which 
encodes a chemokine essential for cranial NCC migration12, was 
found nearly 20-fold upregulated in Irx5-depleted embryos relative 
to control embryos. Ectopic expression of Sdf1 in developing head of 
Irx5 morphants was confirmed by in situ hybridization (Fig. 3g,h). 
a
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Figure 1 Clinical and genetic findings in five probands diagnosed with 
Hamamy syndrome. (a) Pedigrees of two inbred families from Jordan and 
Turkey. Filled black symbols, affected individuals (1–5). Crossed symbols, 
individual deceased. Small black circle, miscarriage (sex unspecified). 
SB, stillborn. (b–e) Full facial photographs of affected individuals with 
common craniofacial dysmorphisms, including midface prominence, 
sparse lateral eyebrows, severe telecanthus, agenesis of lacrimal punctuae 
(b, inset), anteverted nostrils, pointed nasal tip, flat philtrum, thin upper 
vermillion border and protruding ears (c,e, inset). Participants gave 
consent for publication of all photos. (f) Femoral radiograph of subject 
5 showing multiple fractures and corrective osteotomy. (g) Panoramic 
radiograph of maxilla and mandible of subject 5 showing loss of lamina 
dura and teeth malocclusion. (h,i) Blood cell separation by density-
gradient centrifugation and blood smear of mother of subject 5 (h) and 
subject 5 (i) show hypochromic microcytic anemia. Scale bar, 10 µm.  
(j) Electrocardiogram of subjects 1–3 showing left intraventricular 
conduction delay (QRS complex >100 ms). V1, fourth intercostal right 
chest lead. (k) Homozygosity mapping delineated a single candidate locus 
encompassing 73 genes on chromosome 16q12.2-q21 (Chr. 16). Locus 
capture followed by massive parallel resequencing in subject 1 identified 
a single biallelic base pair change (c.498C>A) in the IRX5 gene, leading 








































































































Figure 2 Homeodomain IRX5 missense variants behave as hypomorphs. 
(a) Human IRX5 contains two conserved regions, a homeodomain (HD) 
and an Iro box (Ibo). The p.Ala150Pro and p.Asn166Lys missense variants 
map to IRX5 homeodomain helices 2 and 3, respectively. These two 
residues are invariant in all vertebrate and invertebrate IRX5 homologs.  
(b) Transient cotransfections of 10T1/2 cells with constructs encoding 
mouse Irx5 A150P, N166K and ∆HD variants with an Irx5 reporter 
construct (rat Kcnd2 promoter luciferase) show total abrogation of 
transcriptional activity relative to constructs for wild-type Irx5 or Irx5 
S36D/S63D. Data are mean ± s.d. **P < 0.005 (one-tailed Student’s  
t test). (c) In 10T1/2 cells, Irx5 A150P protein was not detected (lane 3) 
compared to wild-type Irx5 (lane 1) or Irx5 N166K (lane 5). However, Irx5 
A150P protein was stabilized (lane 4) after the addition of proteosomal 
degradation inhibitors MG132 or lactacystin to the culture medium.  
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Injection of a human SDF1 promoter luciferase reporter13 into Irx5-
depleted embryos led to greater luciferase activity compared with 
wild type (Fig. 3i). Conversely, overexpression of wild-type mouse 
Irx5 DNA in cultured cells was sufficient to mediate SDF1 promoter 
trans-repression (Fig. 3i and Supplementary Fig. 4). To test whether 
ectopic Sdf1 expression in Irx5 morphants was responsible for the 
defective NCC migration, we reduced endogenous Sdf1 levels by 
co-injection of an Sdf1 morpholino12. We found that proper stream-
ing of NCCs into the first branchial arch was recovered in double 
Irx5-Sdf1 morpholino–injected embryos (Fig. 3j–m). Primordial 
germ cells, whose migration into gonads also depends on Sdf1 
levels14,15, were mislocalized and more scarce within Irx5 morphants 
relative to control embryos (Fig. 3n). This prompted us to re-examine 
index cases for gonadal activity. Scintillography tests on all males 
with homozygous IRX5 mutations showed minimal testis activity 
(Supplementary Fig. 5), consistent with observed hydrocele and 
cryptorchidism (Supplementary Table 1). These data suggest that 
IRX5 is required to repress SDF1 expression for correct chemoattrac-
tion of migratory cell populations in branchial arches and gonads, 
raising the possibility that craniofacial and gonadal anomalies in 
individuals with homozygous IRX5 mutations may stem, in part, 
from a gain of SDF1 signaling during human development.
To clarify the transcriptional output of IRX5, we searched for pro-
tein partners that could modulate its activity. In a meta-analysis of 
human Affymetrix microarrays16, we noted that IRX3, GATA3 and 
TRPS1 defined a syn-expression group with IRX5 (Supplementary 
Table 3). IRX3 and IRX5 are coexpressed and interact at the pro-
tein level11,17. Therefore, we focused on the two GATA zinc-finger 
transcription factors TRPS1 (ref. 18) and GATA3, which are dis-
rupted in trichorhinophalangeal type 1 syndrome19 (MIM190350) 
and hypoparathyroidism sensorineural deafness and renal disease20 
(MIM131320), respectively, two congenital disorders that share clinical 
features with IRX5 syndrome (Supplementary Table 1). In situ 
hybridization showed that Trps1, Gata3 and Irx5 share craniofacial 
domains of expression in X. laevis embryos at stage 33 (Fig. 4a–d). 
Biochemical experiments showed coimmunoprecipitation of Irx5 
by Trps1 or by Gata3, consistent with possible protein-protein inter-
actions during craniofacial development (Fig. 4e,f). Moreover, luci-
ferase assays showed that Trps1 dose-dependently potentiated Irx5 
transactivation (Fig. 4g), whereas Gata3 significantly decreased Irx5-
mediated transactivation of the Kcnd2 reporter (Fig. 4h). Gata3, which 
bound Trps1 alone (Supplementary Fig. 6a), could better coimmu-
noprecipitate Irx5 in the presence of increasing amount of Trps1, sug-
gesting that these three proteins might form a heterotrimeric complex 
Figure 3 Irx5 orchestrates migration of cranial 
NCCs and primordial germ cells by repressing 
Sdf1 expression. (a–e) Cranial NCC migration 
patterns visualized by Twist1 expression in  
X. laevis embryos. Lateral view of head region  
of stage 26 embryos, anterior to the left.  
(a) Expression of Twist1 demarcated NCCs in four 
branchial arches (1–4; n = 36/36). Dashed red 
line outlines eye vesicle and dashed white line  
outlines first branchial arch. Scale bar, 0.25 mm. 
(b) Irx5 morpholino (MO)-injected embryos 
specifically lacked NCCs in first branchial 
arch (n = 23/38). Red arrowhead, ectopic NCC 
migration over eye vesicles. (c) Injection of wild-
type mouse Irx5 DNA in Irx5 morphant embryos 
rescued NCC migration to first branchial arch  
(n = 30/40). (d) Injection of DNA encoding mouse  
Irx5 A150P in Irx5 morphant embryos did not 
rescue NCC migration to first branchial arch  
(n = 27/48). (e) Injection of DNA encoding mouse 
Irx5 N166K partially rescued NCC migration 
in Irx5 morphant embryos (n = 23/48). (f) Irx5 
A150P protein was not detected in embryos 
injected with DNA encoding mouse Irx5 A150P 
compared to embryos injected with DNA 
encoding wild-type mouse Irx5. α-actin, loading 
control. Quantitative RT-PCR results show 
comparable transcription for each Irx5 DNA 
construct injected. Actb, positive control.  
(g,h) At stage 25, Sdf1 was markedly 
overexpressed in head region of Irx5 morphants 
relative to control embryos (n = 18/18). Scale 
bar, 0.25 mm. (i) Injection of a human SDF1 
promoter reporter showed greater basal luciferase 
activity in Irx5-depleted embryos. Overexpression 
of mouse Irx5 in MS5 cells repressed trans-
activation of SDF1 reporter. Data are mean ± s.d. 
*P < 0.05 (one-tailed Student’s t test). (j) Twist1 
expression demarcated NCCs in four branchial 
arches (1–4; n = 70/70). Dashed red line, eye vesicle. Scale bar, 0.25 mm. (k) Sdf1 morpholino–injected embryos did not show overt NCC migration defects 
(n = 46/46). (l) Irx5 morpholino–injected embryos lacked NCCs in first branchial arch (n = 37/58). Dashed black line, absence of first branchial arch.  
(m) Reduction of Sdf1 by injection of Sdf1 morpholino rescued NCC migration to first branchial arch of Irx5 morphants (n = 42/58). (n) Defective migration of 
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(Fig. 4i). In support of this hypothesis, we observed stronger tran-
scriptional repression of both the Kcnd2 and SDF1 promoters when 
Trps1, Gata3 and Irx5 were coexpressed (Fig. 4j and Supplementary 
Fig. 6b). Finally, noting that the p.Asn166Lys Irx5 variant could still 
bind its protein partners (Fig. 4e,f ), we examined whether it retained 
any activity using a Gata3-regulated GCMB reporter21. Notably, the 
p.Asn166Lys Irx5 variant exerted stronger trans-repression than 
wild-type Irx5 when coexpressed with Gata3 (Supplementary 
Fig. 6c). This indicates that the IRX5 missense variants we identified 
may exhibit neomorphic properties, unlike Irx5 knockout mice, which 
carry a null allele9,22.
Our genetic, developmental and biochemical results suggest that 
the stoichiometry of GATA3, TRPS1 and presumably IRX3, bound 
individually or in a molecular complex to IRX5, can modulate its 
transcriptional activity, creating a wide spectrum of craniofacial 
features (Fig. 4k). Haploinsufficiency, which has been observed in 
hypoparathyroidism sensorineural deafness and renal disease as well 
as trichorhinophalangeal type 1 syndrome, supports a gene-dosage 
effect for these transcriptional regulators19,20. Likewise, monosomy 
of IRX3, IRX5 and IRX6 causes a disorder23 similar to that of biallelic 
IRX5 mutations, suggesting that IRX3 and IRX6 are needed to circum-
vent IRX5 haploidy. A picture emerges in which the IRX proteins and 
their comodulators regulate the expression of key signaling molecules 
such as SDF1 during organogenesis and in the pathogenesis of this 
disorder, which we propose to call Hamamy syndrome (MIM611174) 
in recognition of the clinician who first described it5. Finally, children 
exposed to folate antagonists can share similar facial features to indi-
viduals with IRX5 mutations24. There is strong correlation between 
expression of IRX5 and SLC39A6 (Supplementary Table 3), a trans-
porter associated with uptake of the folate inhibitor methotrexate25. 
Similarly, the ear, dental and lacrimal anomalies observed in IRX5 
probands are reminiscent of the lacrimoauriculodentodigital 
(MIM149730) syndrome caused by alterations affecting the FGF10 
pathway26, raising the possibility that the SLC39A6 and FGF10 genes 
may act in concert with or as direct targets of IRX5.
URLs. GenBank, http://www.ncbi.nlm.nih.gov/mapview/; Ensembl, 
http://www.ensembl.org/; University of California Santa Cruz (UCSC), 
human reference genome, build 18, http://genome.ucsc.edu/; Blat-
like Fast Accurate Search Tool, https://secure.genome.ucla.edu/index.
php/BFAST/; SAMTools, http://samtools.sourceforge.net/; SeqWare 
Pipeline, http://sourceforge.net/projects/seqware/; UGET, http://
genome.ucla.edu/~jdong/GeneCorr.html; unabridged protocols, 
http://www.reversade.com-a.googlepages.com/protocols/.
MeThOdS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Homo sapiens IRX5, NM_005853.5; Mus musculus 
Irx5, NM_018826.2; X. laevis Irx5, NM_001085754.1.
Note: Supplementary information is available in the online version of the paper.
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Subjects and clinical assessment. Jordanian index cases were initially diag-
nosed at the Pediatrics Department in Jordan University Hospital by Hanan 
Hamamy5. The affected children in the Turkish family were clinically evalu-
ated at the Medical Genetics Department, Istanbul Medical Faculty, by Hülya 
Kayserili. Ultrasound scanning, electrocardiogram, ophthalmic examination, 
magnetic resonance imaging and dacryoscintillography were undertaken to 
ascertain and document clinical symptoms associated with this syndrome. 
Each participant gave informed consent after approval by the local ethics com-
mission. Additional information is provided in Supplementary Note.
Genotyping and homozygosity mapping. Genomic DNAs of Jordanian 
parents and children were extracted from saliva samples (Puregene DNA 
Purification Kit, Gentra Systems) and genotyped with Illumina Infinium HD 
Human 1M-Duo BeadChips according to manufacturer’s instructions. Call 
rates were >98%, and gender and relationship were verified using Illumina 
BeadStudio software. Mapping was done by searching for shared regions that 
are homozygous and IBD in the three affected individuals using custom pro-
grams written in Mathematica (Wolfram Research) data analysis software. 
Confidence criteria to identify IBD blocks were a minimum of 3 cM and a SNP 
density over the fifth percentile. Centimorgan distances between SNPs were 
determined from the HapMap2 recombination rate map. Candidate regions 
were further refined by exclusion of common homozygous segments with any 
unaffected family members. Homozygosity mapping of the Turkish family was 
done using SNP genotyping data of the affected boy and unaffected parents 
and sibling generated from Affymetrix GeneChip Human Mapping NspI 250K 
arrays. The Visual Genome Studio (VIGENOS) program (Hemosoft) devel-
oped at the Gene Mapping Laboratory facility of Hacettepe University Medical 
Faculty was used for genome-wide haplotyping of SNP data27.
Genomic loci capture. Briefly, custom arrays (Agilent 244K) were designed to 
target every exonic sequence of the genes present in the IBD region on chromo-
some 16 between genomic coordinates 52812847 and 61978673. In total, 730 
contigs encompassing 208042 base pairs were targeted. A DNA library from 
subject 1 was prepared according to the Illumina library generation protocol 
version 2.3, hybridized to custom arrays according to the Agilent CGH 244K 
array protocol, and washed, eluted and amplified28. The sample was submit-
ted to one channel of Illumina flow cell and sequenced by Illumina Genome 
Analyzer (GAII) using standard manufacturer’s protocol. The image data was 
processed by the provided GA Pipeline (Firecrest version 1.3.4 and Bustard 
version 1.3.4) and all sequences were aligned to the human reference genome 
(UCSC, build 18; see URLs) by Blat-like Fast Accurate Search Tool (BFAST; see 
URLs). Variants were called using SAMtools pileup tool (SAMtools; see URLs) 
and the variants were submitted to an internal database for further filtration 
and annotation. Mismatches were filtered to identify variants seen ten or more 
times, in which the variant was called as homozygous and did not overlap 
with a known dbSNP129 entry mismatch. Nonsynonymous mutations were 
identified using additional SeqWare tools and the “knownGene” gene model 
from the UCSC hg18. The open source SeqWare project, which provides a 
Laboratory Information Management System (LIMS) tool for tracking samples 
(SeqWare LIMS) and a pipeline for sequence analysis (SeqWare Pipeline; see 
URLs), was used throughout this work29.
Mutation analysis. Positional candidate genes were obtained from GenBank 
and Ensembl databases (see URLs). Flanking primers for each exon were 
manually designed and direct Sanger resequencing was done with the BigDye 
Terminator cycle sequencing kit (Applied Biosystems). Primer sequences are 
in Supplementary Table 4.
Luciferase assay. 10T1/2, 293T and MS5 cells were cotransfected with luci-
ferase reporters and expression vectors (encoding mouse wild-type Irx5 and 
the A150P, N166K, HD and S36D/S63D variants) at 60–70% confluency using 
Fugene HD (Roche) in 24-well plates. After 48 h of incubation, firefly and 
Renilla luciferase assays were carried out on cell lysates using Dual-Luciferase 
Reporter 1000 Assay System (Promega), and enzyme activities were measured 
with Spectramax plate reader (Molecular Devices). For luciferase assays car-
ried out in vivo, 55 pg of firefly and 3 pg of Renilla constructs were mixed in 
water or in pure Irx5 morpholino and injected into two- to four-cell stage 
X. laevis embryos. Five embryos were lysed in 100 µl at stage 25 and analyzed 
in the same way.
Western blot analysis. Embryos or transfected cells were lysed in RIPA buffer 
supplemented with protease inhibitor cocktails (Roche). Extracted proteins 
were separated by electrophoresis on SDS polyacrylamide gels with DTT, 
followed by transfer on polyvinylidene difluoride membranes. The follow-
ing antibodies were used for probing western blots: mouse antibody to Irx5 
(Sigma; WH0010265M1), mouse antibody to actin (Chemicon; Mab1501R), 
mouse antibody to β-catenin (Sigma; C2206) and mouse antibody to Protein 
C (Roche; 11814508001). To block protein ubiquitin-dependent degradation, 
10 µM lactacystin (Sigma) or MG132 (Calbiochem) was added to cultured 
cells overnight.
Quantitative PCR. We reverse transcribed 1 µg RNA isolated from trans-
fected 10T1/2 cells using the Revert Aid kit (Fermentas) and oligo(dT) primer. 
Quantitative PCR was done with Power SYBR Green (Applied Biosystems). 
Primer sequences are in Supplementary Table 4.
Microinjection of morpholino oligonucleotides and DNAs. The Irx5 mor-
pholino11 and Sdf1 morpholino12 synthesized by Gene Tools were resuspended 
in sterile water to a concentration of 1 mM. At the two- to four-cell stage, 
the Irx5 morpholino was injected pure (123 ng per embryo) and Sdf1 mor-
pholino was injected at 25 ng per embryo. For rescue experiments, 80 pg of 
nonlinearized DNA in pCS2+ encoding wild-type mouse Irx5 or p.Ala150Pro 
and p.Asn166Lys Irx5 variants were co-injected with the Irx5 morpholino. 
Morpholino sequences are in Supplementary Table 4.
Embryological methods. Protocols for fertilization, injections and whole-mount 
in situ hybridization are at our protocol website (see URLs). A stereomicroscope 
equipped with an integrated digital camera (Leica; M205 FA) was used to cap-
ture images of embryos in successive focal planes. Images were then merged 
into one picture with Photoshop CS4 (Adobe).
Coimmunoprecipitation. Proteins were extracted from transfected HEK293T 
with lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.1% Nonidet P-40; 
0.05% deoxycholate, 1 mM CaCl2) supplemented with protease inhibitor cock-
tails (Roche). Protein C–tagged proteins (Gata3 or Trps1) were first immuno-
precipitated on Anti-Protein C Affinity Matrix (Roche) during 5 h at 4 °C. 
After several washes of the matrix with lysis buffer, untagged protein (Irx5 or 
Gata3) was co-incubated overnight at 4 °C. Bound proteins were eluted from 
the beads using a wash buffer (20 mM Tris, pH 7.5, 0.5 M NaCl, 1 mM CaCl2). 
Proteins were dissociated in reducing loading buffer and analyzed by western 
blotting using the indicated antibodies.
Statistical analysis. Each experiment was repeated at least three times and 
data were expressed as mean ± s.d. Significance of pairwise comparisons was 
determined by Student’s t test. Significant differences were considered as those 
with P < 0.05 (*) or P < 0.005 (**).
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ABSTRACT: Pompe disease is an autosomal recessive lyso-
somal glycogen storage disorder, characterized by progres-
sive muscle weakness. Deficiency of acid α-glucosidase
(EC; 3.2.1.20/3) can be caused by numerous pathogenic
variants in the GAA gene. The Pompe Disease Muta-
tion Database at http://www.pompecenter.nl aims to list
all variants and their effect. This update reports on 94
variants. We examined 35 novel and 34 known mutations
by site-directed mutagenesis and transient expression in
COS-7 cells or HEK293T cells. Each of these mutations
was given a severity rating using a previously published
system, based on the level of acid α-glucosidase activity in
medium and transfected cells and on the quantity and qual-
ity of the different molecular mass species in the posttrans-
lational modification and transport of acid α-glucosidase.
This approach enabled to classify 55 missense mutations
as pathogenic and 13 as likely nonpathogenic. Based on
their nature and the use of in silico analysis (Alamut R©
software), 12 of the additional 25 novel mutations were
predicted to be pathogenic including 4 splicing mutations,
6 mutations leading to frameshift, and 2 point mutations
causing stop codons. Seven of the additional mutations
were considered nonpathogenic (4 silent and 3 occurring
in intron regions), and 6 are still under investigation.
Hum Mutat 00:1–6, 2012. C© 2012 Wiley Periodicals, Inc.
KEY WORDS: GAA; Pompe disease; α-glucosidase; acid
maltase; glycogenosis; lysosomal storage disorder
Introduction
Pompe disease (MIM# 232300) also known as glycogen storage
disease type II and acid maltase deficiency encompasses a contin-
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uous clinical spectrum with regard to the age at which the first
symptoms occur. All patients eventually manifest progressive mus-
cle weakness [Engel et al., 2004; Hirschhorn and Reuser, 2001; van
der Ploeg and Reuser, 2008]. The most severely affected infants
(classic-infantile Pompe disease) have hypertrophic cardiomyopa-
thy as additional clinical characteristic. The average life expectancy
of patients with classic-infantile Pompe disease is less than one year
[Kishnani and Howell, 2004; Van den Hout et al., 2003]. Patients
without cardiac involvement can present from early childhood to
late adulthood and have a shorter life expectancy than unaffected
individuals in the same age category [Gungor et al., 2011].
The Pompe Disease Mutation Database aims to list all α-
glucosidase (GAA) variations and to describe their effect so to
facilitate diagnosis and counseling in patients and families with
Pompe disease. It also aims to provide insight in the genotype–
phenotype correlation in this very heterogeneous disease. The 1
July (2011) edition of the Pompe Disease Mutation Database at
http://www.pompecenter.nl provides a list of 372 sequence vari-
ants in the GAA gene (MIM# 606800; RefSeq NT_024871.11;
NM_000152.3; NP 000143.2). Seventy-six of these variants are
marked as nonpathogenic, 248 as pathogenic, 2 are presumably
nonpathogenic, while the effect of 46 other variants is marked as
unknown. One hundred and sixteen of the pathogenic mutations
are listed as very severe, 91 as potentially less severe, 23 as less se-
vere, and 18 as potentially mild. Since then many cases of Pompe
disease patients have been diagnosed and analyzed in our collabo-
rating centers and a wealth of new sequence variations has come to
light. This update of the Pompe disease mutation database reports
on the identification of 60 novel sequence variations including 3
deletions, 3 insertions, 2 nonsense mutations, 4 silent mutations, 4
splice site mutations, and 3 nonpathogenic intronic variations with
predictable effect. Thirty-five novel missense mutations were inves-
tigated regarding their effect on the synthesis and function of acid
α-glucosidase by site-directedmutagenesis and transient expression
in COS-7 or HEK293T cells. Six mutations are still under inves-
tigation. This update further reports on the effect of 33 missense
mutations and 1 in frame deletion that were published previously
but were not yet investigated as to their functional effect.
Methods
The DNA analysis was performed as part of diagnostic prac-
tice with informed consent of the patients. One case in this study
concerned mutation analysis in a proven carrier of Pompe disease.
C© 2012 WILEY PERIODICALS, INC.
All other cases were suspected to be affected with Pompe disease and
diagnosed by a combination of clinical findings and enzymatic assay.
The DNA was isolated from leukocytes or skin fibroblasts. The cod-
ing exons and the exon–intron boundaries of the acid α-glucosidase
gene (GAA) were amplified and subsequently sequenced using an
ABI 3730 DNA Analyser under GLP conditions as described [Kroos
et al., 2008]. NM_000152.3 was used as reference sequence for the
coding regions, whereby the “A” nucleotide of the ATG translation
initiation codon at nucleotide position 368 constitutes +1 number-
ing of the cDNA sequence. This ATG codon represents +1 for the
amino acid numbering as set forth by the acid α-glucosidase pre-
protein sequence NP_000143.2. The positions of intronic sequence
variations were assigned based on the cDNA sequence and the ge-
nomic contig sequence NT_024871.11 whereby the “A” of the ATG
start codon is at position 481925. The three reference sequences
used in this study can be found at http://www.pompecenter.nl.
To investigate whether silent mutations and intronic variations
not located in splice sites could possibly cause alternative splicing,
we performed in silico analysis using the Alamut R© software (In-
teractive Biosoftware, member of the Human Genome Variation
Society and of the EBI SME Support Forum). Because all the mis-
sense mutations and the 9 bp deletion were found in the Caucasian
GAA∗01-type allele, the single-base changes, and the deletion were
introduced in the corresponding wild-type GAA cDNA expression
construct pSHAG2 by site-directed mutagenesis according to the
manufacturer’s protocol (Stratagene R© Quick Change Site-directed
Mutagenesis kit number 200516). The integrity of the resultingmu-
tant constructs was in each case confirmed by full-length sequenc-
ing of the GAA cDNA insert. Two independently obtained mutant
constructs were used to transfect COS-7 or HEK293T cells and to
express acid α-glucosidase. The wild-type GAA cDNA construct
(pSHAG2) and a mock transfection with a plasmid containing a
cDNA construct unrelated to GAA (pITA) served as a positive and
a negative control. The cells were harvested 72 hr later and the acid
α-glucosidase activity (EC: 3.2.1.20/3) was measured in the culture
media and in the cell homogenates using 4-methylumbelliferyl-α-
glucopyranoside as substrate. In addition to measuring the acid
α-glucosidase activities in the media and the cells, the synthesis of
acid α-glucosidase was studied by SDS-PAGE and immunoblotting.
Cell homogenates were directly applied onto the gel. The enzyme in
themedia was first concentrated by immuno-precipitationwith anti
α-glucosidase antibodies and then applied [Hermans et al., 1998].
Different molecular mass species reflect the sequential, posttransla-
tional, and modification steps of the enzyme during transport from
the endoplasmic reticulum to the lysosomes [Hasilik and Neufeld,
1980]. The mutation severity rating that we used was as previously
described and gives an account of the quality and the quantity of
the different molecular mass species as well as the activity of acid
α-glucosidase in the transfected cells and in the media [Kroos et al.,
2008].
Results and Discussion
DNA analyis has become integrated part of the diagnosis of
Pompe disease. Over the past two years, a large number of Pompe
disease patients were seen in our clinical and metabolic diagnostic
centers, and DNA analysis was performed in most cases. One case
in this study concerned mutation analysis in a proven carrier of
Pompe disease. All other cases were suspected to be affected with
Pompe disease and diagnosed by a combination of clinical findings
and enzymatic assay. The DNA was isolated from leukocytes or skin
fibroblasts andDNA analysis was performedwith informed consent
of the patients. Table 1 lists a collection of 68 missense mutations
(Table 1A—novel mutations; and Table 1B—previously published
mutations) and one in-frame deletion (Table 1C) that were inves-
tigated as to their effect. All these mutations were introduced in a
wild-type GAA cDNA expression construct by site-directed muta-
genesis to investigate their effect. The severity of the sequence vari-
ations is judged by a rating system as previously described [Kroos
et al., 2008]. The system takes into account how much of each of
the characteristic forms of acid α-glucosidase (processed and un-
processed) is detectable in transiently transfected cells and in the
medium in which they are maintained. It also judges the quality
of these forms in terms of having the proper molecular mass and
includes the acid α-glucosidase activity in cells and media. The sum
of these recordings results in a severity class, whereby A stands for
“very severe,” B for “potentially less severe,” C for “less severe,” D
for “potentially mild,” E for “presumably nonpathogenic,” and F
for “nonpathogenic” [Kroos et al., 2008]. Class A mutations are
characterized by complete absence of any molecular form of acid
α-glucosidase as detected by immunoblotting (Cross Reactive Im-
munologic Material-negative; CRIM-negative), and by lack of any
residual acid α-glucosidase activity in a transient expression system.
In contrast to class A mutations, class B, C, D, E, and F mutations
are all CRIM-positive.
According to the method of severity rating, none of the 35 newly
discovered missense mutations (Table 1A) received the label “very
severe.” Twenty-fivemutations were classified as “potentially less se-
vere” (class B), and one as “less severe” (class C) on basis of the rela-
tive height of the acid α-glucosidase activity in the transfected cells.
One sequence variant was classified as “potentially mild” (class D)
because that sequence variation allowed formore than 20% residual
activity in the cells, and all molecular forms of acid α-glucosidase
were clearly detectable by immunoblotting. Four missense muta-
tions in this serieswere scored as “presumablynonpathogenic” (class
E) and 4 as “nonpathogenic” (class F) since the introduction of these
sequence variants in the wild-typeGAA cDNA expression construct
did not lead to a dramatic reduction of the acid α-glucosidase ac-
tivity nor to abnormalities in the posttranslational modification.
Class Bmutations aremutations that do not hamper the very first
step of acid α-glucosidase synthesis. The 110 kD precursor protein
is typically detectable in either normal or subnormal amount inside
the cells, but not always in the medium. The apparent molecular
mass can be either normal or abnormal due to differences in charge,
folding, proteolytic processing or glycosylation. Processed forms of
acid α-glucosidase can be absent or present, but are mostly catalyti-
cally inactive. Patients with Pompe disease carrying these mutations
are classified as CRIM-positive patients as they express a molecular
form of acid α-glucosidase that can be visualized by immunoblot-
ting [Bali et al., 2011]. The adjective “potentially” less severe implies
that these variantsmight behave differently in situ. In practice, how-
ever, most of these class B variants are very severe on the basis of
available clinical data.
The missense mutations c.1A>T and c.2T>C both obliterate the
start codon. Interestingly, it seems that in our in vitro system a
downstreamATG is used as alternative start codon since amolecular
species of approximately 85 kD was visible in very low amount in
HEK293T cells transfected with these mutant constructs.
The missense mutation c.266G>A (p.Arg89His) was detected in
combination with c.546+45G>C in both GAA alleles of a severely
affected infant. However, when c.266G>A was analyzed by transient
expression in HEK293T cells, it behaved like a class E variant. We
are currently investigating the possibility that the combination of
c.266G>A with c.546+45G>C is pathogenic.
A previous update of the Pompe Disease Mutation Database in-
cluded 20missensemutations and one deletion of three amino acids
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Table 1A. Severity Rating of Novel Missense Mutations
Severity ratinga
Exon Variant Result M110 C110 C95 C76 M%Wt C%Wt Classb Nr
2 c.1A>T p.? 1,1 2,2c 1,1 1,1 1.0 0 B 1
2 c.2T>C p.? 1,1 2,2c 1,1 1,1 3.6 0 B 2
2 c.221G>A p.Arg74His 4,4 4,4 4,4 4,4 72 103 F 3
2 c.266G>A p.Arg89His 3,4 3,4 3,4 3,4 20.0 43.5 E 4
2 c.307T>C p.Cys103Arg 1,1 3,4 2,4 1,1 1,1 0 B 5
2 c.322T>G p.Cys108Gly 1,1 3,4 3,4 1,1 1.3 8.2 B 6
2 c.380G>T p.Cys127Phe 1,1 5,4 3,4 1,1 2.4 1.5 B 7
3 c.658G>T p.Val220Leu 4,4 4,4 4,4 4,4 100 100 F 8
3 c.664G>A p.Val222Met 4,4 4,4 4,4 4,4 112 98 F 9
3 c.671G>A p.Arg224Gln 2,4 2,4 1,1 1,1 0.1 0.7 B 10
4 c.701C>G p.Thr234Arg 1,1 3,4 3,4 1,1 5.3 1.6 B 11
4 c.701C>A p.Thr234Lys 1,1 3,4 3,4 1,1 3.4 2.7 B 12
5 c.868A>G p.Asn290Asp 4,4 4,4 4,4 4,4 38 71 E 13
5 c.947A>T p.Asn316Ile 2,4 4,4 1,1 1,1 0 0 B 14
6 c.1004G>A p.Gly335Glu 1,1 4,4 3,4 1,1 0.6 0.2 B 15
7 c.1082C>T p.Pro361Leu 1,1 3,2 1,1 1,1 0.1 3.9 B 16
7 c.1190C>T p.Pro397Leu 2,2 4,4 1,1 1,1 0 0 B 17
8 c.1256A>T p.Asp419Val 3,4 3,4 3,4 3,4 5.1 21.3 D 18
9 c.1370C>A p.Pro457His 1,1 3,4 2,4 1,1 0.5 0 B 19
9 c.1373A>G p.Tyr458Cys 3,3 2,4 3,4 3,4 7.0 45 E 20
11 c.1568C>A p.Ser523Tyr 4,4 4,4 2,4 2,4 0 0 B 21
12 c.1672T>A p.Cys558Ser 3,3 4,3 1,1 1,1 0.3 4.8 B 22
12 c.1724A>G p.Tyr575Cys 3,4 3,4 1,1 1,1 0.2 2 B 23
12 c.1726G>C p.Gly576Arg 2,3 4,3 1,1 1,1 0.6 3.8 B 24
13 c.1781G>A p.Arg594His 1,1 4,4 3,4 1,1 1.4 0.1 B 25
13 c.1802C>T p.Ser601Leu 1,1 3,4 2,4 1,1 0.5 0.4 B 26
13 c.1804A>G p.Thr602Ala 4,4 5,4 3,4 3,4 1.8 5.8 C 27
13 c.1879T>C p.Ser627Pro 1,1 2,4 2,4 2,4 0.1 0.5 B 28
13 c.1886C>T p.Pro629Leu 4,4 4,4 4,4 4,4 29.0 49 E 29
14 c.1943G>A p.Gly648Asp 1,1 4,4 1,1 1,1 0 0 B 30
15 c.2105G>T p.Arg702Leu 1,1 5,4 2,4 1,1 1.3 0.4 B 31
15 c.2152G>A p.Val718Ile 4,4 4,4 4,4 4,4 158 127 F 32
16 c.2227C>A p.Gln743Lys 1,1 3,4 3,4 1,1 1.1 4.1 B 33
17 c.2456G>C p.Arg819Pro 1,1 5,4 3,4 1,1 2.0 0.4 B 34
19 c.2746G>T p.Val916Phe 1,1 2,4 2,4 1,1 0 0 B 35
The nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG initiation codon in RefSeq NM_000152.3; the amino acid numbering is
according to NP 000143.2.
a The severity rating in digits reports on the quantity (first digit) and quality (second digit) of the precursor (110 kD), the intermediate (95 kD), and the mature (76 kD) forms of
acid α-glucosidase as they are detectable in the medium (M) of transfected COS-7 and HEK293T cells and in the cell homogenates (C) by immunoblotting. First digit, quantity:
1 = not detectable; 2 = barely detectable; 3 = clearly present, but clearly less than normal; 4 = normal amount; Second digit, quality: 1 = too little present to judge; 2 = apparent
molecular mass too low; 3 = apparent molecular mass too high; 4 = apparent molecular mass normal. The columns labeled M% and C% report on the acid α-glucosidase activity
in the medium (M) and in the cells (C) as percentage of the wild-type activity (Wt).
bClass A mutations are “very severe,” class B mutations are “potentially less severe,” class C mutations are “less severe,” class D mutations are “potentially mild,” class E mutations
are “presumably nonpathogenic,” and class F mutations are “nonpathogenic.”
cOnly one molecular species with a mass of approximately 85 kD was detected.
with unknown functional effect [Kroos et al., 2008]. We have now
analyzed also these mutations as to their effect by transient expres-
sion, and the results are presented inTables 1B and 1C. The samewas
done for thirteen additional missense mutations that were recently
reported in the literature (included in Table 1B). Twenty-five of
those 33missense mutations obtained the classification “potentially
less severe” (class B) (Table 1B). Also the three amino acids deletion
turned out to be a class B mutation (Table 1C). The class E and F
mutations deserve attention as they were scored in our analysis as
being “presumably nonpathogenic” (class E) or “nonpathogenic”
(class F). However, our analysis does not test for splicing defects and
it is notable that c.1075G>A and c.1754G>A are both located near a
splice-site and are predicted by in silico analysis to cause abnormal
splicing. Mutation c.2132C>G is located in cis on a GAA allele that
contains a proven pathogenic mutation. The outcome of c.811A>G
and c.136T>C as nonpathogenic class F mutations remains enig-
matic as they were described in infants with Pompe disease having
only one other proven pathogenic GAAmutation.
The deletion c.461_469del (Table 1C) results in an in-frame dele-
tion of three amino acids. The precursor is smaller than 110 kD, less
abundant, and is not further processed.
Twelve GAA sequence variations, other than missense muta-
tions, were identified with a predictable pathogenic effect (Table 2).
Among these were five mutations causing frame shift, four muta-
tions located in either a splice acceptor or splice donor site, and
two mutations introducing a premature stop codon. One of these
latter two mutations, c.2242G>T (p.Glu748∗) in exon 16, was tran-
siently expressed in HEK293T cells to confirm its deleterious effect.
In accordance with the position of the premature stop, we thereby
detected a truncated form of acid α-glucosidase with a molecular
mass of approximately 86 kD. In vivo, however, this nonsensemuta-
tion might lead to nonsense mediated mRNA decay. Furthermore,
in silico analysis predicts that c.2242G>Tmight also lead to aberrant
splicing.
Apart frompathogenicmutationswe encountered seven sequence
variations with a predictable nonpathogenic effect (Table 3A). Four
of them were silent and three were located deeper in the introns. In
silico analysis did not predict any of these sequence variations to be
pathogenic.
Moreover, these variations were found in the DNA of patients
who had two other clearly pathogenic sequence variations. Fi-
nally, Table 3B lists six novel GAA sequence variations that require
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Table 1B. Severity Rating of Previously Published Missense Mutations
Severity ratinga
Exon Variant Result M110 C110 C95 C76 M%Wt C%Wt Classb Refc
2 c.136T>C p.Ser46Pro 4,4 4,4 4,4 4,4 85.3 100.2 F b
3 c.569G>A p.Arg190His 1,1 3,4 1,1 1,1 1.3 3.9 B a
3 c. 650C>T p.Pro217Leu 1,1 3,4 1,1 1,1 2.1 13.3 C b
3 c. 671G>C p.Arg224Pro 1,1 3,4 1,1 1,1 0.8 0 B c
4 [c.752C>T+ c.761C>T] [p.Ser251Leu+p.Ser254Leu] 1,1 3,4 1,1 1,1 1.7 3.3 B c
4 c.811A>G p.Thr271Ala 4,4 4,4 4,4 4,4 71.7 83.6 F c
4 c.853C>T p.Pro285Ser 3,4 3,4 3,4 3,4 0.2 4.8 C a
5 c.871C>T p.Leu291Phe 3,4 4,4 3,4 3,4 0.7 0.7 B a
5 c.872T>C p.Leu291Pro 3,4 4,4 3,4 2,4 1.4 0.7 B a
5 c.953T>A p.Met318Lys 1,1 3,4 2,4 1,1 0.2 3.2 B a
6 c.1003G>A p.Gly335Arg 1,1 4,4 3,4 1,1 0.4 0.8 B a
6 c.1040C>G p.Pro347Arg 2,4 2,4 1,1 1,1 0.8 1 B a
6 c.1075G>A p.Gly359Arg 2,4 3,4 3,4 3,4 14.2 54.3 E d
10 c.1445C>G p.Pro482Arg 2,3 4,4 2,4 1,1 0 0 B a
10 c.1448G>T p.Gly483Val 2,3 4,4 2,4 1,1 0 0 B a
10 c.1456G>C p.Ala486Pro 3,3 4,3 1,1 1,1 3,0 0 B b
11 c.1561G>C p.Glu521Gln 3,4 4,4 2,4 1,1 0 0 B a
11 c.1564C>T p.Pro522Ser 1,1 2,4 2,4 1,1 0.8 0.8 B a
11 c.1574T>A p.Phe525Tyr 4,4 4,4 4,4 4,4 9.8 13.4 D c
12 c.1669A>T p.Ile557Phe 2,4 3,3 2,4 2,4 0.3 2.7 B c
12 c.1673G>C p.Cys558Ser 2,4 3,3 2,4 2,4 0.3 2.1 B e
12 c.1710C>G p.Asn570Lys 1,1 3,4 2,4 1,1 0.5 0.9 B a
12 c.1716C>G p.His572Gln 2,3 3,3 1,1 1,1 0 0 B a
12 c.1754G>A p.Arg585Lys 4,4 4,4 4,4 4,4 89 94 F a
13 c.1781G>C p.Arg594Pro 1,1 3,4 2,4 1,1 0.2 1.2 B a
13 c.1834C>T p.His612Tyr 2,4 3,3 2,4 2,4 0.2 0.0 B b
13 c.1841C>A p.Thr614Lys 1,1 3,4 2,4 1,1 0.1 1.7 B a
14 c.1905C>A p.Asn635Lys 1,1 2,4 1,1 1,1 0.1 0.0 B b
15 c.2132C>G p.Thr711Arg 4,4 3,4 4,4 4,4 65.3 86.0 F c
16 c.2210C>A p.Thr737Asn 1,1 4,4 2,4 2,4 0 0 B a
16 c.2228A>G p.Gln743Arg 2,4 3,4 2,4 2,4 1.0 0.8 B a
16 c.2237G>C p.Trp746Ser 1,1 3,4 2,4 2,4 2.0 0.1 B a
20 c.2804T>C p.Leu935Pro 1,1 2,4 2,4 1,1 0.8 0.5 B a
The nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG initiation codon in RefSeq NM_000152.3; the amino acid numbering is
according to NP 000143.2.
a,bAnnotations are the same as those in Table 1A.
cThe letters refer to publications first reporting on these variations: a (Kroos et al., 2008), b (Oba-Shinjo et al., 2009), c (Labrousse et al., 2009), d (Muller-Felber et al., 2007), and
e (Alcantara-Ortigoza et al., 2010).
Table 1C. Severity Rating of a Deletion of Three Amino Acids
Severity ratinga
Exon Variant Result M110 C110 C95 C76 M%Wt C%Wt Classb Refc
2 c.461_469del p.Arg154_Thr156del 1,1 3,2 1,1 1,1 1.4 0.5 B a
The nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG initiation codon in RefSeq NM_000152.3; the amino acid numbering is
according to NP 000143.2.
a,bAnnotations are the same as those in Table 1A.
cThe letter refers to the publication first reporting on this variation: a (Kroos et al., 2008 listed in Table 5).
further investigation. Among these are three novel missense mu-
tations, one in frame deletion, and two intronic variations that
can potentially affect splicing. For instance, 546+45G>C could be
pathogenic as the patient was homozygous for this mutation and
had only one other homozygous sequence variation, c.266G>A
(p.Arg89His), which by itself was found to be nonpathogenic (Ta-
ble 1A). Alternatively, the combination [c.546+45G>C+266G>A]
might be pathogenic.
Conclusion
New mutations continuously emerge and add to the remark-
ably long list of sequence variations in the GAA gene coding for
acid α-glucosidase, one of the many lysosomal enzymes. Sixty-
eight of the 94 sequence variants, presented in this study, re-
ceived the label “pathogenic” based on the nature of the muta-
tions or on the effect they had on the synthesis and function
of acid α-glucosidase when transiently expressed in cells trans-
fected with mutated GAA-cDNA constructs. Eighty-one percent
of the 68 missense mutations that we investigated were proven
to be pathogenic and to hamper the synthesis or posttransla-
tional processing of acid α-glucosidase, but none of these muta-
tions blocked the synthesis completely (class B mutations). Patients
with one of these mutations are likely to present as CRIM-positive
individuals because their mutant acid α-glucosidase immunologi-
cally cross-reacts with antibodies raised against the normal human
enzyme.
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Table 2. Novel Frame Shifts, Premature Stops and Splice-Site
Mutations
Position Variant Result Predicted effectNr
Exon 2 c.186_196dup p.Arg66Hisfs∗80 Pathogenic 36
Exon 2 c.483dup p.Lys162Glnfs∗15 Pathogenic 37
Exon 4 c.836G>A p.Trp279∗ Pathogenic 38
Exon 8 c.1293_1312del p.Gln433Aspfs∗66 Pathogenic 39
Intron 10 c.1551+1G>T r.0? Pathogenic 40
Intron 11 c.1637-2A>G r.0? Pathogenic 41
Exon 13 c.1848dup p.Val617Argfs∗19 Pathogenic 42
Intron13–intron14 c.1889-27_2040+23del p.Glu630_Leu680delfs Pathogenic 43
Exon16 c.2242G>T p.Glu748∗ Pathogenic 44
Intron 17 c.2481+1G>A r.0? Pathogenic 45
Intron 17 c.2481+2T>C r.0? Pathogenic 46
Exon 18 c.2495_2496del Thr832Asnfs∗51 Pathogenic 47
The nucleotide numbering reflects cDNA numbering with +1 corresponding to the A
of the ATG initiation codon in RefSeq NM_000152.3; the amino acid numbering is
according to NP 000143.2.
Table 3A. Novel Silent Mutations and Intronic Variants
Position Variant Result Predicted effect Nr
Exon 2 c.54C>T p.( = ) Nonpathogenic 48
Exon 5 c.861C>T p.( = ) Nonpathogenic 49
Exon 5 c.915G>A p.( = ) Nonpathogenic 50
Intron 7 c.1194+5G>A – Nonpathogenic 51
Exon 14 c.1923G>A p.( = ) Nonpathogenic 52
Intron 14 c.2041-64del – Nonpathogenic 53
Intron 18 c.2646+39G>A – Nonpathogenic 54
The nucleotide numbering reflects cDNA numbering with +1 corresponding to the A
of the ATG initiation codon in RefSeq NM_000152.3.
Table 3B. Novel Sequence Variations Still to be Investigated
Position Variant Result Predicted effect Nr
Intron 2 c.546+45G>C r.spl? – 55
Exon 5 c.929T>G p.Val310Gly – 56
Exon 7 c.1171A>G p.Met391Val – 57
Intron 8 c.1326+5G>A r.spl? – 58
Exon 13 c.1832G>A p.Gly611Asp – 59
Exon 15 c.2097_2102del p.Thr700_Leu701del – 60
The nucleotide numbering reflects cDNA numbering with +1 corresponding to the A
of the ATG initiation codon in RefSeq NM_000152.3; the amino acid numbering is
according to NP 000143.2.
Thesenewfindingswill be entered in thePompeDiseaseMutation
Database at www.pompecenter.nl with the aim to facilitate diagnosis
and counseling of patients and families with Pompe disease and to
provide better insight in the genotype–phenotype correlation and
the effect of therapy in this very heterogeneous disease.
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Abstract Background Coagulation factor II G20210A
and coagulation factor V (Leiden) G1691A single nucleo-
tide polymorphisms (SNPs) are major inherited risk factors
of venous thromboembolism. In view of the heterogeneity
in their world distribution and lack of sufficient informa-
tion about their distribution among Chechans, we addres-
sed the prevalence of these SNPs in the Chechan
population in Jordan, a genetically isolated population.
Methods and Results factor II G20210A and factor V
Leiden SNPs were analysed by polymerase chain reaction
and restriction fragment length polymorphism (PCR–
RFLP) method and Amplification refractory mutation
detection system (ARMS) respectively in 120 random
unrelated subjects from the Chechan population in Jordan.
Among the subjects studied for factor II G20210A muta-
tion there were three individuals carrying this mutation as
heterozygous (one female and two male), giving a
prevalence of 2.5 % and an allele frequency of 1.25 %. No
homozygous factor II allele was found. Factor V Leiden
G1691A mutation was detected as heterozygous in 22 of
120 of individuals (17 female and five male) indicating a
prevalence of 18.3 % and allele frequency of 9.2 %. No
homozygous allele was found. Conclusion Our results
indicated that prevalence of factor II G20210A mutation in
the Chechan population is similar to prevalence in Jordan
and Caucasian populations (1–6 %) while the prevalence
of factor V Leiden was higher in the Chechan population
compared to Jordan and Caucasian populations (2–15 %).
Keywords Genetic polymorphisms  Ethnicity 
Thrombosis
Introduction
Thrombosis represents one of the most common causes of
morbidity and mortality in societies [1]. Haemostatic dis-
equilibrium is the key mechanism for all types of thrombo-
ses. Venous thrombosis (VTE) is a common multifactorial
disease involving the interaction of environmental factors
such as aging, obesity, surgery, pregnancy and post-partum,
and oral contraceptives or cancer, with genetic predisposing
risk factors [1]. The most common genetic risk factors
implicated in VTE, are the polymorphisms of the pro-
thrombin G20210A and factor V Leiden [2–4]. The study of
their frequencies in various populations provides perspec-
tives for both clinical medicine, population genetics and
biological anthropology [1].
Dahlback et al. [5]. reported activated protein C resis-
tance (APCR) which until now has constituted the most
frequently encountered genetic abnormality in patients
with VTE (20–30 % of cases). This condition is due in
R. Dajani (&)
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more than 90 % of cases to a single mutation (G1691A) in
the factor V gene [2]. In 1996, Poort et al. [4] described
factor II G20210A which is present in 8–10 % of throm-
bosis patients. The coinheritance of these relatively com-
mon genetic conditions, which is not a rare event, further
increases the relative risk of thrombosis, i.e., factor V
Leiden plus factor II G20210A [6, 7]. Similarly, the com-
bination with an environmental risk factor is associated
with a substantial increased risk of venous thromboembo-
lism [8].
Flanking SNPs and microsatellites demonstrate a single
origin for both factor II G20210A and factor V G1691A
and indicate that the polymorphisms arose 1,050–1,200
generations ago (21,000–36,000 years ago for 20–30 year
generations) [9, 10]. Based on the frequencies of the two
polymorphisms, it has been suggested that they originated
in the Middle East. Several studies argued that factor II
G20210A and factor V G1691A were maintained at poly-
morphic frequencies among Caucasoids, because they
conferred an evolutionary advantage of reduced bleeding
[11]. The various prevalences of thrombophilia in different
ethnic populations have been established. A high preva-
lence of the factor V Leiden mutation in Middle Eastern
subjects and a virtual absence of this mutation in Asian
population has been suggested [9]. The ethnic and geo-
graphic distribution prevalence of factor II G20210A and
factor V Leiden among general population ranges from 1 to
4 and 3 to 15 %, respectively [1].
These genetic prothrombotic factors demonstrate
peculiar patterns of geographical distribution and there-
fore represent valuable tools for population genetics. We
are interested in studying the prevalence of these
thrombophilic mutations in the Chechan population in
Jordan. The Chechans, who call themselves Noxchii and
their land Noxchiin moxk, are the largest indigenous
nationality of the North Caucasus. Most of Chechans in
Jordan belong to the Naqshbandi tariqat [12]. The
Chechans immigrated to Jordan about 140 years ago and
are genetically isolated because of cultural reasons.
Chechans in Jordan have managed to keep their separate
sense of identity and ethnicity during the last one hundred
years, even after large waves of Bedouin and Palestinian
immigration into Jordan over the course of the twentieth
century. The Chechan population is around 10,000 [13].
Jaradat has confirmed that the mitochondrial DNA vari-
ation in the HV1 region is significantly different between
the Chechan and Arab populations in Jordan (S. Jaradat,
personal communication).
This study aimed to assess the prevalence of factor II
G20210A and factor V Leiden in 120 unrelated random
samples from the Chechan population, living in Jordan. We
hypothesize that the prevalences of these thrombophilic
mutations in this population are different from other
populations because of their separate ethnicity. Since the
prevalences of these thrombophilic mutations are studied in
the Chechan population in Jordan we also wanted to
compare the prevalences of these factors in the general
Jordanian population and to other countries and world
regions. This is the first report on the prevalence of these
factors in the Chechan population.
Materials and methods
This study has been approved by the IRB committee at the
Hashemite University.
A random sample of unrelated individuals (N = 120) of
both sexes, mean age of 45 (range 13–81 years) from the
Chechan population in Jordan were recruited after signing
a consent form indicating their acceptance to participate in
the study. The sample size was calculated based on the
assumption that the prevalence of factor II mutation in the
Caucasian population is 2 %. The sample size needed to
estimate the prevalence of factor II mutation with a pre-
cision of 3 % at a level of confidence of 95 % is 88 sub-
jects. The sample size was calculated using Epicalc 2000.
The samples were taken during the period between August
2008 and March 2009. Each participant in the study filled
out a survey that included pedigree information. The names
and ethnicity of parents, grandparents, great grand parents
both maternal and paternal and any individual with non
Chechan heritage for even one person in his/her pedigree
was excluded.
Sample collection
Nine millilitre of whole blood was drawn in EDTA tubes
from 120 peoples by Vacutainer system. Genomic DNA
was isolated from whole blood sample using the phenol–
chloroform protocol [14].
PCR-reactions
The PCR-reactions [4] were performed in a final volume of
25 lL containing 5 lL from 5X Go Taq buffer (Promega)
for factor II, and 109 buffer (Applied Biosystem) for factor
V, 2.5 lL from 2 mM dNTPs (invitrogen) 15 lL sterile
distilled water, 10 pmol forward and 10 pmol reverse
primers (Alpha DNA, Canada), 1 U (5 U/lL) Taq poly-
merase (Go Taq DNA polymerase, Promega) and 1.5 lL
target DNA (50–100 lg/mL).
Detection of the G20210A polymorphism in factor II
gene was performed by means of polymerase chain reac-
tion followed by restriction enzyme analysis. The forward
9134 Mol Biol Rep (2012) 39:9133–9138
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primer for factor II (G20210A) is 50-TCTAGAAA-
CAGTTGCCTGGC-30 and the reverse primer is 50-ATA-
GCACTGGGAGCATTGAAGC-30 [4]. The thermal
cycling conditions for factor II consisting of 5 min dena-
turation at 95 followed by 35 cycles of denaturation at
95 C for 25 s, annealing at 55 C for 25 s, extension at
72 C for 40 s, then the final extension step at 72 C for
5 min and kept at 4 C until use. After overnight incuba-
tion with 5 U of HindIII restriction enzyme for the
G20210A at 37 C, PCR reactions were run on 3 % aga-
rose gels for 1.30 h at 90 V stained with ethidium bromide.
The factor II wild type had only one band: 345 bp,
G20210A genotype had three bands: 345, 322 and 23 bp,
and AA homozygote had two bands: 322 and 23 bp.
For factor V Leiden (G1691A) the PCR reaction were
carried out by Amplification refractory mutation detection
system (ARMS), the wild-type primer is 50-GGA-
CAAAATACCTGTATTCCTC-30, the mutant primer is 50-
GGACAAAATACCTGTATTCCTT-30, and the common
primer is 50-CTTTCAGGCAGGAACAACACC-30 [15].
The thermal cycling conditions consisting of 5 min dena-
turation at 95 followed by 35 cycles of denaturation at
95 C for 25 s, annealing at 61 C for 25 s, extension at
72 C for 40 s, then the final extension step at 72 C for
5 min, kept at 4 C until use. PCR reaction was run on 2 %
agarose gel for 45 min at 150 V and stained with ethidium
bromide, the product size was 233 bp.
Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS), version 15. Frequen-
cies, percentages, and means were used to describe data.
Data were expressed as percentages of the mean or as
frequency of the allele. Percentages were compared using
v2-test or Fisher exact test wherever appropriate. A p value
of less than 0.05 was considered statistically significant.
Results
The prevalences and allele frequencies of factor II
G20210A and factor V Leiden G1691A were determined
for 120 random unrelated Chechan subjects. The subjects
were of both sexes 43 males (36 %) and 77 females (64 %)
with a mean age of 45 (range 13–81 years).
Among the 120 individuals studied for factor II
G20210A mutation there were three individuals carrying
this mutation as heterozygous (one female and two male),
giving a prevalence of 2.5 % (95 % CI: 0–5.3) and an
allele frequency of 1.25 %. No homozygous factor II allele
was found (Fig. 1). There was no significant difference in
factor II G20210A frequency with respect to gender (4.7 %
in males vs. 1.3 % in females) (Table 1). Furthermore, the
observed homozygote to heterozygote ratio was consistent
Fig. 1 Detection of factor II
gene mutation G20210A by
PCR–RFLP analysis. HindIII
digested fragment were
separated by 3 % agarose gel
electrophoresis and visualized
by ethidium bromide staining.
Lanes 1, 3–9, 11–15 represent
an individuals with normal
factor II genotype, 345 bp.
Lanes 2, 10 represent an
individuals with heterozygous
for FII-G20210A digested by
HindIII, 345 and 322 fragments
Table 1 Genotype and allele frequency of factor II G20210A mutation














Total 120 117 (97.5) 3 (2.5) 0–5.3 0.292 0.00 1.25
Male 43 41 (95.3) 2 (4.7) 0–10.9 0.00 2.3
Female 77 76 (98.7) 1 (1.3) 0–3.8 0.00 0.65
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with the Hardy–Weinberg equilibrium (p = 0.975,
pq = 0.025, and q = 0) v2 = 0.02, p [ 0.05.
Factor V G1691A mutation was detected as heterozy-
gous in 22 of 120 of individuals (17 female and five male)
indicating a prevalence of 18.3 % (95 % CI 11.4–25.2) and
allele frequency of 9.2 %. No homozygous allele was
found, Fig. 2. There was no significant difference in factor
V Leiden frequency with respect to gender (11.6 % in
males vs. 22.1 % in females) (Table 2). Furthermore, the
observed homozygote to heterozygote ratio was consistent
with the Hardy–Weinberg equilibrium (p = 0.817,
pq = 0.183, and q = 0.00) v2 = 0.99, p [ 0.05.
There are no subjects with both mutations in factor II
and factor V Leiden.
Discussion
The prevalence of factor II mutation in the Caucasian
population varies between 1 and 6 %, with an overall
prevalence of about 2 % [1]. In Jordan the prevalence of
factor II G20210A mutation was 2 % [16]. Our studies
have found that the prevalence of factor II G20210A is
2.5 % in the Chechan population comparable to the prev-
alence in Jordan. The prevalence of factor II mutation is
rarely seen in Asian populations [17]. Among Arab popu-
lations the allele frequency is 1.36 % in Lebanon, 1.28 %
in Tunis, 0.52 % in Bahrain and 0.0 % in Saudi Arabia
[18]. In a separate study on Middle Eastern Arab popula-
tions the prevalence has been reported to be 1.7 % [19].
Fig. 2 Detection of factor V
Leiden gene mutation G1691A
by polymerase chain reaction–
Amplification refractory
mutation system (PCR–ARMS)
analysis. Bands were separated
by 2 % agarose gel
electrophoresis and visualized
by ethidium bromide staining.
Lane M represents a 100-bp
molecular weight marker. Every
number represents two lanes;
numbers 1, 3, 4–11, 13, 15–20
represents normal FV genotype
with one band in first lane for
every numbers (241 bp).
Numbers 2, 12, and 14
represents heterozygous factor
V Leiden mutation (R506Q)
with two bands in both lanes for
every number. Number 21
represents positive control for
factor V Leiden mutation.
Number 22 represents negative
control for factor V Leiden
mutation. Number 23 represents
blank
Table 2 Genotype and allele frequency of factor V Leiden mutation














Total 120 98 (81.7) 22 (18.3) 11.4–25.2 0.156 0.0 9.2
Male 43 38 (88.4) 5 (11.6) 2.0–21.2 0.0 5.8
Female 77 60 (77.9) 17 (22.1) 12.8–31.3 0.0 11.0
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The allele frequency of factor II in the Turkish population
and Turkish Cypriotes is 1.37 and 4.0 % respectively [20].
Among southern Europeans a rate of 3 % for factor II
polymorphism has been reported which is higher than the
1.7 % reported for northern European populations [21]
(Table 3).
The prevalence of factor V Leiden varies between 2 and
15 % in the healthy Caucasian population [1]. The preva-
lence factor V Leiden in the Chechan population is 18.3 %.
In comparison with percentage of prevalence for Jordani-
ans 15 % [16] and more recently 21.8 % in a study done by
Nusier et al. [22], the Chechans have a higher percentage
than other populations. A high prevalence of factor V
Leiden has been reported in Caucasians but not in non-
Caucasians [1]. For example the allele frequency of factor
V Leiden polymorphism among Caucasoid subpopulations
ranges from 1 to 8.5 %. This polymorphism is not found
among African blacks Chinese, Japanese and native North
and South Americans or Greenland Inuits [9].
The mean allele frequency among European populations
is 2.7 %. In Cyprus the incidence is 12 % and in Sweden is
15 % [23]. Among Arabs the highest frequency is in Leba-
non 7.88 % followed by Tunis 3.5 %, Bahrain 1.5 % and
Saudi Arabia 1.0 % [18]. The allele frequency in north India
is 1.9 % [24], in western Iran 2.97 % and in Tehran 5.5 %
[25]. The frequency in Turkey is 4.5–4.9 % [23]. The allele
frequency in the Chechan population is 9.2 % which is high
compared to other populations (Table 4). Thus suggesting a
single origin of the mutation. The data obtained from dif-
ferent studies support and suggest that this mutation arose in
the Eastern Mediterranean and migrated to European regions
with the migrants [9]. This supports the history that states the
Chechans to be more ancient as a race having a higher
prevalence of factor V Leiden.
Thus, factor II G20210A and factor V Leiden are
restricted to European populations, which tends to argue
for their monocentric origin. Their founding effect is pos-
terior to the separation of the Caucasoids and Mongoloids
(21,000–34,000 years ago according to haplotype analysis)
[9, 10] and their dispersion was probably associated with
the Neolithic migrations into Europe [11]. In their review
of about 6,000 individuals from 26 populations from Eur-
ope and neighbouring countries, Lucotte and Mercier [23]
concluded that factor V Leiden may have expanded from
the Anatolian region, close by the zone where the process
of agriculture is thought to have begun.
Factor V Leiden is the largest inherited risk factor of
VTE [26]. However, the pathogenesis of VTE is multi-
factorial [1]. Although our results do not support random
screening for factor V Leiden, its high prevalence among
apparently healthy individuals in the Chechan population
recommends screening for factor V Leiden in relatives of
factor V Leiden carriers, in individuals with family history
of VTE, and in high-risk situations, including pregnancy,
use of oral contraceptives, and surgery.
Thus, these two inherited prothrombotic polymorphisms
represent interesting tools for population genetics studies.
The knowledge of these frequencies in the Middle East
region through population-based studies will contribute to
a better understanding of the interaction between genetic
and environmental risk factors underlying thrombosis. The
relationship between venous thrombophilia and these
mutations have to be further studied in the Chechan
population.
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Table 3 Genotype frequency of factor II G20210A mutation in dif-
ferent populations






Saudi Arabia 0.0 [18]
Turkish 1.37 [20]
Turk cypriotes 4.0 [20]
Southern Europeans 3 [21]
Northern Europeans 1.7 [21]
Asians Rare [17]
Table 4 Allele frequency of factor V Leiden mutation in different
populations







Saudi Arabia 1 [18]
Turkey 4.5–4.9 [23]
North India 1.9 [24]
Western Iran 2.97 [25]
Tehran 5.5 [25]
Sweden 15 [23]
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Short communication
Sanjad Sakati syndrome: a case series from Jordan
J. Albaramki,1 K. Akl,1 A. Al- Muhtaseb,1 M. Al-Shboul,2 T. Mahmoud,2 M. El-Khateeb 2 and H. Hamamy 3
ABSTRACT Sanjad Sakati syndrome is a rare autosomal recessive disorder that has been described in Arabs. We 
report 8 patients from 7 Jordanian families, 6 of whom underwent genetic testing and were found to have a 12 
bp (155-166 del) deletion within the tubulin-specific chaperone E (TBCE gene) in exon 3 at 1q42-43. All patients 
had severe growth retardation, distinct phenotypic features and hypoparathyroidism. Parental consanguinity was 
recorded in all families. This is the first genetically proven case series of Sanjad Sakati syndrome in Jordan.
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ﻥﺩﺭﻷﺍ ﻦﻣ ﺕﻻﺎﺣ ﺔﻠﺴﻠﺳ :ﰐﺎﻛﺎﺳ ﺩﺎﺠﻧﺎﺳ ﺔﻣﺯﻼﺘﻣ
ﻲﻣﺎﲪ ﻥﺎﻨﺣ ،ﺐﻴﻄﳋﺍ ﺪﻤﳏ ،ﺩﻮﻤﳏ ﺍﺭﺎﲤ ،ﻝﻮﺒﺸﻟﺍ ﺪﻤﳏ ،ﺐﺴﺘﺤﳌﺍ ﺀﺎﻴﻠﻋ ،ﻞﻘﻋ ﻝﲈﻛ ،ﻲﻜﻣﺍﱪﻟﺍ ﺔﻧﺎﲨ
 ﻦﻣ ﴇﺮﻣ 8 ﻦﻋ ﻥﻮﺜﺣﺎﺒﻟﺍ ﻎﻠﺑﺃ ﺪﻗﻭ .ﺏﺮﻌﻟﺍ ﲔﺑ ﻪﻔﺻﻭ ﻖﺒﺳ ﻲﺤﻨﺘﳌﺍ ﻱﺪﺴﳉﺍ ﻲﻐﺒﺼﻟﺎﺑ ﻂﺒﺗﺮﻣ ﺭﺩﺎﻧ ﺏﺍﺮﻄﺿﺍ ﻲﻫ ﰐﺎﻛﺎﺳ ﺩﺎﺠﻧﺎﺳ ﺔﻣﺯﻼﺘﻣ :ﺔﺻﻼﳋﺍ
 (TBCE) ﻱﺇ ﲔﻟﻮﺑﻮﻴﺘﻟﺍ ﻦﻋ ﻝﻭﺆﺴﳌﺍ ﻲﻋﻮﻨﻟﺍ ﲔﳉﺍ ﻦﻤﺿ (del 155-166)  ﻊﺿﻮﳌﺍ ﰲ ﻦﺒ ﹶﺧ ﺪﺟﻭﻭ ،ﺕﺎﻨﻴﳉﺍ ﺭﺎﺒﺘﺧﺍ ﺎﻬﻨﻣ 6 ـﻟ ﻱﺮﺟﺃ ،ﺔﻴﻧﺩﺭﺃ ﴎﺃ 7
 ﺓﺭﻭﺎﺠﳌﺍ ﺩﺪﻐﻟﺍ ﰲ ﺭﻮﺼﻗﻭ ،ﻱﺮﻫﺎﻈﻟﺍ ﻂﻤﻨﻟﺍ ﰲ ﺓﺰﻴﳑ ﺢﻣﻼﻣ ﻊﻣ ،ﻮﻤﻨﻟﺍ ﰲ ﺪﻳﺪﺷ ﺮﺧﺄﺗ ﴇﺮﳌﺍ ﻊﻴﲨ ￯ﺪﻟ ﻥﺎﻛﻭ .1q42-43 ﻊﺿﻮﳌﺍ ﰲ 3 ﻥﻮﺴﻜﻳﻹﺍ ﰲ
 ﰐﺎﻛﺎﺳ ﺩﺎﺠﻧﺎﺳ ﺔﻣﺯﻼﺘﳌ ﺎﲥﺎﺒﺛﺇ ﻢﺗ ﻲﺘﻟﺍ ﺔﻴﺛﺍﺭﻮﻟﺍ ﺕﻻﺎﺤﻠﻟ ﺔﻠﺴﻠﺳ ﻝﻭﺃ ﻲﻫ ﻩﺬﻫﻭ .ﴎﻷﺍ ﻊﻴﲨ ﰲ ﻦﻳﻮﺑﻷﺍ ﲔﺑ ﺔﺑﺍﺮﻗ ﺩﻮﺟﻭ ﻞ ﱢﺠ ﹸﺳﻭ .(ﺕﺎﻘﻳﺭﺪﻟﺍ) ﺔﻴﻗﺭﺪﻠﻟ
.ﻥﺩﺭﻷﺍ ﰲ
Le syndrome de Sanjad-Sakati : une série de cas en Jordanie
RÉSUMÉ Le syndrome de Sanjad-Sakati est un trouble autosomique récessif rare qui a été décrit dans la 
population arabe. Nous avons étudié les dossiers de huit patients faisant partie de sept familles jordaniennes ; 
les analyses génétiques réalisées sur six d'entre eux ont révélé une délétion de 12 bp (155-166 del) dans l'exon 3 
localisé en 1q42-43 dans le gène TBCE codant la protéine chaperon E spécifique de la tubuline. Tous les 
patients présentaient un grave retard de croissance, des caractéristiques phénotypiques singulières et une 
hypoparathyroïdie. Une consanguinité des parents a été observée dans toutes les familles. Il s'agit de la première 
série de cas du syndrome de Sanjad-Sakati confirmés génétiquement en Jordanie.
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Introduction
Sanjad Sakati syndrome or hypopar-
athyroidism-retardation-dysmorphism 
(HRD) is an autosomal recessive disorder 
that was first described in 1988 [1]. It is 
characterized by congenital hypoparathy-
roidism, growth and mental retardation 
with distinct phenotypic features. It is 
linked to the TBCE gene on chromosome 
1q42-43 which encodes for the tubulin-
specific chaperone E protein [2–4].
Sanjad Sakati syndrome has been re-
ported in areas of the Middle East and has 
a high prevalence among Arabs. Since it 
may be confused with other syndromes 
that can present with hypocalcaemia 
and dysmorphic features, genetic testing 
allows Sanjad Sakati to be excluded in 
any child presenting with hypocalcaemia 
and deep-set eyes. The availability of ge-
netic testing enables accurate diagnosis 
of affected children, discovery of carriers 
and prospective counselling as well as 
prenatal diagnosis of Sanjad Sakati syn-
drome in high-risk families.
This case series reports 8 patients 
with Sanjad Sakati syndrome from 7 
families in Jordan, 6 of whom had genet-
ic testing. There have been no previous 
reports with genetic testing from Jordan. 
Case series
Hospital records were reviewed for the 
period 2001–2009 only these 8 cases 
were found. Information was extracted 
from the medical records and personal 
interview.
All the patients first presented 
during the neonatal period, at around 
2–3 weeks of age, with hypocalcaemic 
seizures. Two of the patients were first 
seen in 2007, 2 in 2004 and 1 each 
in 2001, 2002, 2006, 2009. Their cur-
rent mean age is 5 years (range 11 
months–10 years). There were 3 fe-
males and 5 males and 6 of them had 
low birth weight.
All 8 patients had measurements 
taken of their calcium, phosphorus and 
parathyroid hormone (PTH) levels; 7 
had brain imaging and skeletal survey, 
and 3 patients had an ophthalmologi-
cal assessment. All of the patients were 
diagnosed biochemically to have hy-
poparathyroidism by the low levels 
of PTH, hypocalcaemia and elevated 
phosphorus levels (Table 1). All of 
the patients were put on vitamin D 
and calcium supplements. One patient 
developed generalized non-uraemic 
calcification and another had mild bi-
lateral medullary renal nephrocalcino-
sis as a complication of the treatment. 
One patient had refractory hyper-
phosphataemia.
Three patients had recurrent hos-
pital admissions for various infections, 
such as pneumonia and meningitis, and 
2 patients died at home in 2009 from 
unknown causes. 
Phenotypic features
All the patients had severe failure to 
thrive, microcephaly, delayed motor 
milestones, mental retardation and 
learning difficulties. All of them had 
teeth abnormalities such as delayed 
teething, dental caries or abnormal 
teeth. They had distinct dysmorphic 
features including deep-set eyes, mi-
crognathia, depressed nasal bridge, 
microphthalmia, prominent forehead 
and small hands and feet (Figure 1, Ta-
ble 2).One patient had large ears and a 
high-arched palate.
Family history
Parental consanguinity was reported 
in all 7 families. The parents of 3 cases 
were first cousins. Three patients had 
a positive family history of the same 
condition, 2 of them were siblings. One 
of the patients had a sibling who had 
been diagnosed prenatally by genetic 
testing at 11 weeks of pregnancy and 
the mother had undergone a selective 
abortion of the affected fetus.
Imaging results
Seven patients underwent brain imag-
ing: 2 cases showed bilateral symmetri-
cal calcifications in the basal ganglia, 1 
had thinning of the corpus callosum 
and 1 patient had craniosynostosis; the 
rest had normal brain imaging. Skeletal 
survey was normal in all patients. Bone 
age was assessed for 2 patients and was 
delayed in both.
Table 1 Characteristic of cases






PTH Brain CT Consanguinity Genetic 
testing
Died
1 Male Apr-2004 7.9 8.6 Low Not done Second degree Yes –
2 Male Nov-2001 6.3 10.0 Low Calcification, thin 
corpus callosum
Second degree No –
3 Male Jun-2006 4.80 13.7 Low Normal Second degree No –
4. Male Oct-2007 7.79 8.44 Low Normal First degree Yes Yes
5 Male Aug-2007 8.69 8.58 Low Normal First degree Yes –
5 Female Aug-2002 6.32 9.68 Low Normal First degree Yes Yes
7 Female Aug-2009 4.95 11.95 Low Craniosynostosis Second degree Yes –
8 Female Feb-2004 7.90 7.3 Low Calcification Second degree Yes –
PTH = parathyroid hormone; CT = computed tomography.
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Ophthalmological assessment
Ophthalmological assessment was done 
for 3 patients and it showed abnormal 
retinal vessels dilatation and tortuos-
ity in 1, bilateral dense central corneal 
opacity suggestive of congenital cataract 
in another who needed lensectomy, and 
papilloedema in the third patient.
Genetic testing
EDTA-blood samples  were col-
lected from each patient at the time of 
presentation, and DNA was extracted 
using the conventional phenol–chlo-
roform proteinase K method [5]. The 
isolated DNA was dissolved in water and 
diluted to a concentration of 200 ng/μL.
Polymerase chain reaction (PCR) 
was performed to identify 12 bp 
(155–166 del) deletion in exon 3 of 
the TBCE gene since this mutation has 
been commonly described in of San-
jad Sakati syndrome in nearby Middle 
Eastern countries. Samples were am-
plified in duplicate along with positive 
and negative controls. The sequence of 
forward and reverse PCR primer was 
designed by Primer 3 software. PCR 
reactions were carried out in 25 μL reac-
tion mixture containing 10 mmol/L 
Tris hydrochloride pH 8.3, 50 mmol/L 
potassium chloride, 1.5 mmol/L mag-
nesium chloride, 0.2 mmol/L dNTPs, 
10 mmol/L primers and 1 U of hot star 
Taq polymerase (Qiagen, USA). The 
amplification conditions used were: 
95 °C for 4 minutes, followed by 30 cy-
cles at 94 °C for 45 seconds, annealing 
at 62 °C for 45 seconds and extension at 
72 °C for 1 minute. PCR products were 
directly run over 3% (3:1) low electro-
endosmosis (LE) and low molecular 
mass polypeptide (LMP) agarose gel 
(Promega, USA) for 120 minutes at 
80 V in 1 × Tris boric EDTA buffer. 
The gel was then stained with ethidium 
bromide (Promega, USA), visualized 
by illumination with ultraviolet light, 
and documented by photography (Gel 
Doc, Bio-Rad, USA). The size of the 
product was about 138 bp for the nor-
mal allele and 126 bp for the mutant 
allele (Figure 2).
Six patients underwent genetic test-
ing. All of them had 12 bp (155–166 del) 
deletion within the TBCE gene in exon 3.
For prenatal diagnosis, around 30 
mg of chorionic villi were obtained at 11 
weeks of gestation using the transcervi-
cal approach. Chorionic villi were rinsed 
in hypotonic solution (37% sodium 
chloride) and the whitish, branched tis-
sue which represent the fetal tissue were 
used for DNA extraction by the phenol–
chloroform–proteinase K method [5].
Prenatal diagnosis was carried out 
for 1 case for a consanguineous couple 
with 2 affected children (boy and girl). 
The fetal sample showed homozygous 
deletion of the 12 bp (155–166 del) 
within the TBCE gene in the fetus. Both 
parents were heterozygous for the dele-
tion mutation.
Discussion
This is the first genetically proven case 
series of Sanjad Sakati syndrome from 
Jordan. A recent review from Kuwait 
revealed a high incidence of the condi-
tion of 7–8 per 100 000 live births [3].
Sanjad Sakati syndrome is a rare 
autosomal recessive disorder and was 
first described in Arabs by Sanjad et al. in 
Saudi Arabia in 1988 [1] and in 1991 [6], 
followed by reports from other coun-
tries [7–9]. In 1998, Parvari et al. used 
homozygosity and linkage disequilib-
rium to map the gene on chromosome 
1q42-43 [2] and in 2002 demonstrated 
that mutation of the TBCE gene caused 
Sanjad Sakati and autosomal recessive 
Kenny–Caffey syndrome [3].
Figure 1 One of our patients with low-set 
ears, deep-set eyes and micrognathia: 
permission was granted by the family to 
show the photograph
Table 2 Clinical picture of Sanjad Sakati syndrome in 8 Jordanian patients





Small hands and feet 8
Hypoparathyroidism 8
Mental retardation and learning difficulties 8
Affected sibling 3
Consanguinity 8
First cousin parents 3/7a
Second cousin parents 4/7a
Positive genetic testing 6
Normal skeletal survey 8
Brain calcification 2/7b
Thin corpus callosum 1/7b
aNo. of families assessd = 7.
bOne patient did not have brain imaging.
IUGR = intrauterine growth retardation.
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The TBCE gene encodes for a pro-
tein that participates in beta tubulin 
folding. Homozygous deletion of 12 bp 
in exon 3 of the TBCE gene was con-
firmed to be the cause of this syndrome 
(OMIM 241410) [4]. This mutation 
has been described in Arabs with Sanjad 
Sakati syndrome, but in 2006 Cour-
ten et al. described a 4.5-year-old girl 
with the syndrome who did not have a 
mutation in the TBCE gene and found 
another possible gene locus [10]. 
The syndrome can be confused with 
autosomal recessive Kenny–Caffey 
syndrome, caused by mutation in the 
TBCE gene, that shares similar phe-
notypic features but in addition has 
osteosclerosis, medullary stenosis of 
long bones, and normal intelligence. 
Sanjad Sakati syndrome is characterized 
by congenital hypoparathyroidism, pre-
natal and postnatal growth retardation, 
developmental delay as well as mental 
retardation. The common dysmorphic 
features are microcephaly, prominent 
forehead, deep-set eyes, micrognathia, 
depressed nasal bridge, small hands 
and feet, dental anomalies and micro-
phthalmia. Ophthalmic manifestations 
include errors of refraction, retinal 
Figure 2 Lanes 1, 2, 4: homozygous for 12 bp (155–166 del) deletion; Lane 3: 
heterozygous for 12 bp (155–166 del) deletion; Lanes 5: negative controls; Lane 6: 
blank and M: 50 bp DNA ladder
vascular tortuosity, strabismus [11], 
and corneal opacities [12]. Thin corpus 
callosum has been described in patients 
with this syndrome [13]. Patients with 
Sanjad Sakati syndrome have increased 
susceptibility to recurrent infections but 
have normal immunological profile. Di 
George syndrome should also be con-
sidered in patients with hypoparathy-
roidism but these patients usually have 
cardiac defects and impaired immune 
functions and special facial features dif-
ferent from those found in Sanjad Saka-
ti syndrome. Genetic testing is used to 
differentiate between these syndromes.
Our patients had a high rate of pa-
rental consanguinity reaching 100%, 
much higher than the 12.5% reported 
in Kuwait indicating a high rate of het-
erozygous carriers in Kuwait [7].
The treatment of patients with Sanjad 
Sakati syndrome is a challenge for most 
physicians especially in controlling their 
high phosphate levels, and the adverse 
effects of therapy include generalized cal-
cifications, as seen in one of our patients.
Nowadays, genetic testing for San-
jad Sakati syndrome can confirm the 
diagnosis and provide the option of pre-
natal testing in families with an affected 
child, or for parents with genetically 
proven carrier state.
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Background
Temtamy preaxial brachydactyly syndrome (OMIM: 605282) is a rare autosomal
recessive disorder first described in 1998. In 2010, CHYS1 was identified as the
causative gene. So far, the syndrome has been reported and homozygous CHYS1
mutations have been confirmed in 11 patients from consanguineous families
originating from Turkey (n=3), Egypt (n=2), Pakistan (n=3), Jordan (n=2), and
Sri Lanka (n=1).
Patients and methods
Here, we report on five new Egyptian patients with Temtamy preaxial brachydactyly
syndrome from three consanguineous families. Phenotype analysis of all reported
positive cases in the literature, including our patients (n=16), is carried out to define
the characteristic clinical features of this syndrome.
Results
All five patients were found to have recessive mutations in CHYS1. One family was
compound heterozygous and all the other families carried homozygous missense
mutations. Phenotype analysis of all reported positive cases in the literature defined
and confirmed the characteristic clinical features, mainly the facial dysmorphism,
typical digital malformations, and associated anomalies.
Conclusion and recommendations
We conclude that Temtamy preaxial brachydactyly syndromeTPBS is an easily
identifiable dysmorphic syndrome. The rarity of worldwide reports could be because of
underdiagnosis. Because of some phenotypic overlap with other preaxial
brachydactyly syndromes, further clinical and molecular research is required to define
possible genetic heterogeneity, genotype–phenotype correlations, and the functional
role of encoded proteins in digital differentiation and development.
Keywords:
CHYS1, phenotype definition, skeletal development, Temtamy preaxial brachydactyly
syndrome
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Introduction
Temtamy preaxial brachydactyly syndrome (TPBS; MIM
605282) was first reported in 1998 in an Egyptian patient
as a new autosomal recessive multiple congenital anomaly
syndrome characterized by bilateral, symmetric preaxial
brachydactyly and hyperphalangism of the digits, facial
dysmorphism, dental anomalies, sensorineural hearing
loss, and delayed motor and mental development
(Temtamy et al., 1998). An additional Egyptian patient
with similar manifestations apart from hearing loss was
further described by Temtamy and Aglan (2008).
The TPBS causative gene studied in the two previously
reported Egyptian patients and in an additional three sibs
from a consanguineous Turkish family was first reported
at the European Society of Human Genetics (ESHG)
annual meeting in Vienna, 2009 (Li et al., 2009).
Molecular studies were carried out on an additional
patient from Sri Lanka and on three Pakistani sibs with
TPBS (Race et al., 2010), in addition to those presented
at the ESHG meeting (2009) by Li et al. (2010). The
researchers showed that loss of chondroitin synthase 1
(CHSY1) function underlies the pathogenesis of auto-
somal recessive TPBS. CHSY1 encodes an evolutionarily
conserved type II transmembrane protein comprising a
Fringe motif and a glycosyltransferase domain, whose
combined enzymatic activity is crucial for the biosynth-
esis of chondroitin sulfates. The researchers also obtained
similar zebrafish phenotypes after CHSY1 knockdown as
well as overexpression, which might explain why in
64 Original article
2090-8571 & 2012 Middle East Journal of Medical Genetics DOI: 10.1097/01.MXE.0000414918.78299.94
Copyright © Middle East Journal of Medical Genetics. Unauthorized reproduction of this article is prohibited.
humans, brachydactyly can be caused by mutations
leading either to loss or to gain of bone morphogenetic
protein/growth and differentiation factor signaling. This
was further supported by a back-to-back manuscript
by Tian et al. (2010) reporting on two affected siblings
with TPBS, offspring of consanguineous Jordanian
parents. The researchers detected a truncating frameshift
mutation in the same gene CHSY1 and concluded that
CHSY1 is a secreted FRINGE enzyme required for the
adjustment of NOTCH signaling throughout human and
fish embryogenesis and particularly during limb pattern-
ing (Tian et al., 2010).
In this study, we contribute to the literature five
additional Egyptian TPBS patients with CHYS1 muta-
tions aiming to identify the clinical manifestations in all
reported cases in order to define the phenotypic
spectrum of this syndrome.
Patients and methods
Five Egyptian patients (four boys, one girl) from three
unrelated families were diagnosed at the Limb Malforma-
tions and Skeletal Dysplasia Clinic, National Research
Centre (NRC), with TPBS. Two families had two similarly
affected sibs each. All patients were offspring of con-
sanguineous parents. Their age at presentation ranged from
1 year and 10 months to 7 years and 5 months. Pedigree
analysis, clinical and orodental examination, anthropometric
measurements, radiological studies of limb anomalies, and
bone densitometry (DEXA) were carried out for all cases.
Intelligence quotient assessment, hearing test by audio-
metry, eye examination, abdominal ultrasound, and brain
imaging were carried out for selected cases.
Molecular studies
Genomic DNA was isolated from whole-blood samples using
the standard phenol/chloroform extraction method. To check
for CHSY1 mutations, the following PCR primers were
used: E1F (50-GAGCTAAGCCGGAGGATGTG-30) and E1R
(50-ATCCCGCCTCTGATCTTTTC-30) for exon 1; E2F
(50-GAACCAAGCAGGCCAAGTAG-30) and E2R (50-CCAA
CTTCAACCCTCAAAGA-30) for exon 2; E3F1 (50-TTT
GTGTGCTGTGGTCCATT-30) and E3R1 (50-GTAAA
TACGCGTGCCTCCTC-30), E3F2 (50-TGGAGATGATC
AATGCCAAC-30) and E3R2 (50-TGGGTCATACTGGCT
GAAGA-30), and E3F3 (50-TGCCTGTGTCTGGAGAG
TTTT-30) and E3R3 (50-AGGCAAACACTGATCACC
TTC-30) for exon 3.
PCR reactions were carried out at a final volume of 50 ml
containing 100 ng template DNA using HotStarTaq DNA
polymerase (Qiagen, New York, USA). The PCR thermal
cycling program was set as follows: 951C for 15min,
followed by 35 cycles of 45 s denaturation at 951C, 50 s
annealing at 561C, and 50 s of extension at 721C, with a
final extension at 721C for 10min. PCR products were gel
recovered using the QIAquick Gel Extraction Kit
(Qiagen). Sequence analysis was carried out using the
BigDye Terminator cycle sequencing kit (Applied Bio-
systems, California, USA), and products were run on a




A 7.5-year-old boy, the first child of apparently healthy
parents who are first cousins, was referred to us because
of short stature and hand anomalies. He has a normal
female sib and a similarly affected younger brother
(Fig. 1a). Pregnancy and delivery histories were un-
remarkable. He had a normal history of motor develop-
ment. On examination, frontal bossing, a round flat face,
wide palpebral fissures, and microstomia and micro-
gnathia were noted (Fig. 1b). Orodental manifestations
included a high arched palate and a deep overbite.
Skeletal examination indicated brachydactyly with radial
deviation of the first to third fingers, clinodactyly of the
third and fourth fingers, and camptodactyly of the fourth
and fifth fingers, with skin webbing between the fingers
(Fig. 1c). Both feet had low inserted broad and short
big toes, with clinodactyly of the second to fifth toes
and a wide gap between the big toes and the second
toes (Fig. 1d). Mild pectus excavatum was noted.
Muscle tone and reflexes were normal. No abnormal-
ities in the external genitalia were noted. Radiographs
of both the hands showed preaxial brachydactyly with
hyperphalangism of the index fingers and flexion
deformity in the left second proximal and distal
phalanges (Fig. 1e). His bone age was severely
delayed. Short toes with hypoplastic medially deviated
middle and terminal phalanges were detected on
radiographs of both feet. An extra phalanx was seen
at the right toes (Fig. 1f). His height was 103.3 cm
(– 3.9 SD); the weight and head circumference mea-
surements were consistent with his age. A learning
disability was reported. Stimulation tests indicated a
normal growth hormone level. The thyroid profile was
normal. Serum calcium, phosphorus, and alkaline
phosphatase were normal. No abnormalities were
detected by computed tomographic scan of the brain.
Fundus examination was normal. DEXA indicated
osteopenia at the femur and the spine (Z-scores:
– 1.34 and – 1.21, respectively). Abdominal ultrasound
indicated mild hepatosplenomegaly.
Patient 2
A 4-year-old boy, younger brother of patient 1, was
studied. On examination, he was found to be similarly
affected as his older brother (patient 1). Facial features
and digital anomalies are shown in Fig. 1g–k.
Molecular studies on both the patients indicated a
(TGT4CGT; c.2251T4C) homozygous mutation in exon
3 of CHSY1, causing a missense mutation (p.C751R) in the
extracellular type-A glycosyltransferase domain of CHSY1
(Figs 4a and 5a, d). Each parent was heterozygous for the
same single nucleotide polymorphism.
Family 2
Patient 3
A 6.5-year-old boy, offspring of parents who are first
cousins, was studied. He has a normal older brother
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and had a twin sib who died at birth. There was a mild
delay in motor development. On examination, double
hair whorl, frontal bossing, a round flat face, wide
palpebral fissures, malar hypoplasia, microstomia,
micrognathia, a short neck, and low-set nipples with
redundant skin at the abdomen were observed
(Fig. 2a). Orodental manifestations included a highly
attached thick upper labial frenum, enamel hypopla-
sia, and hypocalcification in addition to microdontia
and a talon cusp in the upper central incisors (Fig. 2b).
A panoramic view indicated absent lower permanent
first incisors and confirmed talon cusps. Hand exam-
ination indicated preaxial brachydactyly with short,
low inserted thumbs; a wide space between the first
and the second fingers, clinodactyly of the fifth
fingers, and abnormal dermatoglyphics (Fig. 2c). The
patient had limited supination of both elbows. Knock
knees, brachydactyly with bilateral low inserted broad
big toes, a wide gap between the first and the second
toes, and bilateral medial deviation of all toes more on
the left side were observed (Fig. 2d). Exaggerated
hyperlordosis with mild scoliosis were additional
skeletal features. He had hypotonia, normal reflexes,
and normal external genitalia. A radiograph of both the
hands showed short first and second metacarpals, an
extra phalanx at the index fingers, flexion deformity of
the third metacarpophalangeal joints, and hypoplastic
pointed distal phalanx of fifth fingers (Fig. 2e). Short
broad delta epiphyses of the first metatarsals, short
quadrangular proximal phalanx, and hyperphalangism
of the first toes were detected on a radiograph of both
feet (Fig. 2f). His height at 7.5 years of age was 107 cm
(– 3.0 SD) and his head circumference was 49.5 cm
(– 2.0 SD); his weight was the mean weight for his age.
Psychological assessment indicated a cooperative child
with delayed language, and his intelligence quotient was
within the category of mild mental subnormality. The
thyroid profile was normal. MRI of the brain indicated a
hypovoluminous peritrigonal white matter with an abnor-
mal white matter signal suggestive of postischemic brain
insult (Fig. 2g). Fundus examination was normal. Hearing
assessment showed bilateral otitis media. DEXA indicated
borderline osteoporosis at the femur (Z-score: – 2.09) and
osteopenia at the spine (Z-score: – 1.36). Abdominal ultra-
sound indicated mild hepatosplenomegaly.
Molecular studies showed a homozygous single nucleo-
tide polymorphism (GGG4TGG; c.664G4T) in exon 2
Figure 1
(a) Pedigree of family 1. (b) Facial features of patient 1. (c, d) Hands and feet of patient 1. (e, f) Radiographic films of the hands and feet of patient 1.
(g) Facial features of patient 2. (h, i) Hands and feet of patient 2 (j, k). Radiographic films of the hands and feet of patient 2. Note the characteristic
facial features with a wide-eye look, relative macrophthalmos, and malar hypoplasia. Preaxial brachydactyly, abducted thumbs and big toes,
hyperphalangism, and camptodactyly are evident in the hands and feet.
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of CHSY1, leading to a missense mutation, p.G222W, in
the FRINGE domain of the CHSY1 enzyme (Figs 4b and




A 6.5-year-old boy, offspring of apparently normal parents
who are first cousins, was studied. He has a normal female
Figure 2
(a) Facial features of patient 3. Note the round face, wide-eye look, malar hypoplasia, and short neck. (b) Dental anomalies of patient 3 showing talon
cusps. (c, d) Hands and feet of patient 3. (e, f) Radiographic films of the hands and feet of patient 3. Note the preaxial brachydactyly, abducted
thumbs and big toes, hyperphalangism, and camptodactyly. (g) MRI scan of the brain of patient 3 showing an abnormal white matter signal.
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sib and a younger similarly affected sister (Fig. 3a).
Pregnancy and delivery histories were unremarkable. He
had a normal history of motor development. On examina-
tion, frontal bossing, a flat face with malar hypoplasia, wide
palpebral fissures, and microstomia and micrognathia were
noted (Fig. 3b). Orodental manifestations included a
Figure 3
(a) Pedigree of family 3. (b) Facial features of patient 4. (c, d) Hands and feet of patient 4. (e, f) Radiographic films of hands and feet of patient 4. (g)
Facial features of patient 5. (h, i) Hands and feet of patient 5. (j, k) Radiographic films of the hands and feet of patient 5. Note the milder affection
compared with that in patients 1–3.
Figure 4
Chromatogram sequencing results showing the mutated codon in each family, all arising from single nucleotide polymorphisms in the homozygous
state (families 1 and 2) or a compound heterozygous state in family 3.
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pseudo lower labial cleft, a thick upper labial frenum, a
high arched palate, and enamel hypocalcification. Hand
examination indicated brachydactyly, low inserted broad
thumbs, short second and third fingers with a medial
deviation of the left index finger, and broad metaphyses at
the wrists (Fig. 3c). Both feet had low inserted broad and
short big toes with a wide gap between the big toes and
the second toes and a medial deviation of the second to
fifth toes (Fig. 3d). Muscle tone and reflexes were normal.
No abnormalities in the external genitalia were noted. A
radiograph of both the hands showed short first metacar-
pals with hyperphalangism of the first and second fingers,
short proximal phalanges of all fingers, and short middle
and terminal phalanges of first to third fingers (Fig. 3e). A
radiograph of both feet indicated a bilateral adducted
forefoot with replacement of the first metatarsal by short
deformed bones, short toes with hypoplastic medially
deviated phalanges, and hyperphalangism of the big toes
(Fig. 3f). His anthropometric measurements were consis-
tent with his age, although relatively short limbs were
noted. Serum calcium, phosphorus, and alkaline phospha-
tase were normal. No abnormalities were detected by
computed tomography scan of the brain. Hearing assess-
ment was normal.
Patient 5
A 2-year-old girl, the younger sister of patient 4, was
studied. On examination, she was found to be similarly
affected as her older brother. The facial features and
digital anomalies are shown in Fig. 3g–k.
Molecular studies on both the patients indicated
compound heterozygosity in exon 3, CCT4TCA
(c.1075C4T) and AGA4ACA (c.1763G4A), causing,
respectively, the heterozygous missense changes p.P359S
and p.R588T (Figs 4c and 5c, d).
Table 1 presents the phenotype analysis of our five new
reported cases with TPBS and the 11 previously reported
cases (all associated with autosomal recessive CHSY1
mutations) in order to define the phenotypic spectrum of
the syndrome.
Discussion
The present study reports on five additional Egyptian
patients, offspring of consanguineous parents with the
Figure 5
Chondroitin synthase 1 (CHSY1) proteins from human, cattle, dog,
mouse, frog, fish, chicken, fly, and worm were aligned for the
phylogenetic conservation of the affected amino acid C751 in family
1 (a) and G222 in family 2 (b; red asterisks). The compound
heterozygous mutation affecting residues P359 and R588 in family 3
are conserved in vertebrate species, but not in invertebrate species
(c; blue asterisks). (d) Summary of reported mutations in CHSY1 in
probands with Temtamy preaxial brachydactyly syndrome. The novel
mutations found in this study are shown in red (top), whereas mutations
described in previous studies are shown in black (bottom).
Table 1 Phenotype analysis of reported Temtamy preaxial








Carpal–tarsal fusion 5/16 31
Development
Learning disability, mental subnormality 10/16 63
Delayed motor development 6/16 38
Short stature 9/16 56
Craniofacial anomalies
Wide-eye look and malar hypoplasia 15/16 94
Round face 12/16 75
Microstomia and micrognathia 9/12 56
Dental anomalies 12/16 75
Talon cusps 2/16 12.5
Other skeletal manifestations
Osteopenia/osteoporosis 5/NA
Pectus deformity 4/16 25
Coxa valga/genu recurvatum, talipes deformity 2/16 12.5









Sensorineural hearing affection 4/16 25
Laryngomalacia 1/NA
Brain neuroimaging changes
Cerebellar vermis anomalies 2/NA
Cortical atrophy 3/NA
Degenerative cortical and cerebellar changes 1/NA
Other affected systems
Mild hepatosplenomegaly 2/NA
Recurrent severe respiratory tract infections 2/NA
Renal anomalies 1/NA
Hypocellular bone marrow 1/NA
Severe progressive course 2/16 12.5
ENT, ears, nose, throat; NA, not applicable.
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TPBD phenotype, including the characteristic facial
features and digital anomalies reported previously
by Temtamy et al. (1998). The five patients from three
families were found to have CHYS1 missense mutations.
Three of the described TPBS cases in this report had a
novel homozygous mutation in either exon 2 or 3 of the
CHYS1 gene, leading to missense mutations in residues
that are highly conserved across vertebrate and inverte-
brate species (Fig. 5). Two sibs were compound hetero-
zygous and had a milder phenotype. The occurrence of
compound heterozygous Egyptian sibs, offspring of
consanguineous parents, suggests a high mutation rate
in the community, which warrants further investigations.
The mutation rate for CHSYI should be determined in
various populations.
Phenotype analysis of the 16 reported cases indicates that
preaxial brachydactyly, hyperphalangism, camptodactyly,
and clinodactyly are universal findings in the syndrome.
Mental subnormality, short stature, a round face, relative
microcephaly, a wide-eye look, malar hypoplasia, dental
anomalies, microstomia, micrognathia, and osteopenia or
osteoporosis were common findings. Follow-up of the first
reported case in the literature by the first two authors of
this manuscript indicated the progressive course of the
syndrome with the development of kyphoscoliosis, pectus
excavatum, osteoporosis, and degenerative cortical and
cerebellar developments (Temtamy et al., 2010). This
emphasizes that follow-up of affected patients is
necessary to detect the progressive nature of the
syndrome, the appearance of brain changes using MRI,
and the deafness apparent with age in some cases.
Of importance to the role of functional polymorphisms of
CHSY1 in the general populations is a recent genome-
wide association meta-analysis that reported that allelic
variants near CHSY1 were significantly associated with
central corneal thickness in mixed Asians (Cornes et al.,
2012). This finding lends further support to CHSY1’s role
during zebrafish and human eye morphogenesis as
reported by Tian et al. (2010).
Awareness of the characteristic findings in the syndrome is
important for a proper diagnosis and further molecular
studies. TPBS is an easily recognizable dysmorphic syn-
drome. The rarity of worldwide reports could be because of
underdiagnosis. Clarkson et al. (2004) described a case as the
Catel–Manzke syndrome and questioned the possibility of
an extended phenotype or a probable new syndrome. After
reviewing the manuscript, the possibility of TPBS in this
patient was considered by Temtamy (2005).
Because of some phenotypic overlap with other preaxial
brachydactyly syndromes, further clinical and molecular
research is required to define a possible genetic hetero-
geneity, genotype–phenotype correlations, milder expres-
sivity in compound heterozygotes, and the roles of other
genes and their encoded proteins in digital differentiation
and growth. It is important to integrate CHSY1 function
in the cascade of signaling events controlled by the bone
morphogenetic protein/growth and differentiation factor
pathway, which is most often deregulated in human
brachydactylies. In particular, it will be pivotal for
understanding the role of CHSY1 in characterizing its
proteoglycan targets. These targets should be post-
translationally modified by the covalent addition of
chondroitin sulfate moieties, and they serve as essential
glycosminoglycans during limb patterning and outgrowth.
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ARTICLE
TMEM237 Is Mutated in Individuals with a Joubert
Syndrome Related Disorder and Expands the Role
of the TMEM Family at the Ciliary Transition Zone
Lijia Huang,1,21 Katarzyna Szymanska,2,21 Victor L. Jensen,3,21 Andreas R. Janecke,4,5 A. Micheil Innes,6
Erica E. Davis,7 Patrick Frosk,8 Chunmei Li,3 Jason R. Willer,7 Bernard N. Chodirker,8
Cheryl R. Greenberg,8 D. Ross McLeod,6 Francois P. Bernier,6 Albert E. Chudley,8 Thomas Mu¨ller,4
Mohammad Shboul,9 Clare V. Logan,2 Catrina M. Loucks,6 Chandree L. Beaulieu,1 Rachel V. Bowie,10
Sandra M. Bell,2 Jonathan Adkins,11 Freddi I. Zuniga,12 Kevin D. Ross,13 Jian Wang,14
Matthew R. Ban,14 Christian Becker,15 Peter Nu¨rnberg,15,16 Stuart Douglas,1 Cheryl M. Craft,12
Marie-Andree Akimenko,17 Robert A. Hegele,14 Carole Ober,13 Gerd Utermann,5 Hanno J. Bolz,18,19
Dennis E. Bulman,20 Nicholas Katsanis,7 Oliver E. Blacque,10 Dan Doherty,11 Jillian S. Parboosingh,6
Michel R. Leroux,3,22,* Colin A. Johnson,2,22 and Kym M. Boycott1,22,*
Joubert syndrome related disorders (JSRDs) have broad but variable phenotypic overlap with other ciliopathies. The molecular etiology
of this overlap is unclear but probably arises from disrupting common functional module components within primary cilia. To identify
additional module elements associated with JSRDs, we performed homozygosity mapping followed by next-generation sequencing
(NGS) and uncovered mutations in TMEM237 (previously known as ALS2CR4). We show that loss of the mammalian TMEM237, which
localizes to the ciliary transition zone (TZ), results in defective ciliogenesis and deregulation ofWnt signaling. Furthermore, disruption of
Danio rerio (zebrafish) tmem237 expression produces gastrulation defects consistent with ciliary dysfunction, and Caenorhabditis elegans
jbts-14 genetically interacts with nphp-4, encoding another TZ protein, to control basal body-TZ anchoring to the membrane and cilio-
genesis. Both mammalian and C. elegans TMEM237/JBTS-14 require RPGRIP1L/MKS5 for proper TZ localization, and we demonstrate
additional functional interactions between C. elegans JBTS-14 and MKS-2/TMEM216, MKSR-1/B9D1, and MKSR-2/B9D2. Collectively,
our findings integrate TMEM237/JBTS-14 in a complex interaction network of TZ-associated proteins and reveal a growing contribution
of a TZ functional module to the spectrum of ciliopathy phenotypes.Introduction
Ciliopathies, including the Joubert syndrome related dis-
orders (JSRDs [MIM 213300]), represent an expanding
group of physiological and developmental disorders
caused by dysfunction of primary cilia.1–4 These microtu-
bule-based structures are present on nearly every cell
type in mammals and perform critical functions asso-
ciated with sensory perception (e.g., vision, hearing, smell,
and mechanosensation) and developmental signaling
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developmental syndromes that are characterized by a
specific midhindbrain malformation (hypoplasia of the
cerebellar vermis; abnormally deep interpeduncular fossa
at the level of the isthmus and upper pons; and horizontal-
ized, thickened and elongated superior cerebellar pedun-
cles), visualized as the molar tooth sign (MTS) on brain
imaging. Additional findings can include polydactyly,
ocular coloboma, retinal dystrophy, renal disease, and
hepatic fibrosis.8 The JSRDs are genetically heterogeneous
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these only account for approximately 50% of mutations in
affected individuals.8 The typically autosomal-recessive
and genetically heterogeneous ciliopathies Meckel-Gruber
syndrome (MKS [MIM 249000]), nephronophthisis (NPHP
[MIM 256100]), and Bardet-Biedl syndrome (BBS [MIM
209900]) phenotypically overlap with the JSRDs. MKS is
a more severe group of disorders characterized by posterior
fossa defects including occipital encephalocele as well as
cystic dysplastic kidneys, hepatic bile duct proliferation,
and polydactyly.25 NPHP is characterized primarily by
renal cysts and is the most frequent cause of end-stage
kidney disease in the first three decades of life.26 Primary
features of BBS include rod-cone dystrophy, polydactyly,
truncal obesity, learning disabilities, hypogonadism
and/or genital anomalies, and renal manifestations
including NPHP.2,3
The ciliary basal body is a modified centriolar structure
that is anchored to theplasmamembraneand is responsible
for nucleating the ciliary axoneme, whose formation
depends on intraflagellar transport (IFT). The transition
zone (TZ), termed connecting cilium in photoreceptor
cells, is the most proximal region of the axoneme and is
characterized by Y-shaped structures of unknown composi-
tion that join the axonemal doublet microtubules to
the ciliary membrane. Recently, many JSRDs/MKS/NPHP
proteins have been found to localize either at the basal
body, or more specifically, at the ciliary TZ just distal to
the basal body.24,27 These include the evolutionarily con-
served B9 domain-containing proteins (MKS1 [MIM
609883], MKSR1/B9D1 [MIM 614144], and MKSR2/B9D2
[MIM 611951]) as well as MKS3/Meckelin/TMEM67 [MIM
609884], MKS5/RPGRIP1L [MIM 610937], MKS6/CC2D2A
[MIM 612013], NPHP1 [MIM 607100], and NPHP4 [MIM
607215]. Studies in Caenorhabditis elegans have provided
evidence that TZ-associated proteins collectively par-
ticipate in basal body-TZ anchoring to the membrane
and establishing a functional ciliary gate during ciliogene-
sis.27–30 Several related roles for many of the above-men-
tioned proteins in mammalian cells have been ascribed,
including basal body migration, docking, ciliogenesis,
ciliary gate function, and cellular signaling.24–26,31,32
Whether there are additional TZ components relevant to
these cellular processes, some of which could be implicated
in human diseases, remains unclear.
Here, we identified mutations in TMEM237 in individ-
uals affected with a JSRD and studied this largely uncharac-
terized gene, which encodes a predicted tetraspan
transmembrane protein (TMEM) TMEM237/JBTS-14.
Our findings reveal that TMEM237 is important for cilio-
genesis in mammalian cells, Danio rerio (zebrafish), and
C. elegans. Importantly, we show that TMEM237 interacts
functionally with NPHP4, MKS2, MKSR1/B9D1, MKSR2/
B9D2, and MKS5/RPGRIP1L at the transition zone.
Together, our studies expand the interaction network of
TZ proteins and reveal a growing contribution of the TZ
in ciliogenesis, signaling, and the JBTS-MKS-NPHP ciliop-
athy spectrum.714 The American Journal of Human Genetics 89, 713–730, DecembMaterial and Methods
Research Subjects
We used standard methods to isolate genomic DNA from periph-
eral blood of the affected persons and family members or from
frozen fetal tissue or amniocytes. Informed consent was obtained
from all participating individuals, and the studies were approved
by the Ethics Boards of the Children’s Hospital of Eastern Ontario,
Leeds (East) Local Research Ethics Committee, University of
Calgary, University of Washington, the University Hospital of
Cologne, Duke University, and according to Austrian legislation.
Homozygosity Mapping and Haplotype Analysis
Hutterite Families
A genome scan was initiated with DNA samples from four affected
individuals. The samples were amplified individually with a set
of 400 polymorphic microsatellite markers (ABI PrismTM Linkage
Mapping Set Version 2) with an average spacing of 10 cM and
heterozygosity of 0.79. Criteria for regions of interest included
homozygosity in at least two out of the four affected individuals
and allele sharing in the remaining affected individual(s). For
candidate regions, DNA from nine affected individuals and their
family members were analyzed with the markers of interest as
well as additional microsatellite markers from the 5 cM Linkage
Mapping Set (Applied Biosystems) and/or from the Ge´ne´thon,
deCode, or Marshfield maps. Haplotypes were constructed manu-
ally, and phase was assigned on the basis of the minimum
number of recombinants. LOD scores were not calculated because
they were estimated to be below significance for each nuclear
family.
Tyrol Families
The 10K Affymetrix SNP array was used to perform genetic
mapping with DNA sample from one affected individual. For
candidate regions, DNA from all three affected individuals and
their family members were analyzed with additional dense micro-
satellite markers. Haplotypes were constructed manually, and
phase was assigned on the basis of the minimum number of re-
combinants.
Next-Generation Sequencing and Analysis
We used an array capture approach followed by high-throughput
Roche 454 sequencing in one affected Hutterite child and his
carrier mother. A custom array (NimbleGen) was designed with
oligonucleotide probes targeting the minimal region of overlap
between the Hutterite and Austrian families. The results from
454 sequencing were analyzed with NextGENe software
(SoftGenetics). Sequence reads that passed the quality filtering
were aligned to the reference sequences of the human genome
with the Sequence Alignment function. Homozygous single
nucleotide variants, microinsertions, and microdeletions were
called, and variants were filtered out when they were present in
dbSNP132.
Cells
Mouse inner medullary collecting duct (IMCD3) cells were grown
in Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F12
supplemented with 10% fetal calf serum at 37C/5% CO2. Fibro-
blasts from a normal control were maintained in Fibroblast
GrowthMedium (Genlantis) supplemented with 0.2mg/ml genet-
icin. Fibroblast lines derived from the affected individuals were
grown in DMEM/F12 medium.er 9, 2011
Antibodies
The following primary antibodies were used: rabbit anti-
Tmem237, FLJ-FM, and FLJ-LG, have been described previ-
ously;33 mouse anti-polyglutamylated tubulin clone GT-335
(Enzo Life Sciences); rabbit anti-GFP (Living Colors A.v. Peptide
Antibody, Clontech); rabbit-anti-g-tubulin, mouse anti-b-actin
clone AC-15 (Abcam Ltd.); and mouse anti-RhoA (Cytoskeleton).
Rabbit anti-meckelin C terminus, raised against amino acids
982-995, has been described previously.34 Rabbit anti-TMEM216
has also been described.19 Secondary antibodies were Alexa-Fluor
488-, Alexa-Fluor 568-conjugated goat anti-mouse IgG, and goat
anti-rabbit IgG (Molecular Probes). Alexa-Fluor 488 phalloidin
conjugate (Molecular Probes) was used to visualize F-actin and
40,6-diamidino-2-phenylindole (DAPI) to visualize nuclei.
Whole-Cell Extract Preparation and Immunoblotting
Whole-cell extracts (WCE) containing total soluble proteins were
prepared from confluent IMCD3 cells that had been transiently
transfected with 1.0 mg plasmid constructs in 90mm tissue culture
dishes, or scaled down as appropriate. Proteins were analyzed by
SDS-PAGE (with 4%–12% acrylamide gradient gels) and immuno-
blot analysis according to standard protocols with either rabbit
polyclonal antisera (final dilutions of 3200–1,000) or mouse
monoclonal antibodies (MAbs) (31,000–5,000). Appropriate
HRP-conjugated secondary antibodies (Dako) were used (final
dilutions of 310,000–25,000) for detection by the enhanced
chemiluminescence Femto West immunoblot detection system
(Pierce). Full scans of immunoblots are shown in Figure S10 (avail-
able online).
RhoA Activation Assays
The activated GTP-bound isoform of RhoAwas specifically assayed
in pull-down assays with a GST fusion protein of the Rho effector
rhotekin (Cytoskeleton) with conditions recommended by the
manufacturers. WCEs were processed as rapidly as possible at
4C and snap-frozen in liquid nitrogen. Total RhoA (in WCEs)
and pull-down protein was immunodetected on immunoblot
with a proprietary RhoA monoclonal antibody (Cytoskeleton).
Immunoblot analysis for total RhoA and b-actin were used as
loading controls.
Canonical Wnt Activity (Topflash) Luciferase Assays
For luciferase assays of canonical Wnt activity, fibroblasts were
grown in 48-well plates and cotransfected with 0.25 mg Topflash
firefly luciferase construct (or Fopflash as a negative control);
0.25 mg of expression constructs (pCMV HA-meckelin, pCMV
GFP-TMEM216, pEGFPN1-TMEM237, or empty pCMV-HA/
pEGFPN1 vector); and 0.05 mg of pRL-TK (Promega; Renilla lucif-
erase construct used as an internal control reporter). Cells were
treated with Wnt3A- [MIM 606359] or Wnt5A- [MIM 164975]
conditioned media to stimulate or inhibit the canonical Wnt
pathway. We obtained Wnt3A- or Wnt5A-conditioned media
from stably-transfected L cells with Wnt3A or Wnt5A expression
vectors.35 Controlmedia were obtained from untransfected L cells.
Activities from firefly and Renilla luciferases were assayed with the
Dual-Luciferase Reporter Assay system (Promega) on a Mithras
LB940 (Berthold Technologies) luminometer. Minimal responses
were noted with coexpression of the Fopflash negative control
reporter construct (data not shown). Raw readings were normal-
ized with Renilla luciferase values. Results reported are from at
least three independent biological replicates.The AmericanTransfection and siRNA
For transfection with plasmids, cells at 80% confluencywere trans-
fected with TransIT-LK (Mirus) according to the manufacturer’s
instructions and as described previously.34 For RNAi knockdown,
siRNA duplexes were designed against mouse Tmem237 sequence
(NC_000067.5) with Ambion’s custom Silencer Select siRNA
service. Antisense sequences were as follows: Tmem237: duplex 1
50-GGAUCUUAGUGAAGAGUUATT and duplex 2 50-GAACGAAA
ACGGCAUUGAUTT. The medium or low GC nontargeting scram-
bled siRNA duplexes (Invitrogen) were used as negative controls.
IMCD3 cells were transfected with 100 pmol of each siRNA at
60%–80% confluency with Lipofectamine RNAiMax (Invitrogen)
and as described previously.19Immunofluorescence and Confocal Microscopy
Cells were seeded at 2 3 104 cells/well on glass coverslips in
six-well plates and fixed in ice-cold methanol (5 min at 20C)
or 2% paraformaldehyde (20min at room temperature). Permeabi-
lization, blocking methods and immunofluorescence staining
were essentially as described previously.34 Primary antibodies
were used at final dilutions of 3200–1,000. Secondary antibodies
and phalloidin conjugate were diluted 3200. Confocal images
were obtained with a Nikon Eclipse TE2000-E system controlled
and processed by EZ-C1 3.50 (Nikon) software. Images were assem-
bled with Adobe Illustrator CS2.Whole-Mount In Situ Hybridization on Zebrafish
Embryos
Whole-mount in situ hybridization was performed as described
previously.36 Briefly, full-length cDNAs of zebrafish tmem237a
(XM_680251.3), tmem237b (NM_001004636.1), krox20
(NM_130997.2), and myoD (NM_131262.2) were obtained by
RT-PCR amplification from total RNA extracted from 24 hpf
embryos. The cDNAs were cloned into pGEM-T vector (Promega)
and used as templates for in vitro synthesis of antisense RNA
probes. Embryos were fixed in 4% paraformaldehyde in PBS,
hybridized with DIG-labeled riboprobes at 65C, and followed
by incubation with anti-DIG antibody conjugated with alkaline
phosphatase (AP) (Roche). NBT and BICP were used as the
substrates of AP to generate the purple coloration.Morpholino Knockdown and Rescue
Two splice-blocking morpholino antisense oligonucleotides (MO)
(zf.tmem237a MO: 50-TTGTCTGTGTGAAAGGCAGAAATCA-30
and zf.tmem237bMO: 50- TGGAAACCTACACTTAACAATATGT-30)
(Gene Tools) were used to knockdown tmem237a (NC_007120.5)
and tmem237b (NC_007117.5), respectively, in zebrafish. Gene-
specificMOsor controlMO (2ng for rescue and1ng for interaction
studies) were microinjected into one-two cell stage embryos.
Full-length cDNA of human TMEM237 (NM_001044385.1) was
obtained by RT-PCR amplification of total RNA extracted from a
human fibroblast cell line, which was then subcloned into pCS2þ
vector. The human TMEM216 and humanMKS3 cDNAs subcloned
into pCS2þ vector were described previously.37,38 In vitro mRNA
synthesis was carried out with the mMessagemMachine kit
(Ambion). The synthetic mRNA was coinjected with MOs where
indicated. For gastrulation phenotypes, embryos were scored
according to previously established objective criteria37–39 at 8–10
somiteswithmasked scoring,n¼76–112embryos/injectionbatch.
The efficacy of the morpholinos is shown in Figure S11.Journal of Human Genetics 89, 713–730, December 9, 2011 715
C. elegans Strain Construction and Imaging
All strains were maintained and cultured at 20C. Those carrying
mutations in C. elegans mksr-1(ok2092), mksr-2(tm2452), mks-5
(tm3100), mks-3(tm2547), mks-6(gk674), and nphp-4(tm925),
were obtained from the C. elegans Gene Knockout Consortium
and the National Bioresource Project and outcrossed to wild-type
(N2) at least four times. Standard mating procedures were used
to introduce GFP-tagged protein constructs for JBTS-14 and
MKS-2 into different genetic backgrounds. Single-worm PCR reac-
tions were used to genotype the various mutants. GFP-tagged vari-
ants of C. elegans JBTS-14 and MKS-2 were generated by producing
translational constructs containing each native promoter and all
the exons and introns fused in-frame to EGFP; transgenic lines
for these constructs were generated as reported previously.40
Subcellular localization was assessed by fluorescence microscopy
for both the wild-type (N2) or the indicated TZ mutant back-
grounds. Mislocalization phenotypes were confirmed by
analyzing at least 50 individuals for each strain.C. elegans Phenotypic Assays for Ciliary Structure
and Chemosensation
Assays for defective osmotic avoidance were performed as
described with a ring of 8 M glycerol and five individuals per
ring for 10 min.41 The filling of environmentally exposed ciliated
sensory neuronswith DiI was completed as previously described.40
Dye-stained worms were imaged with fluorescence microscopy
and intensities were quantitated with ImageJ.Transmission Electron Microscopy
Transmission ElectronMicroscopy (TEM)was performed on staged
young adult worms exactly as described previously.42Identification of jbts-14 Mutant Strain
A nonsense allele (gk287997) of jbts-14 (F53A9.4) was identified
by genome sequencing of an EMS-mutagenized C. elegans strain.Generation of mks-2 Mutant Strain
The mutagenesis protocol for generating an mks-2 (C30B5.9)
allele was modified from the protocol described previously.43
Strain EG1642 (genotype lin-15B (n765)X; oxEx166[HSP::
MosTransposase þ cc::gfp]) carrying the extrachromosomal Mos
transposase under a heat-shock promoter was crossed into strain
ttTi38815, which contains a Mos1 insertion in an intergenic
region ~2.4 kb away from C30B5.9 (mks-2). Two hundred and fifty
young adult (ttTi38815;nxEx166[HSP::MosTransposase þ cc::gfp])
worms (P0) were placed on one plate and heat shocked (33C in
a water bath for 1 hr; 1 hr in a 20C room; 33C in the water
bath for 1 hr again). After 2 hr recovery at 20C, the P0 worms
were placed onto individual plates and allowed to lay eggs (F1)
for 40 hr at 20C. The P0 worms were removed and the plates
were placed at 20C until the worms were grown to the F2 gener-
ation. Then, ~50% of worms (a population of F1 and F2) from each
plate were recovered, and crude DNA lysates (200 ml) were
prepared as described at Protocol Online. To identify lysates con-
taining an mks-2 deletion, we performed PCR by using a primer
set (GTACTATAGCGGTGCATTCCAAC and AAAAAACCAACAG
AACCAGGCTGC) flanking the gene and Mos1 transposon. One
lysate containing an ~3.5 kb deletion was identified. We cloned
400 worms from this plate and screened them by using the same
PCR strategy. Using this scheme, we isolated one allele, mks-716 The American Journal of Human Genetics 89, 713–730, Decemb2(nx111), containing a 3573 bp deletion that removes the entire
mks-2 coding region.Results
Mutations in TMEM237 Cause a JSRD
To uncover additional genes mutated in ciliopathies, we
investigated a group of ten related Canadian Hutterite
individuals with a severe JSRD44 that was previously re-
ported as MKS45 (Table 1). The known loci for JSRDs and
MKS were excluded by homozygosity mapping, which
suggested that this condition represented a distinct JSRD
locus.44 Genome-wide homozygosity mapping with
microsatellite markers with the DNA from four affected
individuals localized the gene to the JBTS-14 locus on
2q33. Genotyping additional affected and healthy family
members refined the region to a 7.5 Mb interval between
D2S2327 and D2S1384 (Figure 1A and Figure S1A).
A JSRD in a consanguineous family from Tyrol, Austria46
(Table 1), was mapped to an overlapping 9.3 Mb region
between D2S115 and D2S325 (Figure 1A and Figure S1B).
Theminimal gene-rich region (D2S115-D2S1384) contains
more than 70 genes; we excluded over 30 of these by using
Sanger sequencing.
We next employed an array capture approach followed
by high-throughput Roche 454 sequencing in one af-
fected Hutterite child and his carrier mother and iden-
tified a homozygous C to T transition in TMEM237
([NM_001044385.1] c.52C>T) leading to a premature
stop codon ([NP_001037850.1] p.Arg18*) (Figures 1B–1E).
Screening of normal Hutterite controls (N¼ 1758) revealed
a carrier frequency of 6% for this mutation, but none of the
Hutterite controls carried themutation in the homozygous
state. Furthermore, the mutation was not identified in
over 105 normal Northern European controls. We next
sequenced all the coding and exon/intron boundaries of
TMEM237 in the Austrian JSRD family and identified
a homozygous change (c.677þ1G>T) at the splice donor
site of intron 9 (Figures 1C and 1E, and Table S1), which
was not present in the Northern European controls. Subse-
quently, we performed RT-PCR on RNA from a fibroblast
cell line derived from an affected individual; two abnormal
transcripts were obtained with primers bordering exons 8
and 11. Sequencing of the products revealed: (1) the usage
of a cryptic splice donor site at the beginning of exon 9 and
a cryptic splice acceptor site in exon 10, leading to a dele-
tion of 65 amino acids and an insertion of a Serine residue
(p.Phe187_Ala251delinsSer) and (2) the skipping of exon
9, resulting in a premature stop codon (p.Arg186*)
(Figure 1D and Figure S2).
We screened an additional 201 individuals with JSRD
and 90 individuals with MKS/JSRD and identified two
additional families with mutations in TMEM237. In a Jor-
danian child born to consanguineous parents (Table 1),
a homozygous TMEM237 frameshift mutation in exon 13
(c.1066dupC) was identified (Figures 1C and 1E). Theer 9, 2011















1 3.5 years M L 8 years Hutterite MTS, PF, H CK Nys, Str, OA – c.52C>T p.Arg18*
2 2.5 years F D 7 years Hutterite MTS, PF,
H, En
CK Nys, Str – c.52C>T p.Arg18*
Family B
3 27 years F D 28 years Hutterite CVH – Nys, Str – c.52C>T p.Arg18*
4 6 years F D 12 years Hutterite CVH – Nys, Str – c.52C>T p.Arg18*
Family C
5 10 years M D 12 years Hutterite MTS – Nys, Str, C IB c.52C>T p.Arg18*
Family D
6 0 days F D SB Hutterite En, H CK ND CP c.52C>T p.Arg18*
7 2 days F D 2 days Hutterite H CK ND P c.52C>T p.Arg18*
Family E
8 5 years F L 9 years Hutterite MTS, En CK Nys, Str, C VSD c.52C>T p.Arg18*
Family F
9 4 months F D 13 months Hutterite En, H,
DWV
CK Nys, Str – c.52C>T p.Arg18*
Family G
10 4 years M L 8 years Hutterite MTS, PF CK Nys, Str – c.52C>T p.Arg18*
Family H
11 3 weeks F D 3 weeks Hutterite MTS, DWV,
H, En
CK ND – c.52C>T p.Arg18*
12 3 months F D 3 months Hutterite MTS, DWV,
H, En
CK Nys – c.52C>T p.Arg18*
Family I
13 3 years M L 3 years Hutterite MTS,
DWV, H
CK Nys – c.52C>T p.Arg18*
Family J
14 1 days F D 2 days Hutterite En CK ND – c.52C>T p.Arg18*
Family K








CK MGDA no LF c.677þ1G>T p.Phe187_Ala251
delinsSer; p.Arg186*
VIII-5 2 years F L 11 years Austrian CVA, BH CK Nys, MGDA – c.677þ1G>T p.Phe187_Ala251
delinsSer; p.Arg186*
Family L
1 1.5 years M ND ND Jordanian MYC, CVI ND ND – c.1066dupC p.Gln356Profs*23
Family M








The following abbreviations are used: –, not affected; BH, brain stem hypoplasia; C, coloboma; CCH, corpus callosum hypoplasia; CK,cystic kidney; CP, cleft
palate; CVA, cerebellar vermis aplasia; CVH, cerebellar vermis hypoplasia; CVI, cortical visual impairment; D, deceased; DWV, Dandy–Walker variant; En, encepha-
locele; H, hydrocephalus; IB, intracranial bleed; L, living; LF, liver fibrosis; MGDA, morning glory disc anomaly; MC, meningocele; MYC, meningomyelocele; MTS,
molar tooth sign; ND, no data; Nys, nystagmus; OA, optic atrophy; P, postaxial polydactyly; PF, posterior fossa abnormality; SB, stillborn; Str, strabismus; VSD,
ventricular septal defect.
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Figure 1. Mutations in TMEM237 Cause a Joubert Syndrome Related Disorder
(A) Chromosomal location of the overlapping JSRD loci of the Hutterite families and the Austrian family.
(B) Targeted sequence capture followed by massively parallel sequencing and data analysis identified a homozygous mutation in
TMEM237 (ALS2CR4) in an affected Hutterite individual. The black box shows the G>A change at the genomic level. The red box shows
the resultant amino acid change (R>X). The green highlights show that all the sequence reads from the affected child contain an A.
(C) TMEM237 genomic organization.
(D) Domain structure of TMEM237 protein. Yellow indicates the transmembrane domains. Grey indicates the extramembrane region.
Red arrows and blue arrows indicate the highly conserved shortmotifs of basic and acidic amino acids, respectively. Black arrows indicate
the positions of identified mutations.
(E) Sequence traces of normal controls (top) and affected individuals (bottom) are shown.frameshift mutation is predicted to result in a truncated
protein (p.Gln356Profs*23) (Figure 1D) and was absent in
over 105 normal Jordanian controls. Compound heterozy-
gous mutations c.[943þ1G>T]þ[76C>T] were identified
(Figures 1C and 1E) in an affected child from a nonconsan-
guineous JSRD family of European and Spanish descent
(Table 1); her mother carries the c.76C>T mutation, and
the father carries the c.943þ1G>T mutation. c.76C>T is
a nonsense mutation resulting in a premature stop codon
(p.Gln26*). We performed RT-PCR on RNA from a lympho-
blast cell line derived from the affected individual; one
abnormal transcript was obtained with primers bordering
exons 8 and 13 (Figure S3). Sequencing of the product re-
vealed deletion of exons 11 and 12, leading to a deletion
of 56 amino acids (p.IIe291_Trp346del) (Figure 1D). These
mutations were absent in over 105 normal controls.
Together, these data demonstrate that mutations in
TMEM237 are causative for JSRD and implicate a largely718 The American Journal of Human Genetics 89, 713–730, Decembuncharacterized member of the tetraspan transmembrane
protein family, TMEM237, in normal functions of the
primary cilium.
TMEM237 spans 23 kb on 2q33 and contains 14 exons.
Two alternative TMEM237 transcripts (1 [NM_001044385.1]
and 2 [NM_152388.2]), translating into two protein iso-
forms, a (NP_001037850.1) and b (NP_689601.2), have
been proposed in humans. Each transcript utilizes one of
the two alternative exons, 1 and 2, which are spliced in
a mutually exclusive manner. All positional information
in this paper refers to transcript 1 and isoform a. In two
mouse proteomic studies, Tmem237was found in the photo-
receptor connecting ciliumcomplexandouter segments.47,48
TMEM237 is a predicted tetraspan transmembrane pro-
tein with both amino and carboxyl termini directed to the
cytoplasmic side.33 Alignment of metazoan orthologs with
thehumanprotein revealed strong conservation of repetitive
shortmotifs of bothbasic (R and/orK) and acidic (D and/or E)er 9, 2011
Figure 2. TMEM237 Is Localized to the Ciliary Transition Zone Region and Mutation or Knockdown Results in Defective Ciliogenesis
(A) Overlapping localization of endogenous N-terminal (N-term) or C-terminal (C-term) mouse Tmem237 (red) and polyglutamylated
(polyglut.) tubulin (green) at the base of primary cilia and/or mother centriole (arrowheads in magnified insets) of IMCD-3 cells. The
scale bar represents 5 mm.
(B) Two different TMEM237-mutated fibroblasts lines (JSRD1with homozygous splice-sitemutation c.677þ1G>Tand JSRD2with homo-
zygous nonsense mutation c.52C>T as indicated) show defective ciliogenesis and pairing of centrioles (marked by g-tubulin, red)
compared to a normal control line. The scale bar represents 5 mm. Ciliogenesis is quantitated in the lower panel (n ¼ 500 to 600 for
each line; statistical significance of comparisons are shown (**p < 0.01, ****p < 0.0001 Student t test); error bars indicate standard error
of the mean (SEM).
(C) Tmem237 antisera against the C-terminal mouse protein detects a specific 45 kD band33 in immunoblot of control cells transfected
with scrambled (scr.) siRNA that is lost after transfection with Tmem237 siRNA duplexes (dup.) 1 or 2. Equal loading is indicated by
immunoblot analysis for b-actin.
(D) Defective ciliogenesis in IMCD-3 cells after Tmem237 siRNA knockdown with duplexes (dup.) 1 or 2. Cells stained and ciliogenesis
quantified as in (B); the scale bar represents 10 mm.amino acid residues throughout the intracellular N-terminal
region and predicted intracellular loops between transmem-
brane helices (Figure 1D and Figure S4). Members of
the TMEM family, TMEM216/MKS2 [MIM 613277] and
meckelin/MKS3/TMEM67, have both been implicated in
JSRDs andMKS14,19,20,49 and both localize to the ciliary basal
body or TZ region. Because other tetraspan transmembrane
proteins function through the formation of complexes with
each other and other membrane proteins such as Frizzled
receptors,50 it suggests that TMEM237, TMEM216, and
MKS3 might cooperate in maintaining normal ciliary
functions.
Loss of TMEM237 Causes Ciliogenesis Defects
in Mammalian Cells
To elucidate potential roles for TMEM237, we first deter-
mined the subcellular localization of the encoded protein.
We used two affinity-purified polyclonal antibodies raisedThe Americanagainst mouse Tmem237 amino acids 76-88 (FLJ-FM) and
390-403 (FLJ-LG) in the amino- and carboxy-terminal
domains, respectively.33 These antibodies were used for
immunocytochemical staining of a polarized monolayer
of ciliated mouse inner medullary collecting duct
(IMCD3) cells. Discrete signals at the proximal region of
primary cilia were observed, consistent with localization
to the TZ (Figure 2A).
We next explored the role of TMEM237 function in
ciliogenesis. Quantitative real-time (qRT) PCR was used
to measure TMEM237 transcript expression in fibroblasts
derived from the affected individual with the splice-site
mutation (c.677þ1G>T, line JSRD1), and the nonsense
mutation (c.52C>T, p.Arg18*, line JSRD2), because exist-
ing antibodies were not specific for human TMEM237.
Total TMEM237 transcript levels in the JSRD1 and JSRD2
lines were reduced by 99.6% and 98.4%, respectively
(Figure S5), although low levels of an exon-skippedmutantJournal of Human Genetics 89, 713–730, December 9, 2011 719
transcript were detectable by RT-PCR in JSRD1 with the
c.677þ1G>T splice-site mutation (Figure S2A). A failure
in ciliogenesis was observed in these fibroblasts, after
48 hr of serum starvation (Figure 2B) but not in controls;
similar results were seen previously in cells deficient for
MKS3 and TMEM216.19,31 These data were quantified by
analyzing the percentage of cells with evident cilia
(defined as >1 mm in length) versus those without cilia
(defined as <1 mm in length) (Figure 2B). It is possible
that the low levels of the exon-skipped mutant transcript
in JSRD1 (c.677þ1G>T) were sufficient to maintain some
ciliogenesis in those fibroblasts. For independent con-
firmation of these results, we also tested for ciliogenesis
defects in IMCD3 cells disrupted for TMEM237 by tran-
sient siRNA knockdown. We first confirmed that the ex-
pected 45 kDa protein recognized by immunoblotting
with the FLJ-LG antibody33 in immunoblotting experi-
ments was lost after transient siRNA knockdown (Figure 2C
and Figure S6). Consistent with the results obtained from
fibroblasts from affected individuals, transfection with
two separate Tmem237 siRNA duplexes impaired ciliogen-
esis in polarized cells (Figure 2D and Figure S7).
TMEM237 Disruption Results in Deregulation
of Wnt Signaling
Many aspects of actin-dependent polarized cell behavior,
including morphogenetic cell movements51 and ciliogene-
sis,52 are mediated by the planar cell polarity (PCP)
pathway of noncanonical Wnt signaling.53 Perturbation
of noncanonical Wnt signaling is implicated in the patho-
genesis of MKS19,34,37 and deregulation of the canonical
b-catenin pathway is implicated in the ciliopathy disease
state.54,55 To assess whether these pathways were per-
turbed after TMEM237 mutation or loss, we first deter-
mined levels of key mediators in fibroblasts from affected
and control individuals. Immunoblot analysis of protein
extract from affected individuals demonstrated constitu-
tive phosphorylation and hyperactivation of Dishevelled-1
(Dvl1 [MIM 601365]), a core Wnt signaling protein,56 and
an increase in both soluble and total levels of b-catenin
[MIM 116806] (Figure 3A). Levels of downstream effectors
for both canonical and noncanonical Wnt signaling,
cyclin-D1 [MIM 168461] and phosphorylated myosinIIB
[MIM 160776] were also assessed with immunoblot anal-
ysis. We observed a slight increase in phosphorylated
myosinIIB levels and a striking decrease in the amount of
cyclin-D1 in JSRD2 cells (Figure 3A). We next assayed
RhoA [MIM 165390] activation because the Rho family
of small GTPases are key PCP mediators.57 Consistent
with previous results after MKS3 or TMEM216 mutation
or knockdown,19,34 we found that RhoA signaling was
hyperactivated in TMEM237-mutated fibroblasts (Fig-
ure 3A) or after Tmem237 knockdown (Figure 3B) despite
normal total amounts of RhoA in these cells. RhoA local-
ized to the basal body in confluent IMCD3 cells (Figure 3C),
supporting a role in mediating centrosome docking at the
apical cell surface prior to ciliogenesis.19,56 However, after720 The American Journal of Human Genetics 89, 713–730, DecembTmem237 knockdown, RhoA was mislocalized to periph-
eral regions of the basal body and to basolateral cell-
cell contacts (Figure 3C), consistent with translocation
of ectopically-activated RhoA to the cytosol.58 Because
RhoA modulates the actin cytoskeleton in the PCP
pathway, we evaluated the cytoskeletal phenotype of
TMEM237 fibroblast lines from affected individuals; strik-
ingly, we uncovered prominent actin stress fibers in these
but not in control cells (Figure 3C).
TMEM237-mutated fibroblasts carrying the putative
null mutation c.52C>T (line JSRD2) also demonstrated
dysregulated canonical Wnt signaling (over 5-fold basal
levels) compared to control fibroblasts upon stimulation
with Wnt3A-conditioned media (Figure 3D). Treatment
with Wnt5A had no effect on activation; however, as ex-
pected, Wnt5A suppressed the activation by Wnt3A (Fig-
ure 3D). Deregulated Wnt signaling activation by Wnt3A
was also apparent in mouse embryonic fibroblasts (MEFs)
derived from wild-type Mks3þ/þ and knockout mutant
Mks3/ E18 embryos (Figure 3E). Interestingly, responses
were attenuated by expression of TMEM237, MKS3, and
TMEM216, indicating either partial complementation of
MKS3 loss by other TZ-localized members of the TMEM
family or Wnt signal compensation from another cellular
site (or process).
Knockdown of tmem237 Causes Developmental
Defects in Zebrafish
To provide complementary evidence of a role for TMEM237
in ciliary function, signaling, and development, we turned
to zebrafish, an established vertebrate model system for
ciliopathies.37–39,59 Two zebrafish paralogs of TMEM237,
tmem237a and tmem237b, have been annotated. They
share over 50% protein sequence identity with human
TMEM237 (Figure S4) and demonstrate a significant over-
lap in expression pattern in the developing central nervous
system, the eyes, pharyngeal arch cartilage, and the
pectoral fin buds (Figure S8). The PCP pathway is known
to play an essential role in polarized convergent extension
(CE) movements during gastrulation and neurulation.60
To investigate the possible role of TMEM237 in the PCP
pathway and embryonic development, we examined mor-
phant phenotypes after knockdown of tmem237. When
disrupting both tmem237a and tmem237b simultaneously,
we observed defects in midsomitic embryos that are con-
sistent with other ciliary morphants,19,37–39,59 including
shortening of the anterior-posterior axis and small anterior
structures, kinking of the notochord, and broadening
and thinning of the somites (Figure 4A). To quantify these
defects, wemeasured the widening of the 5th rhombomere
and the shortening of the notochord as labeled by krox20
and myoD riboprobes, respectively, on whole-embryo flat-
mounts; results suggest altered convergence to the midline
and extension along the anterior-posterior axis (Figures 4B
and C). These defects could be rescued significantly by co-
injection of human TMEM237mRNA (Figure 4D). Notably,
coinjection with either human MKS3 or TMEM216 mRNAer 9, 2011
Figure 3. Deregulation of Wnt Signaling Following Mutation or Loss of TMEM237
(A) Immunoblots showing the relative levels of the indicated endogenous mediators of both canonical and noncanonical-PCP Wnt
signaling in normal control fibroblasts compared to the TMEM237-mutated fibroblast line (JSRD2 c.52C>T line). Identical results
were seen for the JSRD1 c.677þ1G>T line (data not shown).
(B) Increase in levels of activated RhoA-GTP after Tmem237 siRNA knockdown with duplexes (dup.) 1 or 2, compared to scrambled (scr.)
siRNA. Levels of b-actin are shown as loading controls. Positive control for the assay (loading with nonhydrolyzable GTPgS) and a nega-
tive control (loading with GDP) are shown on the left.
(C) Pericentriolar and basolateral subcellular localization of RhoA (top panels) and increase of actin stress fibers (bottom panels; visual-
ized by phalloidin staining, green) in TMEM237-mutated fibroblast lines; the scale bars represent 10 mm.
(D) TOP Flash assays of canonical Wnt signaling, showing deregulation in affected fibroblasts (JSRD2 c.52C>T, red) compared to normal
control cells (green) after treatment with 0.53 L cell control-conditioned media (control), and conditioned media containing expressed
Wnt3A and/or Wnt5A, as indicated. Activity is expressed as ratios of luciferase reporter construct expression, normalized for loading by
measurement of a Renilla construct expression. Values shown are means of three independent replicates; error bars indicate SEM.
(E) TOP Flash assays of canonical Wnt signaling after cotransfection of Mks3þ/þ andMks3/ MEFs with reporter constructs and empty
vector control, wild-type GFP-TMEM237, HA-MKS3, or GFP-TMEM216 as indicated. The empty vector results combine the data from
cotransfections with pCMV-HA and pGFPN1. Responses are shown to L cell control-conditioned media (control, blue bars, values
are means of three independent replicates) and conditioned media containing expressed Wnt3A (0.5 3 Wnt3A, brown bars, values
are means of four independent replicates). Error bars indicate SEM. Statistical significance of comparisons are shown (*p < 0.05,
**p < 0.01, Student t test).also led to significant improvement of tmem237morphant
phenotypes that were indistinguishable from rescue with
human TMEM237 transcript (Figure 4D). Furthermore,
reciprocal injections (TMEM237 mRNA coinjected with
either mks3 or tmem216 MOs) also resulted in significant
improvement (Figures 4E and 4F). Together, these data
suggest a functional complementation of TMEM237,
TMEM216, and MKS3, consistent with the in vitro func-
tional attenuation of canonical Wnt signaling in mamma-
lian cells (Figure 3E).The AmericanTMEM237 Functionally Interacts with Other
Transition Zone Proteins to Control Basal
Body-Transition Zone Anchoring to the Membrane
To ascertain whether TMEM237 functions together with
other ciliopathy proteins localized at the ciliary transition
zone, we turned to the model organism C. elegans, where a
functional network of TZ-associated proteins (MKS-1,
MKSR-1/B9D1, MKSR-2/B9D2, MKS-3, MKS-5, MKS-6,
NPHP-1, and NPHP-4) has been established and shown to
be important for cilium formation and function.27–30,61–64Journal of Human Genetics 89, 713–730, December 9, 2011 721
Figure 4. Zebrafish Morphant Phenotypes and Functional Complementation of TMEM Proteins
(A) Representative live embryo images of tmem237 morphants at 8–10 somites (top, lateral view; bottom, dorsal view). Class I and II
embryos were scored on the basis of previously established objective criteria.37,38,59 Class I, short anterior-posterior axis, small anterior
structures, and mild somitic defects; Class II, severe defects in head and eye development, shortening of the body axis, kinked noto-
chords, and broadening of the somites; Class III, severe thinning and shortening of the body axis, curved notochord, broadened and
thin somites, and an ovoid embryonic shape suggestive of dorsalization—embryos were severely delayed in development and typically
did not survive past the ten somite stage.
(B) Zebrafish embryo flatmounts at the six somite stage hybridized with krox20 and myoD riboprobe cocktails. Representative embryos
are shown: control MO (Ctr) injected (left); tmem237MOs (MO) injected (right). Gastrulation defects were measured in two dimensions
(medial-lateral and anterior-posterior) by the length of the 5th rhombomere (horizontal lines) and notochord (vertical lines),
respectively.
(C) Quantification of the mean length of the 5th rhombomere or notochord of morphants (n ¼ 29) are shown as the percentage of the
mean length of the controls (n ¼ 22). t test, *p < 0.01; **p < 0.001; error bars indicate SEM.
(D) Coinjection of tmem237 MOs with human TMEM237 mRNA, MKS3 mRNA, or TMEM216 mRNA significantly rescued morphant
phenotypes at eight to ten somites.
(E) TMEM237 can partially ameliorate mks3 suppression defects of midsomitic embryos. Comparison of rescue efficiency of human
MKS3 versus TMEM237 mRNA is shown.
(F) TMEM237 mRNA rescues tmem216 suppression phenotypes in a manner indistinguishable from TMEM216 mRNA coinjection in
midsomitic embryos (***p < 0.0001; NS, not significant for D and F).We first confirmed that, as with mammalian TMEM237
(Figures 2A and 5A), the C. elegans ortholog, which we
name JBTS-14, localizes to the ciliary TZ. In IMCD3 cells,
Tmem237 localized to proximal regions of the cilium
(Figure 2A) but just distal to the basal body (Figures 5A
and 5B, marked with g-tubulin and Dvl-1, respectively).
In C. elegans, GFP-tagged JBTS-14 also concentrated to this
ciliary region (marked by the tdTomato-tagged IFT dynein
subunit XBX-1) within the cilia of head (amphid) and tail722 The American Journal of Human Genetics 89, 713–730, Decemb(phasmid) sensory neurons (Figure 6A). This localization
is identical to that of other established C. elegans TZ
proteins.27 Next, we identified a likely null mutant in the
C. elegans jbts-14 from a deep-sequenced EMS-mutagenized
animal. Similar to otherC. elegans single TZ genemutants,27
the jbts-14 mutant displayed no gross structural or func-
tional ciliary defects, as judged by its ability to take up
fluorescent dye through environmentally-exposed ciliary
endings (Figure 6B), and its ability to sense its chemicaler 9, 2011
Figure 5. Ciliopathy TMEM Proteins Are
Anchored at the Transition Zone by MKS5/
RPGRIP1L
(A) In scrambled (scr.) siRNA-treated IMCD-3
cells, Tmem237 (red channel) is at proximal
regions of the cilium and partially colocalizes
with g-tubulin (green channel) at the basal
body, consistent with Tmem237 localization to
the TZ. Colocalization with g-tubulin is disrupted
after Rpgrip1l siRNA knockdown with duplexes
(dup.) 1 or 2. Insets showmagnified regions (indi-
cated by arrowheads on the main image) for the
red and green channels only; the scale bars repre-
sent 5 mm.
(B) Top panels: Dvl-1 (green channel) is at the
basal body that colocalizes with g-tubulin (red
channel) in IMCD-3 cells, as described previ-
ously.19 Rpgrip1l siRNA knockdown does not
disrupt overall basal body architecture. Bottom
panels: in scrambled (scr.) siRNA-treated
IMCD-3 cells, Tmem237 partially colocalizes
with Dvl-1, but this is disrupted after Rpgrip1l
siRNA knockdown.
(C) As above, but with RhoA staining; magnified
insets are indicated by white frames.environment (an avoidance of a high osmolarity solution;
Figure 6C). Importantly,we identified a functional (genetic)
interaction between jbts-14 and another ciliopathy-associ-
ated gene, nphp-4. Compared to the single jbts-14 or
nphp-4 single mutants, the jbts-14;nphp-4 double mutant
displays prominent dye-filling (dyf) and osmolarity avoid-
ance (osm) phenotypes (Figures 6B and C). Such dyf and
osm phenotypes occur with essentially all known ciliary
mutants in the worm.65
To provide a more detailed look at the ciliary anomalies
in the jbts-14;nphp-4 double mutant, we performed TEM
on this strain. In wild-type amphid channel neurons,
ciliary axonemes extend from a basal body region that con-
tains transition fibers and is found at the distal dendrite
tip; the axonemes are defined at their proximal ends by
the TZ compartment that makes axoneme-to-membrane
connections via Y-links and are followed by microtubule
doublets in the middle segment compartment and singlets
in the distal segment compartment (wild-type TEMs and
corresponding schematics shown in Figure 7). As expected,
the single jbts-14mutant displayed an essentially wild-type
ciliary ultrastructure (data not shown). In contrast, the
jbts-14;nphp-4 double mutant displays distinct cilium
formation anomalies, such as axonemes that are either
truncated or absent (Figure 7A). Strikingly, improper
associations between the basal body-TZ region and the
ciliary membrane are almost always observed, coincident
with the loss or reduction of Y-link connectors (Figure 7B).
In extreme cases, the TZ is fully disconnected (unan-
chored) from the ciliary membrane, existing instead as
an ectopic structure within the distal dendrite regionThe American Journal of Huma(Figure 7B; þ10 image). In addition, many
vesicle or membrane accumulations are
found in proximity to the TZ, somethingnever observed in wild-type animals. Overall, these ciliary
phenotypes are very similar to those observed in other
TZ genemutant combinations with nphp-4.27 This strongly
suggests that JBTS-14 (TMEM237) has a ciliogenesis
function that overlaps with that of at least five other
TZ proteins: namely, MKS-1, MKSR-1/B9D1, MKS-3/Meck-
elin/TMEM67, MKS-5/RPGRIP1L, and MKS-6/CC2D2A.
Such a shared function is consistent with our finding that
the localization of C. elegans JBTS-14 to the TZ depends on
multiple other TZ proteins (see below), all of which are
implicated in JSRDs, MKS, and NPHP ciliopathies.
To determine whether these ciliary phenotypes are
specific for JBTS-14 or are general to other ciliopathy-
associated TMEMs, we studied MKS-2/TMEM216. The
mammalian TMEM216 is another tetraspan transmem-
brane protein localizing to the base of cilia,19 and it can
partially complement TMEM237 loss in vitro and in vivo
(Figures 3E and 4D). As expected, the C. elegans MKS-2/
TMEM216 ortholog specifically localizes to the TZ (Fig-
ure 6A) and functions in a manner similar to JBTS-14.
We used transposon-mediated mutagenesis to obtain a
likely null allele of mks-2 and found, as with jbts-14, that
the single mutant displays no ciliary or chemotaxis defects
but functionally interacts with nphp-4 (Figures 6B and 6C).
To further delineate the functional and modular or hierar-
chical relationships between ciliopathy-associated TMEMs
and other established TZ proteins, we determined whether
GFP-tagged JBTS-14 or MKS-2 proteins localized correctly
in different TZ gene mutant backgrounds. In mks-5
mutants, both JBTS-14 and MKS-2 failed to localize to the
TZ and displayed a diffuse staining pattern within then Genetics 89, 713–730, December 9, 2011 723
Figure 6. C. elegans JBTS-14 Functionally Interacts with NPHP-4 to Promote Ciliogenesis and Forms Part of a Functional Assembly of
Proteins at the Transition Zone that Includes MKSR-1/B9D1, MKSR-2/B9D2, MKS-2, and MKS-5/RPGRIP1L
(A) C. elegans JBTS-14 and MKS-2 (GFP-tagged) localize specifically to the transition zone (TZ) in amphid (head) and phasmid (tail) cilia.
The TZ is immediately distal to the basal body (BB) on the ciliary axoneme, both of which are marked by the tdTomato-tagged XBX-1
intraflagellar transport protein.
(B) Disruption of jbts-14 ormks-2 alone does not cause overt ciliogenesis defects, as judged by the ability of worms to take up fluorescent
dye through environmentally-exposed cilia. In contrast, the jbts-14;nphp-4, ormks-2;nphp-4 double-mutant animals are dye-filling defec-
tive, indicative of cilia structure defects. The osm-5 ciliary mutant, which lacks cilia altogether, is included as a control.
(C) jbts-14 ormks-2 single mutants can avoid a high osmolarity solution, which depends on functional cilia, whereas the jbts-14;nphp-4
or mks-2;nphp-4 double mutants are defective in this chemosensory behavior. Chi-square test, *p<0.0001; error bars indicate SEM.
(D) The localization of JBTS-14 (left panels) andMKS-2 (right panels) depends on the presence of several other TZ proteins but not others,
as indicated by yes (properly localized) or no and a dotted ellipse for a mislocalized protein. The following abbreviations are used:
BB, basal body; cil, cilium; TZ, transition zone; den, dendrite. The scale bar represents 5 mm.
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Figure 7. Basal Body-Transition Zone
Attachment to the Ciliary Membrane Is
Disrupted in Mutant Strain Lacking JBTS-
14 and NPHP-4
(A) Low and high-magnification images of
C. elegans amphid channel sensory cilia
from TEM serial cross sections of the am-
phidal pore. Top row: images from the
distal pore region. Boxed numbers denote
proximal positioning of sections relative
to the top row sections. In wild-type (N2)
worms, the amphid pore contains ten
axonemes, each consisting of a distal
segment (top row: nine singlet microtu-
bules), a middle segment (second row:
doublet microtubules) and a transition
zone (TZ) (third row: ring of doublet mi-
crotubules drawn together by the apical
ring and connected to the ciliary mem-
brane via Y-links). At the base of the cilia,
within the far distal dendrite region, are
transition fibers and occasional vesicles.
In jbts-14;nphp-4 mutants, two to three
axonemes are typically missing from the
distal pore (top row, left image) and occa-
sionally from more proximal regions (þ4;
left image), microtubule number is some-
times elevated (þ4; right image), and
Y-links are consistently missing or reduced
from the transition zone compartment
(þ7; middle and right images). In distal
dendrite regions, vesicles and membranes
are often abnormally accumulated (þ8;
middle image) and incomplete, ectopically
positioned, ciliary axonemes are occasion-
ally observed (þ8; right image). The open
arrowhead indicates a transition fiber.
The scale bars represent 200 nm.
(B) High-magnification images of transi-
tion zone phenotypes in the jbts-14;
nphp-4 double mutant presenting multiple
examples of the phenotypes described
above, as well as an image showing an un-
docked TZ in the distal dendrite region
(þ10). The arrow indicates an apical ring;
the closed arrowhead, Y-links; and the
open arrowhead, inner microtubules.
Images taken from three independently
sectioned worms. Boxed numbers denote
proximal positioning of sections relative to the distal end of the amphidal pore. Schematics to the right of each row depict normal
and abrogated ciliary structures in wild-type and jbts-14;nphp-4 mutant worms, respectively. The scale bars represent 200 nm.
(C) Schematics of amphid channel cilia (longitudinal and transverse views) showing the major ultrastructural defects observed,
including the loss of TZ connections to the ciliary membrane via Y-links. TZ subcompartment (microtubules and Y-links) is highlighted
in green, dendritic membrane is highlighted in red.dendrite and cilium (Figure 6D), indicating that MKS-5/
RPGRIP1L is required for proper TZ localization of
these two TMEM proteins, similar to that reported for
C. elegans MKS-3 as well.27 To confirm this result in
mammalian cells, we performed knockdowns of Mks5/
Rpgrip1l in IMCD3 cells and stained for Tmem237 and
the basal body markers g-tubulin (Figure 5A) or Dvl1
(Figure 5B), and RhoA (Figure 5C). We observed that after
scrambled siRNA transfection, basal body architecture
was intact (Figure 5B) and that Tmem237 was just distal
to the basal body (Figures 5A and 5B; marked by either
g-tubulin or Dvl-1, respectively). This localization to theThe AmericanTZ was disrupted after knockdown of Mks5/Rpgrip1l.
RhoA was also mislocalized to peripheral regions of the
basal body and to basolateral cell-cell contacts (Figure 5C),
a pattern identical to that in the cellular phenotype after
Tmem237 knockdown (Figure 3C) as well as Tmem216/
Mks2 knockdown.19
We then further assessed the functional requirements for
C. elegans JBTS-14 and MKS-2 localization to the TZ. We
uncovered two additional TZ components, the B9 domain
proteins MKSR-1/B9D1 and MKSR-2/B9D2, whose func-
tions are required for the proper TZ localization of JBTS-
14 and MKS-2 (Figure 6D). Furthermore, C. elegans MKS-2Journal of Human Genetics 89, 713–730, December 9, 2011 725
is at least partially delocalized in the mks-6 mutant. In
contrast, both JBTS-14 and MKS-2 localized normally in
two other mutants,mks-3 and nphp-4 (Figure 6D). Interest-
ingly, although C. elegans MKS-2 localizes properly in the
jbts-14 mutant, the reciprocal experiment shows that
JBTS-14 is mislocalized in the mks-2 mutant. Thus, in a
hierarchical or modular interaction network, JBTS-14
could potentially be considered peripheral with respect
to MKS-2, whereas MKS-2 connects JBTS-14 to other TZ
proteins. Together, these data demonstrate that both
JBTS-14 and MKS-2 are likely to be part of a hierarchical
or modular assembly that includes other established TZ
proteins. Because MKS5/RPGRIP1L is required for the
correct localization of JBTS-14/TMEM237 at the TZ in
both C. elegans and mammalian cells, such functional
modules are likely to be evolutionarily conserved.Assessing the Possible Contribution of TMEM237
to BBS
The potential functional overlap of TMEM237 with other
bona fide ciliopathy causal loci (both in vitro and in vivo),
as well as the documented genetic overlap across ciliopa-
thies, raised the question of whether loss of function in
this gene transcript could contribute to other overlapping
clinical phenotypes. To begin to address this question, we
sequenced TMEM237 in 90 individuals of Northern
European origin who had been diagnosed with BBS but
were unselected for known mutations. We found one
heterozygous change (p.Asp155Ala) in a BBS family with
a heterozygous, functionally null BBS6 [MIM 604896]
Thr57Ala mutation,38,66 which was not present in
HapMap, the 1000 Genomes Project, or an additional
200 controls. When tested by our established in vivo zebra-
fish-based complementation assay,37–39,59 this allele was
shown to be hypomorphic, because it could only partially
rescue tmem237 MO phenotypes (Figure S9A). Digenic
inheritance is unlikely because of segregation of the alleles
in the family and the fact that we observed no synergistic
effect when subeffective doses of tmem237 and bbs6 MOs
were coinjected in zebrafish embryos (Figure S9B).Discussion
Ciliopathies are a unique group of genetically heteroge-
neous human developmental disorders that collectively
affect nearly every tissue and organ in the body, presenting
with a wide array of physiological and developmental
phenotypes.1–6,67 Remarkably, although discrete clinical
entities such as Joubert syndrome, Meckel-Gruber
syndrome, Bardet-Biedl syndrome, and nephronophthisis
are apparent, there is considerable phenotypic overlap
between these conditions and even allelism at a number
of loci.6,8 A key question is therefore whether the pheno-
typic overlap—and variability—of these cilium-associated
disorders can be explained by a common molecular and
cellular etiology.726 The American Journal of Human Genetics 89, 713–730, DecembMany of the known JBTS/MKS/BBS/NPHP proteins
from vertebrates or other species such as C. elegans have
now been ascribed roles in cilium biogenesis and signaling
at the ciliary transition zone.27–30 To gain further insight
into the genetic causes of the MKS/JBTS group of ciliopa-
thies, we first mapped a locus for JSRD type 14 (JBTS-14)
in the Canadian Hutterites, leading to the identification
of mutations in TMEM237. The mutations identified in
this study are all predicted to be null, suggesting that
complete loss or near-absence of TMEM237 causes the
JSRD type 14 phenotype. Despite this common mecha-
nism, it is interesting to note that the large subgroup of
the affected individuals with cystic kidneys also have
posterior fossa findings in addition to a MTS, suggesting
that these developmental pathways are affected by addi-
tional, probably genetic, modifying factors. Although
mutations in TMEM237 only account for <1% cases in
our JSRDs-MKS cohort, the high carrier frequency of the
c.52C>T mutation in the Hutterite population (approxi-
mately 1:15) means that carrier testing, cascade testing in
families, and prenatal diagnosis will be of high clinical
utility. Families with JSRDs will also benefit from improved
diagnosis and accurate genetic counseling.
To further elucidate themolecular etiology of TMEM237-
associated JSRD, we characterized the function of the
TZ-localized TMEM237 protein. Loss of human TMEM237
results in failure of ciliogenesis and deregulation of both
canonical and noncanonical/PCPWnt signaling pathways.
These findings are strikingly similar to previous studies of
both TMEM216 and MKS3,19,34 two additional transmem-
brane proteins associated with JSRDs and MKS. MKS3 and
TMEM216 have been suggested to be noncanonical Wnt
receptors that regulate the RhoApathway and thusmediate
the cytoskeleton rearrangements required for basal body
docking at the apical region of the cells prior to ciliogene-
sis.34 Importantly,wedemonstrate that inacomplementary
zebrafish model system, disruption of TMEM237 causes
developmental (convergent extension) phenotypes com-
parable to those obtained upon abrogation of TZ-localized
proteins, including TMEM216 and MKS3.19 Furthermore,
we now show by both an in vitro (Figure 3E) and an in vivo
(Figures 4D–4F) assay that there is the probable functional
complementation of TMEM237, TMEM216, and MKS3.
This finding, and the similarities between the three TMEMs
in cellular localization, protein structure, role in cilium
formation and function, and clinical phenotypes caused
by mutations indicate that TMEM237, TMEM216, and
MKS3 probably function in the same pathway or module
to regulate ciliogenesis and signaling. This conclusion
is supported by the functional interaction of C. elegans
TZ-localized proteins belonging to the MKS module in
mediating basal body-TZ attachment to the membrane
and cilium formation.27 We speculate that TMEM237,
TMEM216, MKS3, and perhaps other TMEMs form a
receptor-coreceptor complex at the ciliary TZ to mediate
and integrate signaling pathways impacting the primary
cilium.er 9, 2011
One of the central questions remaining concerning the
molecular etiology and underlying phenotypic variability
of the JBTS-MKS-NPHP ciliopathy spectrum is whether
the ciliary defects arise from disruption in one or more
macromolecular assemblies, or modules, comparable to
that of the BBSome, an oligomeric protein complex con-
taining proteins associated with BBS.68,69 Support for this
model comes from the study of C. elegans, which has sug-
gested the existence of two genetically defined modules:
one, being an MKS module (consisting of MKS-1,
MKSR-1/B9D1, MKSR-2/B9D2, MKS-3, and MKS-6), and
the other, an NPHP module, consisting of NPHP-1 and
NPHP-4.27 Specifically, disruption of any single mutant, or
combination of mutants, in gene(s) within either module
abrogates a ciliary gate function but does not significantly
impair the structure of most cilia; in contrast, disrupting
any combination of two genes, one from each module,
causes transition zone structure anomalies that are con-
comitant with loss of basal body-TZ anchoring to the
membrane and ciliary axoneme structure defects. Impor-
tantly, these modules are largely consistent with a physical
interaction network recently uncovered in mammalian
cells.22 For example, NPHP1 and NPHP4 are ascribed to
a distinct protein interaction module, coincident with the
genetically-defined C. elegans NPHP module, and MKS1
and MKS6 are part of a physical interaction network that
is consistent with the two respective genes being compo-
nents of the C. elegans MKS genetic module. Additionally,
disruption of individual mammalian TZ proteins (such as
MKS1 andMKS3) in mouse models is on the whole pheno-
typically less severe than that observed for disruptionof IFT,
which causes global defects in ciliogenesis;27 this suggests
a functional redundancy in mammals that might be
similar to that observed in C. elegans and could be exposed
by analysis of mouse double knockouts. In this study, we
show thatC. elegans JBTS-14 (TMEM237) functionally inter-
acts with NPHP-4 to promote basal body-TZ attachment
to the membrane and cilium formation. Such functions
parallel those reported for the other C. elegans TZ-localized
proteins belonging to the MKS module and thus implicate
JBTS-14 in the same molecular pathway.
Overall, our analyses of TMEM237 in mammalian cells,
zebrafish, and C. elegans strongly support a role for this
tetraspan transmembrane protein within an expansive
genetic and physical interaction network of proteins local-
ized to the TZ, where it participates in a functional module
that regulates cilium biogenesis and signaling. Our find-
ings therefore extend the interaction network of ciliopathy
proteins at the TZ, revealing additional complexity at
this ciliary region, and underline the importance of an evo-
lutionary conserved JSRD-MKS-NPHP functional module
for cilium biogenesis and signaling.Supplemental Data
Supplemental Data include 11 figures and 1 table and can be
found with this article online at http://www.cell.com/AJHG/.The AmericanAcknowledgments
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Loss of CHSY1, a Secreted FRINGE Enzyme, Causes Syndromic
Brachydactyly in Humans via Increased NOTCH Signaling
Jing Tian,1 Ling Ling,1 Mohammad Shboul,1 Hane Lee,2 Brian O’Connor,2 Barry Merriman,2
Stanley F. Nelson,2 Simon Cool,1 Osama H. Ababneh,3 Azmy Al-Hadidy,3 Amira Masri,3
Hanan Hamamy,4 and Bruno Reversade1,5,*
We delineated a syndromic recessive preaxial brachydactyly with partial duplication of proximal phalanges to 16.8 Mb over 4 chromo-
somes. High-throughput sequencing of all 177 candidate genes detected a truncating frameshift mutation in the gene CHSY1 encoding
a chondroitin synthase with a Fringe domain. CHSY1 was secreted from patients’ fibroblasts and was required for synthesis of
chondroitin sulfate moieties. Noticeably, its absence triggered massive production of JAG1 and subsequent NOTCH activation, which
could only be reversed with a wild-type but not a Fringe catalytically deadCHSY1 construct. In vitro, depletion of CHSY1 by RNAi knock-
down resulted in enhanced osteogenesis in fetal osteoblasts and remarkable upregulation of JAG2 in glioblastoma cells. In vivo, chsy1
knockdown in zebrafish embryos partially phenocopied the human disorder; it increased NOTCH output and impaired skeletal,
pectoral-fin, and retinal development. We conclude that CHSY1 is a secreted FRINGE enzyme required for adjustment of NOTCH
signaling throughout human and fish embryogenesis and particularly during limb patterning.Introduction
Precise diagnosis of brachydactylies, defined by the short-
ening of fingers and/or toes, is often difficult because of
their vast diversity and partial clinical overlap. Five main
types of brachydactylies, termed brachydactyly (BD) types
A– E (MIM 112500, MIM 112600, MIM 112700, MIM
112800, MIM 112900, MIM 112910, MIM 113000, MIM
113100, MIM 113200, MIM 113300, MIM 112440, and
MIM 607004), are classified according to which metacar-
pals and/or metatarsals, phalanges, and digits are affected.1
At the molecular level, extracellular components of two
signaling pathways, BMP/GDF and Hedgehog, have been
shown to cause shortening of digits in humans. Defective
BMP/GDF signaling accounts for BDA2, BDB, and BDC
and can be caused by mutations in the genes encoding
the extracellular BMP antagonist NOGGIN (MIM
602991), the BMP ligand GDF5 (MIM 601146), BMP2
(MIM 112261), and the BMP receptors BMPR1B (MIM
603248) and ROR2 (MIM 602337).2–6 The Hedgehog
pathway accounts for BDA1, which is caused by mutations
in the ligand IHH (MIM 600726), and mutations in SHH
(MIM 600725) cause triphalangeal thumb–polysyndactyly
syndrome (MIM 174500).7,8 Recently, mutations in the
extracellular ligand PTHLH (MIM 168470) were found to
be responsible for BDE, which can also be caused by
HOXD13 (MIM 142989) mutations.9,10
Here we report on the genetic etiology of a syndromic
recessive preaxial brachydactyly caused by a loss-of-func-
tion mutation in the evolutionarily conserved gene
CHSY1 (MIM 608183). CHSY1 encodes a type II transmem-
brane protein comprising a Fringe motif and a glycosyl-1Institute of Medical Biology, A*STAR, Singapore; 2Department of Human Gene
Los Angeles, CA 90095, USA; 3Departments of Ophthalmology, Radiology and P
Genetic Medicine and Development, Geneva University Hospital, Geneva, S
Singapore
*Correspondence: bruno@reversade.com
DOI 10.1016/j.ajhg.2010.11.005. 2010 by The American Society of Human
The Amtransferase domain. CHSY1 was found to be secreted, and
functional experiments carried out in patients’ cells,
human fetal osteoblasts cells, and gliobastoma cells
revealed remarkable NOTCH upregulation in the absence
of CHSY1 activity. Knockdown of chsy1 in developing
zebrafish embryos was able to partially phenocopy the
human disorder: it enhanced Notch signaling and
impaired skeletal and pectoral-fin development while
triggering dramatic retinal overgrowth. Taken together,
our results identify an additional layer of control in the
genetic pathway that operates in the vertebrate developing
limb. Our data also suggest that CHSY1, because of its
FRINGE activity, might represent another class of extracel-
lular modulators of NOTCH signaling.Material and Methods
Patients and Clinical Assessment
The affected children were initially diagnosed at the National
Center for Diabetes, Endocrinology & Genetics in Jordan by
Prof. Hanan Hamamy. Genomic DNA from saliva samples
(Oragene, Canada) from the five members of this kindred and
skin biopsies from one affected sibling (II:2) and his unaffected
sister (II:1) were obtained after parents gave their informed
consent and the local ethics commission gave its approval.Genotyping and Homozygosity Mapping
To performhomozygosity and identity-by-descent (IBD)mapping,
we analyzed the SNP chip data of the affected and unaffected
siblings by using custom programs (B. Merriman) written in the
Mathematica (Wofram Research) data-analysis software. In brief,
we determined candidate IBD homozygous blocks in an individualtics, David Geffen School of Medicine, University of California, Los Angeles,
ediatrics, Faculty of Medicine, University of Jordan, Jordan; 4Department of
witzerland; 5Department of Pediatrics, National University of Singapore,
Genetics. All rights reserved.
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Quadv1_B) genotype data, we used AB genotypes to define bound-
aries of homozygous blocks. Blocks that were larger than 2 cM in
size were classified as candidate IBD homozygous blocks. Centi-
Morgan distances between SNPs were determined from the
HapMap Phase II recombination rate map. Regions of identity
(both alleles inherited IBD) between pairs of siblings were deter-
mined in a similar pedigree-free fashion. The final exclusion
mapping that allowed us to obtain candidate disease loci was per-
formed by mathematical manipulation of the various intervals
defined by homozygosity and identity mapping. Specifically, we
defined candidate disease loci as those thatwere homozygous iden-
tical by descent in affected siblings, identical by descent between
affected siblings, and not identical by descent for unaffected
siblings. We obtained candidate disease loci by taking the mathe-
matical intersection of the intervals of homozygosity and identity,
respectively, and then the mathematical complement of these by
the intervals of identity between affected-unaffected sibling pairs.Capture of Genomic Loci
In brief, custom arrays (Agilent 244K) were designed to target
every exonic sequence of the genes present in the four
homozygous indentical-by-descent regions (chr3: 147266776–
155630168; chr5: 168552990–174355393; chr12: 18663–545927;
and chr15: 99141618–100314150), excluding the highly repeated
regions. In total, 1009 contigs encompassing 320,677 bp were
targeted. DNA library for one affected subject was prepared accord-
ing to the Illumina library generation protocol version 2.3 and was
hybridized to the custom arrays according to the Agilent CGH
244K array protocol, then washed, eluted, and amplified. The
sample was submitted to one channel of Illumina flowcell
and sequenced by Illumina Genome Analyzer (GAII) according
to the standard manufacturer’s protocol. The image data were
processed by the provided GA Pipeline (Firecrest version 1.3.4
and Bustard version 1.3.4), and all sequences were aligned to the
human reference genome (UCSC build 18) by Blat-like Fast
Accurate Search Tool (BFAST). We filtered mismatches to
identify variants that were seen ten or more times and that did
not overlap with a known dbSNP129 entry polymorphism. Non-
synonymous mutations were identified with additional SeqWare
tools and the ‘‘knownGene’’ gene model from the UCSC hg18.
The open-source SeqWare project that provides a LIMS tool for
tracking samples (SeqWare LIMS) and a pipeline for sequence anal-
ysis (SeqWare Pipeline) was used throughout this work.Mutation Analysis
Positional candidate genes were obtained from the GenBank and
Ensembl databases. Genes were analyzed by direct sequencing of
DNA with primers flanking each exon. Primer sequences were
based on the reference sequences of each gene. The primer
sequences for CHSY1 (NM_014918.4) and HTLF (NM_002158.3)
mutation screening are given in Table S4. Sequence analysis was
done with the BigDye Terminator cycle sequencing kit (Applied
Biosystems, Foster City, CA), and products were run on a 3730
DNA Analyzer (Applied Biosystems, Foster City, CA).Cell Culture
Primary human skin fibroblasts were cultivated in DMEM (Lonza)
supplemented with 10% fetal calf serum (FCS) (Lonza). Human
fetal osteoblast (hFOB) cells were obtained from ATCC (USA)
and maintained in Ham’s F12 DMEM supplemented with 10%2 The American Journal of Human Genetics 87, 1–11, December 10,FCS and 0.3 mg/ml G418 (Invitrogen, USA) at 33.5C. Human
gliobastoma (T98G) cells were obtained from ATCC (USA) and
maintained in EMEM (ATCC) supplemented with 10% FCS. Inhi-
bition of g-secretase activity was carried out by incubation of cells
with 2 or 5 mM of g–secretase inhibitor X (Calbiochem, 565771)
added fresh daily for 72 hr.
RNA Interference
hFOB and gliobastoma cells were seeded at 20,000 cells/cm2 in
6-well plates and transfected via Lipofectamine 2000 (Invitrogen,
USA) with two siRNAs specific for humanCHSY1 (25 pmol of each)
or scrambled siRNA as a negative control. The siRNAs were
purchased from QIAGEN (Germany), and their sequence is given
in Table S4. For Taqman realtime PCR, cells were assayed 48 or
72 hr after transfection.
Quantitative PCR
RNA was isolated from patients’ fibroblasts, T98G cells, and hFOB
cells by the Trizol (Invitrogen) method. RNA (1 mg) was reverse
transcribed with the Revert Aid kit (Fermentas) and random
hexamers. Quantitative PCR was performed with Taqman probes
(Applied Biosystems). Primers, ABI probes, assay IDs, and
sequences are given in Table S4.
Statistical Analysis
Each experiment was repeated at least three times, and data were
expressed as means 5 SE. Differences among treatments were
analyzed by a Student’s t test. Significant differences were consid-
ered to be those with a p value of < 0.05.
Immunoblot Analysis
Supernatant fractions were obtained after incubation of primary
skin fibroblasts in Pro293a-CDM conditioning serum-free media
(BioWhittaker) for 72 hr. Cells were lysed in RIPA extraction
buffer. Electrophoresis of samples in SDS polyacrylamide gels
with or without DTT was followed by transfer on PVDF
membranes. The following antibodies were used for probing
immunoblots: mouse anti-ACTIN (Chemicon; Mab1501R), rat
anti-NOTCH2 (Developmental Studies Hybridoma Bank;
C651.6DbHN), goat anti-JAG1 (Santa Cruz Biotechnology; sc-
6011), goat anti-HES1 (R&DSystems; AF3317), and rabbit anti-
CHSY1 (Proteintech; 14420-1-AP).
Immunohistochemistry Analysis
For immunostaining, skin biopsies were fixed in 4% (weight/
volume) paraformaldehyde in 13 PBS and embedded in wax,
and sections of 5 mm were placed on coverslips. A mouse mono-
clonal antibody against Chondroitin Sulfate (Sigma; CS-56) was
incubated for 1 hr in 10% normal goat serum at room temperature
at a 1: 200 dilution. For visualization, an anti-mouse IgG-HRP
(Dako) conjugate was applied. Images were collected with a stereo-
microscope M205 FA equipped with an ICD camera from Leica.
Morpholino Oligos, RNA Injections, and
Embryological Methods
Two 25 bp Morpholino (MO) antisense oligomers, CS1 and CS2,
for zebrafish chsy1were obtained fromGene Tools; their sequences
are given in Table S4. MOs were resuspended in sterile water to
a concentration of 3 mM according to the manufacturer’s instruc-
tions. Embryos were injected at the 1 cell stage with 1 nl consisting2010
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mount in situ hybridization, and alcian blue staining can be found
at our laboratory’s website. A ZeissAxioplan microscope equipped
with a Zeiss AxioCam HRc was used for capturing images of
embryos. Pictures were assembled with Photoshop CS5.Results
A Frameshift Mutation in CHSY1 Is Identified
by Homozygosity Mapping and High-Throughput
Sequencing
Homozygosity mapping was performed on a Jordanian
consanguineous family consisting of two unaffected
parents (I:1 and I:2, Figure 1A), two affected children
(II:2 and II:3, Figure 1A), and one unaffected sibling (II:1,
Figure 1A). The clinical synopsis included congenital skel-
etal anomalies most evident on the hands and feet,
symmetrical and bilateral preaxial brachydactyly, micro-
gnathia, short stature, and variable degrees of learning
disability (Figures 1B–1D; see also Figure S1). X-ray exami-
nations revealed unified capitate and hamate bones and
partial duplication of proximal phalanges of digits 1 to 3,
suggestive of hyperphalangism (Figures 1C and 1D). The
clinical features of the two index cases in this study match
those described earlier by Dr. Samia Temtamy in another
inbred family from Egypt.11 On the basis of their compar-
ison (Figure S1), we reason that this Jordanian family
might represent another case of Temtamy Preaxial Brachy-
dactyly Syndrome (MIM 605282).
Genotyping of the five individuals on 610k Illumina SNP
arrays and subsequent identical-by-descent mapping
revealed four candidate regions totaling 16.8 Mb on chro-
mosomes 3, 5, 12, and 15 (Figure 1E). To screen the 177
candidate genes in these regions for mutations, we em-
ployed a targeted genomic loci capture12 followed by
high throughput resequencing (Figure 1F). In one affected
proband, 224 genomic mismatches were identified; of
these, two were homozygous and located in the coding
region of HTLF (MIM 143089) and CHSY1 (Table S1). The
HLTF mutation did not cosegregate with the disease in
the family. The nonsense mutation in CHSY1, caused by
a 1 bp deletion (Figure 1F), was inherited according to
the autosomal-recessive pattern inferred by this pedigree.
Because CHSY1 lies at the telomeric end of chromosome
15q, hemizygous deletions of CHSY1 occur in patients
with chromosome 15q26-qter Deletion Syndrome (MIM
612626);13 these distinct genetic diseases share some
common phenotypes, which are compared in Figure S1.
CHSY1 encodes chondroitin synthase 1, an evolution-
arily conserved sugar-synthesizing enzyme present both
in invertebrates and vertebrates (Figure 1G). Human
CHSY1, and its paralogous protein CHSY3 (MIM
609963), consists of a carboxy-terminal type-A glycosyl-
transferase catalytic site and an N-terminal Fringe
domain.14,15 When aligned to the three canonical FRINGE
proteins, i.e., LUNATIC (MIM 602576), MANIC (MIM
602577), and RADICAL (MIM 602578) FRINGE, theThe AmCHSY1 and CHSY3 proteins show conservation of the
DXD motif, which is required for the glycosyltransferase
activity of FRINGE enzymes (Figure 1H).16,17The CHSY1 Frameshift Mutation Abolishes CHSY1
Protein Synthesis and Depletes Chondroitin Sulfates
in Patients
The biallelic one-base cytosine deletion in codon 32 of the
ORF of CHSY1 (c.96 del) introduces a frameshift leading to
a premature stop codon 2 amino acids downstream at
position 34 (p.Glu33SerFSX1). This nonsense mutation is
predicted to yield a severely truncated CHSY1 protein
missing both its catalytic domains (Figure 2A). To confirm
the absence of CHSY1 in affected individuals, we isolated
and cultured dermal fibroblasts from the male proband
(II:2) and his noncarrier unaffected sibling (II:1). CHSY1,
of the expected molecular weight, i.e, 88 kDa, was detected
by immunoblotting in nonreducing conditions in the
supernatant of primary fibroblasts but was undetectable
in that of mutant fibroblasts (Figure 2B). In reducing
conditions, CHSY1 migrated at 60 kDa, suggesting that
the mature secreted protein might comprise two or more
peptides linked by disulfide bridges. It is noteworthy that
soluble CHSY1 was found to accumulate in the superna-
tant of primary human fibroblast cultures, whereas its
primary amino acid sequence does not target it a priori
for secretion. In support of our finding, CHSY1 was previ-
ously reported to be the most prominent extracellular
protein in the conditioned medium of co-cultures
involving myeloma cells and osteoclasts;18 hence, CHSY1
might be processed for secretion in the Golgi via shedding
of its N-terminal transmembrane domain (Figure 2A). This
is in contrast to canonical FRINGE enzymes, which are
known to reside in the cis-Golgi and not in the extracel-
lular milieu unless overexpressed.16
CHSY1 is pivotal to the biosynthesis of chondroitin
sulfates (CSs), which belong to the glycosaminoglycans
(GAGs), consisting of alternating glucuronic acid (GlcUA)
and N-acetyl galactosamine (GalNAc) residues. Once
synthesized, CSs are covalently bound to side chains of
extracellular proteoglycans. CHSY1 possesses both the
glucuronyltransferase II and N-acetylgalactosaminyl-trans-
ferase II enzymatic activities necessary for the synthesis of
the repeating disaccharide unit of CS.14 To determine the
impact of the loss of CHSY1 activity on the deposition
and distribution of CSs, immunohistochemistry on
patients’ skin sections was performed with a monoclonal
antibody directed at CS groups. Lower levels of CS in the
stratum corneum, stratum germinativum, and dermal
layers of the affected patient (II:2) relative to the control
(II:1) were seen (Figures 2C and 2D). CS levels were also
reduced in cultures of CHSY1-deficient primary fibroblasts
(data not shown), which had a slower growth rate and
different cell morphology than control fibroblasts (Figures
2C and 2D, insets). Taken together, our data suggest the
CHSY1 is a secreted enzyme involved in the synthesis oferican Journal of Human Genetics 87, 1–11, December 10, 2010 3
Figure 1. Phenotypic Characteristics of Investigated Patients with Syndromic Recessive Brachydactyly Caused by a Frameshift Muta-
tion in CHSY1
(A) Affected children, male (II:2) and female (II:3), were born to first-cousin parents (I:1 and I:2) with one unaffected child (II:1).
(B) Head shot of affected boy (II:2) with protruding eyes, downward turn of mouth, and micrognathia.
(C) X-ray radiograph of male proband’s right hand when he was 8 years of age, showing partial duplications of proximal phalanges in
digits 1, 2, and 3 (inset: hand photograph).
(D) X-ray radiograph and picture of male proband’s right foot showing severe skeletal anomalies. The big toe exhibits short and dupli-
cated metatarsals and proximal phalanges. The second and fourth proximal phalanges are duplicated as well.
(E) Homozygosity mapping delineated four candidate loci totaling 19 cM on chromosomes 3, 5, 12, and 15.
(F) Genomic capturing and resequencing of candidate loci revealed a 1 bp deletion in CHSY1 on chromosome 15; this deletion caused an
early-termination stop codon at amino acid 34 of the CHSY1 enzyme.
(G) Phylogenetic tree showing conservation of CHSY1 across invertebrate and vertebrate species.
(H) The CHSY1 enzyme and its paralogous protein CHSY3 bear a Fringe domain that aligns to that of canonical MANICAL (MFNG),
RADICAL (RFNG), and LUNATIC (LFNG) FRINGE. A conserved DDD motif is highlighted with a star.
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leads to a loss of function in humans.
Loss of CHSY1 Activity Triggers Massive NOTCH
Activation in Patients’ Cells
To gain insights into the pathogenesis of the disease, we
sought to determine how secreted CHSY1 activity was
coupled to known extracellular proteins causing brachy-
dactyly in mice and humans.1,19 Out of 16 genes whose4 The American Journal of Human Genetics 87, 1–11, December 10,mutations result in brachydactyly,1,19 CHSY1 transcripts
were most correlated with those of the NOTCH2 (MIM
600275) and NOTCH1 (MIM 190198) receptors (Table
S2). Because CHSY1 bears a Fringe domain, which modu-
lates ligand interaction with NOTCH receptors,20 and
because NOTCH2 activation was shown to be regulated
by CHSY1 levels in co-cultures of myeloma cells and oste-
oclasts,18 we assessed components of the NOTCH
signaling pathway in patients’ primary fibroblast cell2010
Figure 2. Loss of CHSY1 Results in Depletion of Chondroitin Sulfates and Activation of NOTCH Signaling
(A) The full-length CHSY1 (WT) consists of a type II transmembrane domain, a Fringe motif, and a type A glycosyltransferase domain.
The frameshift mutation (MUT) deletes more than 95% of CHSY1, including both of its putative catalytic sites, marked with an asterisk.
(B) CHSY1 is found in the supernatant of primary fibroblast cultures from unaffected sibling II:1 (WT) but not from that of the affected
proband II:2 (MUT).
(C and D) Depletion of CS, a product of the CHSY1 enzyme, is observed by immunohistochemistry in the skin of affected II:2 (D) versus
unaffected sibling II:1 (C). CHSY1-deficient primary fibroblasts (D, inset) have aberrant morphologies and slower growth rates than
control fibroblasts (C, inset).
(E) Massive upregulation of JAG1 and HES1 in affected primary fibroblasts, indicative of abnormally high NOTCH signaling, is observed
by q-PCR analysis. Mutant CHSY1 transcripts were not subjected to nonsense-mediated decay. Upregulation of NOTCH signaling was
reversed by the addition of a g-secretase inhibitor.
(F) Overexpression of intact CHSYI, but not of a Fringe-dead CHSY1 D171A mutant, can reverse NOTCH activation in CHSY1-deficient
fibroblasts.
(G) Abnormally high JAG1 protein production is seen in CHSY1-deficient fibroblasts (lanes 3 and 4) compared to control fibroblasts
(lanes 1 and 2). Addition of a g-secretase inhibitor rescues NOTCH activationmeasured by HES1 levels in CHSY1-deficient cells (compare
lanes 3 and 4).
Values in (E) and (F) represent means5 SE of data from three independent experiments, *p < 0.05.
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dance of JAG1 (MIM 601920), a NOTCH ligand, and
HES1 (MIM 139605), an immediate target of NOTCH,
were found to be significantly upregulated—14-fold and
18-fold, respectively—in comparison to unaffected cells
(Figure 2E). Levels of NOTCH1 and NOTCH2 were moder-
ately increased. Endogenous CHSY1 transcripts were found
to be higher in CHSY1 null cells, suggesting that the
reported frameshift does not trigger the surveillance
nonsense-mediated-decay pathway. Addition of a g-secre-
tase inhibitor, blocking NOTCH signaling at the receptor
level,21 partially rescued NOTCH over-activation inThe AmCHSY1-deficient patient cells (Figure 2E). The remarkable
transcriptional upregulation of JAG1 and HES1 was
confirmed at the protein level by immunoblotting
(Figure 2G); an average 10-fold increase in JAG1 protein
synthesis was seen in primary CHSY1-deficient fibroblasts
at various passages (compare lanes 1 and 3, Figure 2G).
Likewise, inhibiting g-secretase activity partially rescued
HES1 levels in CHSY1-deficient cells. JAG1 levels were
also reduced, albeit to a lesser extent (compare lanes 3
and 4, Figure 2G).
Next, to determine whether CHSY1-mediated NOTCH
inhibition required the Fringe domain, we carried outerican Journal of Human Genetics 87, 1–11, December 10, 2010 5
Figure 3. CHSY1 Knockdown Promotes NOTCH Signaling and Enhances Osteogenesis In Vitro
(A) CHSY1 siRNA in human fetal osteoblasts (hFOB) cells achieved 75% knockdown with concurrent 6-fold upregulation of HES1, an
immediate NOTCH target. Other genes belonging to the NOTCH pathway were moderately but significantly upregulated.
(B) CHSY1 siRNA triggered upregulation of osteogenic markers, indicative of premature differentiation, whereas proliferation markers
were downregulated.
(C) CHSY1 siRNA in human glioblastoma cells (T98G) achieved 87% knockdown and a paralleled 10-fold upregulation of HES1 and
24-fold increase in JAG2 transcription.
Values in (A)–(C) represent means5 SE of data from three independent experiments, *p < 0.05.
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regulation in CHSY1-deficient cells could only be reversed
by transfection of wild-type human CHSY1 but not of
a D171A Fringe catalytically dead mutant construct17
(Figure 2F), indicating that CHSY1 requires an intact Fringe
domain to execute its function. Together, these results
argue that secreted CHSY1, via its Fringe domain, exerts
NOTCH inhibitory activity in human primary skin fibro-
blasts and that its absence triggers massive JAG1 protein
synthesis.
CHSY1 Knockdown by siRNA in Human Osteoblast
Progenitor Cells Triggers NOTCH Activation and
Premature Osteogenic Differentiation
To address the ossification anomalies, we then modeled
loss of CHSY1 by siRNA in a human fetal osteoblast
(hFOB) progenitor cell line (Figures 3A and 3B). CHSY1
siRNA, which achieved more than 75% knockdown effi-
ciency, resulted in markedly increased NOTCH signaling,
as indicated by the 6-fold increase in the abundance of
HES1 transcripts (Figure 3A); levels of JAG1, JAG2 (MIM
602570), and NOTCH1 were moderately but significantly
increased. Concurrent with NOTCH upregulation, markers
of osteogenic differentiation such as ALPL (MIM 171760),
BSPH1 (MIM 147563), BGLAP (MIM 112260), OSX (MIM
606633), and RUNX2 (MIM 600211) were significantly
augmented, whereas markers of proliferation such as6 The American Journal of Human Genetics 87, 1–11, December 10,CCND1 (MIM 168461) and C-MYC (MIM 190080) were
reduced (Figure 3B). Alkaline phosphatase activity was
increased by 40% (data not shown). Taken together, these
results suggest that CHSY1 knockdown, which leads to
NOTCH activation, suffices to bring about premature, or
enhanced, osteogenic differentiation in a hFOB progenitor
cell line. These in vitro data provide a possible patho-
mechanism for the observed accessory bones and hyper-
phalangism seen in the two affected children.
To substantiate CHSY1’s specificity on NOTCH
signaling, we repeated RNAi knockdown in a human
neural glioblastoma cell line (Figure 3C). Unexpectedly,
JAG2, but not JAG1 as in primary patient fibroblasts, was
greatly increased (24-fold). As in hFOB and patient primary
cells, HES1 levels were also upregulated, indicative of
robust NOTCH activation. Together, these in vitro experi-
ments argue that CHSY1 bears widespread repressive
activity on NOTCH signaling and that this inhibition is
likely to be gene and tissue specific.
Loss of Function of chsy1 in Zebrafish Embryos
Impairs Skeletogenesis and Leads to Increased Notch
Signaling
To model, in vivo, the birth defects observed in CHSY1
mutant individuals, we next performed chsy1 morpholino
(MO) injections in developing zebrafish embryos (Figure 4).
To block translation of maternal and zygotic chsy12010
Figure 4. chsy1 Knockdown in Zebrafish Embryos Affects Segmentation and Increases Notch Signaling
(A) Six-day-old wild-type embryo.
(B) Six-day-old chsy1 MO-injected embryo with a protruding mouth-piece, eyes joined at the midline, and arched trunk.
(C) Six-day-old chsy1 MO-injected embryo rescued with 200 pg of human CHSY1 mRNA.
(D) Ten-somite-stage wild-type embryo stained with pax2.1marking the optic stalk (os), midbrain-hindbrain boundary (mhb), otic plac-
odes (op), and pronephric duct (pd) and with papc marking the pre-somitic mesoderm (psm) and the tailbud (tb).
(E) Ten-somite stage chsy1morphant embryo displays a fused anterior eyefield, near-absent isthmic organizer, and otic placodes marked
by pax2.1. Aberrant segmentation of the pre-somitic mesoderm and lack of papc staining in the tailbud indicate anomalies in somito-
genesis.
(F and F0) Wild-type (F) and chsy1morphant (F0) 24 hpf embryos stained for the Notch ligand jag2. Note ectopic or delayed clearance of
jag2 expression in trunk somites.
(G and G0) Wild-type (G) and chsy1morphant (G0) 24 hpf embryos stained for the Notch ligand deltaC. Note the enhanced expression in
presomitic mesoderm at the tailbud level.
(H and H0) Wild-type (H) and chsy1morphant (H0) 24 hpf embryos that were stained with lim1 and whose expression is downregulated
by Notch signaling. The loss of lim1 expression in head and trunk structures indicates greater-than-normal Notch signaling in chsy1mor-
phants relative to controls.
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described.22 chsy1 was ubiquitously present from the un-
fertilized oocyte to the end of somitogenesis (Figure S2).
By day two, its expression was limited to head structures;
there was prominent expression in the inner ear and
diffuse expression in developing chondrocytes of the
pectoral-fin bud (Figure S2J). Compared to wild-type
siblings at 6 days (Figure 4A), morphant chsy1 embryos
developed into stunted larvae with severe eye anomalies
and cartilage and pectoral-fin defects (Figure 4B). The spec-
ificity of the MOs was addressed by rescue experiments;
chsy1 MOs were coinjected with human CHSY1 mRNA at
the one-cell stage. In 87% (n ¼ 149/171) of the coinjected
embryos, chsy1 morphant phenotypes were rescued
(Figure 4C; see also Table S3). At the ten-somite stage,
chsy1 morphants exhibited obvious segmentation anoma-
lies marked by poorly segmented presomitic mesoderm
and absence of papc expression in the tailbud (Figures 4D
and 4E). Anterior defects in chsy1 morphants comprised
a single anterior eyefield, as opposed to split eyefields in
control embryos, and reduced pax2.1 expression in oticThe Amplacodes and in themidbrain-hindbrain boundary (Figures
4D and 4E). By 24 hpf, expression of the two notch ligands
jag2 and deltaC was increased in chsy1 morphants as
compared to wild-type embryos (Figures 4 F–4G0), jag2
was found to be ectopically expressed in trunk paraxial
mesoderm, indicative of impaired segmentation, whereas
deltaC levels in tailbud and presomitic mesoderm were
enhanced (Figures 4F–4G0). We next assessed lim1, a target
of Notch signaling whose expression is repressed by the
Notch pathway.23 Reflecting greater-than-normal Notch
activity in chsy1 morphants, lim1 expression was visibly
dampened in head and trunk structures relative to those
of control embryos (Figures 4H and 4H0). Collectively,
these results indicate that chsy1 activity is essential for
toning down Notch signaling across various embryonic
structures during zebrafish development.
Zebrafish chsy1 Morphant Embryos Partially
Phenocopy Human Disorder
By day 5, zebrafish chsy1 morphant embryos exhibited
major skeletal anomalies encompassing severe jawerican Journal of Human Genetics 87, 1–11, December 10, 2010 7
Figure 5. Phenotypes of chsy1 Zebrafish Morphant Embryos Partially Phenocopy Human Disorder
(A) Ventral view of alcian-blue-stained 5-day-old wild-type embryo.
(B) Three representative chsy1 MO-injected embryos exhibiting variable phenotypic penetrance, including skeletal anomalies (arrow-
heads), massive overgrowth of retinas, and pectoral-fin defects ranging from asymmetric development to unilateral or bilateral aplasia
(asterisks).
(C) Percentage of eyes and pectoral-fin defects scored in chsy1MO compared to wild-type embryos. (Asym., asymmetric; Abst., absent).
(D) Hematoxylin and Eosin (H&E) head sections of 5-day-old wild-type embryo.
(E) H&E sections throughmidline-joining retinas of chsy1morphant embryos at 5 days of development. Note hyperplasia of pigmented
epithelium (pe) and increased cell numbers in the ganglion cell layer (gcl).
(F and F0) Pectoral fin of a 6-day-old wild-type embryo. (F0) High-magnification view of the endoskeletal disc showing cartilage tissue with
monolayered chondrocytes stained with alcian blue.
(G and G0) Pectoral fin of a mildly affected 6-day-old chsy1MO-injected embryo exhibiting hypoplasia of the endoskeletal disc (ed) rela-
tive to the fin blade (fb). (G0) High-magnification view of cartilage tissue with multilayered disorganized chondrocytes in the endoskel-
etal disc of chsy1 morphant embryo stained with alcian blue.
(H) Lateral view of 5-day-old chsy1 morphant embryos with severe jaw hypoplasia and eye defects.
(I) Ethmoid plate of a 5-day-old wild-type embryo stained with alcian blue.
(J) Irregularly shaped ethmoid plate of a 5-day-old chsy1 morphant embryo.
(K) Affected girl (II:3), showing bilateral macrophthalmia and blue sclera.
(L) Color fundus photographs of affected girl (II:3) at 6 years of age. The girl had bilateral tilted eye discs and normal visual acuity in each
eye.
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inent eyes (Figures 5A–5G0). The anterior paired pectoral
fins, which are analogous to the mammalian forelimbs,
were affected in 65% (n¼ 94/144) of MO-injected embryos
(Figure 5C). Anomalies in the development of the pectoral
fins ranged from pronounced asymmetries to unilateral or
bilateral aplasia (Figures 5A and 5B). Bright-field images of8 The American Journal of Human Genetics 87, 1–11, December 10,dissected pectoral fins from mildly affected chsy1-mor-
phant embryos revealed structural anomalies of the endo-
skeletal disc, a structure analogous to the bones found in
higher pentadactyl vertebrates. In contrast, fin blades, of
which no equivalent tissue exists in mammals, were
relatively normal in morphants (Figures 5F and 5G).
Higher magnification of alcian-blue-stained chondrocytes2010
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multilayered tissue (Figure 5G0) as opposed to the mono-
layer tissue organization in wild-type limb buds
(Figure 5F0). Other remarkable cartilage defects, including
disgenesis of the ethmoid plate (Figures 5I and 5J), in the
neurocranium resulted in a protruding-snout, ‘‘seahorse’’
phenotype (Figure 5H).
Unexpectedly, eye anomalies were also present in more
than 50% (n ¼ 84/144) of morphant embryos (Figures
5A–5E). In extreme cases, chsy1 morphants developed
four eyes resembling complete bilateral retinal duplications
(Figure 5B). Histological examination showed instead one
pair of overgrown retinas, which joined at the midline.
No lens duplication was recorded. chsy1 morphant eyes
presented with the expected retinal cell layers but had
augmented cell numbers in the ganglion cell layer and the
pigmented epithelium (Figures 5D and 5E). This prominent
eye phenotype found in chsy1morphant fish prompted us
to re-examine our two human index cases for possible
ocular anomalies. Fundoscopic evaluations did not reveal
altered retinal thickness, but we noted that both probands
exhibited macrophthalmia accompanied by bilateral blue
sclera, remnants of pupillarymembrane over the crystalline
lens, and tilted optic discs in both eyes (Figures 5K and 5L).
This suggests thatCHSY1mayplaya role ineyemorphogen-
esis in humans as well. Thus, knockdown of chsy1 in zebra-
fish embryos revealed a conserved role for CHSY1 during
embryogenesis in vertebrates. The phenotypes observed
upon knockdown of chsy1 in fish partially phenocopy the
human disorder, revealing a conserved role for CHSY1 in
skeletal development and limb morphogenesis during
vertebrate embryogenesis.Discussion
In summary, loss of CHSY1 is a cause of recessive syn-
dromic brachydactyly and evokes phenotypes that overlap
with mutations in the BMP, GDF, and Hedgehog path-
ways.1 The pathophysiological basis of this syndrome
appears to be enhanced, or premature, ossification—
possibly driven by greater-than-normal NOTCH
signaling—leading to congenital skeletal anomalies most
obvious in digits. This is consistent with studies performed
in mice, where appropriate Notch signaling was found to
be essential for the normal progression of chondrocyte
differentiation into bone in the developing appendicular
and axial skeletal elements.24 The particular splitting of
proximal phalanges in digits 1, 2, and 3 in this syndrome
might be explained by double epiphyses growing along
the longitudinal, rather than horizontal, axis. An analo-
gous situation has been reported in Brachydactyly type
A2, caused by mutations in GDF5, where a single epiph-
ysis, albeit turned, results in a triangular bone.3
At the molecular level, we propose that CHSY1 inhibits
theNOTCHpathway in the extracellular space via its Fringe
domain. The aberrant production of JAG1 protein inThe Amhuman CHSY1-deficient fibroblasts raises the possibility
that ectopic NOTCH signaling mediated by JAG1 during
embryogenesis could in part be responsible for the birth
defects specific to this syndrome. Control of CHSY1 activity
in a tissue-specificmannermay therefore constitute a thera-
peutic target for patients with Alagille syndrome (MIM
118450) caused by JAG1 haploinsufficiency.25,26
We speculate that CHSY1, which needs an intact Fringe
domain to exert its NOTCH inhibitory activity, might
post-translationally modify NOTCH-related proteins.
However, substantiating that NOTCH receptors, or their
ligands, are actual substrates of CHSY1 will require
biochemical evidence. If so, CSs, of which two paralogs
exist in the human genome, might function as a new class
of FRINGE enzymes controlling NOTCH output during
developmental, physiological, or pathological processes.
Concurrently and alternatively, CHSY1 loss, which leads
to reduced CS moieties and therefore altered proteoglycan
synthesis, might affect other signaling pathways associated
with brachydactylies. When one considers that sulfated
glycans canmodulate FGF/FGFR interactions, that CS affect
IHH signaling,27,28 and that both FGF and IHH can in turn
regulate BMP/GDF,29 it is conceivable that reduced CS
might impede digit development by altering these path-
ways, instead of or in addition to NOTCH signaling.
The in vivo knock-down experiments carried out in
zebrafish embryos confirmed chsy1’s role during skeleto-
genesis and unmasked its importance during eye develop-
ment. Emulating the results obtained in cell culture, Notch
over-activation, marked by jag2 upregulation and silencing
of lim1, in chsy1 morphant embryos argues that chsy1 is
also necessary for driving repression of Notch signaling
during development. It is noteworthy that chsy1morphant
embryos bear striking resemblance to the maternal zebra-
fish mutant pug described by the group of Mary Mullins.30
Pug mutants lack pectoral fins, have eyes joined at the
midline, and present with segmentation anomalies similar
to what is described here. It is therefore tempting to spec-
ulate that pugmight be a chsy1maternal mutant. Although
chsy1 and pug might not be allelic, these two genes might
instead delineate a common pathway controlling limb
patterning in addition to the oocyte-to-embryo transition.
In support of CHSY1’s putative role in the earliest stages of
development, RNA-interference-mediated depletion of
ChSy (paralogous to human CHSY1) in C. elegans triggers
cytokenesis reversal, and blocks cell divisions at the 2- to
4-cell stage.31 Should CHSY1’s role during oogenesis be
conserved in humans, we are aware that the reported
loss-of-function mutation in this study would only
unmask the zygotic function of CHSY1. In contrast, a bial-
lelic maternal mutation might lead to early embryonic
lethality, and signs of sterility in homozygous CHSY1
mutant women should hereafter be anticipated.
Supporting Data
In the same issue, Li et al. report on the characterization of
five loss-of-function alleles of CHSY1 as being responsibleerican Journal of Human Genetics 87, 1–11, December 10, 2010 9
Please cite this article in press as: Tian et al., Loss of CHSY1, a Secreted FRINGE Enzyme, Causes Syndromic Brachydactyly in Humans via
Increased NOTCH Signaling, The American Journal of Human Genetics (2010), doi:10.1016/j.ajhg.2010.11.005for Temtamy Preaxial Brachydactyly Syndrome. With
the exception of hearing loss, clinical manifestations in
their affected cases match those described in the two
proband herein. Their work indicates that transcriptional
regulation of chsy1 expression in zebrafish is regulated by
the BMP pathway, which is a prominent cause of brachy-
dactylies in humans. Taken together, our findings outline
a possible means, through CHSY1 regulation, by which
BMP signals are coupled to NOTCH signaling, a scenario
often reiterated during the course of discreet develop-
mental programs.Supplemental Data
Supplemental Data include two figures and four tables and can be
found with this article at http://www.cell.com/AJHG/.Acknowledgments
We are indebted to the family for kindly partaking in this study.
We thank H. Hall, K. Rogers, and S. Rogers for their diligent exper-
tise with histology. The help of C.Y. Lim, C. Bonnard, N. Beillard,
L. Ho, and S. Chng is gratefully acknowledged.We are also grateful
to K. Sampath, Y-J. Jiang, and K. Sugahara for sharing reagents and
to S. Roy for teaching us how to dissect pectoral fins. This study
was supported by grants from A*STAR and the Society in Science
Branco Weiss Foundation to B.R.
Received: September 16, 2010
Revised: November 3, 2010
Accepted: November 12, 2010
Published online: December 2, 2010Web Resources
The URLs for data presented herein are as follows:
Blat-like Fast Accurate Search Tool (BFAST)32, http://sourceforge.
net/apps/mediawiki/bfast/index.php?title¼Main_Page
Ensembl, http://www.ensembl.org
HapMap Phase II recombination rate map, http://www.hapmap.
org/downloads/recombination/latest/
Human reference genome (UCSC build 18), http://genome.ucsc.
edu
GenBank, http://www.ncbi.nlm.nih.gov/mapview
Gene-gene correlation tool33, http://genome.ucla.edu/~jdong/
GeneCorr.html
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/omim
Pipeline for sequence analysis (SeqWare Pipeline), http://seqware.
sourceforge.net
Reversade laboratory’s website, http://www.reversade.comReferences
1. Temtamy, S.A., and Aglan, M.S. (2008). Brachydactyly. Orpha-
net J. Rare Dis. 3, 15.
2. Lehmann, K., Seemann, P., Silan, F., Goecke, T.O., Irgang, S.,
Kjaer, K.W., Kjaergaard, S., Mahoney, M.J., Morlot, S., Reissner,
C., et al. (2007). A new subtype of brachydactyly type B caused10 The American Journal of Human Genetics 87, 1–11, December 10by point mutations in the bonemorphogenetic protein antag-
onist NOGGIN. Am. J. Hum. Genet. 81, 388–396.
3. Seemann, P., Schwappacher, R., Kjaer, K.W., Krakow, D.,
Lehmann, K., Dawson, K., Stricker, S., Pohl, J., Plo¨ger, F.,
Staub,E., et al. (2005).Activatinganddeactivatingmutations in
the receptor interaction site of GDF5 cause symphalangism or
brachydactyly type A2. J. Clin. Invest. 115, 2373–2381.
4. Dathe, K., Kjaer, K.W., Brehm, A., Meinecke, P., Nu¨rnberg, P.,
Neto, J.C., Brunoni, D., Tommerup, N., Ott, C.E., Klopocki,
E., et al. (2009). Duplications involving a conserved regulatory
element downstream of BMP2 are associated with brachydac-
tyly type A2. Am. J. Hum. Genet. 84, 483–492.
5. Lehmann, K., Seemann, P., Stricker, S., Sammar, M., Meyer, B.,
Su¨ring, K., Majewski, F., Tinschert, S., Grzeschik, K.H., Mu¨ller,
D., et al. (2003). Mutations in bone morphogenetic protein
receptor 1B cause brachydactyly type A2. Proc. Natl. Acad.
Sci. USA 100, 12277–12282.
6. Schwabe, G.C., Tinschert, S., Buschow, C., Meinecke, P., Wolff,
G., Gillessen-Kaesbach, G., Oldridge, M., Wilkie, A.O., Ko¨mec,
R., and Mundlos, S. (2000). Distinct mutations in the receptor
tyrosine kinase gene ROR2 cause brachydactyly type B. Am. J.
Hum. Genet. 67, 822–831.
7. Gao, B., Guo, J., She, C., Shu, A., Yang, M., Tan, Z., Yang, X.,
Guo, S., Feng, G., and He, L. (2001). Mutations in IHH, encod-
ing Indian hedgehog, cause brachydactyly type A-1. Nat.
Genet. 28, 386–388.
8. Sun, M., Ma, F., Zeng, X., Liu, Q., Zhao, X.L., Wu, F.X., Wu,
G.P., Zhang, Z.F., Gu, B., Zhao, Y.F., et al. (2008). Triphalangeal
thumb-polysyndactyly syndrome and syndactyly type IV are
caused by genomic duplications involving the long range,
limb-specific SHH enhancer. J. Med. Genet. 45, 589–595.
9. Klopocki, E., Hennig, B.P., Dathe, K., Koll, R., de Ravel, T.,
Baten, E., Blom, E., Gillerot, Y., Weigel, J.F., Kru¨ger, G., et al.
(2010). Deletion and point mutations of PTHLH cause brachy-
dactyly type E. Am. J. Hum. Genet. 86, 434–439.
10. Johnson, D., Kan, S.H., Oldridge, M., Trembath, R.C., Roche,
P., Esnouf, R.M., Giele, H., and Wilkie, A.O. (2003). Missense
mutations in the homeodomain of HOXD13 are associated
with brachydactyly types D and E. Am. J. Hum. Genet. 72,
984–997.
11. Temtamy, S.A., Meguid, N.A., Ismail, S.I., and Ramzy, M.I.
(1998). A new multiple congenital anomaly, mental retarda-
tion syndrome with preaxial brachydactyly, hyperphalan-
gism, deafness and orodental anomalies. Clin. Dysmorphol.
7, 249–255.
12. Lee,H., O’Connor, B.D.,Merriman, B., Funari, V.A., Homer, N.,
Chen, Z., Cohn, D.H., and Nelson, S.F. (2009). Improving the
efficiency of genomic loci capture using oligonucleotide arrays
for high throughput resequencing. BMC Genomics 10, 646.
13. Rump, P., Dijkhuizen, T., Sikkema-Raddatz, B., Lemmink,
H.H., Vos, Y.J., Verheij, J.B., and van Ravenswaaij, C.M.
(2008). Drayer’s syndrome of mental retardation, micro-
cephaly, short stature and absent phalanges is caused by
a recurrent deletion of chromosome 15(q26.2—>qter). Clin.
Genet. 74, 455–462.
14. Kitagawa, H., Uyama, T., and Sugahara, K. (2001). Molecular
cloning and expression of a human chondroitin synthase. J.
Biol. Chem. 276, 38721–38726.
15. Yada, T., Sato, T., Kaseyama, H., Gotoh,M., Iwasaki, H., Kikuchi,
N., Kwon, Y.D., Togayachi, A., Kudo, T., Watanabe, H., et al.
(2003). Chondroitin sulfate synthase-3. Molecular cloning and
characterization. J. Biol. Chem. 278, 39711–39725., 2010
Please cite this article in press as: Tian et al., Loss of CHSY1, a Secreted FRINGE Enzyme, Causes Syndromic Brachydactyly in Humans via
Increased NOTCH Signaling, The American Journal of Human Genetics (2010), doi:10.1016/j.ajhg.2010.11.00516. Johnston, S.H., Rauskolb, C., Wilson, R., Prabhakaran, B.,
Irvine, K.D., and Vogt, T.F. (1997). A family of mammalian
Fringe genes implicated in boundary determination and the
Notch pathway. Development 124, 2245–2254.
17. Munro, S., and Freeman,M. (2000). The notch signalling regu-
lator fringe acts in the Golgi apparatus and requires the glyco-
syltransferase signature motif DXD. Curr. Biol. 10, 813–820.
18. Yin, L. (2005). Chondroitin synthase 1 is a key molecule in
myeloma cell-osteoclast interactions. J. Biol. Chem. 280,
15666–15672.
19. Pan, Y., Liu, Z., Shen, J., and Kopan, R. (2005). Notch1 and 2
cooperate in limb ectoderm to receive an early Jagged2 signal
regulating interdigital apoptosis. Dev. Biol. 286, 472–482.
20. Hicks, C., Johnston, S.H., diSibio, G., Collazo, A., Vogt, T.F.,
and Weinmaster, G. (2000). Fringe differentially modulates
Jagged1 and Delta1 signalling through Notch1 and Notch2.
Nat. Cell Biol. 2, 515–520.
21. Milano, J., McKay, J., Dagenais, C., Foster-Brown, L., Pognan,
F., Gadient, R., Jacobs, R.T., Zacco, A., Greenberg, B., and Ciac-
cio, P.J. (2004). Modulation of notch processing by gamma-
secretase inhibitors causes intestinal goblet cell metaplasia
and induction of genes known to specify gut secretory lineage
differentiation. Toxicol. Sci. 82, 341–358.
22. Zhang, J., Lefebvre, J.L., Zhao, S., and Granato, M. (2004). Ze-
brafish unplugged reveals a role for muscle-specific kinase
homologs in axonal pathway choice. Nat. Neurosci. 7,
1303–1309.
23. Appel, B., Givan, L.A., and Eisen, J.S. (2001). Delta-Notch
signaling and lateral inhibition in zebrafish spinal cord devel-
opment. BMC Dev. Biol. 1, 13.
24. Mead, T.J., and Yutzey, K.E. (2009). Notch pathway regulation
of chondrocyte differentiation and proliferation during
appendicular and axial skeleton development. Proc. Natl.
Acad. Sci. USA 106, 14420–14425.The Ame25. Li, L., Krantz, I.D., Deng, Y., Genin, A., Banta, A.B., Collins,
C.C., Qi, M., Trask, B.J., Kuo, W.L., Cochran, J., et al. (1997).
Alagille syndrome is caused by mutations in human Jagged1,
which encodes a ligand for Notch1. Nat. Genet. 16, 243–251.
26. Boyer-Di Ponio, J., Wright-Crosnier, C., Groyer-Picard, M.T.,
Driancourt, C., Beau, I., Hadchouel, M., and Meunier-Rotival,
M. (2007). Biological function of mutant forms of JAGGED1
proteins in Alagille syndrome: inhibitory effect on Notch
signaling. Hum. Mol. Genet. 16, 2683–2692.
27. Cortes, M., Baria, A.T., and Schwartz, N.B. (2009). Sulfation of
chondroitin sulfate proteoglycans is necessary for proper
Indian hedgehog signaling in the developing growth plate.
Development 136, 1697–1706.
28. Ha¨cker, U., Nybakken, K., and Perrimon, N. (2005). Heparan
sulphate proteoglycans: The sweet side of development. Nat.
Rev. Mol. Cell Biol. 6, 530–541.
29. Minina, E., Kreschel, C., Naski, M.C., Ornitz, D.M., and Vort-
kamp, A. (2002). Interaction of FGF, Ihh/Pthlh, and BMP
signaling integrates chondrocyte proliferation and hypertro-
phic differentiation. Dev. Cell 3, 439–449.
30. Wagner, D.S., Dosch, R., Mintzer, K.A., Wiemelt, A.P., and
Mullins, M.C. (2004). Maternal control of development at
the midblastula transition and beyond: Mutants from the
zebrafish II. Dev. Cell 6, 781–790.
31. Mizuguchi, S., Uyama, T., Kitagawa,H., Nomura, K.H., Dejima,
K., Gengyo-Ando, K., Mitani, S., Sugahara, K., and Nomura, K.
(2003). Chondroitin proteoglycans are involved in cell divi-
sion of Caenorhabditis elegans. Nature 423, 443–448.
32. Homer, N., Merriman, B., and Nelson, S.F. (2009). BFAST: An
Alignment Tool for Large Scale Genome Resequencing. PLoS
ONE 4, e7767.
33. Day, A., Dong, J., Funari, V.A., Harry, B., Strom, S.P., et al.
(2009). Disease gene characterization through large-scale
co-expression analysis. PLoS ONE 4, e8491.rican Journal of Human Genetics 87, 1–11, December 10, 2010 11
1 
 
The American Journal of Human Genetics Volume 87 
Supplemental Data 
Loss of CHSY1, a Secreted FRINGE Enzyme, Causes Syndromic 
Brachydactyly in Humans via Increased NOTCH Signaling 
Jing Tian, Ling Ling, Mohammad Shboul, Hane Lee, Brian O’Connor, Barry Merriman, Stanley F. 
Nelson, Simon Cool, Osama H. Ababneh, Azmy Al-Hadidy, Amira Masri, Hanan Hamamy, and Bruno 
Reversade 
 
Figure S1. Phenotypic characteristics of investigated patients 
(A) Hands and feet photographs of affected brother (II:4) and sister (II:5) showing marked 
brachydactyly and abnormally positioned fingers. Right hand showing brachydactyly in digits 
1-4, with a wide space between digits 3 and 4, and clinodactyly of digits 4 and 5. Left hand 
showing brachydactyly in digits 1-4, with camptodactyly of digit 5. Both feet showing 
brachydactyly with medial deviation of digits 2-5 on the right and digits 4 and 5 on the left, 
and with plantar deviation of digits 4 and 5 bilaterally.  
(B) Hands and feet radiographs of affected brother (II:4) and sister (II:5) showing bilateral 
involvement. Carpal bones show fusion of capitate and hamate with short first and third 
metacarpals. First and second proximal phalanges are duplicated bilaterally. Short proximal 
and middle phalanges in digits 2-4 with fusion. Digits 5 revealed clinodactyly due to 
deformed middle phalanges. Feet radiographs show unified calcaneum, cuboid, lateral and 
middle cuneiform bones. The great toes reveal short and duplicated metatarsals and proximal 
phalanges. The second and fourth proximal phalanges are duplicated and there is evident 
clinodactyly at right 2nd, 3rd, 4th and 5th toes and left 3rd, 4th and 5th toes.  
(C) Clinical synopsis of investigated patients compared with Temtamy Preaxial 
























Consanguinity  + + - 
Number of affected 






Delayed milestones +/- + + 
Short stature + + + 






Learning disability +/- + + 
Hearing impairment - + - 
Renal anomaly +/- - +/- 
External male 
genitalia 
- + + 
Blepharophimosis - - + 
Primary optic atrophy - 
 
+ - 
Tilted optic disc +/- - - 
Talon cusps - + - 
Brachydactyly + + + 
Congenital cardiac 
anomalies 
- - + 
Partial camptodactyly + +  
Duplicated 
phalanges/metatarsals 
+ + - 
Absent phalanges - - + 
Symphalangism + + - 
Capitate hamate 
fusion 
+ + - 
11 ribs + n.d. - 
kyphoscoliosis and 
pectus excavatum 
- + - 
Coaxa valga + - - 
Genu recurvatum +/- - - 
 








Figure S2. Developmental expression pattern of chsy1 during zebrafish embryogenesis  
(A) H&E section of growing oocytes.  
(B) chsy1 transcripts are abundant in growing oocytes. Scale bar: 100 µm.  
(C) Maternally-supplied chsy1 transcripts are localized to the animal pole in the zygote.  
(D) At the 8-cell stage, chsy1 mRNA is present in all cells.  
(E) By the dome stage, chsy1 transcripts are ubiquitous.  
(F) After the mid-blastula transition, in the gastrulating embryo at 50% epiboly, zygotic 
expression of chsy1 is ubiquitous.  
(G) At the onset of neurulation (90% epiboly), chsy1 transcripts are present in all cells.  
(H) Unrestricted transcription of chsy1 is observed in all tissues by the 8-10-somite stage.  
(I) Expression of chsy1 is seen in the tailbud and head structures of one-day old embryos 
while no expression is visible in the trunk.  
(J) Persistent and restricted expression of chsy1 in the head structures of 3-day old embryos. 
Top inset: Prominent chsy1 staining is seen in the epithelial protrusions of the inner ears at 72 
hpf. Bottom inset: 72 hpf pectoral fin bud showing chsy1 expression in growing chondrocytes 







Table S1. List of mismatches and mutations following loci-capturing and re-sequencing 
of the 4 genomic candidate regions identified by homozygosity mapping 






Table S2. Computed CHSY1 transcript correlations with genes coding for extracellular 





















































































10 chr4:96244580-96294895  BMPR1B 229975_at 0.02 
 
11 chr11:69294966-69299352 FGF4 206783_at -0.01 
































1: correlated, indicative of co-expression 
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Table S4. List of PCR primers, Q-PCR primers, siRNAs and Morpholinos  
 
Genomic DNA primer sequences 
 
Gene Exon primer sequence Product size 
[bp] 






   





Human and Zebrafish cDNA primer sequences used for cloning 
 
Gene primer sequence Product size 
[bp] 
























Human cDNA primer sequences used for Quantitative PCR 
 





Hs00208704_m1   
HES1 
 
Hs00172878_m1   
JAG1 
 
Hs01070036_m1   
JAG2 
 
Hs00171432_m1   
NOTCH1 
 
Hs01062014_m1   
NOTCH2 
 
Hs01050719_m1   
ALPL 
 
Hs01029144_m1   
ACTIN 
 








Hs00277039_m1   
C-MYC 
 
Hs00153408_m1   
BSPH1 
 
 probe ct g+Ct +T+Ta a+Tt +Ttg +Ct+C agc 
Left primer AGAGGAAGCAATCACCAAAATGA 






TTG T+GT C+CA AG+C AG+G A+GG 
+GC 
  Left primer GGTGCAGAGTCCAGCAAAGG 






CTT +TC+C A+CA +AA+C T+CT 
+CAT +CTC 
  Left primer CATGCCTCCTCAGCTCACCTT 
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Abstract
Background: The detection and diagnosis of b-thalassaemia
for populations with molecular heterogeneity, or diverse eth-
nic groups, has increased the need for the development of
an array high-throughput diagnostic tool that can deliver
large scale genetic detection. We report on the update and
validation of the ThalassoChip, a b-thalassaemia genetic
diagnostic tool which is based on arrayed primer extension
(APEX) technology.
Methods: ThalassoChip slides with new and redesigned
probes were prepared for testing the microarray. Six hundred
and sixty DNA samples collected from eight Mediterranean
countries were used for standardisation, optimisation and val-
idation of the ThalassoChip. The b-globin gene region was
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amplified by PCR, the products were hybridised to the
probes after fragmentation and the APEX reaction followed.
Results: The ThalassoChip was updated with new probes
and now has the ability to detect 57 b-globin gene mutations
and three single nucleotide polymorphisms (SNPs) in a sin-
gle test. The ThalassoChip as well as the PCR and APEX
reactions were standardised and optimised using 500 DNA
samples that were previously genotyped using conventional
diagnostic techniques. Some probes were redesigned in order
to improve the specificity and sensitivity of the test. Vali-
dation of the ThalassoChip performed using 160 samples
analysed in blinded fashion showed no error.
Conclusions: The updated version of the ThalassoChip is
versatile, robust, cost-effective and easily adaptable, but most
notably can provide comprehensive genetic diagnosis for b-
thalassaemia and other haemoglobinopathies.
Clin Chem Lab Med 2010;48:1713–8.
Keywords: arrayed primer extension technology; diagnostic
test; microarrays; thalassaemia.
Introduction
b-Thalassaemia is an autosomal recessive disorder caused by
a reduction or lack of production of b-globin chains. b-Tha-
lassaemia still remains one of the most significant single
gene disorders as most thalassaemia patients require regular
lifelong blood transfusions to survive, and early detection is
essential to support the care of patients. In addition, molec-
ular characterisation of carriers plays a central role in disease
prevention, and is an absolute requirement when offering
prenatal diagnosis to carrier couples (1). However, the cur-
rent increase in migration patterns have complicated the
identification of mutations due to the presence of a wider
spectrum of mutations in most countries worldwide (2–4).
Current molecular diagnostic approaches for thalassaemia
include PCR-based techniques capable of detecting the wide
spectrum of a- and b-globin gene mutations. The methods
include allele-specific oligonucleotide (ASO) probes, ampli-
fication refractory mutation system (ARMS) and sequencing
for point mutations and gap-PCR for specific deletions. Oth-
er indirect methods include denaturing gradient gel electro-
phoresis (DGGE), as well as denaturing high performance
liquid chromatography (dHPLC). More recently, several
emerging techniques including multiplex ligation-dependent
probe amplification (MLPA) and quantitative multiplex PCR
short fluorescent fragments (QMPSF) for the detection of
deletions, and real-time PCR and high-resolution melting
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Figure 1 b-Globin gene including positions of the four sets of primers used for PCR amplification.
curve analysis for the detection of point mutation have been
used (5, 6).
Microarray technology is able to explore genetic abnor-
malities of polygenic disorders, such as heart disease, mental
illness, and infectious diseases, and to distinguish patholog-
ical entities, such as acute myeloid leukaemia and acute lym-
phoblastic leukaemia (7, 8). Microarrays are used to study
the therapeutic response to drugs and establish genetic pro-
files of treated and untreated patients. Microarrays can revo-
lutionise the diagnosis of b-thalassaemia and Hb variants (9).
Chan et al. in 2004 (10) developed a thalassaemia array cov-
ering the commonest mutations of a- and b-thalassaemias in
Southeast Asia. Nanogen Microelectronic technology was
used for the detection of b-thalassaemia mutations (11, 12).
We developed and validated a microarray chip, called
ThalassoChip, to serve as a high throughput, large scale
b-globin mutation and polymorphism detection system (13,
14). The ThalassoChip is able to detect mutations and SNPs
at low concentrations of genetic samples, and can show
detectable signal with just 0.15 ng of human genomic DNA
(15).
The ThalassoChip is based on arrayed primer extension
(APEX) technology. It involves extension of oligonucleo-
tides probes that are designed to stop a single nucleotide
short relative to the position of the allelic variant (16). The
probes are immobilised via the 59 end on a glass surface,
while their 39 end is free for enzymatic extension. An ampli-
con containing the region which harbours the mutation(s) or
single nucleotide polymorphisms (SNPs) under investigation
is hybridised to the complementary probe sequence that is
immobilised on the microarray chip. A single base extension
of the probe is performed by incorporation of the appropriate
dye-labelled dideoxynucleotide complementary to the variant
base, followed by termination of the reaction. An automatic
laser imaging system, Genorama QuattroImager, is used to
read the APEX slide. Fluorescent labels (Fluorescein, Cy3,
Cy5 and Texas Red) for the four dideoxynucleotides are read
at four different emission wavelengths (17–20).
In this study, we report on the update and validation of
the ThalassoChip, a b-thalassaemia genetic diagnostic tool
which is based on APEX technology. This system has the
ability to detect over 60 b-globin gene mutations and poly-
morphisms in a single step.
Materials and methods
Spotting
Probes (oligonucleotides) of 20–25 nucleotide bases in length were
designed to be complementary to known SNPs and mutation
regions, but terminating one base before the variant nucleotide posi-
tion, were used for spotting. The microarray slides have a double-
sided amino-silane coating onto which the oligos are elec-
trostatically attached by their 59 termini (21). The slide coating has
the ability to preserve the probes anchored to the slide. Each spot
has a diameter of 90–100 mm, with a minimum distance of 150 mm
(optimal 250–375 mm) between spots.
New probes have been designed to update the ThalassoChip. The
oligonucleotide probes were synthesised according to the wild type
sequence, with an amino-linking group at the 59 end attached to the
glass slide. The 39 end of the probe is free for enzymatic extension
by DNA polymerase during the APEX reaction step. For each nucle-
otide variation, probes were designed to target both sense and anti-
sense strands, and each probe was spotted in duplicate in order to
increase the reliability of diagnosis. The b-globin gene sequence
was derived from the NCBI database with accession number
NG_000007.
The ThalassoChip routine screening process involved the follow-
ing steps: a) DNA extraction and amplification of the appropriate
region by PCR, b) purification of the amplified region followed by
fragmentation, c) hybridisation of amplicons followed by APEX
reaction, oligonucleotide probe extension by a single fluorescently
labeled ddNTP, d) genotype determination using a four-channel
imager.
DNA samples
During the standardisation and validation process of the
ThalassoChip, 660 human genomic DNA samples with various gen-
otypes were tested. Five hundred DNA samples were extracted from
whole blood using either the Puregene Blood Core Kit C (Qiagen,
Hilden, Germany) or the QIAmp DNA Blood Mini kit (Qiagen,
GmBh, Hilden, Germany). One hundred and sixty DNA samples
were provided by the collaborating partners, from countries, such
as Cyprus, Egypt, Morocco, Jordan, Saudi Arabia, Israel, Greece
and Italy. The DNA sample concentration was adjusted to
50–100 ng/mL using pure sterile water. All samples used in this
study were obtained with informed consent from the patients, and
all work was performed in accordance to the declaration of Helsinki
ethical guidelines as reflected in a priori approval by the Cyprus
national Ethics Committee.
Polymerase chain reaction
Four sets of primers were designed to amplify the b-globin regions
that contain the majority of mutations and polymorphisms (Figure
1). Each set of primers covered an area approximately 200 bases
long. The primers were designed taking into consideration their
melting temperature (Tm), their propensity to form dimers with
themselves or with other primers, and care was taken to avoid
annealing of the primers to SNPs or mutations. Optimal PCR con-
ditions were selected for each set of primers. Primer sequences were
designed as follows: Primer set 1: Forward: 59-CTAAGCCAGTGC-
CAGAAGAGCCAAG-39; Reverse: 59-TCAGTGCCTATCAGAAA-
CCCAAGAG-39. Primer set 2: Forward: 59-GGGTTTCTGATAGG-
CACTGACTCTCTC-39; Reverse: 59-ACTGTACCCTGTTACTTC-
TCCCCTT-39. Primer set 3: Forward: 59-TTCAGGGCAATA-
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Figure 2 Image from the BaseCaller 4.5 software used for the APEX analysis of sequence IVSI-128 (T™G).
The four-channel fluorescent images from each type of flurophore dNTP are shown in the top right boxes marked A, C, G and T, respectively.
The sense strand (top) and anti-sense strand (bottom) are each determined twice to minimize errors. PicDB image from previous samples
can be seen on the lower right hand corner. Sample observed in the PicDM images labeled M1 is WT, M2 is heterozygous for IVSI-128
and M4 is the negative control.
ATGATACAATG-39; Reverse: 59-AAGTGATGGGCCAGCACA-
CAG-39. Primer set 4: Forward: 59-GTGTGCTGGCCCAT-
CATCTTG-39; Reverse: 59-CCTCCCACATTCCCTTTTTAG-39.
The PCR reaction (25 mL) contained the following reagents:
10=PCR buffer (500 mM KCl, 15 mM MgCl2 and 100 mM Tris-
HCl, Amersham Pharmacia Biotech, Uppsala Sweden), 2 mL of
deoxynucleoside triphosphate mix (2 mM dATP, 2 mM dCTP, 2 mM
dGTP, 1.6 mM dTTP, and 0.04 mM dUTP), 10 pmol/mL of primers,
2.5 U of Taq Polymerase (5 U/mL; Amersham Pharmacia Biotech,
Uppsala, Sweden) and 100 ng of human genomic DNA. The PCR
programme that produced the greatest yield followed the touch-
down PCR protocol which also avoids amplification of non-specific
sequences (22). The initial incubation was performed at 958C for
5 min followed by 5 cycles of denaturation at 958C for 30 s and
primer annealing at 608C and extension at 728C for 20 s. The pro-
gramme continued with another 30 cycles of annealing at 588C for
30 s and then changed to 20 s for the final 8 cycles. The final
extension was performed at 728C for 5 min. PCR products were
purified and concentrated (to 15 mL in volume) using the Qiagen
QIAquick PCR Purification Kit (Hilden, Germany) as per the manu-
facturer’s protocol. Each PCR product was tested by gel electropho-
resis to ensure that each set of PCR reactions produced a single
product of the expected size.
Fragmentation
All PCR products amplified included 20% substitution of dTTPs
with dUTPs. This enabled subsequent fragmentation with thermo-
labile uracil-N-glycosylase (by HK, Madison, WI, USA) which
hydrolyses the N-glycosidic bond between the deoxyribose sugar
and uracil in DNA that contains deoxyuridine when it is heated to
388C. During the fragmentation process shrimp alkaline phosphatase
(SAP) was also added which catalyses the release of the 59 phos-
phate group from the DNA. Dephosphorylation of the excess dNTPs
that remain after PCR can interfere with the APEX reaction. The
fragmentation mixture (30 mL) consisted of: 10=UNG buffer
w500 mM Tris-HCl, pH 9.0; 200 mM (NH4)2SO4x, 0.03 U/mL of
SAP (1 U/mL) (Amersham Bioscience Inc., Milwaukee, WI, USA),
0.03 U/mL of UNG (1 U/mL) (Epicentre Technologies, Madison,
WI, USA) and approximately 75 ng/mL of purified PCR product.
The fragmented PCR product was heated to 958C for 10 min which
enabled the deactivation of the SAP enzyme as well as denaturation
of the double stranded DNA duplexes. Fragmentation efficiency was
confirmed by electrophoresis.
Amplicon hybridisation and the APEX reaction
During the APEX reaction, the microarray oligonucleotide probes
were extended by a single fluorescently-labeled dideoxynucleoside
triphosphate which was complementary to the DNA template. The
DNA polymerase reaction was run at high temperature (588C) to
avoid or minimize undesirable secondary structure oligos, while per-
mitting efficient hybridisation to the target site. Each slide was incu-
bated for 15 min and any excess reagents were removed by washing
the slides with boiling water, allowing annealed DNA to denature
and wash away. This process can avoid background fluorescence
and rehybridisation of unbound oligonucleotides.
The buffer reaction mixture (40 mL) that was used consisted of
Tris-HCl/MgCl2 buffer (260 nM, pH 9.5 and 65 mM, respectively;
Amersham Pharmacia Biotech, Uppsala, Sweden), four different ter-
minator nucleotides, each tagged with individual fluorophores:
12 mM of Fluorescein ddUTP, 19 mM of Cy3 ddCTP, 12 mM of
Texas Red ddATP, 12 mM of Cy5 ddGTP (NEN, Boston, MA, USA,
and Amersham Pharmacia Biotech, Uppsala, Sweden), 12 mM
Thermosequenase DNA polymerase (Amersham Pharmacia Bio-
tech, Uppsala, Sweden) and 70 ng/mL of denatured DNA.
Workstation
The device used for the detection of mutations and polymorphisms
during the validation of the chip was the Genorama QuattroImager
detector 003 (Genorama Ltd., Tartu, Estonia). The detector is a four-
channel imaging system composed of laser light sources and an
integrated camera. The signal detection process is based on the
recording of fluorescence emitted at the surface of the ThalassoChip
that permits homologous exposure. The appropriate frequency of
light source stimulates the labelled nucleotides to emit light that is
captured by a charged coupled devised digital camera with 20 mm
resolution (23).
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Table 1 List of the b-globin mutations and polymorphisms that have been spotted on the ThalassoChip and validation results.
Common name HGVS nomenclature N/M M/M
1 –101 (C™T) HBB:c.–151C)T 1
2 –92 (C™T) HBB:c.–142C)T 1
3 –88 (C™T) HBB:c.–138C)T 1
4 –87 (C™G) HBB:c.–137C)G 1
5 –30 (T™A/C) HBB:c.–80T)A/HBB:c.–80T)C 1
6 –28 (A™C) HBB:c.–78A)C 1
7 q20 (C™G/T) (SNP) HBB:c.–31C)T 17 2
8 q22 (G™A) HBB:c.–29G)A 1
9 q30 (T™C) HBB:c.–21C)G 2
10 q33 (C™G) HBB:c.–18C)G 1
11 Cd 1 delG HBB:c.4delG 1
12 Cd 2 (CAC™CAT) (SNP) HBB:c.9C)T 6
13 Cd 5 (CCT™del-CT) HBB:c.17_18delCT 9
14 Cd 6 (GAG™ AAG) HbC HBB:c.19G)A 1
15 Cd 6 (GAG™del-A) HBB:c.20delA 1
16 Cd 6 (GAG™GTG) HbS HBB:c.20A)T 1
17 Cd 8 (AAG™del-AA) HBB:c.25_26delAA 5
18 Cd 8/9 insG HBB:c.27_28insG 4
19 Cd 9/10 insT HBB:c.30_31insT 1
20 Cd 15 (G™A) HBB:c.48G)A 3
21 Cd 22–24 delAAGTTGG HBB:c.68_74delAAGTTGG 1
22 Cd 24 (T™A) HBB:c.75T)A 1
23 Cd 24 delG/insCAC HBB:c.74delinsCAC 1
24 Cd 25/26 insT HBB:c.78_79insT 1
25 Cd 26 (GAG™AAG) HbE HBB:c.79G)A 1
26 Cd 27 (GCC™TCC) Hb Knossos HBB:c.82G)T 1
27 Cd 28 delC HBB:c.85delC 1
28 Cd 30 (A™G) HBB:c.91A)G 5
29 IVSI-1 (G™A/T) HBB:c.92q1G)A / HBB:c.92q1G)T 9 1
30 IVS-2 (T™G) HBB:c.92q2T)G 1
31 IVSI (-3)/Cd 29 (C™T) HBB:c.90C)T 1
32 IVSI-5 (G™A/T/C) HBB:c.92q5G)A/HBB:c.92q5G)T/HBB:c.92q5G)C 8
33 IVSI-6 (T™C) HBB:c.92q6T)C 12
34 IVSI del17bp HBB:c.93–17_93–1delTATTTTCCCACCCTTAG 1
35 IVSI del25bp HBB:c.93–21_96del 3
36 IVSI del44bp HBB:c.76_92q27del 1
37 IVSI-110 (G™A) HBB:c.93–21G)A 14 1
38 IVSI-116 (T™G) HBB:c.93–15T)G 1
39 IVSI-128 (T™G) HBB:c.93–3T)G 1
40 IVSI-130 (G™C/A) HBB:c.93–1G)C/HBB:c.93–1G)A 3
41 Cd 30 (G™C) HBB:c.93G)C 3
42 Cd 36/37 delT HBB:c.112delT 2
43 Cd 37 (G™A) HBB:c.113G)A 9 2
44 Cd 39 (CAG™TAG) HBB:c.118C)T 16 2
45 Cd 44 (TCC™del-C) HBB:c.135delC 1
46 Cd 76 (GCT™del-C) HBB:c.230delC 0
47 Cd 90 (G™T) HBB:c.271G)T 1
48 IVSII-1 (G™A) HBB:c.315q1G)A 2 1
49 IVSII-74 (G™T) (SNP) HBB: c.315q74G)T 2
50 IVSII-654 (C™T) HBB:c.316–197C)T 1
51 IVSII-666 (T™C) HBB:c.316–185T)C 1
52 IVSII-705 (T™G) HBB:c.316–146T)G 1
53 IVSII-745 (C™G) HBB:c.316–106C)G 17 2
54 IVSII-844 (C™G) HBB:c.316–7C)G 0
55 IVSII-848 (C™A) HBB:c.316–3C)A 1
56 IVSII-849 (A™C) HBB:c.316–2A)C 1
57 Cd106/107 insG HBB:c.321_322insG 1
58 Cd 121 (GAA™CAA) Hb D HBB:c.364G)C 1
59 Cd 121 (GAA™AAA) Hb O HBB:c.364G)A 1
60 q1570 (T™C) HBB:c.*q96T)C 1
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Data processing
Image analysis software was used to determine the genotype exten-
sion that has been produced during the APEX reaction, and each
image was merged producing a single output file. Two types of
software were used for the analysis, both of which are included in
the Genorama Genotyping software. The BaseCaller software is
used for data processing and single sample analysis (Figure 2) while
the PicDB software was used for simultaneous analysis and com-
parison of multiple images.
Results
ThalassoChip update
New probes have been designed to update the ThalassoChip
which can now detect 54 b-thalassaemia mutations that are
common in Mediterranean countries, three haemoglobin var-
iants (HbS, HbE and HbC) and three SNPs located in the
b-globin gene (Table 1). The three SNPs that were included
in the ThalassoChip are Cd 2 (CAC™CAT), IVSII-74 (G™
T) and q20 (C™G/T) polymorphism that is 100% associ-
ated with the IVSII-745 (C™G) b0-thalassaemia mutation.
Chip standardisation
Five hundred human genomic DNA samples were used for
standardisation and optimisation of the ThalassoChip. All
samples were previously genetically tested using convention-
al methods. The samples were used for the comprehensive
determination and assessment of each probe, as well as for
standardisation of the PCR reaction mixes, PCR programmes
and optimisation of APEX conditions. Probes that showed
low signal intensity were improved by changes made to the
probe length or sequence that improved melting temperature.
Changes in binding affinity had to be assured that did not
induce changes in binding specificity.
Chip validation
After the standardisation process, 160 human genomic DNA
samples were run in blinded fashion. All samples were sub-
sequently shown to be concordant with the conventional
diagnosis that was made previously. All samples were
screened against the 60 mutations and polymorphisms. As
shown in Table 1, at least one sample from the pool was
heterozygous (N/M) or homozygous (M/M) for each muta-
tion and polymorphism with the exception of IVSII-844
(C™G) and Cd 76 (GCT™del-C); due to their rarity in the
Mediterranean region, only wild type alleles were tested. The
normal allele for each probe was validated more than 140
times.
A general limiting factor in this study was the inadequate
signal detection levels emitted from the Texas Red labelled
ddATP. No changes were observed when the dye concentra-
tion was increased. Replacing the adenosine fluorophore with
a higher intensity fluorescent dye could have improved the
APEX analysis.
The relative fluorescent light intensity emitted when a
sample is homozygous for an allele is usually twice as
intense compared to a heterozygous sample, since the het-
erozygous sample has half of its probes extended with wild
type nucleotide and the other half with the mutant nucleotide.
This phenomenon can make peak assignment difficult when
dealing with heterozygous samples.
Discussion
The ThalassoChip potentially offers an alternative approach
for the diagnosis of b-thalassaemia mutations and haemo-
globin variants. The microarray is a diagnostic tool with low
operating costs. It is estimated that each test costs 40 7, and
can determine a wide spectrum of mutations and polymor-
phisms in a single experiment. This tool can provide diag-
nosis for populations with molecular heterogeneity. The
current version of the ThalassoChip contains probes that can
detect mutations common in the Mediterranean region, but
it is being continuously updated to include more mutations
that can cover more diverse ethnic groups. The APEX reac-
tions are entirely reproducible under standardised conditions.
These conditions include 1) the use of good quality human
genomic DNA at the appropriate concentration, 2) optimised
PCR amplification conditions, 3) successful DNA fragmen-
tation 4) use of the optimised APEX reaction conditions.
The ThalassoChip can now serve as a diagnostic tool for
b-thalassaemia and other haemoglobinopathies, but can also
progress to an automated system that includes a greater num-
ber of mutations, even those underlying a- and d-thalassae-
mia. The only disadvantage of this approach when compared
to DNA sequencing is that the microarray chip is limited to
detecting only known nucleotide changes for which the
APEX probes have been designed, whereas previously unde-
tected polymorphisms and new mutations will be missed.
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Mutations in PYCR1 cause cutis laxa with
progeroid features
Bruno Reversade1,33, Nathalie Escande-Beillard1,33, Aikaterini Dimopoulou2, Bjo¨rn Fischer2, Serene C Chng1,
Yun Li3, Mohammad Shboul1, Puay-Yoke Tham1, Hu¨lya Kayserili4, Lihadh Al-Gazali5, Monzer Shahwan6,
Francesco Brancati7,8, Hane Lee9, Brian D O’Connor9, Mareen Schmidt-von Kegler2,10, Barry Merriman9,
Stanley F Nelson9, Amira Masri11, Fawaz Alkazaleh11, Deanna Guerra12, Paola Ferrari13, Arti Nanda14,
Anna Rajab15, David Markie16, Mary Gray16, John Nelson17, Arthur Grix18, Annemarie Sommer19,
Ravi Savarirayan20, Andreas R Janecke21, Elisabeth Steichen22, David Sillence23, Ingrid Hauer24,
Birgit Budde25, Gudrun Nu¨rnberg25, Peter Nu¨rnberg25, Petra Seemann10,26, De´sire´e Kunkel26,
Giovanna Zambruno27, Bruno Dallapiccola7, Markus Schuelke28, Stephen Robertson29, Hanan Hamamy6,
Bernd Wollnik3,30,31, Lionel Van Maldergem32, Stefan Mundlos2,10,26 & Uwe Kornak2,10
Autosomal recessive cutis laxa (ARCL) describes a group
of syndromal disorders that are often associated with a
progeroid appearance, lax and wrinkled skin, osteopenia
and mental retardation1–3. Homozygosity mapping in
several kindreds with ARCL identified a candidate region
on chromosome 17q25. By high-throughput sequencing of
the entire candidate region, we detected disease-causing
mutations in the gene PYCR1. We found that the gene
product, an enzyme involved in proline metabolism, localizes
to mitochondria. Altered mitochondrial morphology,
membrane potential and increased apoptosis rate upon
oxidative stress were evident in fibroblasts from affected
individuals. Knockdown of the orthologous genes in Xenopus
and zebrafish led to epidermal hypoplasia and blistering that
was accompanied by a massive increase of apoptosis. Our
findings link mutations in PYCR1 to altered mitochondrial
function and progeroid changes in connective tissues.
Wrinkly skin and bone loss are typical features associated with
aging. In some monogenetic diseases these changes occur prema-
turely, resulting in a progeroid appearance of affected individuals.
As a clinical feature, wrinkly skin or cutis laxa is used as a
common denominator of several overlapping syndromal disorders
including autosomal dominant cutis laxa (MIM123700), autoso-
mal recessive cutis laxa type I (MIM219100), autosomal recessive
cutis laxa type II (ARCL2; MIM219200, also called wrinkly skin
syndrome (WSS; MIM278250)), de Barsy syndrome (DBS;
MIM219150), and gerodermia osteodysplastica (MIM231070)1–4.
Diagnosis is often difficult in these conditions owing to a broad
clinical overlap5,6.
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Here we describe mutations in PYCR1 associated with a spectrum
of disorders characterized by wrinkly skin, osteopenia and progeroid
appearance. The clinical features of the 35 affected individuals from 22
families included in our study are summarized in Table 1. They
include congenital skin wrinkling, most pronounced on the dorsum of
hands and feet; generalized connective tissue weakness; finger con-
tractures; hernias; osteopenia; and a triangular face with a progeroid
appearance that is due to lax skin and hypoplasia of the jaw often
resulting in prognathism (Fig. 1a–d). Ultrastructural investigation of
the skin showed rarefaction and fragmentation of elastic fibers similar
to changes described in ARCL2 (Fig. 1e–h). No glycosylation abnorm-
alities were detected by standard diagnostics (data not shown). A
variable degree of mental retardation was observed in all cases but one.
In many subjects, agenesis of the corpus callosum was evident.
Although most affected individuals were classified as having geroder-
mia osteodysplastica or WSS, more severely affected individuals also
showed childhood cataracts or dystonic movements and were there-
fore diagnosed as having DBS1,3,5–9.
Homozygosity mapping in five consanguineous families revealed a
minimal candidate region of 2.8 Mb on chromosome 17q25 between
markers rs8065431 and rs1046896 (Fig. 1i). To screen the 59 candidate
genes in this region for disease-causing mutations we combined
conventional sequencing and genomic locus capture followed by
high-throughput sequencing (H. Lee, B. O’Connor, B. Merriman,
N. Homer, Z. Chen et al., unpublished data) (Fig. 1j). The latter
identified 552 genomic mismatches, of which 7 were newly identified
SNPs that cause non-synonymous changes (Supplementary Table 1).
We next cross-examined genes with mutations in four other
sequenced samples to evaluate the causality of the observed changes.
Both methods identified mutations in PYCR1, the gene encoding the
enzyme D1-pyrroline-5-carboxylate reductase 1 (PYCR1).
In total, we identified eight missense mutations, one frameshift
mutation, five splice-site mutations and one 22-bp deletion encom-
passing the exon-intron boundary of exon 5 (Table 1 and Supple-
mentary Fig. 1a). Six of these mutations were recurrent, even
though the affected individuals did not have a common ethnic
background. Bioinformatic analysis predicted deleterious effects for
all changes with the exception of the heterozygous A189V, for
which we cannot rule out the possibility that it is a rare variant
(Supplementary Fig. 1b).
As skin was the most severely affected organ, we isolated skin
fibroblasts from probands and their unaffected siblings to examine
PYCR1 protein expression (Fig. 2). Strongly reduced PYCR1 protein
levels were detected in a subject (S.J.) with a homozygous splice site
mutation and in a compound heterozygous subject (D.I.) with a
missense and a frameshift mutation (Fig. 2a). The missense mutations
G206W (T.P.) and R251H (E.U.) resulted in a reduction in protein
abundance relative to control cells (Fig. 2b–f). The PYCR1 protein,
which has been often described as cytosolic, colocalized with various
mitochondrial markers (data not shown), among them D1-pyrroline-
5-carboxylate synthase (P5CS), which also belongs to the proline meta-
bolic pathway (Fig. 2b)10,11. We therefore conclude that PYCR1 is a
mitochondrial protein and that the reported mutations lead to a loss
of function.
Pycr1 was most highly expressed in bone and skin, the two tissues
most severely affected in human subjects (Supplementary Fig. 2a).
Two paralogs of PYCR1 exist in human, the highly similar PYCR2
and the more distantly related PYCRL. No significant expression
























J.I. Iraq 1 + ++ +  +     WSS Hom 138+1G4A ND 2
T.P. Palestine 1 + +   ND + + +  WSS Hom 616G4T G206W 5 7
S.P. Palestine 3 + ++ +  + +/ +/   GO or WSS Hom 617_633+6del ND 5 5
I.K. Kuwait 2 + ++ ++ ++ ++  +   GO or WSS Hom 797G4A R266Q + splicing 6 6
F.S. Kuwait 1 + + ++ ++ ++  +   GO or WSS Hom 797G4A R266Q + splicing 6 6
S.J. Jordan 5 + ++  + ND + +   WSS Hom 797+2_797
+5del
K215_D319del 6
D.I. Italy 1 + ++  ++ ++ ND +   GO Het 11delG G4fsX50 1
Het 355C4G R119G 4
S.O. Oman 1  ++ +  +  +   GO Het 356G4A R119H 4
Het 566C4T A189V 5
G.O. Oman 3 ND ++   + ND +   GO Hom 356G4A R119H 4 1
H.B. Bahrain 2 + ++ ++ +  ND +   GO Hom 535G4A A179T 4
M.A. Austria 1 + + ++ + ++ ND +   GO Hom 540+1G4A ND 4
M.Q. Qatar 1 ND ++ ++ + ++ ND +   GO Hom 616G4A G206R 5
H.U. United States 1 + +    + +   GO Hom 633+1G4C ND 5 8
N.A. Australia 1 + ++ + + ND ND +   GO Het 633+1G4C ND 5
Het 797+1G4T ND 6
A.S. Syria 1 + +  + + + +   GO Hom 797+2_797+5del K215_D319del 6 5
D.T. Turkey 1 + ++ +  ND ND +/   DBS Hom 355C4G R119G 4
M.F. Italy 1 + ++ ND ++ ND ND + +  DBS Het 355C4G R119G 4 3
DBS Het 356G4A R119H 4
S.T. Turkey 2 + + +  ND + + +  DBS Hom 540+1G4A ND 6
E.U. United States 1 + ++ + ++ ND + +  + DBS Hom 752G4A R251H 6
J.A. Australia 3 + ++   ND ND ++ + + DBS Hom 769G4A A257T 6 9
K.T. Turkey 1  + +  ND + +   DBS Hom 797G4A R266Q + splicing 6
I.T. Turkey 1 + + +  ND  +   DBS Hom 797+2_797+5del K215_D319del 6
GO, gerodermia osteodysplastica; WSS, wrinkly skin syndrome; DBS, de Barsy syndrome. No. aff. ind., number of affected individuals in family; IUGR, intrauterine growth
retardation; Hom, homozygous; Het, heterozygous. ND, not determined; +/, mild; +, average; ++, strong. For hernias: +, unilateral; ++, bilateral.
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changes in fibroblasts from individuals with PYCR1 mutations were
observed for PYCR2 or for ALDH18A1, encoding P5CS (Supple-
mentary Fig. 2b). As PYCR1 catalyzes the obligatory and final step
in de novo proline synthesis, we first investigated whether affected
individuals showed hypoprolinemia. Serum proline levels in affected
individuals were slightly low, but within normal range (Supple-
mentary Fig. 3a). Likewise, cultured skin fibroblasts did not show
evidence of low proline (Supplementary Fig. 3b) or of reduced pro-
liferation rates in medium without proline (Supplementary Fig. 3c),
arguing against a proline auxotrophy.
On the basis of the mitochondrial localization of PYCR1, we
examined the mitochondrial network in more detail. Ultrastructural
analysis revealed abnormal morphology of mitochondria and their
cristae (Fig. 3a,b). These differences were exacerbated upon oxidative
stress (Fig. 3c–e). Addition of H2O2 to the cell
culture medium induced the collapse of the
filamentous mitochondrial network in cells
from affected individuals, whereas almost no
changes were observed in mitochondria of
control cells (Fig. 3e). Under normal culture
conditions, affected and control fibroblasts
showed no differences in their levels of apop-
tosis or mitochondrial membrane potential.
However, after a short exposure to H2O2 a
decreased mitochondrial membrane potential
and a fivefold increase in cell death in affected
fibroblasts compared to controls was observed
(Fig. 3f,g). This suggests that PYCR1 is
involved in the cell’s response to oxidative
stress. In contrast, we detected no significant differences in the
respiration rates or reactive oxygen species (ROS) production between
affected and control cells (Supplementary Fig. 4).
We next addressed PYCR1’s function during embryogenesis, as
patients show ARCL phenotypes at birth. As PYCR1 is conserved
throughout evolution (Fig. 4a)12, we used a morpholino-based knock-
down strategy (Fig. 4b) to model the disease in Xenopus embryos. By
stage 30, Pycr1 morphant embryos showed obvious skin defects and
failed, in a cell-autonomous fashion, to develop eyes and a tail bud
(Fig. 4c–f). By the swimming tadpole stage, skin hypoplasia led to
regions of ectodermal edema (Fig. 4g,h). Histological sections revealed
disorganization of the skin epithelium, with enlarged cells and nuclei
(Fig. 4i,j). We observed a similar phenotype upon morpholino
knockdown of the Pycr1 and Pycr2 genes in zebrafish (Supplementary
Chr. 17









































































Figure 1 Phenotypic characteristics and genetic
findings of subjects with PYCR1-related
autosomal recessive cutis laxa with progeroid
appearance. (a) Affected 2-year-old girl from
family T.P., initially diagnosed with wrinkly skin
syndrome. (b) Affected 18-month-old girl from
family D.I. clinically categorized as having
gerodermia osteodysplastica. (c) Newborn boy
from family E.U. diagnosed with de Barsy
syndrome. Typical facial gestalt including
triangular face, malar hypoplasia and dysplastic,
large ears. (d) Skin wrinkling at the dorsum of the
hand and typical adducted thumb in an affected
individual from family H.B. Participants gave
consent for publication of all photos.
(e–h) Findings in skin biopsy from affected
individual from family D.I. (e,f) Weigert staining
reveals sparse, thinned and fragmented elastic
fibers in the reticular dermis compared to control
(f); scale bar, 100 mm. (g,h) Ultrastructural
analyses corroborate the markedly reduced elastic
fiber (arrows) size with a reduction in both the
fibrillar and amorphous components in an
affected individual from family D.I. compared to
control (h); scale bar, 500 nm. (i) Homozygosity
mapping resulted in a minimal candidate region
of 2.8 Mb on chromosome (chr.) 17q25 between
markers rs8065431 and rs1046896. Only the
four most informative pedigrees are shown.
(j) Genomic capture followed by next-generation
sequencing of the maximal candidate region
extending from 72.05–78.77 Mb. A sequence
change of C4T was sequenced seven times in a
subject from family G.O. This base change
resulted in a single R119H substitution in PYCR1.
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Fig. 5a–j). Microinjection of human PYCR1 mRNA partially rescued
the phenotype observed in frogs and fish (Supplementary Figs. 5
and 6). Pycr1 morphant frogs had no circulating red blood cells
(Supplementary Videos 1 and 2), as validated by the loss of Scl
expression, a marker of primitive hematopoiesis (Fig. 5a,b). To rule
out the possibility that the skin atrophy was caused by anemia,
we performed a parabiosis experiment joining control and Pycr1
morphant embryos. Despite shared blood
circulation (Supplementary Video 3), skin
hypoplasia and stunted growth were not
rescued in parabiotic Pycr1 morphants even
though fewer regions of edema were observed
(Fig. 5c–e). We conclude that the ancestral
Pycr1 gene in Xenopus plays dual but inde-
pendent roles during blood and skin devel-
opment that may be attributed to the
paralogous PYCR1 and PYCR2 genes in
human. Indeed, a role for PYCR2 in human
erythrocytes has been well documented10,11.
The marked increased cell death in the
developing skin of frogs and fish, as revealed
by acridine orange and TUNEL staining
(Fig. 5f–i and Supplementary Fig. 5i,j),
underscores the specific requirement for
Pycr1 in this particular tissue. This parallels
the data obtained with cells from affected
individuals. Together these lines of evidence
suggest that PYCR1 mutants have compro-
mised mitochondrial function that leads to
apoptosis during embryogenesis and a general inability to thrive
during adult life.
PYCR1 belongs to the NAD(P)H-binding Rossmann-fold domain
superfamily and catalyzes the conversion of D1-pyrroline-5-carboxy-
late to L-proline. Determination of the crystal structure revealed
that the mature enzyme consists of five homodimer subunits around
























Figure 2 Effect of PYCR1 mutations. (a) Immunoblot analysis of PYCR1 protein expression in primary
skin fibroblasts from controls and patients. Actin served as a loading control. PYCR1 expression is
absent in affected individuals D.I. and S.J., whereas E.U. and T.P. show a substantial reduction.
(b–f) Immunofluorescent detection of PYCR1 and P5CS in mitochondria from skin fibroblasts. (b) In
control (Ct) fibroblasts, PYCR1 and the mitochondrial matrix protein P5CS colocalize. In fibroblasts
from subjects D.I. (e) and S.J. (f), immunostaining for PYCR1 is undetectable. In contrast, in fibroblasts
from T.P. (c) and E.U. (d), PYCR1 staining in mitochondria is lower in intensity relative to control.
























































































Figure 3 Loss of PYCR1 causes increased sensitivity to oxidative stress. (a,b) Ultrastructural analysis of mitochondrial morphology. Whereas mitochondria
in control fibroblasts (a) have regularly arranged cristae, fibroblasts from affected individual D.I. (b) show strongly altered cristae and a smaller diameter.
Scale bar, 1 mm. (c,d) Changes in mitochondrial morphology upon oxidative stress. Addition of 500 mM H2O2 to cell culture medium for 10 min leads to
mitochondrial network collapse in fibroblasts from affected individual from family S.J. (d); tubular mitochondrial network remains largely intact in control
cells (c). Scale bar, 20 mm. (e) Quantification of mitochondrial morphology changes upon oxidative stress. Without oxidative stress (gray), most control
(n ¼ 3) and affected (n ¼ 4) cells showed tubular mitochondria. Only a few cells with fragmented or intermediate (interm.) morphologies were seen.
In contrast, under oxidative stress (black) the number of cells with fragmented mitochondria increased much more in affected cells than in control.
(f) Quantification of apoptotic cell death by TUNEL 24 h after oxidative stress. Fibroblasts from control (Ct; n ¼ 2) and affected individuals (Aff; n ¼ 4)
showed no differences in apoptosis under normal culture conditions (control). Fivefold more (P ¼ 0.026) apoptosis was observed in cells from affected
individuals 24 h after a 10 min incubation with 200 mM H2O2. Normalized to Ct cells in control experiment. Data in e,f averaged from three independent
experiments; error bars, s.d. (g) Mitochondrial membrane potential is reduced in fibroblasts from affected individuals S.J. and D.I. after 2 h incubation
with 200 mM H2O2 but unchanged in control cells. Representative results.
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linked to the proline metabolic pathway13. Most notably, P5CS
deficiency causes a condition of mental retardation, joint hyper-
mobility and skin laxity (MIM612652)14–16. As in the subjects
described herein, P5CS deficiencies are not consistently characterized
by low serum proline14,15. Furthermore, fibroblasts from the subjects
described here did not show the proliferation defect described
upon P5CS deficiency16. The phenotype of PYCR1-related disease
overlaps with other forms of cutis laxa, mirrored by the fact that
affected individuals from this cohort have been previously described
under the diagnoses WSS, gerodermia osteodysplastica or DBS1,3,5–9.
Whereas gerodermia osteodysplastica caused by mutations in GORAB
(formerly known as SCYL1BP1) does not lead to intellectual impair-
ment, ARCL2 often includes mild or moderate mental retardation
and brain anomalies2,17,18. The mutations we detected cluster in exons
4, 5 and 6, which encode the catalytic sites of PYCR1 and are
predominantly missense and splice-site mutations. Although a
wide range of phenotypes was observed (see Table 1), no clear
genotype-phenotype correlation could be discerned. Mutations in
ATP6V0A2, encoding subunit a2 of the V-ATPase complex that
localizes to endosomes and the Golgi apparatus, have been identified
in ARCL2 (ref. 19). The GORAB gene also encodes a Golgi-localized
protein18. The phenotypic similarities suggest a common, yet to be
determined, pathogenetic mechanism in these conditions. Notably,
increased apoptosis is also seen in fibroblasts from individuals with
ARCL2 having ATP6V0A2 defects20.
Besides energy production, mitochondria serve many different
functions, among them the generation of potentially harmful
ROS21. ROS are involved in the regulation of apoptosis and as
such have become a central focus of aging research22. ROS were
initially regarded as toxic side products of oxidative phos-
phorylation, and their importance for redox-dependent signaling
processes has emerged only recently22,23. Indeed, proline has
been implicated in the regulation of ROS abundance, and PYCR1
and PYCR2 have been implicated in the regulation of the
NAD(P)H/NAD(P)+ ratio in the cytoplasm and in the mitochon-
drion10,11,24. Mitochondrial fragmentation is a known pheno-
menon that has been described as impairing cellular function in























































Figure 4 Phenotype of Pycr1 Xenopus morphants. (a) Pycr1 is evolutionary
conserved among bacteria, plants, insects and vertebrates. (b) Design
of a translation-blocking morpholino (MO) oligonucleotide for Xenopus
Pycr1. (c) Control embryo at stage 30. (d) Pycr1 morphants injected
in each blastomere at the four-cell stage failed to grow a tail and had
underdeveloped eyes. (e) Dorsal (D) MO injections impaired eye but
not tail development. (f) Ventral (V) MO injections impaired tail but not
eye development. Arrowheads, skin wrinkles. (g) Control embryo at the
swimming tadpole stage. (h) Pycr1 morpholino-injected embryos showing
severe growth retardation and large regions of ectodermal edema over the
entire body, which develop from wrinkles seen earlier (e,f). (i) Histological
section of skin from control embryo at stage 45 showing bilayered epidermis
consisting of outer periderm and inner sensorial layer. (j) Disorganized
architecture of epidermis with enlarged cells, enlarged nuclei and cellular
protrusions in Pycr1 morphant.
Figure 5 Skin hypoplasia in Pycr1 morphants is accompanied by
spontaneous apoptosis and is independent of anemia. (a) Scl expression
at stage 25 marks site of primitive hematopoiesis in ventral ectoderm of
control embryo. (b) Scl expression was abrogated in Pycr1 morphants
suffering anemia (Supplementary Videos 1 and 2). (c) Parabiosis performed
at stage 22 between a Pycr1-depleted (MO) tadpole (top) and control
(bottom) did not rescue from apoptosis (inset, stage 33), stunted growth
and skin defects despite shared blood circulation (Supplementary Video 3).
(d) Histological staining. Epidermis of Pycr1 parabiotic morphant embryo
remained disorganized relative to control. (e) Histological section through
epidermis of parabiotic control tadpole at stage 45 showing normal skin
architecture. (f) Acridine-orange background staining of control embryo
(inset, bright-field image). (g) Acridine-orange labeling of dying cells (intense
green) in Pycr1 morphant embryos injected only in the ventral (V) half
(inset, bright-field image). Only the ventro-posterior half of the embryo,
derived from the injected ventral blastomeres, is undergoing apoptosis.
(h) TUNEL staining in stage 33 tadpole showing few apoptotic cells (inset,
control at stage 25). (i) Pycr1 morphants, with a markedly increased number
of dying cells at stage 33 relative to control (inset, stage 25).
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fusion have also been shown to trigger cellular senescence26.
Although the exact role of PYCR1 in mitochondrial function and
integrity remains to be determined, its orthologs in other species,
such as Saccharomyces, Arabidopsis and Drosophila, have been
linked to stress resistance, which suggests that human PYCR1 as
well may provide adaptive protection against stress by maintaining a
reservoir of rapidly mobilizable proline and reducing equivalents
in mitochondria10,12.
In summary, mutations in PYCR1 leading to a loss of PYCR1
function are a major cause of autosomal recessive cutis laxa,
evoking a phenotype that overlaps with gerodermia osteodysplastica,
ARCL2 and DBS. The pathophysiological basis appears to be an
impaired mitochondrial function leading to developmental defects
through increased apoptosis. Our finding highlights the importance
of mitochondrial function in the process of aging and might
help to develop new treatment strategies for common age-
related disorders22.
METHODS
Methods and any associated references are available in the online
version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. GenBank RefSeq DNA: Homo sapiens PYCR1
isoform A, NM_006907.2; H. sapiens PYCR1 isoform B,
NM_153824.1; Xenopus laevis Pycr1, NM_001091619; Danio rerio
pycr1, BC095354; D. rerio pycr2, BC060905.
Note: Supplementary information is available on the Nature Genetics website.
ACKNOWLEDGMENTS
J. Common and B. Lane for advice and help with primary cultures. J. Gautier for
TUNEL protocol. K. Rogers and S. Rogers for their help and advice on histology.
This study was supported by the German Federal Ministry of Education and
Research (BMBF) by grant 01GM0623 (SKELNET) to U.K. and S.M. and
grants 01GM0880 and 01GM0801 to B.W., a grant from the Deutsche
Forschungsgemeinschaft (Collaborative Research Centre 577) to U.K. and P.N.,
and by A*STAR and the Branco Weiss Foundation to B.R.
AUTHOR CONTRIBUTIONS
B.R., N.E.-B., S.M. and U.K. designed the study. H.K., L.A.-G., M. Shahwan,
B.R., F.B., S.F.N., A.M., F.A., D.G., P.F., A.N., A.R., D.M., M.G., J.N., A.G.,
A.S., R.S., A.R.J., E.S., D.S., B.D., S.R., H.H., B.W. and L.v.M. made clinical
diagnoses and collected clinical data and samples. B.R., B.M., A.D., G.N.,
B.F., Y.L., B.B., P.N. and B.W. conducted genotyping and linkage analysis.
H.L., B.O., B.M. and S.N. performed genomic loci capture. B.R., N.E.-B.,
A.D., B.F., D.K., S.C., M.S., P.-Y.T. performed immunoblotting, immunostaining,
TUNEL, and proline level and FACS analysis. B.R., N.E.-B. and S.C.
performed Xenopus work, ISH and Pycr1 constructs. U.K., B.F., M.S.-v.K.
and P.S. performed zebrafish work. B.F., U.K. and M. Schuelke performed
respiratory chain measurements. I.H. and G.Z. were responsible for
ultrastructural and histological analysis of skin biopsies. B.R., N.E.-B., S.M.
and U.K. wrote the manuscript.
Published online at http://www.nature.com/naturegenetics/.
Reprints and permissions information is available online at http://npg.nature.com/
reprintsandpermissions/.
1. Rajab, A. et al. Geroderma osteodysplasticum hereditaria and wrinkly skin syndrome in
22 patients from Oman. Am. J. Med. Genet. A 146A, 965–976 (2008).
2. Morava, E. et al. Defining the phenotype in an autosomal recessive cutis laxa syndrome
with a combined congenital defect of glycosylation. Eur. J. Hum. Genet. 16, 28–35
(2008).
3. Guerra, D. et al. The De Barsy syndrome. J. Cutan. Pathol. 31, 616–624 (2004).
4. Zhang, M.C. et al. Cutis laxa arising from frameshift mutations in exon 30 of the elastin
gene (ELN). J. Biol. Chem. 274, 981–986 (1999).
5. Al-Gazali, L.I., Sztriha, L., Skaff, F. & Haas, D. Gerodermia osteodysplastica and
wrinkly skin syndrome: are they the same? Am. J. Med. Genet. 101, 213–220 (2001).
6. Nanda, A. et al. Gerodermia osteodysplastica/wrinkly skin syndrome: report of three
patients and brief review of the literature. Pediatr. Dermatol. 25, 66–71 (2008).
7. Hamamy, H., Masri, A. & Ajlouni, K. Wrinkly skin syndrome. Clin. Exp. Dermatol. 30,
590–592 (2005).
8. Sommer, A. Photo essay–geroderma osteodysplastica. Am. J. Med. Genet. C. Semin.
Med. Genet. 145C, 291–292 (2007).
9. Kunze, J. et al. De Barsy syndrome–an autosomal recessive, progeroid syndrome. Eur.
J. Pediatr. 144, 348–354 (1985).
10. Phang, J.M., Pandhare, J. & Liu, Y. The metabolism of proline as microenvironmental
stress substrate. J. Nutr. 138, 2008S–2015S (2008).
11. Hagedorn, C.H. & Phang, J.M. Transfer of reducing equivalents into mitochondria by
the interconversions of proline and delta 1-pyrroline-5-carboxylate. Arch. Biochem.
Biophys. 225, 95–101 (1983).
12. Meng, Z. et al. Crystal structure of human pyrroline-5-carboxylate reductase. J. Mol.
Biol. 359, 1364–1377 (2006).
13. Mitsubuchi, H., Nakamura, K., Matsumoto, S. & Endo, F. Inborn errors of proline
metabolism. J. Nutr. 138, 2016S–2020S (2008).
14. Baumgartner, M.R. et al. Delta1-pyrroline-5-carboxylate synthase deficiency: neuro-
degeneration, cataracts and connective tissue manifestations combined with hyper-
ammonaemia and reduced ornithine, citrulline, arginine and proline. Eur. J. Pediatr.
164, 31–36 (2005).
15. Bicknell, L.S. et al. A missense mutation in ALDH18A1, encoding Delta1-pyrroline-5-
carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syn-
drome. Eur. J. Hum. Genet. 16, 1176–1186 (2008).
16. Baumgartner, M.R. et al. Hyperammonemia with reduced ornithine, citrulline, arginine
and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-
pyrroline-5-carboxylate synthase. Hum. Mol. Genet. 9, 2853–2858 (2000).
17. Van Maldergem, L. et al. Cobblestone-like brain dysgenesis and altered glycosylation in
congenital cutis laxa, Debre type. Neurology 71, 1602–1608 (2008).
18. Hennies, H.C. et al. Gerodermia osteodysplastica is caused by mutations in
SCYL1BP1, a Rab-6 interacting golgin. Nat. Genet. 40, 1410–1412 (2008).
19. Kornak, U. et al. Impaired glycosylation and cutis laxa caused by mutations in the
vesicular H+-ATPase subunit ATP6V0A2. Nat. Genet. 40, 32–34 (2008).
20. Hucthagowder, V. et al. Loss-of-function mutations in ATP6V0A2 impair vesicular
trafficking, tropoelastin secretion, and cell survival. Hum. Mol. Genet. 18, 2149–2165
(2009).
21. Wallace, D.C. A mitochondrial paradigm of metabolic and degenerative diseases,
aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39,
359–407 (2005).
22. Balaban, R.S., Nemoto, S. & Finkel, T. Mitochondria, oxidants, and aging. Cell 120,
483–495 (2005).
23. D’Autreaux, B. & Toledano, M.B. ROS as signalling molecules: mechanisms that
generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813–824 (2007).
24. Krishnan, N., Dickman, M.B. & Becker, D.F. Proline modulates the intracellular redox
environment and protects mammalian cells against oxidative stress. Free Radic. Biol.
Med. 44, 671–681 (2008).
25. Knott, A.B., Perkins, G., Schwarzenbacher, R. & Bossy-Wetzel, E. Mitochondrial
fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505–518 (2008).
26. Lee, S. et al. Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate
cellular senescence. J. Biol. Chem. 282, 22977–22983 (2007).
6 ADVANCE ONLINE PUBLICATION NATURE GENETICS
LET TERS
ONLINE METHODS
Subjects. Several of the subjects presented here have already been described in
the literature. All other individuals were recruited based on a clinical diagnosis
of either gerodermia osteodysplastica, autosomal recessive cutis laxa (also called
wrinkly skin syndrome) or de Barsy syndrome. Inclusion criteria were a
progeroid appearance; lax, wrinkly skin at early age; hernias; hip dislocation;
and osteopenia. In some individuals, mental retardation, brain malformations
(abnormality of the corpus callosum), athetoid movements and/or cataracts
were present; these individuals were considered to have de Barsy syndrome.
DNA samples were obtained from 22 families after participants gave their
informed consent and after approval by the local ethics commission (Ethik-
kommission der Charite´).
Genotyping and linkage analysis. We performed genome-wide linkage analysis
in eight families using the GeneChip Human Mapping 250K Arrays (Affyme-
trix). Genotypes were called by the GeneChip DNA Analysis Software (v2.0,
Affymetrix). We verified sex by counting heterozygous SNPs on the
X chromosome. Relationship errors were evaluated with the help of the
program Graphical Relationship Representation. The program PedCheck27
was applied to detect mendelian errors and data for SNPs with such errors
were removed from the data set. Nonmendelian errors were identified by using
the program MERLIN28 and genotypes unlikely for related samples were
deleted. Nonparametric linkage analysis using all genotypes of a chromosome
simultaneously was carried out with MERLIN. Parametric linkage analysis was
performed by a modified version of the program GENEHUNTER 2.1 through
stepwise use of a sliding window with sets of 110 or 200 SNPs29. Haplotypes
were reconstructed with GENEHUNTER 2.1 and presented graphically with
HaploPainter30.
Mutation analysis. Positional candidate genes were obtained from the Gen-
Bank and Ensembl databases. Genes were analyzed by direct sequencing of
DNA with primers flanking each exon. Primer sequences were based on the
reference sequences of each gene. The primer sequences for PYCR1 mutation
screening are given in Supplementary Table 2. Sequence analysis was done
with the BigDye Terminator cycle sequencing kit (Applied Biosystems), and
products were run on a 3730 DNA Analyzer (Applied Biosystems).
Genomic locus capture. Briefly, custom arrays (Agilent 244K) were designed to
target every exonic sequence of the genes present in the locus 17q25 between
72048357 and 78774742, excluding the highly repeated regions. DNA libraries
were prepared following the Illumina library generation protocol version 2.3
and were hybridized to the custom arrays according to the Agilent CGH 244K
array protocol, then washed, eluted and amplified. Each sample was submitted
to one channel of an Illumina flow cell and sequenced by Illumina Genome
Analyzer using standard manufacturer’s protocol. We sequenced a total of five
samples from four different families. The image data was processed by the
provided Genome Analyzer Pipeline version 1.0 and all sequences were aligned
to the human reference genome (University of California Santa Cruz, build 18)
by Blat-like Fast Accurate Search Tool (BFAST (see URLs); N. Homer,
B. Merriman and S.F. Nelson, unpublished data). Mismatches were filtered for
those seen two or more times, where the mutation was seen 100% of the time
(homozygous), and did not overlap with a known dbSNP129 entry mismatch.
The open-source SeqWare project, which provides a laboratory information
management system tool for tracking samples (SeqWare laboratory information
management system) and a pipeline for sequence analysis (SeqWare Pipeline)
was used throughout this work.
Cell culture. Human skin fibroblasts were cultivated in DMEM (Lonza)
supplemented with 10% FCS (Lonza), 1% Ultraglutamine (Lonza) and 1%
penicillin/streptomycin (Lonza) at 5% CO2 and 37 1C.
Quantitative PCR. RNA was isolated from organs of postnatal day 4 mice using
the Trizol (Invitrogen) method. One microgram of RNA was reverse-tran-
scribed using the Revert Aid kit (Fermentas) and random hexamers. Quanti-
tative PCR was performed with SYBR green (Applied Biosystems). Primers are
given in Supplementary Table 2.
Immunoblot analysis. Mitochondrial and cytosolic fractions of whole cell
lysates of primary skin fibroblasts were obtained with a mitochondrial isolation
kit for mammalian cells (Thermo Scientific) and resolved by electrophoresis in
SDS polyacrylamide gels. For immunoblot analysis, PVDF membranes were
probed with anti-actin A5060 (Sigma) 1:1,000 and rabbit anti-PYCR1 (Pro-
teintech) 1:500.
Immunofluorescence analysis. For immunofluorescence, cells were washed in
phosphate-buffered saline (PBS) three times. Cells were fixed in 4% (wt/vol)
paraformaldehyde in PBS for 10 min and permeabilized with 0.4% (vol/vol)
Triton-X100 in 3% BSA in PBS for 10 min at 4 1C. Specific antibodies to
PYCR1 (rabbit anti-PYCR1, Proteintech 1:500) and P5CS (mouse anti-P5CS,
Abnova, 1:300) were incubated overnight in 3% BSA at 4 1C. For visualization
an antibody to mouse immunoglobulin G (anti–mouse IgG) Alexa Fluor 555
conjugate (Invitrogen, Molecular Probes) and an anti-rabbit IgG Alexa Fluor
488 (Invitrogen, Molecular Probes) conjugate was applied. DNA was stained by
DAPI and cells were mounted in Fluoromount (Scientific Services). Images
were collected by using an LSM 510 Meta (Carl Zeiss) with a 63 Plan
Apochromat oil immersion objective.
Ultrastructural analysis. All specimens were fixed for at least 2 h at 19–22 1C
in 3% glutaraldehyde solution in 0.1 M cacodylate buffer, pH 7.4, cut into
pieces ofB1 mm3, washed in buffer, postfixed for 1 h at 4 1C in 1% osmium
tetroxide, rinsed in water, dehydrated through graded ethanol solutions,
transferred into propylene oxide, and embedded in epoxy resin (glycidether
100). Semithin and ultrathin sections were cut with an ultramicrotome
(Reichert Ultracut E). Ultrathin sections were treated with uranyl acetate and
lead citrate, and examined with an electron microscope (Philips EM 400).
Mitochondrial morphology. Morphology of the mitochondrial network was
investigated as previously described31. Fifty-percent-confluent fibroblasts were
loaded with 100 nM Mito Tracker Red CM-H2XRos (Invitrogen). Cells were
incubated with 500 mM H2O2 for 5 min and then fixed in 4% (wt/vol)
paraformaldehyde in PBS for 10 min at 4 1C. DNA was stained by DAPI and
cells were mounted in Fluoromount (Scientific Services). Pictures of every
sample were collected randomly using a BX60 Olympus microscope.
Apoptosis assay. For apoptosis measurement after hydrogen peroxide (neoLab)
treatment, cells were incubated with 200 mM H2O2 for one hour without FCS
as described32. Subsequently medium with 0.4% FCS was added and cells were
incubated at normal conditions for additional 24 h. Cells were fixed in 4% (wt/
vol) paraformaldehyde in PBS for 10 min and permeabilized with 0.1% (vol/
vol) Triton-X100 in 3% BSA in PBS for 2 min on ice. For apoptosis
determination the TUNEL assay (Roche) was performed according to manu-
facturer specifications. Cells were fixed in 4% (wt/vol) paraformaldehyde in
PBS for 10 min at 4 1C. DNA was stained by DAPI and cells were mounted in
Fluoromount (Scientific Services). Pictures were collected randomly. Each
experiment was performed three times. More than 2,000 cells were analyzed
per assay.
Mitochondrial transmembrane potential measurements. To evaluate mito-
chondrial transmembrane potential, primary fibroblasts were treated with
200 mM H2O2 for 2 h without FCS. After two washes in PBS, 5  105 cells
per milliliter were incubated with 40 nM of the fluorescent dye 3,3¢-dihexylox-
acarbocyanine iodide (DiOC6(3); Molecular Probes) for 15 min at 37 1C in
PBS, followed by analysis on a FACSCalibur cytofluorometer (BD Biosciences).
Polarography. Cultured skin fibroblasts of affected (n ¼ 3) and unaffected
(n ¼ 3) subjects were trypsinized and washed in PBS twice. Permeabilization
was done immediately in 50 mg/ml digitonin for 30 s before measurement and
verified by the Trypan blue exclusion test (499% permeabilization was
required). Fibroblasts (7  106) were resuspended in reaction buffer and
injected into the reaction chamber with a Clark-type electrode (Hansatech),
and oxygen concentrations were measured in 0.7-ml reaction volume at 37 1C
with substrates and inhibitors according to standard protocols33. The oxygen
consumption is given as fmol O2 per minute per cell. All measurements were
reproduced two to four times. Epstein-Barr virus–immortalized lymphoblas-
toid cell lines from affected subjects (n ¼ 4), heterozygous parents (n ¼ 2) and
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unaffected controls (n ¼ 2) were grown in RPMI (Lonza) suspension
culture, pelleted by centrifugation and washed twice with PBS. Digitonin
permeabilization was done for 60 s, and 2  107 cells in 0.7 ml were used
for one experiment as described above.
Reactive oxygen species measurement. Skin fibroblasts were trypsinized,
washed in medium and resuspended in PBS containing 0.2% BSA. The cell
suspension was incubated for 15 min with 20 mM 2,7-dichlorodihydrofluor-
escein diacetate (Molecular Probes) at 19–22 1C with and without 1 mM H2O2.
Fluorescence intensity was determined by FACS using a Canto II (Becton
Dickinson) cell sorter and the analysis software Flowjo (Tree Star). Cell viability
was controlled by DAPI (Molecular Probes) incubation.
Proliferation assay. For the assessment of the proliferation rate, 2.5  104 cells
were seeded on glass coverslips. The cells were incubated for 8 h in medium
containing 10 mM bromodeoxyuridine (BrdU) (Roche). Cells were fixed in 4%
(wt/vol) paraformaldehyde in PBS for 10 min after 24, 48 and 72 h and then
incubated in 3 M HCl for 10 min at 19–22 1C. After permeabilization with
0.1% (vol/vol) Triton-X100 in 3% BSA in PBS for 30 min at 4 1C, cells were
incubated with an antibody to BrdU (G3G4, Developmental Studies Hybrido-
ma Bank) 1:500 for 1 h at 19-22 1C. For visualization, an anti–mouse IgG Alexa
Fluor 488 conjugate (Invitrogen, Molecular Probes) was applied. DNA was
stained by DAPI and cells were mounted in Fluoromount (Scientific Services).
The experiment was also performed in medium with 10% dialyzed FCS and in
medium supplemented with 5 mM L-proline (Sigma-Aldrich).
Morpholino oligonucleotides and RNA injections. Morpholino 25-bp anti-
sense oligomers for X. laevis Pycr1, D. rerio pycr1 and D. rerio pycr2 were
obtained from Gene Tools and are described in Supplementary Table 2. The
morpholinos were resuspended in sterile water to a concentration of 1 mM
according to manufacturer’s instructions. Xenopus embryos were injected four
times radially at the two- to four-cell stage with 4 nl (33 ng morpholino per
injection). For zebrafish experiments, morpholinos were injected at the one-cell
stage with 4 nl (33 ng morpholino per injection), or with 2 nl of each
morpholino when co-injected. Synthetic capped mRNAs of human PYCR1
cDNA transcribed in vitro with an SP6 kit (Ambion) was used for rescue
experiments at 200 pg in each blastomere at the four-cell stage for Xenopus
embryos or at 20 pg to 200 pg for zebrafish embryos at the one-cell stage.
Embryological methods. Protocols for fertilization, injections, whole-mount in
situ hybridization and TUNEL34 can be found at our protocols website (see
URLs). Analysis of cell death on live embryos was performed by incubating
tadpoles in the dark for 30 min with acridine orange (2 mg/ml) in Barth
solution35 0.1. After extensive washes in Barth 0.1, images of embryos were
captured under fluorescence (excitation/emission, 500/530 nm) with a Leica
DFC 300 FX camera. Parabiosis was performed at stage 22, on dechorionated
embryos joined by ventral ectoderm after small incisions. Parabiotic embryos
were cultured in Barth 1 until healed and transferred into Steinberg solu-
tion35. A stereomicroscope M205 FA equipped with an ICD camera (Leica) was
used to capture images of embryos in successive focal planes. Images were then
merged into one picture with Photoshop CS3 (Adobe).
Statistical analysis. All error bars represent s.d. The significance of pairwise
comparisons was determined by Student’s t-test. Correction for multiple testing
were done according by the Bonferroni method.
URLs. GenBank, http://www.ncbi.nlm.nih.gov/mapview/. Ensembl, http://
www.ensembl.org/. University of California Santa Cruz human reference
genome (build 18, http://genome.ucsc.edu/). Blat-like Fast Accurate Search
Tool (BFAST, http://genome.ucla.edu/bfast/. SeqWare, http://seqware.source-
forge.net/. Unabridged protocols, http://www.reversade.com-a.googlepages.-
com/protocols.
27. O’Connel, J.R. & Weeks, D.E. PedCheck: a program for identification of genotype
incompatibilities in linkage analysis. Am. J. Hum. Genet. 63, 259–266 (1998).
28. Abecasis, G.R., Cherny, S.S., Cookson, W.O. & Cardon, L.R. Merlin—rapid analysis
of dense genetic maps using sparse gene flow trees. Nat. Genet. 30, 97–101
(2002).
29. Thiele, H. & Nurnberg, P. HaploPainter: a tool for drawing pedigrees with complex
haplotypes. Bioinformatics 21, 1730–1732 (2005).
30. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. & Lander, E.S. Parametric and nonpara-
metric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58,
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